,UniProt ID,InChI Key,Parameter,Value,Unit,Database Source,Database Target ID,Database Ligand ID,Reference,Ligand Name,CID,Molecular Formula,Molecular Weight,IUPAC Name,Canonical SMILES,Isomeric SMILES,InChI Std. ID,XlogP,Hydrogen Bond Donors,Hydrogen Bond Acceptors,GPCR Name,Gene Name,Species,FASTA Sequence
154997,P41146,DBXXUNROIBQTKD-XFQSCKMHSA-N,Kd,4073.8,nM,ChEMBL,CHEMBL2014,CHEMBL3808415,27035422,CHEMBL3808415,127044528.0,C72H107N21O13,1474.782,"(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[3-[(4S)-4-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-oxo-4,5-dihydro-1H-2-benzazepin-2-yl]propanoylamino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]hexanamide",CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCN=C(N)N)NC(=O)CCN3CC4=CC=CC=C4CC(C3=O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=C(C=C(C=C5C)O)C)N,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CCN3CC4=CC=CC=C4C[C@@H](C3=O)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@H](CC5=C(C=C(C=C5C)O)C)N,"InChI=1S/C72H107N21O13/c1-5-40(2)60(68(105)86-52(61(75)98)15-8-9-28-73)92-65(102)55(18-12-31-84-72(80)81)88-66(103)56(35-43-19-23-47(94)24-20-43)90-67(104)57(36-44-21-25-48(95)26-22-44)89-63(100)53(16-10-29-82-70(76)77)85-59(97)27-32-93-39-46-14-7-6-13-45(46)37-58(69(93)106)91-64(101)54(17-11-30-83-71(78)79)87-62(99)51(74)38-50-41(3)33-49(96)34-42(50)4/h6-7,13-14,19-26,33-34,40,51-58,60,94-96H,5,8-12,15-18,27-32,35-39,73-74H2,1-4H3,(H2,75,98)(H,85,97)(H,86,105)(H,87,99)(H,88,103)(H,89,100)(H,90,104)(H,91,101)(H,92,102)(H4,76,77,82)(H4,78,79,83)(H4,80,81,84)/t40-,51-,52-,53-,54+,55-,56-,57-,58-,60-/m0/s1",-0.9,20.0,18.0,Nociceptin receptor,OPRL1,Homo sapiens (Human),MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA
155571,P41146,PULGYDLMFSFVBL-SMFNREODSA-N,Kd,0.19,nM,ChEMBL,CHEMBL2014,CHEMBL396460,25284251,BDBM21842,44361543.0,C79H129N27O22,1809.068,"(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoic acid",CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N,C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)O,"InChI=1S/C79H129N27O22/c1-41(2)33-54(72(122)95-44(5)66(116)103-56(36-59(84)110)73(123)102-53(77(127)128)27-28-58(83)109)104-70(120)49(23-13-15-29-80)100-69(119)52(26-18-32-90-79(87)88)99-65(115)43(4)96-75(125)57(40-107)105-71(121)50(24-14-16-30-81)101-68(118)51(25-17-31-89-78(85)86)98-64(114)42(3)94-61(112)39-93-76(126)63(45(6)108)106-74(124)55(35-47-21-11-8-12-22-47)97-62(113)38-91-60(111)37-92-67(117)48(82)34-46-19-9-7-10-20-46/h7-12,19-22,41-45,48-57,63,107-108H,13-18,23-40,80-82H2,1-6H3,(H2,83,109)(H2,84,110)(H,91,111)(H,92,117)(H,93,126)(H,94,112)(H,95,122)(H,96,125)(H,97,113)(H,98,114)(H,99,115)(H,100,119)(H,101,118)(H,102,123)(H,103,116)(H,104,120)(H,105,121)(H,106,124)(H,127,128)(H4,85,86,89)(H4,87,88,90)/t42-,43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-/m0/s1",-11.0,28.0,27.0,Nociceptin receptor,OPRL1,Homo sapiens (Human),MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA
155593,P41146,PULGYDLMFSFVBL-SMFNREODSA-N,Kd,0.092,nM,ChEMBL,CHEMBL2014,CHEMBL396460,19879767,BDBM21842,44361543.0,C79H129N27O22,1809.068,"(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoic acid",CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N,C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)O,"InChI=1S/C79H129N27O22/c1-41(2)33-54(72(122)95-44(5)66(116)103-56(36-59(84)110)73(123)102-53(77(127)128)27-28-58(83)109)104-70(120)49(23-13-15-29-80)100-69(119)52(26-18-32-90-79(87)88)99-65(115)43(4)96-75(125)57(40-107)105-71(121)50(24-14-16-30-81)101-68(118)51(25-17-31-89-78(85)86)98-64(114)42(3)94-61(112)39-93-76(126)63(45(6)108)106-74(124)55(35-47-21-11-8-12-22-47)97-62(113)38-91-60(111)37-92-67(117)48(82)34-46-19-9-7-10-20-46/h7-12,19-22,41-45,48-57,63,107-108H,13-18,23-40,80-82H2,1-6H3,(H2,83,109)(H2,84,110)(H,91,111)(H,92,117)(H,93,126)(H,94,112)(H,95,122)(H,96,125)(H,97,113)(H,98,114)(H,99,115)(H,100,119)(H,101,118)(H,102,123)(H,103,116)(H,104,120)(H,105,121)(H,106,124)(H,127,128)(H4,85,86,89)(H4,87,88,90)/t42-,43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-/m0/s1",-11.0,28.0,27.0,Nociceptin receptor,OPRL1,Homo sapiens (Human),MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA
157226,P41146,FWMLORBQOYCLSM-DIRDFJCVSA-N,Kd,1.21,nM,ChEMBL,CHEMBL2014,CHEMBL3343946,25284251,CHEMBL3343946,102454240.0,C47H76N14O9,985.23,"(2S)-6-amino-2-[[(2S,3S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-2,3-ditritiobutanoyl)amino]pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]pentanoyl]amino]-3-methylpentanoyl]amino]hexanamide",CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCN=C(N)N)NC(=O)CC(C)C,[3H]C(C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N)C([3H])(C)C,"InChI=1S/C47H76N14O9/c1-5-28(4)39(45(70)57-33(40(49)65)10-6-7-21-48)61-42(67)35(12-9-23-55-47(52)53)58-43(68)36(25-29-13-17-31(62)18-14-29)60-44(69)37(26-30-15-19-32(63)20-16-30)59-41(66)34(11-8-22-54-46(50)51)56-38(64)24-27(2)3/h13-20,27-28,33-37,39,62-63H,5-12,21-26,48H2,1-4H3,(H2,49,65)(H,56,64)(H,57,70)(H,58,68)(H,59,66)(H,60,69)(H,61,67)(H4,50,51,54)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,39-/m0/s1/i24T,27T/t24?,28-,33-,34-,35-,36-,37-,39-",0.0,14.0,12.0,Nociceptin receptor,OPRL1,Homo sapiens (Human),MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA
158017,P41146,SWIPQMATHCKNQK-NUPJQHTASA-N,Kd,1000,nM,ChEMBL,CHEMBL2014,CHEMBL3808398,27035422,CHEMBL3808398,127043001.0,C77H105FN24O12,1577.841,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[3-[(4S)-4-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-oxo-4,5-dihydro-1H-2-benzazepin-2-yl]propanoylamino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-fluorophenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanamide",CC1=CC(=CC(=C1CC(C(=O)NC(CCCNC(=N)N)C(=O)NC2CC3=CC=CC=C3CN(C2=O)CCC(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC5=CC=C(C=C5)F)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CCCNC(=N)N)C(=O)N)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H]2CC3=CC=CC=C3CN(C2=O)CCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)N[C@@H](CC5=CC=C(C=C5)F)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC6=CNC7=CC=CC=C76)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)N)C)O,"InChI=1S/C77H105FN24O12/c1-42-33-51(104)34-43(2)53(42)39-54(79)66(107)96-58(17-9-30-91-76(85)86)69(110)101-63-37-46-11-3-4-12-47(46)41-102(73(63)114)32-27-64(105)94-57(16-8-29-90-75(83)84)67(108)98-61(36-45-21-25-50(103)26-22-45)71(112)99-60(35-44-19-23-49(78)24-20-44)70(111)97-59(18-10-31-92-77(87)88)68(109)100-62(38-48-40-93-55-14-6-5-13-52(48)55)72(113)95-56(65(80)106)15-7-28-89-74(81)82/h3-6,11-14,19-26,33-34,40,54,56-63,93,103-104H,7-10,15-18,27-32,35-39,41,79H2,1-2H3,(H2,80,106)(H,94,105)(H,95,113)(H,96,107)(H,97,111)(H,98,108)(H,99,112)(H,100,109)(H,101,110)(H4,81,82,89)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t54-,56-,57-,58+,59-,60-,61-,62-,63-/m0/s1",0.5,25.0,18.0,Nociceptin receptor,OPRL1,Homo sapiens (Human),MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA
164035,P31424,DWPQODZAOSWNHB-UHFFFAOYSA-N,Kd,50.1187233627272,nM,IUPHAR,293,1433,16040814,Fenobam,135413554.0,C11H11ClN4O2,266.685,(3E)-1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea,CN1CC(=O)NC1=NC(=O)NC2=CC(=CC=C2)Cl,CN\1CC(=O)N/C1=N\C(=O)NC2=CC(=CC=C2)Cl,"InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18)",1.2,2.0,2.0,Metabotropic glutamate receptor 5,Grm5,Rattus norvegicus (Rat),MVLLLILSVLLLKEDVRGSAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLRSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNLRNPWFQEFWQHRFQCRLEGFAQENSKYNKTCNSSLTLRTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLDSLMKTNFTGVSGDMILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKNNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVIFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNLWKRRGSSGETLRYKDRRLAQHKSEIECFTPKGSMGNGGRATMSSSNGKSVTWAQNEKSTRGQHLWQRLSVHINKKENPNQTAVIKPFPKSTENRGPGAAAGGGSGPGVAGAGNAGCTATGGPEPPDAGPKALYDVAEAEESFPAAARPRSPSPISTLSHLAGSAGRTDDDAPSLHSETAARSSSSQGSLMEQISSVVTRFTANISELNSMMLSTAATPGPPGTPICSSYLIPKEIQLPTTMTTFAEIQPLPAIEVTGGAQGATGVSPAQETPTGAESAPGKPDLEELVALTPPSPFRDSVDSGSTTPNSPVSESALCIPSSPKYDTLIIRDYTQSSSSL
166465,P31424,AWDRAHDWMICWJM-UHFFFAOYSA-N,Kd,20,nM,IUPHAR,293,5394,12565928,methoxymethyl-MTEP,10354477.0,C13H12N2OS,244.312,"4-[2-[5-(methoxymethyl)pyridin-3-yl]ethynyl]-2-methyl-1,3-thiazole",CC1=NC(=CS1)C#CC2=CC(=CN=C2)COC,CC1=NC(=CS1)C#CC2=CC(=CN=C2)COC,"InChI=1S/C13H12N2OS/c1-10-15-13(9-17-10)4-3-11-5-12(8-16-2)7-14-6-11/h5-7,9H,8H2,1-2H3",2.0,0.0,4.0,Metabotropic glutamate receptor 5,Grm5,Rattus norvegicus (Rat),MVLLLILSVLLLKEDVRGSAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLRSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNLRNPWFQEFWQHRFQCRLEGFAQENSKYNKTCNSSLTLRTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLDSLMKTNFTGVSGDMILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKNNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVIFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNLWKRRGSSGETLRYKDRRLAQHKSEIECFTPKGSMGNGGRATMSSSNGKSVTWAQNEKSTRGQHLWQRLSVHINKKENPNQTAVIKPFPKSTENRGPGAAAGGGSGPGVAGAGNAGCTATGGPEPPDAGPKALYDVAEAEESFPAAARPRSPSPISTLSHLAGSAGRTDDDAPSLHSETAARSSSSQGSLMEQISSVVTRFTANISELNSMMLSTAATPGPPGTPICSSYLIPKEIQLPTTMTTFAEIQPLPAIEVTGGAQGATGVSPAQETPTGAESAPGKPDLEELVALTPPSPFRDSVDSGSTTPNSPVSESALCIPSSPKYDTLIIRDYTQSSSSL
179691,P14416,IBCSETAMVUUPMW-PVURQLNPSA-N,Kd,500,nM,ChEMBL,CHEMBL217,CHEMBL3423408,25969169,CHEMBL3423408,118736410.0,C42H57FN8O5,772.967,"(3S,12bR)-N-[6-[[(2S)-1-[[(2S)-1-[(2S,4S)-4-amino-2-carbamoylpyrrolidin-1-yl]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)N2CC(CC2C(=O)N)N)NC(=O)CCCCCNC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)N2C[C@H](C[C@H]2C(=O)N)N)NC(=O)CCCCCNC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C42H57FN8O5/c1-2-3-10-33(41(55)49-34(22-26-13-16-28(43)17-14-26)42(56)51-25-29(44)23-36(51)39(45)53)47-37(52)12-5-4-8-20-46-40(54)27-15-18-35-38-31(19-21-50(35)24-27)30-9-6-7-11-32(30)48-38/h6-7,9,11,13-14,16-17,27,29,33-36,48H,2-5,8,10,12,15,18-25,44H2,1H3,(H2,45,53)(H,46,54)(H,47,52)(H,49,55)/t27-,29-,33-,34-,35+,36-/m0/s1",3.1,6.0,8.0,D(2) dopamine receptor,DRD2,Homo sapiens (Human),MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
179693,P14416,IBCSETAMVUUPMW-PVURQLNPSA-N,Kd,13000,nM,ChEMBL,CHEMBL217,CHEMBL3423408,25969169,CHEMBL3423408,118736410.0,C42H57FN8O5,772.967,"(3S,12bR)-N-[6-[[(2S)-1-[[(2S)-1-[(2S,4S)-4-amino-2-carbamoylpyrrolidin-1-yl]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)N2CC(CC2C(=O)N)N)NC(=O)CCCCCNC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)N2C[C@H](C[C@H]2C(=O)N)N)NC(=O)CCCCCNC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C42H57FN8O5/c1-2-3-10-33(41(55)49-34(22-26-13-16-28(43)17-14-26)42(56)51-25-29(44)23-36(51)39(45)53)47-37(52)12-5-4-8-20-46-40(54)27-15-18-35-38-31(19-21-50(35)24-27)30-9-6-7-11-32(30)48-38/h6-7,9,11,13-14,16-17,27,29,33-36,48H,2-5,8,10,12,15,18-25,44H2,1H3,(H2,45,53)(H,46,54)(H,47,52)(H,49,55)/t27-,29-,33-,34-,35+,36-/m0/s1",3.1,6.0,8.0,D(2) dopamine receptor,DRD2,Homo sapiens (Human),MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
188226,P14416,BUSZPEZABSAFAL-YWNCIPKLSA-N,Kd,16000,nM,ChEMBL,CHEMBL217,CHEMBL3423406,25969169,CHEMBL3423406,118736408.0,C39H52N8O4,696.897,"(3S,12bR)-N-[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)N)NC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C39H52N8O4/c1-2-3-12-32(45-37(49)24-16-17-34-35-28(18-20-47(34)23-24)27-11-5-7-14-30(27)43-35)38(50)46-33(21-25-22-42-29-13-6-4-10-26(25)29)39(51)44-31(36(41)48)15-8-9-19-40/h4-7,10-11,13-14,22,24,31-34,42-43H,2-3,8-9,12,15-21,23,40H2,1H3,(H2,41,48)(H,44,51)(H,45,49)(H,46,50)/t24-,31-,32-,33-,34+/m0/s1",3.5,7.0,6.0,D(2) dopamine receptor,DRD2,Homo sapiens (Human),MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
188227,P14416,BUSZPEZABSAFAL-YWNCIPKLSA-N,Kd,900,nM,ChEMBL,CHEMBL217,CHEMBL3423406,25969169,CHEMBL3423406,118736408.0,C39H52N8O4,696.897,"(3S,12bR)-N-[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)N)NC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C39H52N8O4/c1-2-3-12-32(45-37(49)24-16-17-34-35-28(18-20-47(34)23-24)27-11-5-7-14-30(27)43-35)38(50)46-33(21-25-22-42-29-13-6-4-10-26(25)29)39(51)44-31(36(41)48)15-8-9-19-40/h4-7,10-11,13-14,22,24,31-34,42-43H,2-3,8-9,12,15-21,23,40H2,1H3,(H2,41,48)(H,44,51)(H,45,49)(H,46,50)/t24-,31-,32-,33-,34+/m0/s1",3.5,7.0,6.0,D(2) dopamine receptor,DRD2,Homo sapiens (Human),MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC
204267,P08913,RQQJJXVETXFINY-UHFFFAOYSA-N,Kd,3162277.66016838,nM,IUPHAR,25,1192,"1325028,9584219","5-(N,N-Hexamethylene)amiloride",1794.0,C12H18ClN7O,311.774,3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide,C1CCCN(CC1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N,C1CCCN(CC1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N,"InChI=1S/C12H18ClN7O/c13-8-10(20-5-3-1-2-4-6-20)18-9(14)7(17-8)11(21)19-12(15)16/h1-6H2,(H2,14,18)(H4,15,16,19,21)",1.3,3.0,5.0,Alpha-2A adrenergic receptor,ADRA2A,Homo sapiens (Human),MGSLQPDAGNASWNGTEAPGGGARATPYSLQVTLTLVCLAGLLMLLTVFGNVLVIIAVFTSRALKAPQNLFLVSLASADILVATLVIPFSLANEVMGYWYFGKAWCEIYLALDVLFCTSSIVHLCAISLDRYWSITQAIEYNLKRTPRRIKAIIITVWVISAVISFPPLISIEKKGGGGGPQPAEPRCEINDQKWYVISSCIGSFFAPCLIMILVYVRIYQIAKRRTRVPPSRRGPDAVAAPPGGTERRPNGLGPERSAGPGGAEAEPLPTQLNGAPGEPAPAGPRDTDALDLEESSSSDHAERPPGPRRPERGPRGKGKARASQVKPGDSLPRRGPGATGIGTPAAGPGEERVGAAKASRWRGRQNREKRFTFVLAVVIGVFVVCWFPFFFTYTLTAVGCSVPRTLFKFFFWFGYCNSSLNPVIYTIFNHDFRRAFKKILCRGDRKRIV
208841,P21728,IBCSETAMVUUPMW-PVURQLNPSA-N,Kd,4000,nM,ChEMBL,CHEMBL2056,CHEMBL3423408,25969169,CHEMBL3423408,118736410.0,C42H57FN8O5,772.967,"(3S,12bR)-N-[6-[[(2S)-1-[[(2S)-1-[(2S,4S)-4-amino-2-carbamoylpyrrolidin-1-yl]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)N2CC(CC2C(=O)N)N)NC(=O)CCCCCNC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)N2C[C@H](C[C@H]2C(=O)N)N)NC(=O)CCCCCNC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C42H57FN8O5/c1-2-3-10-33(41(55)49-34(22-26-13-16-28(43)17-14-26)42(56)51-25-29(44)23-36(51)39(45)53)47-37(52)12-5-4-8-20-46-40(54)27-15-18-35-38-31(19-21-50(35)24-27)30-9-6-7-11-32(30)48-38/h6-7,9,11,13-14,16-17,27,29,33-36,48H,2-5,8,10,12,15,18-25,44H2,1H3,(H2,45,53)(H,46,54)(H,47,52)(H,49,55)/t27-,29-,33-,34-,35+,36-/m0/s1",3.1,6.0,8.0,D(1A) dopamine receptor,DRD1,Homo sapiens (Human),MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
210574,P21728,BUSZPEZABSAFAL-YWNCIPKLSA-N,Kd,1900,nM,ChEMBL,CHEMBL2056,CHEMBL3423406,25969169,CHEMBL3423406,118736408.0,C39H52N8O4,696.897,"(3S,12bR)-N-[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)N)NC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C39H52N8O4/c1-2-3-12-32(45-37(49)24-16-17-34-35-28(18-20-47(34)23-24)27-11-5-7-14-30(27)43-35)38(50)46-33(21-25-22-42-29-13-6-4-10-26(25)29)39(51)44-31(36(41)48)15-8-9-19-40/h4-7,10-11,13-14,22,24,31-34,42-43H,2-3,8-9,12,15-21,23,40H2,1H3,(H2,41,48)(H,44,51)(H,45,49)(H,46,50)/t24-,31-,32-,33-,34+/m0/s1",3.5,7.0,6.0,D(1A) dopamine receptor,DRD1,Homo sapiens (Human),MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT
213604,P21917,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,5.012,nM,ChEMBL,CHEMBL219,CHEMBL251541,19208473,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,D(4) dopamine receptor,DRD4,Homo sapiens (Human),MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPGLPPDPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPRGPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
213605,P21917,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,5.012,nM,ChEMBL,CHEMBL219,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,D(4) dopamine receptor,DRD4,Homo sapiens (Human),MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPGLPPDPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPRGPCGPDCAPPAPGLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
218781,P35348,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.2884,nM,ChEMBL,CHEMBL229,CHEMBL836,9379432,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1A adrenergic receptor,ADRA1A,Homo sapiens (Human),MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV
218785,P35348,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.2884,nM,ChEMBL,CHEMBL229,CHEMBL836,11384242,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1A adrenergic receptor,ADRA1A,Homo sapiens (Human),MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV
219666,P35348,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Kd,251.19,nM,ChEMBL,CHEMBL229,CHEMBL6437,6142954,mianserin,4184.0,C18H20N2,264.372,"5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene",CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,"InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3",3.4,0.0,2.0,Alpha-1A adrenergic receptor,ADRA1A,Homo sapiens (Human),MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV
220139,P35348,WNMJYKCGWZFFKR-UHFFFAOYSA-N,Kd,218.78,nM,ChEMBL,CHEMBL229,CHEMBL709,11384242,alfuzosin,2092.0,C19H27N5O4,389.456,"N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide",CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)",1.7,2.0,8.0,Alpha-1A adrenergic receptor,ADRA1A,Homo sapiens (Human),MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEVLGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGLMALLCVWALSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYLPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGMASAKTKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLCRKQSSKHALGYTLHPPSQAVEGQHKDMVRIPVGSRETFYRISKTDGVCEWKFFSSMPRGSARITVSKDQSSCTTARVRSKSFLQVCCCVGPSTPSLDKNHQVPTIKVHTISLSENGEEV
241957,P34969,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,1.2,nM,IUPHAR,12,3247,10807680,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Homo sapiens (Human),MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD
241961,P34969,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,9.7,nM,ChEMBL,CHEMBL3155,CHEMBL282199,21620533,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Homo sapiens (Human),MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD
242175,P34969,JINXBCRENWAIPY-UHFFFAOYSA-N,Kd,15.85,nM,ChEMBL,CHEMBL3155,CHEMBL222755,15588097,CHEMBL222755,11785183.0,C27H37N3O,419.613,"6-[4-(2-methylphenyl)piperazin-1-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamide",CC1=CC=CC=C1N2CCN(CC2)CCCCCC(=O)NC3CCCC4=CC=CC=C34,CC1=CC=CC=C1N2CCN(CC2)CCCCCC(=O)NC3CCCC4=CC=CC=C34,"InChI=1S/C27H37N3O/c1-22-10-4-7-15-26(22)30-20-18-29(19-21-30)17-8-2-3-16-27(31)28-25-14-9-12-23-11-5-6-13-24(23)25/h4-7,10-11,13,15,25H,2-3,8-9,12,14,16-21H2,1H3,(H,28,31)",4.8,1.0,3.0,5-hydroxytryptamine receptor 7,HTR7,Homo sapiens (Human),MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLSEVTASPAPTWDAPPDNASGCGEQINYGRVEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVMPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMAKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYQIYKAARKSAAKHKFPGFPRVEPDSVIALNGIVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTSCSCIPLWVERTFLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPEFVLRACTRRVLLRPEKRPPVSVWVLQSPDHHNWLADKMLTTVEKKVMIHD
258808,P41594,DWPQODZAOSWNHB-UHFFFAOYSA-N,Kd,31.6227766016838,nM,IUPHAR,293,1433,16040814,Fenobam,135413554.0,C11H11ClN4O2,266.685,(3E)-1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea,CN1CC(=O)NC1=NC(=O)NC2=CC(=CC=C2)Cl,CN\1CC(=O)N/C1=N\C(=O)NC2=CC(=CC=C2)Cl,"InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18)",1.2,2.0,2.0,Metabotropic glutamate receptor 5,GRM5,Homo sapiens (Human),MVLLLILSVLLLKEDVRGSAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLTSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNHRNPWFQEFWQHRFQCRLEGFPQENSKYNKTCNSSLTLKTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLESLMKTNFTGVSGDTILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKSNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVVFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNLWKRRGSSGETLRYKDRRLAQHKSEIECFTPKGSMGNGGRATMSSSNGKSVTWAQNEKSSRGQHLWQRLSIHINKKENPNQTAVIKPFPKSTESRGLGAGAGAGGSAGGVGATGGAGCAGAGPGGPESPDAGPKALYDVAEAEEHFPAPARPRSPSPISTLSHRAGSASRTDDDVPSLHSEPVARSSSSQGSLMEQISSVVTRFTANISELNSMMLSTAAPSPGVGAPLCSSYLIPKEIQLPTTMTTFAEIQPLPAIEVTGGAQPAAGAQAAGDAARESPAAGPEAAAAKPDLEELVALTPPSPFRDSVDSGSTTPNSPVSESALCIPSSPKYDTLIIRDYTQSSSSL
272331,P21554,LXMWJJLAVBIJKA-IBGZPJMESA-N,Kd,398.11,nM,ChEMBL,CHEMBL218,CHEMBL1080917,20137935,CHEMBL1080917,46880632.0,C22H24ClF2N5O2S,495.974,"(4R)-5-(4-chlorophenyl)-N-(4,4-difluoropiperidin-1-yl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide",CN=C(NS(=O)(=O)N1CCC(CC1)(F)F)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,CN=C(NS(=O)(=O)N1CCC(CC1)(F)F)N2C[C@H](C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,"InChI=1S/C22H24ClF2N5O2S/c1-26-21(28-33(31,32)29-13-11-22(24,25)12-14-29)30-15-19(16-5-3-2-4-6-16)20(27-30)17-7-9-18(23)10-8-17/h2-10,19H,11-15H2,1H3,(H,26,28)/t19-/m0/s1",4.1,1.0,7.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
272803,P21554,JXUCAZVXNNKWLS-UHFFFAOYSA-N,Kd,2.512,nM,ChEMBL,CHEMBL218,CHEMBL158537,14736243,CHEMBL158537,11237129.0,C23H20Cl2N4O2S,487.399,"5-(4-chlorophenyl)-N-(3-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide",CN=C(NS(=O)(=O)C1=CC(=CC=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,CN=C(NS(=O)(=O)C1=CC(=CC=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,"InChI=1S/C23H20Cl2N4O2S/c1-26-23(28-32(30,31)20-9-5-8-19(25)14-20)29-15-21(16-6-3-2-4-7-16)22(27-29)17-10-12-18(24)13-11-17/h2-14,21H,15H2,1H3,(H,26,28)",5.3,1.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
274747,P21554,IROXUEHWMXXEAF-UHFFFAOYSA-N,Kd,0.3162,nM,ChEMBL,CHEMBL218,CHEMBL160767,14736243,"3-(4-Chlorophenyl)-4-phenyl-N'-(4-chlorophenylsulfonyl)-4,5-dihydro-1H-pyrazole-1-carboxamidine",66766133.0,C22H18Cl2N4O2S,473.372,"5-(4-chlorophenyl)-N'-(4-chlorophenyl)sulfonyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide",C1C(C(=NN1C(=NS(=O)(=O)C2=CC=C(C=C2)Cl)N)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,C1C(C(=NN1C(=NS(=O)(=O)C2=CC=C(C=C2)Cl)N)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,"InChI=1S/C22H18Cl2N4O2S/c23-17-8-6-16(7-9-17)21-20(15-4-2-1-3-5-15)14-28(26-21)22(25)27-31(29,30)19-12-10-18(24)11-13-19/h1-13,20H,14H2,(H2,25,27)",5.0,1.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
275802,P21554,MVOOASXFNPWAHT-UHFFFAOYSA-N,Kd,4.266,nM,ChEMBL,CHEMBL218,CHEMBL1269770,20845959,CHEMBL1269770,49781237.0,C49H53Cl6N7O2,984.71,"5-(4-chlorophenyl)-N-[7-[7-[[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carbonyl]amino]heptyl-methylamino]heptyl]-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide",CC1=C(N(N=C1C(=O)NCCCCCCCN(C)CCCCCCCNC(=O)C2=NN(C(=C2C)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C5=C(C=C(C=C5)Cl)Cl)C6=CC=C(C=C6)Cl,CC1=C(N(N=C1C(=O)NCCCCCCCN(C)CCCCCCCNC(=O)C2=NN(C(=C2C)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C5=C(C=C(C=C5)Cl)Cl)C6=CC=C(C=C6)Cl,"InChI=1S/C49H53Cl6N7O2/c1-32-44(58-61(42-24-22-38(52)30-40(42)54)46(32)34-14-18-36(50)19-15-34)48(63)56-26-10-6-4-8-12-28-60(3)29-13-9-5-7-11-27-57-49(64)45-33(2)47(35-16-20-37(51)21-17-35)62(59-45)43-25-23-39(53)31-41(43)55/h14-25,30-31H,4-13,26-29H2,1-3H3,(H,56,63)(H,57,64)",14.6,2.0,5.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
276493,P21554,VJBPKNVTOBHLKX-UHFFFAOYSA-N,Kd,19.05,nM,ChEMBL,CHEMBL218,CHEMBL484504,18512901,CHEMBL484504,24881409.0,C22H20Cl4N4O,498.229,"1,5-bis(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide",CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=C(C=C(C=C4)Cl)Cl,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=C(C=C(C=C4)Cl)Cl,"InChI=1S/C22H20Cl4N4O/c1-13-20(22(31)28-29-9-3-2-4-10-29)27-30(19-8-6-15(24)12-18(19)26)21(13)16-7-5-14(23)11-17(16)25/h5-8,11-12H,2-4,9-10H2,1H3,(H,28,31)",7.1,1.0,3.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
277250,P21554,NUGSWWVQEYLVFY-UHFFFAOYSA-N,Kd,3.162,nM,ChEMBL,CHEMBL218,CHEMBL351123,14736243,CHEMBL351123,11785374.0,C27H23ClN4O2S,503.017,"5-(4-chlorophenyl)-N'-methyl-N-naphthalen-2-ylsulfonyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide",CN=C(NS(=O)(=O)C1=CC2=CC=CC=C2C=C1)N3CC(C(=N3)C4=CC=C(C=C4)Cl)C5=CC=CC=C5,CN=C(NS(=O)(=O)C1=CC2=CC=CC=C2C=C1)N3CC(C(=N3)C4=CC=C(C=C4)Cl)C5=CC=CC=C5,"InChI=1S/C27H23ClN4O2S/c1-29-27(31-35(33,34)24-16-13-19-7-5-6-10-22(19)17-24)32-18-25(20-8-3-2-4-9-20)26(30-32)21-11-14-23(28)15-12-21/h2-17,25H,18H2,1H3,(H,29,31)",5.9,1.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
277289,P21554,LZYLXHWIPFCZKO-UHFFFAOYSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL218,CHEMBL177393,15771428,CHEMBL177393,21949054.0,C24H22Cl3N3O,474.81,"N-(2-bicyclo[2.2.1]heptanyl)-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-5-methylimidazole-4-carboxamide",CC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NC4CC5CCC4C5,CC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NC4CC5CCC4C5,"InChI=1S/C24H22Cl3N3O/c1-13-22(24(31)28-21-11-14-2-3-15(21)10-14)29-23(19-9-6-17(26)12-20(19)27)30(13)18-7-4-16(25)5-8-18/h4-9,12,14-15,21H,2-3,10-11H2,1H3,(H,28,31)",7.0,1.0,2.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
278581,P21554,LHBMIEHDMBMMTP-UHFFFAOYSA-N,Kd,29.51,nM,ChEMBL,CHEMBL218,CHEMBL1269765,20845959,CHEMBL1269765,49780792.0,C44H43Cl6N7O2,914.575,"5-(4-chlorophenyl)-N-[5-[5-[[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carbonyl]amino]pentylamino]pentyl]-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide",CC1=C(N(N=C1C(=O)NCCCCCNCCCCCNC(=O)C2=NN(C(=C2C)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C5=C(C=C(C=C5)Cl)Cl)C6=CC=C(C=C6)Cl,CC1=C(N(N=C1C(=O)NCCCCCNCCCCCNC(=O)C2=NN(C(=C2C)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C5=C(C=C(C=C5)Cl)Cl)C6=CC=C(C=C6)Cl,"InChI=1S/C44H43Cl6N7O2/c1-27-39(54-56(37-19-17-33(47)25-35(37)49)41(27)29-9-13-31(45)14-10-29)43(58)52-23-7-3-5-21-51-22-6-4-8-24-53-44(59)40-28(2)42(30-11-15-32(46)16-12-30)57(55-40)38-20-18-34(48)26-36(38)50/h9-20,25-26,51H,3-8,21-24H2,1-2H3,(H,52,58)(H,53,59)",12.3,3.0,5.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
280136,P21554,ZWEUSOIZQIEIES-UHFFFAOYSA-N,Kd,309.03,nM,ChEMBL,CHEMBL218,CHEMBL1270563,20845959,CHEMBL1270563,49781683.0,C28H36Cl3N5O,564.98,"N-[5-[5-aminopentyl(methyl)amino]pentyl]-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide",CC1=C(N(N=C1C(=O)NCCCCCN(C)CCCCCN)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)Cl,CC1=C(N(N=C1C(=O)NCCCCCN(C)CCCCCN)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)Cl,"InChI=1S/C28H36Cl3N5O/c1-20-26(28(37)33-16-6-4-8-18-35(2)17-7-3-5-15-32)34-36(25-14-13-23(30)19-24(25)31)27(20)21-9-11-22(29)12-10-21/h9-14,19H,3-8,15-18,32H2,1-2H3,(H,33,37)",6.7,2.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
281016,P21554,HQVHOQAKMCMIIM-UHFFFAOYSA-N,Kd,12.5892541179417 - 15.8489319246111,nM,IUPHAR,56,736,"8622639,9422383",131513-18-3,5689.0,C27H26N2O3,426.516,"[2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone",CC1=C(C2=C3N1C(COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65,CC1=C(C2=C3N1C(COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65,"InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3",4.4,0.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
282163,P21554,NHUPNEJSRIUIAU-UHFFFAOYSA-N,Kd,1.259,nM,ChEMBL,CHEMBL218,CHEMBL1088507,20363132,CHEMBL1088507,46889225.0,C23H23Cl3N4OS,509.874,"N-(azepan-1-yl)-1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-5-methylsulfanylimidazole-4-carboxamide",CSC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCCCC4,CSC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCCCC4,"InChI=1S/C23H23Cl3N4OS/c1-32-23-20(22(31)28-29-12-4-2-3-5-13-29)27-21(18-11-8-16(25)14-19(18)26)30(23)17-9-6-15(24)7-10-17/h6-11,14H,2-5,12-13H2,1H3,(H,28,31)",7.1,1.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
282609,P21554,UEZSMNDTKLDUHX-UHFFFAOYSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL218,CHEMBL176022,15771428,CHEMBL176022,11306088.0,C24H24Cl3N3O,476.826,"1-(4-chlorophenyl)-N-cycloheptyl-2-(2,4-dichlorophenyl)-5-methylimidazole-4-carboxamide",CC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NC4CCCCCC4,CC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NC4CCCCCC4,"InChI=1S/C24H24Cl3N3O/c1-15-22(24(31)28-18-6-4-2-3-5-7-18)29-23(20-13-10-17(26)14-21(20)27)30(15)19-11-8-16(25)9-12-19/h8-14,18H,2-7H2,1H3,(H,28,31)",7.6,1.0,2.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
283792,P21554,UYRUXZWWAPSGQU-FNORWQNLSA-N,Kd,3.56,nM,ChEMBL,CHEMBL218,CHEMBL439647,10633038,CHEMBL439647,44374640.0,C23H31NO4,385.504,"6,6,9-trimethyl-3-[(E)-7-nitrohept-2-enyl]-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol",CC1=CCC2C(C1)C3=C(C=C(C=C3O)CC=CCCCC[N+](=O)[O-])OC2(C)C,CC1=CCC2C(C1)C3=C(C=C(C=C3O)C/C=C/CCCC[N+](=O)[O-])OC2(C)C,"InChI=1S/C23H31NO4/c1-16-10-11-19-18(13-16)22-20(25)14-17(15-21(22)28-23(19,2)3)9-7-5-4-6-8-12-24(26)27/h5,7,10,14-15,18-19,25H,4,6,8-9,11-13H2,1-3H3/b7-5+",5.0,1.0,4.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
285230,P21554,ABYRMVVDOJFFOY-UHFFFAOYSA-N,Kd,0.3981,nM,ChEMBL,CHEMBL218,CHEMBL1081213,20137935,CHEMBL1081213,44608360.0,C23H25ClF3N5O2S,527.991,"5-(4-chlorophenyl)-N'-methyl-4-phenyl-N-[4-(trifluoromethyl)piperidin-1-yl]sulfonyl-3,4-dihydropyrazole-2-carboximidamide",CN=C(NS(=O)(=O)N1CCC(CC1)C(F)(F)F)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,CN=C(NS(=O)(=O)N1CCC(CC1)C(F)(F)F)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,"InChI=1S/C23H25ClF3N5O2S/c1-28-22(30-35(33,34)31-13-11-18(12-14-31)23(25,26)27)32-15-20(16-5-3-2-4-6-16)21(29-32)17-7-9-19(24)10-8-17/h2-10,18,20H,11-15H2,1H3,(H,28,30)",4.8,1.0,8.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
288772,P21554,PYCLMAJRHLLHNO-UHFFFAOYSA-N,Kd,36,nM,ChEMBL,CHEMBL218,CHEMBL355598,10633038,CHEMBL355598,44375207.0,C23H30O2,338.491,"3-hept-1-ynyl-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol",CCCCCC#CC1=CC2=C(C3CC(=CCC3C(O2)(C)C)C)C(=C1)O,CCCCCC#CC1=CC2=C(C3CC(=CCC3C(O2)(C)C)C)C(=C1)O,"InChI=1S/C23H30O2/c1-5-6-7-8-9-10-17-14-20(24)22-18-13-16(2)11-12-19(18)23(3,4)25-21(22)15-17/h11,14-15,18-19,24H,5-8,12-13H2,1-4H3",6.1,1.0,2.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
289712,P21554,WTOBUMBRLRSCSK-UHFFFAOYSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL218,CHEMBL1081993,20137935,SCHEMBL1025583,44476564.0,C22H24ClF2N5O2S,495.974,"2-(4-chlorophenyl)-N-(4,4-difluoropiperidin-1-yl)sulfonyl-N'-methyl-3-phenyl-3,4-dihydropyrazole-5-carboximidamide",CN=C(C1=NN(C(C1)C2=CC=CC=C2)C3=CC=C(C=C3)Cl)NS(=O)(=O)N4CCC(CC4)(F)F,CN=C(C1=NN(C(C1)C2=CC=CC=C2)C3=CC=C(C=C3)Cl)NS(=O)(=O)N4CCC(CC4)(F)F,"InChI=1S/C22H24ClF2N5O2S/c1-26-21(28-33(31,32)29-13-11-22(24,25)12-14-29)19-15-20(16-5-3-2-4-6-16)30(27-19)18-9-7-17(23)8-10-18/h2-10,20H,11-15H2,1H3,(H,26,28)",4.2,1.0,8.0,Cannabinoid receptor 1,CNR1,Homo sapiens (Human),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
300899,P34972,HQVHOQAKMCMIIM-UHFFFAOYSA-N,Kd,1.99526231496888 - 3.98107170553497,nM,IUPHAR,57,736,"7689702,7651369",131513-18-3,5689.0,C27H26N2O3,426.516,"[2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone",CC1=C(C2=C3N1C(COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65,CC1=C(C2=C3N1C(COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65,"InChI=1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3",4.4,0.0,4.0,Cannabinoid receptor 2,CNR2,Homo sapiens (Human),MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
310837,P34976,DZFNZWQGZFYCMN-JTXXMHATSA-N,Kd,>3162.28,nM,ChEMBL,CHEMBL3948,CHEMBL402669,9379447,CHEMBL402669,44340064.0,C70H103N13O13,1334.672,(2R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hexadecanoyloxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-naphthalen-1-ylpropanoic acid,CCCCCCCCCCCCCCCC(=O)OCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC5=CC=CC=C54)C(=O)O)NC(=O)C,CCCCCCCCCCCCCCCC(=O)OC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@H](CC4=CC=CC5=CC=CC=C54)C(=O)O)NC(=O)C,"InChI=1S/C70H103N13O13/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-31-59(86)96-42-57(76-46(6)84)64(89)77-53(29-23-36-74-70(71)72)62(87)81-60(44(2)3)66(91)78-54(38-47-32-34-51(85)35-33-47)63(88)82-61(45(4)5)67(92)79-55(40-50-41-73-43-75-50)68(93)83-37-24-30-58(83)65(90)80-56(69(94)95)39-49-27-22-26-48-25-20-21-28-52(48)49/h20-22,25-28,32-35,41,43-45,53-58,60-61,85H,7-19,23-24,29-31,36-40,42H2,1-6H3,(H,73,75)(H,76,84)(H,77,89)(H,78,91)(H,79,92)(H,80,90)(H,81,87)(H,82,88)(H,94,95)(H4,71,72,74)/t53-,54-,55-,56+,57-,58-,60-,61-/m0/s1",9.5,12.0,15.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
310892,P34976,LAWQVFOUDYBHOB-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL3948,CHEMBL239378,17412584,CHEMBL239378,44438885.0,C24H23N3O4,417.465,2-butyl-3-[[4-(2-carboxypyrrol-1-yl)phenyl]methyl]benzimidazole-4-carboxylic acid,CCCCC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)N4C=CC=C4C(=O)O)C(=O)O,CCCCC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)N4C=CC=C4C(=O)O)C(=O)O,"InChI=1S/C24H23N3O4/c1-2-3-9-21-25-19-7-4-6-18(23(28)29)22(19)27(21)15-16-10-12-17(13-11-16)26-14-5-8-20(26)24(30)31/h4-8,10-14H,2-3,9,15H2,1H3,(H,28,29)(H,30,31)",4.6,2.0,5.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
311710,P34976,RJSWYMPJCFDFTK-UHFFFAOYSA-N,Kd,1.549,nM,ChEMBL,CHEMBL3948,CHEMBL124772,1433184,CHEMBL124772,10094936.0,C24H25N7O2,443.511,4-[butyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-2-methylpyrimidine-5-carboxylic acid,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC(=NC=C4C(=O)O)C,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC(=NC=C4C(=O)O)C,"InChI=1S/C24H25N7O2/c1-3-4-13-31(23-21(24(32)33)14-25-16(2)26-23)15-17-9-11-18(12-10-17)19-7-5-6-8-20(19)22-27-29-30-28-22/h5-12,14H,3-4,13,15H2,1-2H3,(H,32,33)(H,27,28,29,30)",4.2,2.0,8.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
311719,P34976,QVGZPYIJLHJJOG-UHFFFAOYSA-N,Kd,>100,nM,ChEMBL,CHEMBL3948,CHEMBL421865,"Bioorg. Med. Chem. Lett., (1994) 4:1:173",CHEMBL421865,44294823.0,C27H25N7O2,479.544,methyl 4-[propyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]quinazoline-5-carboxylate,CCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=CC=CC(=C54)C(=O)OC,CCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=CC=CC(=C54)C(=O)OC,"InChI=1S/C27H25N7O2/c1-3-15-34(26-24-22(27(35)36-2)9-6-10-23(24)28-17-29-26)16-18-11-13-19(14-12-18)20-7-4-5-8-21(20)25-30-32-33-31-25/h4-14,17H,3,15-16H2,1-2H3,(H,30,31,32,33)",5.1,1.0,8.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
311787,P34976,ZJSMWZXSSHENTD-UHFFFAOYSA-N,Kd,8.318,nM,ChEMBL,CHEMBL3948,CHEMBL121635,1433184,CHEMBL121635,10048997.0,C25H26N6O2,442.523,2-[butyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-6-methylpyridine-3-carboxylic acid,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=C(C=CC(=N4)C)C(=O)O,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=C(C=CC(=N4)C)C(=O)O,"InChI=1S/C25H26N6O2/c1-3-4-15-31(24-22(25(32)33)14-9-17(2)26-24)16-18-10-12-19(13-11-18)20-7-5-6-8-21(20)23-27-29-30-28-23/h5-14H,3-4,15-16H2,1-2H3,(H,32,33)(H,27,28,29,30)",4.8,2.0,7.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
311861,P34976,BSIBQJVOGKCIEL-UHFFFAOYSA-N,Kd,6.457,nM,ChEMBL,CHEMBL3948,CHEMBL48799,"Bioorg. Med. Chem. Lett., (1994) 4:1:173",CHEMBL48799,44211278.0,C26H24N8O2,480.532,"4-[butyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]pyrido[3,2-d]pyrimidine-6-carboxylic acid",CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4N=C(C=C5)C(=O)O,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4N=C(C=C5)C(=O)O,"InChI=1S/C26H24N8O2/c1-2-3-14-34(25-23-21(27-16-28-25)12-13-22(29-23)26(35)36)15-17-8-10-18(11-9-17)19-6-4-5-7-20(19)24-30-32-33-31-24/h4-13,16H,2-3,14-15H2,1H3,(H,35,36)(H,30,31,32,33)",4.5,2.0,9.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
312586,P34976,UYWCGRLVLYRPMH-UHFFFAOYSA-N,Kd,29.51,nM,ChEMBL,CHEMBL3948,CHEMBL300438,"Bioorg. Med. Chem. Lett., (1994) 4:1:173",CHEMBL300438,44294540.0,C24H25N9O,455.526,6-[butyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-9-methyl-7H-purin-8-one,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4NC(=O)N5C,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4NC(=O)N5C,"InChI=1S/C24H25N9O/c1-3-4-13-33(23-20-22(25-15-26-23)32(2)24(34)27-20)14-16-9-11-17(12-10-16)18-7-5-6-8-19(18)21-28-30-31-29-21/h5-12,15H,3-4,13-14H2,1-2H3,(H,27,34)(H,28,29,30,31)",3.4,2.0,7.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
313444,P34976,SJQRUFNZKBQQEK-LTGZKZEYSA-N,Kd,12.59,nM,ChEMBL,CHEMBL3948,CHEMBL425139,"Bioorg. Med. Chem. Lett., (1994) 4:1:87",CHEMBL425139,44383615.0,C27H29N5O3,471.561,ethyl (2E)-2-[1-oxo-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-azaspiro[4.5]decan-3-ylidene]acetate,CCOC(=O)C=C1CC2(CCCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CCOC(=O)/C=C/1\CC2(CCCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,"InChI=1S/C27H29N5O3/c1-2-35-24(33)16-21-17-27(14-6-3-7-15-27)26(34)32(21)18-19-10-12-20(13-11-19)22-8-4-5-9-23(22)25-28-30-31-29-25/h4-5,8-13,16H,2-3,6-7,14-15,17-18H2,1H3,(H,28,29,30,31)/b21-16+",4.4,1.0,6.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
313476,P34976,PIYCIQKRVOYHCA-UHFFFAOYSA-N,Kd,5.012,nM,ChEMBL,CHEMBL3948,CHEMBL1668002,21071232,CHEMBL1668002,53325868.0,C30H33N3O5,515.61,2-butyl-3-[[4-[[carboxy(phenyl)methyl]-ethylamino]phenyl]methyl]-6-methoxybenzimidazole-4-carboxylic acid,CCCCC1=NC2=C(N1CC3=CC=C(C=C3)N(CC)C(C4=CC=CC=C4)C(=O)O)C(=CC(=C2)OC)C(=O)O,CCCCC1=NC2=C(N1CC3=CC=C(C=C3)N(CC)C(C4=CC=CC=C4)C(=O)O)C(=CC(=C2)OC)C(=O)O,"InChI=1S/C30H33N3O5/c1-4-6-12-26-31-25-18-23(38-3)17-24(29(34)35)28(25)33(26)19-20-13-15-22(16-14-20)32(5-2)27(30(36)37)21-10-8-7-9-11-21/h7-11,13-18,27H,4-6,12,19H2,1-3H3,(H,34,35)(H,36,37)",6.0,2.0,7.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
313638,P34976,LPSIVANHQOKDRV-UHFFFAOYSA-N,Kd,74.13,nM,ChEMBL,CHEMBL3948,CHEMBL50007,"Bioorg. Med. Chem. Lett., (1994) 4:1:173",CHEMBL50007,44294518.0,C24H23N9O2,469.509,2-[6-[propyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]purin-7-yl]acetic acid,CCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4N(C=N5)CC(=O)O,CCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4N(C=N5)CC(=O)O,"InChI=1S/C24H23N9O2/c1-2-11-32(24-21-23(25-14-26-24)27-15-33(21)13-20(34)35)12-16-7-9-17(10-8-16)18-5-3-4-6-19(18)22-28-30-31-29-22/h3-10,14-15H,2,11-13H2,1H3,(H,34,35)(H,28,29,30,31)",3.4,2.0,9.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
313653,P34976,POMRKIYLMQTFLO-UHFFFAOYSA-N,Kd,41.69,nM,ChEMBL,CHEMBL3948,CHEMBL51987,"Bioorg. Med. Chem. Lett., (1994) 4:1:173",CHEMBL51987,44294515.0,C25H27N9OS,501.613,N-butyl-9-methyl-8-methylsulfinyl-N-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]purin-6-amine,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4N=C(N5C)S(=O)C,CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC5=C4N=C(N5C)S(=O)C,"InChI=1S/C25H27N9OS/c1-4-5-14-34(24-21-23(26-16-27-24)33(2)25(28-21)36(3)35)15-17-10-12-18(13-11-17)19-8-6-7-9-20(19)22-29-31-32-30-22/h6-13,16H,4-5,14-15H2,1-3H3,(H,29,30,31,32)",3.6,1.0,9.0,Type-1 angiotensin II receptor,AGTR1,Oryctolagus cuniculus (Rabbit),MMLNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLAVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSSKKPVPCFEVE
316199,P32245,CZCIDYFBUVIGBB-KVVACOCFSA-N,Kd,19.95,nM,ChEMBL,CHEMBL259,CHEMBL1161321,12431055,CHEMBL1161321,44366213.0,C58H73N13O9,1096.304,"(3'S,6'R,9'S,15'R,23'S)-15'-[[(2R)-2-acetamidohexanoyl]amino]-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-9'-(naphthalen-2-ylmethyl)-2',5',8',11',14',17'-hexaoxospiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide",CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2(CC3=CC=CC=C3C2)NC1=O)CC4=CC5=CC=CC=C5C=C4)CCCN=C(N)N)CC6=CNC7=CC=CC=C76)C(=O)N)NC(=O)C,CCCC[C@H](C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)C2(CC3=CC=CC=C3C2)NC1=O)CC4=CC5=CC=CC=C5C=C4)CCCN=C(N)N)CC6=CNC7=CC=CC=C76)C(=O)N)NC(=O)C,"InChI=1S/C58H73N13O9/c1-3-4-19-44(65-34(2)72)51(75)69-48-30-49(73)62-25-12-11-21-43(50(59)74)66-54(78)47(29-40-33-64-42-20-10-9-18-41(40)42)68-52(76)45(22-13-26-63-57(60)61)67-53(77)46(28-35-23-24-36-14-5-6-15-37(36)27-35)70-56(80)58(71-55(48)79)31-38-16-7-8-17-39(38)32-58/h5-10,14-18,20,23-24,27,33,43-48,64H,3-4,11-13,19,21-22,25-26,28-32H2,1-2H3,(H2,59,74)(H,62,73)(H,65,72)(H,66,78)(H,67,77)(H,68,76)(H,69,75)(H,70,80)(H,71,79)(H4,60,61,63)/t43-,44+,45+,46-,47-,48+/m0/s1",3.0,12.0,10.0,Melanocortin receptor 4,MC4R,Homo sapiens (Human),MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY
317969,P32245,KKBPPVVSQKSKNV-AREMUKBSSA-N,Kd,12.59,nM,ChEMBL,CHEMBL259,CHEMBL365597,15615531,CHEMBL365597,6918814.0,C29H35Cl2N5O2S,588.592,"3-amino-N-[(2R)-3-(2,4-dichlorophenyl)-1-oxo-1-[4-[2-[(2-thiophen-2-ylethylamino)methyl]phenyl]piperazin-1-yl]propan-2-yl]propanamide",C1CN(CCN1C2=CC=CC=C2CNCCC3=CC=CS3)C(=O)C(CC4=C(C=C(C=C4)Cl)Cl)NC(=O)CCN,C1CN(CCN1C2=CC=CC=C2CNCCC3=CC=CS3)C(=O)[C@@H](CC4=C(C=C(C=C4)Cl)Cl)NC(=O)CCN,"InChI=1S/C29H35Cl2N5O2S/c30-23-8-7-21(25(31)19-23)18-26(34-28(37)9-11-32)29(38)36-15-13-35(14-16-36)27-6-2-1-4-22(27)20-33-12-10-24-5-3-17-39-24/h1-8,17,19,26,33H,9-16,18,20,32H2,(H,34,37)/t26-/m1/s1",3.9,3.0,6.0,Melanocortin receptor 4,MC4R,Homo sapiens (Human),MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY
323649,P32245,NEVVXMYOTHZJES-BYMRNIKTSA-N,Kd,316.23,nM,ChEMBL,CHEMBL259,CHEMBL1161320,12431055,CHEMBL1161320,44366187.0,C52H69N13O9,1020.206,"(6R,14S,17S,20R,23S)-6-[[(2R)-2-acetamidohexanoyl]amino]-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-23-(naphthalen-2-ylmethyl)-5,8,16,19,22,25-hexaoxo-4,9,15,18,21,24-hexazaspiro[2.22]pentacosane-14-carboxamide",CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2(CC2)NC1=O)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C,CCCC[C@H](C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)C2(CC2)NC1=O)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C,"InChI=1S/C52H69N13O9/c1-3-4-15-38(59-30(2)66)45(69)63-42-28-43(67)56-23-10-9-17-37(44(53)68)60-48(72)41(27-34-29-58-36-16-8-7-14-35(34)36)62-46(70)39(18-11-24-57-51(54)55)61-47(71)40(64-50(74)52(21-22-52)65-49(42)73)26-31-19-20-32-12-5-6-13-33(32)25-31/h5-8,12-14,16,19-20,25,29,37-42,58H,3-4,9-11,15,17-18,21-24,26-28H2,1-2H3,(H2,53,68)(H,56,67)(H,59,66)(H,60,72)(H,61,71)(H,62,70)(H,63,69)(H,64,74)(H,65,73)(H4,54,55,57)/t37-,38+,39+,40-,41-,42+/m0/s1",1.5,12.0,10.0,Melanocortin receptor 4,MC4R,Homo sapiens (Human),MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY
328439,Q03431,GKDKCXZPVZTKFP-UHFFFAOYSA-N,Kd,19.5,nM,ChEMBL,CHEMBL1793,CHEMBL242784,17850061,CHEMBL242784,23626557.0,C27H32N6O,456.594,"5-cyclohexyl-1-[4-[2-(1H-imidazol-2-yl)ethylamino]phenyl]-3,8-dimethyl-1,3,4-benzotriazepin-2-one",CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,"InChI=1S/C27H32N6O/c1-19-8-13-23-24(18-19)33(27(34)32(2)31-26(23)20-6-4-3-5-7-20)22-11-9-21(10-12-22)28-15-14-25-29-16-17-30-25/h8-13,16-18,20,28H,3-7,14-15H2,1-2H3,(H,29,30)",5.2,2.0,4.0,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,Homo sapiens (Human),MGTARIAPGLALLLCCPVLSSAYALVDADDVMTKEEQIFLLHRAQAQCEKRLKEVLQRPASIMESDKGWTSASTSGKPRKDKASGKLYPESEEDKEAPTGSRYRGRPCLPEWDHILCWPLGAPGEVVAVPCPDYIYDFNHKGHAYRRCDRNGSWELVPGHNRTWANYSECVKFLTNETREREVFDRLGMIYTVGYSVSLASLTVAVLILAYFRRLHCTRNYIHMHLFLSFMLRAVSIFVKDAVLYSGATLDEAERLTEEELRAIAQAPPPPATAAAGYAGCRVAVTFFLYFLATNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTVFGWGLPAVFVAVWVSVRATLANTGCWDLSSGNKKWIIQVPILASIVLNFILFINIVRVLATKLRETNAGRCDTRQQYRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLALDFKRKARSGSSSYSYGPMVSHTSVTNVGPRVGLGLPLSPRLLPTATTNGHPQLPGHAKPGTPALETLETTPPAMAAPKDDGFLNGSCSGLDEEASGPERPPALLQEEWETVM
328440,Q03431,GKDKCXZPVZTKFP-UHFFFAOYSA-N,Kd,16.98,nM,ChEMBL,CHEMBL1793,CHEMBL242784,17850061,CHEMBL242784,23626557.0,C27H32N6O,456.594,"5-cyclohexyl-1-[4-[2-(1H-imidazol-2-yl)ethylamino]phenyl]-3,8-dimethyl-1,3,4-benzotriazepin-2-one",CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,"InChI=1S/C27H32N6O/c1-19-8-13-23-24(18-19)33(27(34)32(2)31-26(23)20-6-4-3-5-7-20)22-11-9-21(10-12-22)28-15-14-25-29-16-17-30-25/h8-13,16-18,20,28H,3-7,14-15H2,1-2H3,(H,29,30)",5.2,2.0,4.0,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,Homo sapiens (Human),MGTARIAPGLALLLCCPVLSSAYALVDADDVMTKEEQIFLLHRAQAQCEKRLKEVLQRPASIMESDKGWTSASTSGKPRKDKASGKLYPESEEDKEAPTGSRYRGRPCLPEWDHILCWPLGAPGEVVAVPCPDYIYDFNHKGHAYRRCDRNGSWELVPGHNRTWANYSECVKFLTNETREREVFDRLGMIYTVGYSVSLASLTVAVLILAYFRRLHCTRNYIHMHLFLSFMLRAVSIFVKDAVLYSGATLDEAERLTEEELRAIAQAPPPPATAAAGYAGCRVAVTFFLYFLATNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTVFGWGLPAVFVAVWVSVRATLANTGCWDLSSGNKKWIIQVPILASIVLNFILFINIVRVLATKLRETNAGRCDTRQQYRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLALDFKRKARSGSSSYSYGPMVSHTSVTNVGPRVGLGLPLSPRLLPTATTNGHPQLPGHAKPGTPALETLETTPPAMAAPKDDGFLNGSCSGLDEEASGPERPPALLQEEWETVM
328442,Q03431,GKDKCXZPVZTKFP-UHFFFAOYSA-N,Kd,2884.03,nM,ChEMBL,CHEMBL1793,CHEMBL242784,17850061,CHEMBL242784,23626557.0,C27H32N6O,456.594,"5-cyclohexyl-1-[4-[2-(1H-imidazol-2-yl)ethylamino]phenyl]-3,8-dimethyl-1,3,4-benzotriazepin-2-one",CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,"InChI=1S/C27H32N6O/c1-19-8-13-23-24(18-19)33(27(34)32(2)31-26(23)20-6-4-3-5-7-20)22-11-9-21(10-12-22)28-15-14-25-29-16-17-30-25/h8-13,16-18,20,28H,3-7,14-15H2,1-2H3,(H,29,30)",5.2,2.0,4.0,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,Homo sapiens (Human),MGTARIAPGLALLLCCPVLSSAYALVDADDVMTKEEQIFLLHRAQAQCEKRLKEVLQRPASIMESDKGWTSASTSGKPRKDKASGKLYPESEEDKEAPTGSRYRGRPCLPEWDHILCWPLGAPGEVVAVPCPDYIYDFNHKGHAYRRCDRNGSWELVPGHNRTWANYSECVKFLTNETREREVFDRLGMIYTVGYSVSLASLTVAVLILAYFRRLHCTRNYIHMHLFLSFMLRAVSIFVKDAVLYSGATLDEAERLTEEELRAIAQAPPPPATAAAGYAGCRVAVTFFLYFLATNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTVFGWGLPAVFVAVWVSVRATLANTGCWDLSSGNKKWIIQVPILASIVLNFILFINIVRVLATKLRETNAGRCDTRQQYRKLLKSTLVLMPLFGVHYIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLALDFKRKARSGSSSYSYGPMVSHTSVTNVGPRVGLGLPLSPRLLPTATTNGHPQLPGHAKPGTPALETLETTPPAMAAPKDDGFLNGSCSGLDEEASGPERPPALLQEEWETVM
371844,P35408,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,0.3 - 24,nM,IUPHAR,343,1916,"16604093,10634944,10952683,22480736",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP4 subtype,PTGER4,Homo sapiens (Human),MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI
379371,P11229,YNEYTRWEAGPFBC-KQDNUWKFSA-N,Kd,4.92,nM,ChEMBL,CHEMBL216,CHEMBL415038,"Bioorg. Med. Chem. Lett., (1993) 3:6:1247",CHEMBL415038,44457838.0,C22H25N,303.449,"(2S)-2-[(E)-2-(9,10-dihydroanthracen-9-yl)ethenyl]-1-methylpiperidine",CN1CCCCC1C=CC2C3=CC=CC=C3CC4=CC=CC=C24,CN1CCCC[C@H]1/C=C/C2C3=CC=CC=C3CC4=CC=CC=C24,"InChI=1S/C22H25N/c1-23-15-7-6-10-19(23)13-14-22-20-11-4-2-8-17(20)16-18-9-3-5-12-21(18)22/h2-5,8-9,11-14,19,22H,6-7,10,15-16H2,1H3/b14-13+/t19-/m0/s1",5.0,0.0,1.0,Muscarinic acetylcholine receptor M1,CHRM1,Homo sapiens (Human),MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSSSERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEVVIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC
379944,P11229,OVUAAZZCKNENBY-LJQANCHMSA-N,Kd,11.6,nM,ChEMBL,CHEMBL216,CHEMBL279712,"Bioorg. Med. Chem. Lett., (1993) 3:6:1247",CHEMBL279712,44457850.0,C22H25N,303.449,(2R)-2-[2-(10H-anthracen-9-ylidene)ethyl]-1-methylpiperidine,CN1CCCCC1CC=C2C3=CC=CC=C3CC4=CC=CC=C42,CN1CCCC[C@@H]1CC=C2C3=CC=CC=C3CC4=CC=CC=C42,"InChI=1S/C22H25N/c1-23-15-7-6-10-19(23)13-14-22-20-11-4-2-8-17(20)16-18-9-3-5-12-21(18)22/h2-5,8-9,11-12,14,19H,6-7,10,13,15-16H2,1H3/t19-/m1/s1",5.0,0.0,1.0,Muscarinic acetylcholine receptor M1,CHRM1,Homo sapiens (Human),MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSSSERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEVVIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC
380056,P11229,UBRKDAVQCKZSPO-UHFFFAOYSA-N,Kd,630.957621586148,nM,IUPHAR,13,309,8759038,Otenzepad,107867.0,C24H31N5O2,421.545,"11-[2-[2-(diethylaminomethyl)piperidin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one",CCN(CC)CC1CCCCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,CCN(CC)CC1CCCCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,"InChI=1S/C24H31N5O2/c1-3-27(4-2)16-18-10-7-8-15-28(18)17-22(30)29-21-13-6-5-11-19(21)24(31)26-20-12-9-14-25-23(20)29/h5-6,9,11-14,18H,3-4,7-8,10,15-17H2,1-2H3,(H,26,31)",2.0,1.0,5.0,Muscarinic acetylcholine receptor M1,CHRM1,Homo sapiens (Human),MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSSSERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEVVIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC
383865,P11229,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Kd,7943.28234724282,nM,IUPHAR,13,345,9224827,Vinburnine,71203.0,C19H22N2O,294.398,"(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one",CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,"InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1",3.0,0.0,2.0,Muscarinic acetylcholine receptor M1,CHRM1,Homo sapiens (Human),MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSSSERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEVVIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC
389242,P26684,ZUBDGKVDJUIMQQ-UBFCDGJISA-N,Kd,0.15,nM,ChEMBL,CHEMBL4566,CHEMBL437472,"Bioorg. Med. Chem. Lett., (1991) 1:1:33",Et 1,44284481.0,C109H159N25O32S5,2491.914,"(3S)-3-[[(2S)-2-[[(2S)-2-[[(1S,4S,7S,10R,13S,16R,19S,22R,25R,28R,31S,36R,39S,42R,45S)-31-amino-7-(4-aminobutyl)-39-benzyl-4-(2-carboxyethyl)-10-(carboxymethyl)-19,22,28-tris(hydroxymethyl)-42-[(4-hydroxyphenyl)methyl]-16-(2-methylpropyl)-13-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,38,41,44,47-tetradecaoxo-45-propan-2-yl-33,34,49,50-tetrathia-2,5,8,11,14,17,20,23,26,29,37,40,43,46-tetradecazabicyclo[23.22.4]henpentacontane-36-carbonyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-[[(2S,3S)-1-[[(2S,3S)-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid",CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CNC=N3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CO)CO)CC(C)C)CCSC)CC(=O)O)CCCCN)CCC(=O)O)CO)N,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CNC=N3)NC(=O)[C@@H]4CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@H]5CSSC[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N4)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC5=O)CO)CO)CC(C)C)CCSC)CC(=O)O)CCCCN)CCC(=O)O)CO)N,"InChI=1S/C109H159N25O32S5/c1-12-56(9)87(107(163)125-76(109(165)166)39-60-43-113-65-24-18-17-23-63(60)65)134-108(164)88(57(10)13-2)133-99(155)75(42-85(143)144)123-94(150)70(36-54(5)6)118-97(153)73(40-61-44-112-52-114-61)121-103(159)80-49-169-168-48-64(111)89(145)126-77(45-135)102(158)131-81-50-170-171-51-82(105(161)132-86(55(7)8)106(162)124-72(38-59-26-28-62(138)29-27-59)95(151)120-71(96(152)130-80)37-58-21-15-14-16-22-58)129-91(147)67(30-31-83(139)140)116-90(146)66(25-19-20-33-110)115-98(154)74(41-84(141)142)122-92(148)68(32-34-167-11)117-93(149)69(35-53(3)4)119-100(156)78(46-136)127-101(157)79(47-137)128-104(81)160/h14-18,21-24,26-29,43-44,52-57,64,66-82,86-88,113,135-138H,12-13,19-20,25,30-42,45-51,110-111H2,1-11H3,(H,112,114)(H,115,154)(H,116,146)(H,117,149)(H,118,153)(H,119,156)(H,120,151)(H,121,159)(H,122,148)(H,123,150)(H,124,162)(H,125,163)(H,126,145)(H,127,157)(H,128,160)(H,129,147)(H,130,152)(H,131,158)(H,132,161)(H,133,155)(H,134,164)(H,139,140)(H,141,142)(H,143,144)(H,165,166)/t56-,57-,64+,66-,67-,68-,69+,70-,71-,72+,73-,74+,75-,76-,77+,78-,79+,80-,81-,82+,86-,87-,88-/m0/s1",-3.7,32.0,40.0,Endothelin-1 receptor,Ednra,Rattus norvegicus (Rat),MGVLCFLASFWLALVGGAIADNAERYSANLSSHVEDFTPFPGTEFNFLGTTLQPPNLALPSNGSMHGYCPQQTKITTAFKYINTVISCTIFIVGMVGNATLLRIIYQNKCMRNGPNALIASLALGDLIYVVIDLPINVFKLLAGRWPFDHNDFGVFLCKLFPFLQKSSVGITVLNLCALSVDRYRAVASWSRVQGIGIPLITAIEIVSIWILSFILAIPEAIGFVMVPFEYKGEQHRTCMLNATTKFMEFYQDVKDWWLFGFYFCMPLVCTAIFYTLMTCEMLNRRNGSLRIALSEHLKQRREVAKTVFCLVVIFALCWFPLHLSRILKKTVYDEMDKNRCELLSFLLLMDYIGINLATMNSCINPIALYFVSKKFKNCFQSCLCCCCHQSKSLMTSVPMNGTSIQWKNQEQNHNTERSSHKDSMN
389298,P26684,CKAWNKDSMUUPOR-UHFFFAOYSA-N,Kd,229.09,nM,ChEMBL,CHEMBL4566,CHEMBL163638,12617929,CHEMBL163638,10211772.0,C32H32N6O8S,660.702,4-[5-(2-methoxyphenoxy)-6-[(5-methylpyridin-2-yl)sulfonylamino]-2-morpholin-4-ylpyrimidin-4-yl]oxybut-2-ynyl N-phenylcarbamate,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)N3CCOCC3)OCC#CCOC(=O)NC4=CC=CC=C4)OC5=CC=CC=C5OC,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)N3CCOCC3)OCC#CCOC(=O)NC4=CC=CC=C4)OC5=CC=CC=C5OC,"InChI=1S/C32H32N6O8S/c1-23-14-15-27(33-22-23)47(40,41)37-29-28(46-26-13-7-6-12-25(26)42-2)30(36-31(35-29)38-16-20-43-21-17-38)44-18-8-9-19-45-32(39)34-24-10-4-3-5-11-24/h3-7,10-15,22H,16-21H2,1-2H3,(H,34,39)(H,35,36,37)",3.9,2.0,13.0,Endothelin-1 receptor,Ednra,Rattus norvegicus (Rat),MGVLCFLASFWLALVGGAIADNAERYSANLSSHVEDFTPFPGTEFNFLGTTLQPPNLALPSNGSMHGYCPQQTKITTAFKYINTVISCTIFIVGMVGNATLLRIIYQNKCMRNGPNALIASLALGDLIYVVIDLPINVFKLLAGRWPFDHNDFGVFLCKLFPFLQKSSVGITVLNLCALSVDRYRAVASWSRVQGIGIPLITAIEIVSIWILSFILAIPEAIGFVMVPFEYKGEQHRTCMLNATTKFMEFYQDVKDWWLFGFYFCMPLVCTAIFYTLMTCEMLNRRNGSLRIALSEHLKQRREVAKTVFCLVVIFALCWFPLHLSRILKKTVYDEMDKNRCELLSFLLLMDYIGINLATMNSCINPIALYFVSKKFKNCFQSCLCCCCHQSKSLMTSVPMNGTSIQWKNQEQNHNTERSSHKDSMN
389950,P26684,ZWBKTDGFDOSYJJ-RRVUTKFSSA-N,Kd,929,nM,ChEMBL,CHEMBL4566,CHEMBL407887,"Bioorg. Med. Chem. Lett., (1991) 1:1:33",BDBM50279796,77282102.0,C103H147N25O32S5,2407.752,"(3S)-3-[[(2S)-2-[[(2S)-2-[[(1R,4R,7S,10R,13S,16R,19S,22R,25R,28R,31S,36S,39R,42S,45R)-31-amino-7-(4-aminobutyl)-39-benzyl-4-(2-carboxyethyl)-10-(carboxymethyl)-19,22,28-tris(hydroxymethyl)-42-[(4-hydroxyphenyl)methyl]-16-(2-methylpropyl)-13-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,38,41,44,47-tetradecaoxo-45-propan-2-yl-33,34,49,50-tetrathia-2,5,8,11,14,17,20,23,26,29,37,40,43,46-tetradecazabicyclo[23.22.4]henpentacontane-36-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid",CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CO)CO)NC(=O)C(NC(=O)C(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)C(C)C)CC3=CC=C(C=C3)O)CC4=CC=CC=C4)C(=O)NC(CC5=CN=CN5)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)O)N)CO)CCC(=O)O)CCCCN)CC(=O)O)CCSC,C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H]4CSSC[C@H](C(=O)N[C@@H](C(=O)N[C@H]5CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N4)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)C(C)C)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC5=O)CO)CO)CC(C)C)CCSC)CC(=O)O)CCCCN)CCC(=O)O)CO)N,"InChI=1S/C103H147N25O32S5/c1-49(2)31-65-90(146)113-64(28-30-161-9)88(144)118-71(38-81(137)138)95(151)111-62(21-15-16-29-104)86(142)112-63(26-27-79(133)134)87(143)125-78-47-165-164-46-77(100(156)124-75(43-131)97(153)123-74(42-130)96(152)115-65)127-98(154)73(41-129)122-85(141)60(105)44-162-163-45-76(126-93(149)67(33-54-17-11-10-12-18-54)116-92(148)68(34-55-22-24-58(132)25-23-55)120-102(158)82(51(5)6)128-101(78)157)99(155)117-69(36-57-40-106-48-108-57)94(150)114-66(32-50(3)4)91(147)119-70(37-80(135)136)89(145)110-52(7)83(139)109-53(8)84(140)121-72(103(159)160)35-56-39-107-61-20-14-13-19-59(56)61/h10-14,17-20,22-25,39-40,48-53,60,62-78,82,107,129-132H,15-16,21,26-38,41-47,104-105H2,1-9H3,(H,106,108)(H,109,139)(H,110,145)(H,111,151)(H,112,142)(H,113,146)(H,114,150)(H,115,152)(H,116,148)(H,117,155)(H,118,144)(H,119,147)(H,120,158)(H,121,140)(H,122,141)(H,123,153)(H,124,156)(H,125,143)(H,126,149)(H,127,154)(H,128,157)(H,133,134)(H,135,136)(H,137,138)(H,159,160)/t52-,53-,60+,62-,63+,64-,65+,66-,67+,68-,69-,70-,71+,72-,73+,74-,75+,76+,77-,78-,82+/m0/s1",-6.3,32.0,40.0,Endothelin-1 receptor,Ednra,Rattus norvegicus (Rat),MGVLCFLASFWLALVGGAIADNAERYSANLSSHVEDFTPFPGTEFNFLGTTLQPPNLALPSNGSMHGYCPQQTKITTAFKYINTVISCTIFIVGMVGNATLLRIIYQNKCMRNGPNALIASLALGDLIYVVIDLPINVFKLLAGRWPFDHNDFGVFLCKLFPFLQKSSVGITVLNLCALSVDRYRAVASWSRVQGIGIPLITAIEIVSIWILSFILAIPEAIGFVMVPFEYKGEQHRTCMLNATTKFMEFYQDVKDWWLFGFYFCMPLVCTAIFYTLMTCEMLNRRNGSLRIALSEHLKQRREVAKTVFCLVVIFALCWFPLHLSRILKKTVYDEMDKNRCELLSFLLLMDYIGINLATMNSCINPIALYFVSKKFKNCFQSCLCCCCHQSKSLMTSVPMNGTSIQWKNQEQNHNTERSSHKDSMN
392462,P24530,NQDCDWVUSPOECA-UHFFFAOYSA-N,Kd,630.96,nM,ChEMBL,CHEMBL1785,CHEMBL27732,"Bioorg. Med. Chem. Lett., (1996) 6:12:1367",CHEMBL27732,9957883.0,C26H21NO8S,507.513,"1-(1,3-benzodioxol-5-ylmethyl)-3-(1,3-benzodioxol-5-ylsulfanyl)-5,6-dimethoxyindole-2-carboxylic acid",COC1=C(C=C2C(=C1)C(=C(N2CC3=CC4=C(C=C3)OCO4)C(=O)O)SC5=CC6=C(C=C5)OCO6)OC,COC1=C(C=C2C(=C1)C(=C(N2CC3=CC4=C(C=C3)OCO4)C(=O)O)SC5=CC6=C(C=C5)OCO6)OC,"InChI=1S/C26H21NO8S/c1-30-20-9-16-17(10-21(20)31-2)27(11-14-3-5-18-22(7-14)34-12-32-18)24(26(28)29)25(16)36-15-4-6-19-23(8-15)35-13-33-19/h3-10H,11-13H2,1-2H3,(H,28,29)",5.1,1.0,9.0,Endothelin receptor type B,EDNRB,Homo sapiens (Human),MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKSCLCCWCQSFEEKQSLEEKQSCLKFKANDHGYDNFRSSNKYSSS
394299,P32745,NGISEDHBPLFVJG-ARBHAYAYSA-N,Kd,440,nM,ChEMBL,CHEMBL2028,CHEMBL437093,11311064,CHEMBL437093,44280340.0,C50H67N11O11S2,1062.272,"(4R,7S,10S,13S,16S,19S)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-8-methyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N)C(=O)NC(C(C)O)C(=O)N)O,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=C(C=C5)O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)O,"InChI=1S/C50H67N11O11S2/c1-27(62)41(43(53)65)60-48(70)40-26-74-73-25-39(58-44(66)34(52)21-30-16-18-32(64)19-17-30)47(69)56-37(22-29-11-5-4-6-12-29)45(67)57-38(23-31-24-54-35-14-8-7-13-33(31)35)46(68)55-36(15-9-10-20-51)50(72)61(3)42(28(2)63)49(71)59-40/h4-8,11-14,16-19,24,27-28,34,36-42,54,62-64H,9-10,15,20-23,25-26,51-52H2,1-3H3,(H2,53,65)(H,55,68)(H,56,69)(H,57,67)(H,58,66)(H,59,71)(H,60,70)/t27-,28-,34-,36+,37+,38+,39-,40+,41+,42+/m1/s1",0.4,13.0,15.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
394569,P32745,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,8709.64,nM,ChEMBL,CHEMBL2028,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
395897,P32745,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,7244.36,nM,ChEMBL,CHEMBL2028,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
396456,P32745,LAGLXUYHYIDDKB-UHFFFAOYSA-N,Kd,95.5,nM,ChEMBL,CHEMBL2028,CHEMBL1086987,20137944,CHEMBL1086987,46880818.0,C30H38N6O3S,562.733,"[2-[3-(1,3-benzodioxol-5-yl)-2-methylpropyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-[4-([1,2,5]thiadiazolo[3,4-b]pyridin-5-yl)piperazin-1-yl]methanone",CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=NC7=NSN=C7C=C6,CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=NC7=NSN=C7C=C6,"InChI=1S/C30H38N6O3S/c1-20(14-21-6-8-26-27(15-21)39-19-38-26)16-34-17-22-4-2-3-5-23(22)24(18-34)30(37)36-12-10-35(11-13-36)28-9-7-25-29(31-28)33-40-32-25/h6-9,15,20,22-24H,2-5,10-14,16-19H2,1H3",5.4,0.0,9.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
396660,P32745,JDSZHODNCMSGLL-LBDANMEMSA-N,Kd,107.15,nM,ChEMBL,CHEMBL2028,CHEMBL1076627,20137944,CHEMBL1076627,46880590.0,C32H41F2N5O,549.711,"[(4S,4aS,8aR)-2-[(2S)-2-methyl-3-(2-methylimidazo[1,2-a]pyridin-6-yl)propyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-[4-(3,4-difluorophenyl)piperazin-1-yl]methanone",CC1=CN2C=C(C=CC2=N1)CC(C)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC(=C(C=C6)F)F,CC1=CN2C=C(C=CC2=N1)C[C@H](C)CN3C[C@@H]4CCCC[C@@H]4[C@@H](C3)C(=O)N5CCN(CC5)C6=CC(=C(C=C6)F)F,"InChI=1S/C32H41F2N5O/c1-22(15-24-7-10-31-35-23(2)18-39(31)19-24)17-36-20-25-5-3-4-6-27(25)28(21-36)32(40)38-13-11-37(12-14-38)26-8-9-29(33)30(34)16-26/h7-10,16,18-19,22,25,27-28H,3-6,11-15,17,20-21H2,1-2H3/t22-,25-,27-,28+/m0/s1",6.6,0.0,6.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
396748,P32745,JYRKGTLBBJHVGA-UHFFFAOYSA-N,Kd,331.13,nM,ChEMBL,CHEMBL2028,CHEMBL1081804,20137944,CHEMBL1081804,46880682.0,C30H40N4O3,504.675,"[2-[3-(1,3-benzodioxol-5-yl)-2-methylpropyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone",CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC=CC=N6,CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC=CC=N6,"InChI=1S/C30H40N4O3/c1-22(16-23-9-10-27-28(17-23)37-21-36-27)18-32-19-24-6-2-3-7-25(24)26(20-32)30(35)34-14-12-33(13-15-34)29-8-4-5-11-31-29/h4-5,8-11,17,22,24-26H,2-3,6-7,12-16,18-21H2,1H3",5.2,0.0,6.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
396757,P32745,VNECRSRDCNWUSI-UHFFFAOYSA-N,Kd,57.54,nM,ChEMBL,CHEMBL2028,CHEMBL1081441,20137944,CHEMBL1081441,46880638.0,C31H40FN3O3,521.677,"[2-[3-(1,3-benzodioxol-5-yl)-2-methylpropyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-[4-(4-fluorophenyl)piperazin-1-yl]methanone",CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC=C(C=C6)F,CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC=C(C=C6)F,"InChI=1S/C31H40FN3O3/c1-22(16-23-6-11-29-30(17-23)38-21-37-29)18-33-19-24-4-2-3-5-27(24)28(20-33)31(36)35-14-12-34(13-15-35)26-9-7-25(32)8-10-26/h6-11,17,22,24,27-28H,2-5,12-16,18-21H2,1H3",6.0,0.0,6.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
396777,P32745,DBXBILMEEVCMPM-UHFFFAOYSA-N,Kd,239.88,nM,ChEMBL,CHEMBL2028,CHEMBL1086988,20137944,CHEMBL1086988,46880821.0,C31H40N6O3,544.7,"[2-[3-(1,3-benzodioxol-5-yl)-2-methylpropyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-(4-imidazo[1,2-b]pyridazin-6-ylpiperazin-1-yl)methanone",CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=NN7C=CN=C7C=C6,CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=NN7C=CN=C7C=C6,"InChI=1S/C31H40N6O3/c1-22(16-23-6-7-27-28(17-23)40-21-39-27)18-34-19-24-4-2-3-5-25(24)26(20-34)31(38)36-14-12-35(13-15-36)30-9-8-29-32-10-11-37(29)33-30/h6-11,17,22,24-26H,2-5,12-16,18-21H2,1H3",4.7,0.0,7.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
396782,P32745,PXKLEJCHPGUZTI-UHFFFAOYSA-N,Kd,19.95,nM,ChEMBL,CHEMBL2028,CHEMBL1082178,20137944,CHEMBL1082178,46880782.0,C31H39N5O4,545.684,"[2-[3-(1,3-benzodioxol-5-yl)-2-methylpropyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CC(CC1=CC2=C(C=C1)OCO2)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C31H39N5O4/c1-21(14-22-6-9-29-30(15-22)39-20-38-29)17-34-18-23-4-2-3-5-25(23)26(19-34)31(37)36-12-10-35(11-13-36)24-7-8-27-28(16-24)33-40-32-27/h6-9,15-16,21,23,25-26H,2-5,10-14,17-20H2,1H3",5.2,0.0,8.0,Somatostatin receptor type 3,SSTR3,Homo sapiens (Human),MDMLHPSSVSTTSEPENASSAWPPDATLGNVSAGPSPAGLAVSGVLIPLVYLVVCVVGLLGNSLVIYVVLRHTASPSVTNVYILNLALADELFMLGLPFLAAQNALSYWPFGSLMCRLVMAVDGINQFTSIFCLTVMSVDRYLAVVHPTRSARWRTAPVARTVSAAVWVASAVVVLPVVVFSGVPRGMSTCHMQWPEPAAAWRAGFIIYTAALGFFGPLLVICLCYLLIVVKVRSAGRRVWAPSCQRRRRSERRVTRMVVAVVALFVLCWMPFYVLNIVNVVCPLPEEPAFFGLYFLVVALPYANSCANPILYGFLSYRFKQGFRRVLLRPSRRVRSQEPTVGPPEKTEEEDEEEEDGEESREGGKGKEMNGRVSQITQPGTSGQERPPSRVASKEQQLLPQEASTGEKSSTMRISYL
397139,P35346,NGISEDHBPLFVJG-ARBHAYAYSA-N,Kd,92.79,nM,ChEMBL,CHEMBL1792,CHEMBL437093,11311064,CHEMBL437093,44280340.0,C50H67N11O11S2,1062.272,"(4R,7S,10S,13S,16S,19S)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-8-methyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N)C(=O)NC(C(C)O)C(=O)N)O,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=C(C=C5)O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)O,"InChI=1S/C50H67N11O11S2/c1-27(62)41(43(53)65)60-48(70)40-26-74-73-25-39(58-44(66)34(52)21-30-16-18-32(64)19-17-30)47(69)56-37(22-29-11-5-4-6-12-29)45(67)57-38(23-31-24-54-35-14-8-7-13-33(31)35)46(68)55-36(15-9-10-20-51)50(72)61(3)42(28(2)63)49(71)59-40/h4-8,11-14,16-19,24,27-28,34,36-42,54,62-64H,9-10,15,20-23,25-26,51-52H2,1-3H3,(H2,53,65)(H,55,68)(H,56,69)(H,57,67)(H,58,66)(H,59,71)(H,60,70)/t27-,28-,34-,36+,37+,38+,39-,40+,41+,42+/m1/s1",0.4,13.0,15.0,Somatostatin receptor type 5,SSTR5,Homo sapiens (Human),MEPLFPASTPSWNASSPGAASGGGDNRTLVGPAPSAGARAVLVPVLYLLVCAAGLGGNTLVIYVVLRFAKMKTVTNIYILNLAVADVLYMLGLPFLATQNAASFWPFGPVLCRLVMTLDGVNQFTSVFCLTVMSVDRYLAVVHPLSSARWRRPRVAKLASAAAWVLSLCMSLPLLVFADVQEGGTCNASWPEPVGLWGAVFIIYTAVLGFFAPLLVICLCYLLIVVKVRAAGVRVGCVRRRSERKVTRMVLVVVLVFAGCWLPFFTVNIVNLAVALPQEPASAGLYFFVVILSYANSCANPVLYGFLSDNFRQSFQKVLCLRKGSGAKDADATEPRPDRIRQQQEATPPAHRAAANGLMQTSKL
397358,P35346,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,1778.28,nM,ChEMBL,CHEMBL1792,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 5,SSTR5,Homo sapiens (Human),MEPLFPASTPSWNASSPGAASGGGDNRTLVGPAPSAGARAVLVPVLYLLVCAAGLGGNTLVIYVVLRFAKMKTVTNIYILNLAVADVLYMLGLPFLATQNAASFWPFGPVLCRLVMTLDGVNQFTSVFCLTVMSVDRYLAVVHPLSSARWRRPRVAKLASAAAWVLSLCMSLPLLVFADVQEGGTCNASWPEPVGLWGAVFIIYTAVLGFFAPLLVICLCYLLIVVKVRAAGVRVGCVRRRSERKVTRMVLVVVLVFAGCWLPFFTVNIVNLAVALPQEPASAGLYFFVVILSYANSCANPVLYGFLSDNFRQSFQKVLCLRKGSGAKDADATEPRPDRIRQQQEATPPAHRAAANGLMQTSKL
398400,P35346,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,23442.29,nM,ChEMBL,CHEMBL1792,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 5,SSTR5,Homo sapiens (Human),MEPLFPASTPSWNASSPGAASGGGDNRTLVGPAPSAGARAVLVPVLYLLVCAAGLGGNTLVIYVVLRFAKMKTVTNIYILNLAVADVLYMLGLPFLATQNAASFWPFGPVLCRLVMTLDGVNQFTSVFCLTVMSVDRYLAVVHPLSSARWRRPRVAKLASAAAWVLSLCMSLPLLVFADVQEGGTCNASWPEPVGLWGAVFIIYTAVLGFFAPLLVICLCYLLIVVKVRAAGVRVGCVRRRSERKVTRMVLVVVLVFAGCWLPFFTVNIVNLAVALPQEPASAGLYFFVVILSYANSCANPVLYGFLSDNFRQSFQKVLCLRKGSGAKDADATEPRPDRIRQQQEATPPAHRAAANGLMQTSKL
399569,P30874,NGISEDHBPLFVJG-ARBHAYAYSA-N,Kd,61.35,nM,ChEMBL,CHEMBL1804,CHEMBL437093,11311064,CHEMBL437093,44280340.0,C50H67N11O11S2,1062.272,"(4R,7S,10S,13S,16S,19S)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-8-methyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N)C(=O)NC(C(C)O)C(=O)N)O,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=C(C=C5)O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)O,"InChI=1S/C50H67N11O11S2/c1-27(62)41(43(53)65)60-48(70)40-26-74-73-25-39(58-44(66)34(52)21-30-16-18-32(64)19-17-30)47(69)56-37(22-29-11-5-4-6-12-29)45(67)57-38(23-31-24-54-35-14-8-7-13-33(31)35)46(68)55-36(15-9-10-20-51)50(72)61(3)42(28(2)63)49(71)59-40/h4-8,11-14,16-19,24,27-28,34,36-42,54,62-64H,9-10,15,20-23,25-26,51-52H2,1-3H3,(H2,53,65)(H,55,68)(H,56,69)(H,57,67)(H,58,66)(H,59,71)(H,60,70)/t27-,28-,34-,36+,37+,38+,39-,40+,41+,42+/m1/s1",0.4,13.0,15.0,Somatostatin receptor type 2,SSTR2,Homo sapiens (Human),MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
399788,P30874,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,36307.81,nM,ChEMBL,CHEMBL1804,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 2,SSTR2,Homo sapiens (Human),MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
400783,P30874,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,3890.45,nM,ChEMBL,CHEMBL1804,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 2,SSTR2,Homo sapiens (Human),MDMADEPLNGSHTWLSIPFDLNGSVVSTNTSNQTEPYYDLTSNAVLTFIYFVVCIIGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMITMAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYTFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSMAISPTPALKGMFDFVVVLTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGTDDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
401819,P31391,NGISEDHBPLFVJG-ARBHAYAYSA-N,Kd,1000,nM,ChEMBL,CHEMBL1853,CHEMBL437093,11311064,CHEMBL437093,44280340.0,C50H67N11O11S2,1062.272,"(4R,7S,10S,13S,16S,19S)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-8-methyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N)C(=O)NC(C(C)O)C(=O)N)O,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=C(C=C5)O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)O,"InChI=1S/C50H67N11O11S2/c1-27(62)41(43(53)65)60-48(70)40-26-74-73-25-39(58-44(66)34(52)21-30-16-18-32(64)19-17-30)47(69)56-37(22-29-11-5-4-6-12-29)45(67)57-38(23-31-24-54-35-14-8-7-13-33(31)35)46(68)55-36(15-9-10-20-51)50(72)61(3)42(28(2)63)49(71)59-40/h4-8,11-14,16-19,24,27-28,34,36-42,54,62-64H,9-10,15,20-23,25-26,51-52H2,1-3H3,(H2,53,65)(H,55,68)(H,56,69)(H,57,67)(H,58,66)(H,59,71)(H,60,70)/t27-,28-,34-,36+,37+,38+,39-,40+,41+,42+/m1/s1",0.4,13.0,15.0,Somatostatin receptor type 4,SSTR4,Homo sapiens (Human),MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIYLLNLAVADELFMLSVPFVASSAALRHWPFGSVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRAATYRRPSVAKLINLGVWLASLLVTLPIAIFADTRPARGGQAVACNLQWPHPAWSAVFVVYTFLLGFLLPVLAIGLCYLLIVGKMRAVALRAGWQQRRRSEKKITRLVLMVVVVFVLCWMPFYVVQLLNLFVTSLDATVNHVSLILSYANSCANPILYGFLSDNFRRFFQRVLCLRCCLLEGAGGAEEEPLDYYATALKSKGGAGCMCPPLPCQQEALQPEPGRKRIPLTRTTTF
402013,P31391,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,15135.61,nM,ChEMBL,CHEMBL1853,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 4,SSTR4,Homo sapiens (Human),MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIYLLNLAVADELFMLSVPFVASSAALRHWPFGSVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRAATYRRPSVAKLINLGVWLASLLVTLPIAIFADTRPARGGQAVACNLQWPHPAWSAVFVVYTFLLGFLLPVLAIGLCYLLIVGKMRAVALRAGWQQRRRSEKKITRLVLMVVVVFVLCWMPFYVVQLLNLFVTSLDATVNHVSLILSYANSCANPILYGFLSDNFRRFFQRVLCLRCCLLEGAGGAEEEPLDYYATALKSKGGAGCMCPPLPCQQEALQPEPGRKRIPLTRTTTF
402862,P31391,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,5623.41,nM,ChEMBL,CHEMBL1853,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 4,SSTR4,Homo sapiens (Human),MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLVGLVGNALVIFVILRYAKMKTATNIYLLNLAVADELFMLSVPFVASSAALRHWPFGSVLCRAVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRAATYRRPSVAKLINLGVWLASLLVTLPIAIFADTRPARGGQAVACNLQWPHPAWSAVFVVYTFLLGFLLPVLAIGLCYLLIVGKMRAVALRAGWQQRRRSEKKITRLVLMVVVVFVLCWMPFYVVQLLNLFVTSLDATVNHVSLILSYANSCANPILYGFLSDNFRRFFQRVLCLRCCLLEGAGGAEEEPLDYYATALKSKGGAGCMCPPLPCQQEALQPEPGRKRIPLTRTTTF
403641,P30872,NGISEDHBPLFVJG-ARBHAYAYSA-N,Kd,1000,nM,ChEMBL,CHEMBL1917,CHEMBL437093,11311064,CHEMBL437093,44280340.0,C50H67N11O11S2,1062.272,"(4R,7S,10S,13S,16S,19S)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-8-methyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N)C(=O)NC(C(C)O)C(=O)N)O,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=C(C=C5)O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)O,"InChI=1S/C50H67N11O11S2/c1-27(62)41(43(53)65)60-48(70)40-26-74-73-25-39(58-44(66)34(52)21-30-16-18-32(64)19-17-30)47(69)56-37(22-29-11-5-4-6-12-29)45(67)57-38(23-31-24-54-35-14-8-7-13-33(31)35)46(68)55-36(15-9-10-20-51)50(72)61(3)42(28(2)63)49(71)59-40/h4-8,11-14,16-19,24,27-28,34,36-42,54,62-64H,9-10,15,20-23,25-26,51-52H2,1-3H3,(H2,53,65)(H,55,68)(H,56,69)(H,57,67)(H,58,66)(H,59,71)(H,60,70)/t27-,28-,34-,36+,37+,38+,39-,40+,41+,42+/m1/s1",0.4,13.0,15.0,Somatostatin receptor type 1,SSTR1,Homo sapiens (Human),MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
403803,P30872,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,10.23,nM,ChEMBL,CHEMBL1917,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 1,SSTR1,Homo sapiens (Human),MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
403805,P30872,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,7.94327537013265 - 10,nM,IUPHAR,355,2030,15135911,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 1,SSTR1,Homo sapiens (Human),MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
404574,P30872,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,501.19,nM,ChEMBL,CHEMBL1917,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 1,SSTR1,Homo sapiens (Human),MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
404995,P30872,JDSZHODNCMSGLL-LBDANMEMSA-N,Kd,39.81,nM,ChEMBL,CHEMBL1917,CHEMBL1076627,20137944,CHEMBL1076627,46880590.0,C32H41F2N5O,549.711,"[(4S,4aS,8aR)-2-[(2S)-2-methyl-3-(2-methylimidazo[1,2-a]pyridin-6-yl)propyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-4-yl]-[4-(3,4-difluorophenyl)piperazin-1-yl]methanone",CC1=CN2C=C(C=CC2=N1)CC(C)CN3CC4CCCCC4C(C3)C(=O)N5CCN(CC5)C6=CC(=C(C=C6)F)F,CC1=CN2C=C(C=CC2=N1)C[C@H](C)CN3C[C@@H]4CCCC[C@@H]4[C@@H](C3)C(=O)N5CCN(CC5)C6=CC(=C(C=C6)F)F,"InChI=1S/C32H41F2N5O/c1-22(15-24-7-10-31-35-23(2)18-39(31)19-24)17-36-20-25-5-3-4-6-27(25)28(21-36)32(40)38-13-11-37(12-14-38)26-8-9-29(33)30(34)16-26/h7-10,16,18-19,22,25,27-28H,3-6,11-15,17,20-21H2,1-2H3/t22-,25-,27-,28+/m0/s1",6.6,0.0,6.0,Somatostatin receptor type 1,SSTR1,Homo sapiens (Human),MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL
412609,P35367,YLWRKTVVIPNRDE-GOSISDBHSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL231,CHEMBL2146808,22985961,CHEMBL2146808,71456360.0,C22H25ClN4O2,412.918,"5-[(4-chlorophenyl)methyl]-7-[[(2R)-1-(2-methoxyethyl)pyrrolidin-2-yl]methyl]pyrido[2,3-d]pyridazin-8-one",COCCN1CCCC1CN2C(=O)C3=C(C=CC=N3)C(=N2)CC4=CC=C(C=C4)Cl,COCCN1CCC[C@@H]1CN2C(=O)C3=C(C=CC=N3)C(=N2)CC4=CC=C(C=C4)Cl,"InChI=1S/C22H25ClN4O2/c1-29-13-12-26-11-3-4-18(26)15-27-22(28)21-19(5-2-10-24-21)20(25-27)14-16-6-8-17(23)9-7-16/h2,5-10,18H,3-4,11-15H2,1H3/t18-/m1/s1",3.1,0.0,5.0,Histamine H1 receptor,HRH1,Homo sapiens (Human),MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
412633,P35367,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Kd,5400,nM,ChEMBL,CHEMBL231,CHEMBL516,16220969,CYPROHEPTADINE,2913.0,C21H21N,287.406,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine",CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,"InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3",4.7,0.0,1.0,Histamine H1 receptor,HRH1,Homo sapiens (Human),MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS
420140,P08173,UBRKDAVQCKZSPO-UHFFFAOYSA-N,Kd,100,nM,IUPHAR,16,309,8759038,Otenzepad,107867.0,C24H31N5O2,421.545,"11-[2-[2-(diethylaminomethyl)piperidin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one",CCN(CC)CC1CCCCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,CCN(CC)CC1CCCCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,"InChI=1S/C24H31N5O2/c1-3-27(4-2)16-18-10-7-8-15-28(18)17-22(30)29-21-13-6-5-11-19(21)24(31)26-20-12-9-14-25-23(20)29/h5-6,9,11-14,18H,3-4,7-8,10,15-17H2,1-2H3,(H,26,31)",2.0,1.0,5.0,Muscarinic acetylcholine receptor M4,CHRM4,Homo sapiens (Human),MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTVYIIKGYWPLGAVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPARRTTKMAGLMIAAAWVLSFVLWAPAILFWQFVVGKRTVPDNQCFIQFLSNPAVTFGTAIAAFYLPVVIMTVLYIHISLASRSRVHKHRPEGPKEKKAKTLAFLKSPLMKQSVKKPPPGEAAREELRNGKLEEAPPPALPPPPRPVADKDTSNESSSGSATQNTKERPATELSTTEATTPAMPAPPLQPRALNPASRWSKIQIVTKQTGNECVTAIEIVPATPAGMRPAANVARKFASIARNQVRKKRQMAARERKVTRTIFAILLAFILTWTPYNVMVLVNTFCQSCIPDTVWSIGYWLCYVNSTINPACYALCNATFKKTFRHLLLCQYRNIGTAR
421419,P08173,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Kd,25118.8643150958,nM,IUPHAR,16,345,9224827,Vinburnine,71203.0,C19H22N2O,294.398,"(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one",CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,"InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1",3.0,0.0,2.0,Muscarinic acetylcholine receptor M4,CHRM4,Homo sapiens (Human),MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTVYIIKGYWPLGAVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPARRTTKMAGLMIAAAWVLSFVLWAPAILFWQFVVGKRTVPDNQCFIQFLSNPAVTFGTAIAAFYLPVVIMTVLYIHISLASRSRVHKHRPEGPKEKKAKTLAFLKSPLMKQSVKKPPPGEAAREELRNGKLEEAPPPALPPPPRPVADKDTSNESSSGSATQNTKERPATELSTTEATTPAMPAPPLQPRALNPASRWSKIQIVTKQTGNECVTAIEIVPATPAGMRPAANVARKFASIARNQVRKKRQMAARERKVTRTIFAILLAFILTWTPYNVMVLVNTFCQSCIPDTVWSIGYWLCYVNSTINPACYALCNATFKKTFRHLLLCQYRNIGTAR
426511,P20309,PGDYOGMNQCUWMZ-UHFFFAOYSA-N,Kd,63.1,nM,ChEMBL,CHEMBL245,CHEMBL386983,17149881,CHEMBL386983,16094788.0,C21H33N5O7S2,531.643,"3-methoxy-4-[2-[2-[2-[2-[2-[[4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazol-3-yl]oxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-1,2,5-thiadiazole",CN1CCC=C(C1)C2=NSN=C2OCCOCCOCCOCCOCCOC3=NSN=C3OC,CN1CCC=C(C1)C2=NSN=C2OCCOCCOCCOCCOCCOC3=NSN=C3OC,"InChI=1S/C21H33N5O7S2/c1-26-5-3-4-17(16-26)18-19(23-34-22-18)32-14-12-30-10-8-28-6-7-29-9-11-31-13-15-33-21-20(27-2)24-35-25-21/h4H,3,5-16H2,1-2H3",1.1,0.0,14.0,Muscarinic acetylcholine receptor M3,CHRM3,Homo sapiens (Human),MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL
429751,P20309,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Kd,6309.57344480193,nM,IUPHAR,15,345,9224827,Vinburnine,71203.0,C19H22N2O,294.398,"(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one",CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,"InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1",3.0,0.0,2.0,Muscarinic acetylcholine receptor M3,CHRM3,Homo sapiens (Human),MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL
430523,P20309,PXKKBPAWILJYFB-NRFANRHFSA-N,Kd,3.162,nM,ChEMBL,CHEMBL245,CHEMBL494022,19243945,CHEMBL494022,11650778.0,C29H35FN4O,474.624,3-[(dimethylamino)methyl]-N-[[4-fluoro-3-[3-[[(3S)-3-methylpiperazin-1-yl]methyl]phenyl]phenyl]methyl]benzamide,CC1CN(CCN1)CC2=CC=CC(=C2)C3=C(C=CC(=C3)CNC(=O)C4=CC(=CC=C4)CN(C)C)F,C[C@H]1CN(CCN1)CC2=CC=CC(=C2)C3=C(C=CC(=C3)CNC(=O)C4=CC(=CC=C4)CN(C)C)F,"InChI=1S/C29H35FN4O/c1-21-18-34(13-12-31-21)20-24-7-4-8-25(14-24)27-16-22(10-11-28(27)30)17-32-29(35)26-9-5-6-23(15-26)19-33(2)3/h4-11,14-16,21,31H,12-13,17-20H2,1-3H3,(H,32,35)/t21-/m0/s1",3.9,2.0,5.0,Muscarinic acetylcholine receptor M3,CHRM3,Homo sapiens (Human),MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL
431105,P10980,YNEYTRWEAGPFBC-KQDNUWKFSA-N,Kd,2.19,nM,ChEMBL,CHEMBL309,CHEMBL415038,"Bioorg. Med. Chem. Lett., (1993) 3:6:1247",CHEMBL415038,44457838.0,C22H25N,303.449,"(2S)-2-[(E)-2-(9,10-dihydroanthracen-9-yl)ethenyl]-1-methylpiperidine",CN1CCCCC1C=CC2C3=CC=CC=C3CC4=CC=CC=C24,CN1CCCC[C@H]1/C=C/C2C3=CC=CC=C3CC4=CC=CC=C24,"InChI=1S/C22H25N/c1-23-15-7-6-10-19(23)13-14-22-20-11-4-2-8-17(20)16-18-9-3-5-12-21(18)22/h2-5,8-9,11-14,19,22H,6-7,10,15-16H2,1H3/b14-13+/t19-/m0/s1",5.0,0.0,1.0,Muscarinic acetylcholine receptor M2,Chrm2,Rattus norvegicus (Rat),MNNSTNSSNNGLAITSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKEKKEPVANQDPVSPSLVQGRIVKPNNNNMPGGDGGLEHNKIQNGKAPRDGVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSRDDNSKQTCIKIVTKAQKGDVCTPTSTTVELVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
431257,P10980,OVUAAZZCKNENBY-LJQANCHMSA-N,Kd,14.5,nM,ChEMBL,CHEMBL309,CHEMBL279712,"Bioorg. Med. Chem. Lett., (1993) 3:6:1247",CHEMBL279712,44457850.0,C22H25N,303.449,(2R)-2-[2-(10H-anthracen-9-ylidene)ethyl]-1-methylpiperidine,CN1CCCCC1CC=C2C3=CC=CC=C3CC4=CC=CC=C42,CN1CCCC[C@@H]1CC=C2C3=CC=CC=C3CC4=CC=CC=C42,"InChI=1S/C22H25N/c1-23-15-7-6-10-19(23)13-14-22-20-11-4-2-8-17(20)16-18-9-3-5-12-21(18)22/h2-5,8-9,11-12,14,19H,6-7,10,13,15-16H2,1H3/t19-/m1/s1",5.0,0.0,1.0,Muscarinic acetylcholine receptor M2,Chrm2,Rattus norvegicus (Rat),MNNSTNSSNNGLAITSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKEKKEPVANQDPVSPSLVQGRIVKPNNNNMPGGDGGLEHNKIQNGKAPRDGVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSRDDNSKQTCIKIVTKAQKGDVCTPTSTTVELVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
431280,P10980,LWYKXKGPFMXVIY-WPRPVWTQSA-N,Kd,>100000,nM,ChEMBL,CHEMBL309,CHEMBL90409,1732522,CHEMBL90409,15021362.0,C11H17N3O,207.277,"(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]pyrrolidin-2-one",CCC1C(CNC1=O)CC2=CN=CN2C,CC[C@H]1[C@H](CNC1=O)CC2=CN=CN2C,"InChI=1S/C11H17N3O/c1-3-10-8(5-13-11(10)15)4-9-6-12-7-14(9)2/h6-8,10H,3-5H2,1-2H3,(H,13,15)/t8-,10-/m0/s1",0.5,1.0,2.0,Muscarinic acetylcholine receptor M2,Chrm2,Rattus norvegicus (Rat),MNNSTNSSNNGLAITSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKEKKEPVANQDPVSPSLVQGRIVKPNNNNMPGGDGGLEHNKIQNGKAPRDGVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSRDDNSKQTCIKIVTKAQKGDVCTPTSTTVELVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
437214,P08172,CHMIKIFFWBMPHB-UHFFFAOYSA-N,Kd,19.95,nM,ChEMBL,CHEMBL211,CHEMBL85892,12182854,CHEMBL85892,10049361.0,C25H25BrN2O,449.392,N-(1-benzylpiperidin-4-yl)-N-(4-bromophenyl)benzamide,C1CN(CCC1N(C2=CC=C(C=C2)Br)C(=O)C3=CC=CC=C3)CC4=CC=CC=C4,C1CN(CCC1N(C2=CC=C(C=C2)Br)C(=O)C3=CC=CC=C3)CC4=CC=CC=C4,"InChI=1S/C25H25BrN2O/c26-22-11-13-23(14-12-22)28(25(29)21-9-5-2-6-10-21)24-15-17-27(18-16-24)19-20-7-3-1-4-8-20/h1-14,24H,15-19H2",5.7,0.0,2.0,Muscarinic acetylcholine receptor M2,CHRM2,Homo sapiens (Human),MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
437221,P08172,WYJAPUKIYAZSEM-MOPGFXCFSA-N,Kd,63095.7344480193,nM,IUPHAR,14,345,9224827,Vinburnine,71203.0,C19H22N2O,294.398,"(15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one",CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2,"InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1",3.0,0.0,2.0,Muscarinic acetylcholine receptor M2,CHRM2,Homo sapiens (Human),MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
437478,P08172,LNYHYEQQDYJOII-UHFFFAOYSA-N,Kd,213.8,nM,ChEMBL,CHEMBL211,CHEMBL132377,9784091,CHEMBL132377,10722780.0,C38H62N4O4,638.938,6-[(2-methoxyphenyl)methylamino]-N-[8-[6-[(2-methoxyphenyl)methylamino]hexanoyl-methylamino]octyl]-N-methylhexanamide,CN(CCCCCCCCN(C)C(=O)CCCCCNCC1=CC=CC=C1OC)C(=O)CCCCCNCC2=CC=CC=C2OC,CN(CCCCCCCCN(C)C(=O)CCCCCNCC1=CC=CC=C1OC)C(=O)CCCCCNCC2=CC=CC=C2OC,"InChI=1S/C38H62N4O4/c1-41(37(43)25-11-9-17-27-39-31-33-21-13-15-23-35(33)45-3)29-19-7-5-6-8-20-30-42(2)38(44)26-12-10-18-28-40-32-34-22-14-16-24-36(34)46-4/h13-16,21-24,39-40H,5-12,17-20,25-32H2,1-4H3",5.8,2.0,6.0,Muscarinic acetylcholine receptor M2,CHRM2,Homo sapiens (Human),MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR
463419,P33533,STOXPPZNSYPOHZ-UHFFFAOYSA-N,Kd,2.3,nM,ChEMBL,CHEMBL269,CHEMBL129897,1331455,CHEMBL129897,20687026.0,C27H25N3O3S,471.575,"22-(cyclopropylmethyl)-9-isothiocyanato-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaene-2,16-diol",C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C(=CC=C8)N=C=S,C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C(=CC=C8)N=C=S,"InChI=1S/C27H25N3O3S/c31-19-7-6-15-10-20-27(32)11-17-16-2-1-3-18(28-13-34)22(16)29-23(17)25-26(27,21(15)24(19)33-25)8-9-30(20)12-14-4-5-14/h1-3,6-7,14,20,25,29,31-32H,4-5,8-12H2",4.7,3.0,6.0,Delta-type opioid receptor,Oprd1,Rattus norvegicus (Rat),MEPVPSARAELQFSLLANVSDTFPSAFPSASANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCTLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRAPCGGQEPGSLRRPRQATARERVTACTPSDGPGGGAAA
463421,P33533,STOXPPZNSYPOHZ-UHFFFAOYSA-N,Kd,15.7,nM,ChEMBL,CHEMBL269,CHEMBL129897,1331455,CHEMBL129897,20687026.0,C27H25N3O3S,471.575,"22-(cyclopropylmethyl)-9-isothiocyanato-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaene-2,16-diol",C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C(=CC=C8)N=C=S,C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C(=CC=C8)N=C=S,"InChI=1S/C27H25N3O3S/c31-19-7-6-15-10-20-27(32)11-17-16-2-1-3-18(28-13-34)22(16)29-23(17)25-26(27,21(15)24(19)33-25)8-9-30(20)12-14-4-5-14/h1-3,6-7,14,20,25,29,31-32H,4-5,8-12H2",4.7,3.0,6.0,Delta-type opioid receptor,Oprd1,Rattus norvegicus (Rat),MEPVPSARAELQFSLLANVSDTFPSAFPSASANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCTLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRAPCGGQEPGSLRRPRQATARERVTACTPSDGPGGGAAA
463422,P33533,STOXPPZNSYPOHZ-UHFFFAOYSA-N,Kd,60.8,nM,ChEMBL,CHEMBL269,CHEMBL129897,1331455,CHEMBL129897,20687026.0,C27H25N3O3S,471.575,"22-(cyclopropylmethyl)-9-isothiocyanato-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5(10),6,8,15,17,19(25)-heptaene-2,16-diol",C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C(=CC=C8)N=C=S,C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C(=CC=C8)N=C=S,"InChI=1S/C27H25N3O3S/c31-19-7-6-15-10-20-27(32)11-17-16-2-1-3-18(28-13-34)22(16)29-23(17)25-26(27,21(15)24(19)33-25)8-9-30(20)12-14-4-5-14/h1-3,6-7,14,20,25,29,31-32H,4-5,8-12H2",4.7,3.0,6.0,Delta-type opioid receptor,Oprd1,Rattus norvegicus (Rat),MEPVPSARAELQFSLLANVSDTFPSAFPSASANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCTLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRAPCGGQEPGSLRRPRQATARERVTACTPSDGPGGGAAA
467605,P41144,BNAKCEFXXMHXDQ-OAQYLSRUSA-N,Kd,2.43,nM,ChEMBL,CHEMBL3952,CHEMBL38521,7799399,DIPPA,127914.0,C22H23Cl2N3OS,448.406,"2-(3,4-dichlorophenyl)-N-[(1S)-1-(3-isothiocyanatophenyl)-2-pyrrolidin-1-ylethyl]-N-methylacetamide",CN(C(CN1CCCC1)C2=CC(=CC=C2)N=C=S)C(=O)CC3=CC(=C(C=C3)Cl)Cl,CN([C@H](CN1CCCC1)C2=CC(=CC=C2)N=C=S)C(=O)CC3=CC(=C(C=C3)Cl)Cl,"InChI=1S/C22H23Cl2N3OS/c1-26(22(28)12-16-7-8-19(23)20(24)11-16)21(14-27-9-2-3-10-27)17-5-4-6-18(13-17)25-15-29/h4-8,11,13,21H,2-3,9-10,12,14H2,1H3/t21-/m1/s1",6.0,0.0,4.0,Kappa-type opioid receptor,OPRK1,Cavia porcellus (Guinea pig),MGRRRQGPAQPASELPARNACLLPNGSAWLPGWAEPDGNGSAGPQDEQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIILGGTKVREDVDIIECSLQFPDDDYSWWDLFMKICVFVFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFIICWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPIKMRMERQSTSRVRNTVQDPAYMRNVDGVNKPV
467734,P41144,DZIVFTSZIVQCKX-QBGQUKIHSA-N,Kd,3722,nM,ChEMBL,CHEMBL3952,CHEMBL430475,10571174,CHEMBL430475,44334383.0,C26H35N3O,405.586,"N,N-diethyl-4-(N-[(4S)-3-methyl-1-prop-2-enylpiperidin-4-yl]anilino)benzamide",CCN(CC)C(=O)C1=CC=C(C=C1)N(C2CCN(CC2C)CC=C)C3=CC=CC=C3,CCN(CC)C(=O)C1=CC=C(C=C1)N([C@H]2CCN(CC2C)CC=C)C3=CC=CC=C3,"InChI=1S/C26H35N3O/c1-5-18-27-19-17-25(21(4)20-27)29(23-11-9-8-10-12-23)24-15-13-22(14-16-24)26(30)28(6-2)7-3/h5,8-16,21,25H,1,6-7,17-20H2,2-4H3/t21?,25-/m0/s1",5.5,0.0,3.0,Kappa-type opioid receptor,OPRK1,Cavia porcellus (Guinea pig),MGRRRQGPAQPASELPARNACLLPNGSAWLPGWAEPDGNGSAGPQDEQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIILGGTKVREDVDIIECSLQFPDDDYSWWDLFMKICVFVFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFIICWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPIKMRMERQSTSRVRNTVQDPAYMRNVDGVNKPV
472708,P32300,MVEIALIQEDSFAK-QXUSSCGESA-N,Kd,616.6,nM,ChEMBL,CHEMBL3222,CHEMBL2028967,16942034,CHEMBL2028967,70689891.0,C42H49N5O6,719.883,"benzyl N-[(5S)-5-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-6-(benzylamino)-6-oxohexyl]carbamate",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)OCC4=CC=CC=C4)C(=O)NCC5=CC=CC=C5)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@@H](CCCCNC(=O)OCC4=CC=CC=C4)C(=O)NCC5=CC=CC=C5)N)C)O,"InChI=1S/C42H49N5O6/c1-28-21-34(48)22-29(2)35(28)24-36(43)41(51)47-26-33-18-10-9-17-32(33)23-38(47)40(50)46-37(39(49)45-25-30-13-5-3-6-14-30)19-11-12-20-44-42(52)53-27-31-15-7-4-8-16-31/h3-10,13-18,21-22,36-38,48H,11-12,19-20,23-27,43H2,1-2H3,(H,44,52)(H,45,49)(H,46,50)/t36-,37-,38-/m0/s1",5.2,5.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
472727,P32300,ZBEAXZAFQYRZBS-YJIIWGRFSA-N,Kd,25.12,nM,ChEMBL,CHEMBL3222,CHEMBL3797228,27234885,CHEMBL3797228,127046953.0,C27H30N2O2,414.549,"3-[(1R,9R,13R)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-N-naphthalen-1-ylpropanamide",CC1C2CC3=C(C1(CCN2CCC(=O)NC4=CC=CC5=CC=CC=C54)C)C=C(C=C3)O,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CCC(=O)NC4=CC=CC5=CC=CC=C54)C)C=C(C=C3)O,"InChI=1S/C27H30N2O2/c1-18-25-16-20-10-11-21(30)17-23(20)27(18,2)13-15-29(25)14-12-26(31)28-24-9-5-7-19-6-3-4-8-22(19)24/h3-11,17-18,25,30H,12-16H2,1-2H3,(H,28,31)/t18-,25+,27+/m0/s1",3.9,2.0,3.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
473353,P32300,DANFDLDCLSODGV-IGKIAQTJSA-N,Kd,4.786,nM,ChEMBL,CHEMBL3222,CHEMBL607403,11806723,CHEMBL607403,11016690.0,C30H33N5O3,511.626,"(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-N-[2-(1H-benzimidazol-2-yl)ethyl]-3,4-dihydro-1H-isoquinoline-3-carboxamide",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCC4=NC5=CC=CC=C5N4)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)NCCC4=NC5=CC=CC=C5N4)N)C)O,"InChI=1S/C30H33N5O3/c1-18-13-22(36)14-19(2)23(18)16-24(31)30(38)35-17-21-8-4-3-7-20(21)15-27(35)29(37)32-12-11-28-33-25-9-5-6-10-26(25)34-28/h3-10,13-14,24,27,36H,11-12,15-17,31H2,1-2H3,(H,32,37)(H,33,34)/t24-,27-/m0/s1",3.6,4.0,5.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
473470,P32300,YMUGYNHZXSBYNF-LENAEUCASA-N,Kd,1.622,nM,ChEMBL,CHEMBL3222,CHEMBL556063,19642675,CHEMBL556063,45273693.0,C37H37N5O4,615.734,"(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-N-[(2S)-1-(1H-benzimidazol-2-yl)-1-oxo-3-phenylpropan-2-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC4=CC=CC=C4)C(=O)C5=NC6=CC=CC=C6N5)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)C5=NC6=CC=CC=C6N5)N)C)O,"InChI=1S/C37H37N5O4/c1-22-16-27(43)17-23(2)28(22)20-29(38)37(46)42-21-26-13-7-6-12-25(26)19-33(42)36(45)41-32(18-24-10-4-3-5-11-24)34(44)35-39-30-14-8-9-15-31(30)40-35/h3-17,29,32-33,43H,18-21,38H2,1-2H3,(H,39,40)(H,41,45)/t29-,32-,33-/m0/s1",5.4,4.0,6.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
473717,P32300,ULBJIWJGABTABW-WOFUPGFCSA-N,Kd,15.14,nM,ChEMBL,CHEMBL3222,CHEMBL438681,17339114,CHEMBL438681,44431288.0,C41H46N6O5,702.856,"benzyl N-[(1S)-5-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-1-(1H-benzimidazol-2-yl)pentyl]carbamate",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCC(C4=NC5=CC=CC=C5N4)NC(=O)OCC6=CC=CC=C6)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)NCCCC[C@@H](C4=NC5=CC=CC=C5N4)NC(=O)OCC6=CC=CC=C6)N)C)O,"InChI=1S/C41H46N6O5/c1-26-20-31(48)21-27(2)32(26)23-33(42)40(50)47-24-30-15-7-6-14-29(30)22-37(47)39(49)43-19-11-10-18-36(38-44-34-16-8-9-17-35(34)45-38)46-41(51)52-25-28-12-4-3-5-13-28/h3-9,12-17,20-21,33,36-37,48H,10-11,18-19,22-25,42H2,1-2H3,(H,43,49)(H,44,45)(H,46,51)/t33-,36-,37-/m0/s1",5.5,5.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
474440,P32300,HEKBLCZSNQVJKZ-IARZGTGTSA-N,Kd,8.71,nM,ChEMBL,CHEMBL3222,CHEMBL502302,18680274,CHEMBL502302,25033947.0,C32H36N4O6,572.662,"(3R)-3-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-4-(N-methylanilino)-4-oxobutanoic acid",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)N(C)C4=CC=CC=C4)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@H](CC(=O)O)C(=O)N(C)C4=CC=CC=C4)N)C)O,"InChI=1S/C32H36N4O6/c1-19-13-24(37)14-20(2)25(19)16-26(33)31(41)36-18-22-10-8-7-9-21(22)15-28(36)30(40)34-27(17-29(38)39)32(42)35(3)23-11-5-4-6-12-23/h4-14,26-28,37H,15-18,33H2,1-3H3,(H,34,40)(H,38,39)/t26-,27+,28-/m0/s1",0.4,4.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
474496,P32300,JQERUKPESNWSQA-UIOOFZCWSA-N,Kd,33.88,nM,ChEMBL,CHEMBL3222,CHEMBL501451,11806723,H-Dmt-Tic-Gly-NH-Ph,11016572.0,C29H32N4O4,500.599,"(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-N-(2-anilino-2-oxoethyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NC4=CC=CC=C4)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)NCC(=O)NC4=CC=CC=C4)N)C)O,"InChI=1S/C29H32N4O4/c1-18-12-23(34)13-19(2)24(18)15-25(30)29(37)33-17-21-9-7-6-8-20(21)14-26(33)28(36)31-16-27(35)32-22-10-4-3-5-11-22/h3-13,25-26,34H,14-17,30H2,1-2H3,(H,31,36)(H,32,35)/t25-,26-/m0/s1",3.0,4.0,5.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
474518,P32300,JKBJCPFUZMWEMK-TXIPYEPDSA-N,Kd,1.585,nM,ChEMBL,CHEMBL3222,CHEMBL225479,15588089,CHEMBL225479,44421433.0,C31H43N5O6,581.714,"(4S)-4-[[2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-5-(5-aminopentylamino)-5-oxopentanoic acid",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCC(=O)O)C(=O)NCCCCCN)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3CC2C(=O)N[C@@H](CCC(=O)O)C(=O)NCCCCCN)N)C)O,"InChI=1S/C31H43N5O6/c1-19-14-23(37)15-20(2)24(19)17-25(33)31(42)36-18-22-9-5-4-8-21(22)16-27(36)30(41)35-26(10-11-28(38)39)29(40)34-13-7-3-6-12-32/h4-5,8-9,14-15,25-27,37H,3,6-7,10-13,16-18,32-33H2,1-2H3,(H,34,40)(H,35,41)(H,38,39)/t25-,26-,27?/m0/s1",-0.8,6.0,8.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
474688,P32300,VSPCTLNQMKBUFW-ORYMTKCHSA-N,Kd,87.1,nM,ChEMBL,CHEMBL3222,CHEMBL388800,17497839,Dmt-Pro-Dmt-Phe-NH2,44424810.0,C35H43N5O6,629.758,"(2S)-1-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(4-hydroxy-2-methylphenyl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide",CC1=CC(=CC(=C1CC(C(=O)N2CCCC2C(=O)NC(CC3=C(C=C(C=C3)O)C)C(=O)NC(CC4=CC=CC=C4)C(=O)N)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=C(C=C(C=C3)O)C)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N)N)C)O,"InChI=1S/C35H43N5O6/c1-20-14-25(41)12-11-24(20)18-30(33(44)38-29(32(37)43)17-23-8-5-4-6-9-23)39-34(45)31-10-7-13-40(31)35(46)28(36)19-27-21(2)15-26(42)16-22(27)3/h4-6,8-9,11-12,14-16,28-31,41-42H,7,10,13,17-19,36H2,1-3H3,(H2,37,43)(H,38,44)(H,39,45)/t28-,29-,30-,31-/m0/s1",3.3,6.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
475059,P32300,OLHDSEHCXLLTLE-QKDODKLFSA-N,Kd,2570.4,nM,ChEMBL,CHEMBL3222,CHEMBL111028,11212102,CHEMBL111028,44340096.0,C32H45N5O7,611.74,"(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-(2,6-dimethylphenyl)propanoyl]amino]-4-methylpentanoic acid",CC1=C(C(=CC=C1)C)CC(C(=O)NC(CC(C)C)C(=O)O)NC(=O)CNC(=O)CNC(=O)C(CC2=C(C=C(C=C2C)O)C)N,CC1=C(C(=CC=C1)C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=C(C=C(C=C2C)O)C)N,"InChI=1S/C32H45N5O7/c1-17(2)10-27(32(43)44)37-31(42)26(14-24-18(3)8-7-9-19(24)4)36-29(40)16-34-28(39)15-35-30(41)25(33)13-23-20(5)11-22(38)12-21(23)6/h7-9,11-12,17,25-27,38H,10,13-16,33H2,1-6H3,(H,34,39)(H,35,41)(H,36,40)(H,37,42)(H,43,44)/t25-,26-,27-/m0/s1",0.8,7.0,8.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
475302,P32300,FLBOXTBSDMMGNU-UJLGHMMASA-N,Kd,3.162,nM,ChEMBL,CHEMBL3222,CHEMBL469027,18637671,CHEMBL469027,24949687.0,C30H32N2O3,468.597,"(1S,2S,16R,24R)-25-(cyclopropylmethyl)-17-oxa-14,25-diazaoctacyclo[16.9.1.15,9.01,16.02,24.04,15.022,28.014,29]nonacosa-4(15),5,7,9(29),18,20,22(28)-heptaene-2,19-diol",C1CCN2C3=C(CC4(C5CC6=C7C4(C3OC7=C(C=C6)O)CCN5CC8CC8)O)C9=C2C(=CC=C9)C1,C1CCN2C3=C(C[C@]4([C@H]5CC6=C7[C@]4([C@H]3OC7=C(C=C6)O)CCN5CC8CC8)O)C9=C2C(=CC=C9)C1,"InChI=1S/C30H32N2O3/c33-22-10-9-19-14-23-30(34)15-21-20-6-3-5-18-4-1-2-12-32(25(18)20)26(21)28-29(30,24(19)27(22)35-28)11-13-31(23)16-17-7-8-17/h3,5-6,9-10,17,23,28,33-34H,1-2,4,7-8,11-16H2/t23-,28+,29+,30-/m1/s1",3.9,2.0,4.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
475344,P32300,ILXRQRZSIAELNE-IBGZPJMESA-N,Kd,616.6,nM,ChEMBL,CHEMBL3222,CHEMBL92707,11133082,CHEMBL92707,44325572.0,C20H23FN2O2,342.414,"(2S)-2-amino-1-(7-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-3-(4-hydroxy-2,6-dimethylphenyl)propan-1-one",CC1=CC(=CC(=C1CC(C(=O)N2CCC3=C(C2)C=C(C=C3)F)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CCC3=C(C2)C=C(C=C3)F)N)C)O,"InChI=1S/C20H23FN2O2/c1-12-7-17(24)8-13(2)18(12)10-19(22)20(25)23-6-5-14-3-4-16(21)9-15(14)11-23/h3-4,7-9,19,24H,5-6,10-11,22H2,1-2H3/t19-/m0/s1",2.8,2.0,4.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
475526,P32300,XLVQVCOZHAPLOB-NQERJWCQSA-N,Kd,10,nM,ChEMBL,CHEMBL3222,CHEMBL606601,15267245,CHEMBL606601,10950220.0,C24H30N4O4,438.528,"(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]-3,4-dihydro-1H-isoquinoline-3-carboxamide",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C)C(=O)N)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@H](C)C(=O)N)N)C)O,"InChI=1S/C24H30N4O4/c1-13-8-18(29)9-14(2)19(13)11-20(25)24(32)28-12-17-7-5-4-6-16(17)10-21(28)23(31)27-15(3)22(26)30/h4-9,15,20-21,29H,10-12,25H2,1-3H3,(H2,26,30)(H,27,31)/t15-,20+,21+/m1/s1",1.4,4.0,5.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
475816,P32300,RBFLTKCFTXQSNZ-KCHLEUMXSA-N,Kd,2.951,nM,ChEMBL,CHEMBL3222,CHEMBL450566,18680274,H-Dmt-Tic-Asp-NH-Bzl,25034010.0,C32H36N4O6,572.662,"(3S)-3-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-4-(benzylamino)-4-oxobutanoic acid",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)NCC4=CC=CC=C4)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@@H](CC(=O)O)C(=O)NCC4=CC=CC=C4)N)C)O,"InChI=1S/C32H36N4O6/c1-19-12-24(37)13-20(2)25(19)15-26(33)32(42)36-18-23-11-7-6-10-22(23)14-28(36)31(41)35-27(16-29(38)39)30(40)34-17-21-8-4-3-5-9-21/h3-13,26-28,37H,14-18,33H2,1-2H3,(H,34,40)(H,35,41)(H,38,39)/t26-,27-,28-/m0/s1",0.2,5.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
476089,P32300,XFKPEXYNTQLONY-YIOBJHAYSA-N,Kd,0.2239,nM,ChEMBL,CHEMBL3222,CHEMBL499099,18680274,CHEMBL499099,25034016.0,C32H35N5O5,569.662,"(3R)-3-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-(1-methylbenzimidazol-2-yl)propanoic acid",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C4=NC5=CC=CC=C5N4C)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@H](CC(=O)O)C4=NC5=CC=CC=C5N4C)N)C)O,"InChI=1S/C32H35N5O5/c1-18-12-22(38)13-19(2)23(18)15-24(33)32(42)37-17-21-9-5-4-8-20(21)14-28(37)31(41)35-26(16-29(39)40)30-34-25-10-6-7-11-27(25)36(30)3/h4-13,24,26,28,38H,14-17,33H2,1-3H3,(H,35,41)(H,39,40)/t24-,26+,28-/m0/s1",0.4,4.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
476282,P32300,GKMIMMIVGJGXPV-HBMCJLEFSA-N,Kd,5.888,nM,ChEMBL,CHEMBL3222,CHEMBL2369980,15267245,CHEMBL2369980,11784954.0,C25H30N4O6,482.537,"(2R)-4-amino-2-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-4-oxobutanoic acid",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)N)C(=O)O)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@H](CC(=O)N)C(=O)O)N)C)O,"InChI=1S/C25H30N4O6/c1-13-7-17(30)8-14(2)18(13)10-19(26)24(33)29-12-16-6-4-3-5-15(16)9-21(29)23(32)28-20(25(34)35)11-22(27)31/h3-8,19-21,30H,9-12,26H2,1-2H3,(H2,27,31)(H,28,32)(H,34,35)/t19-,20+,21-/m0/s1",-1.7,5.0,7.0,Delta-type opioid receptor,Oprd1,Mus musculus (Mouse),MELVPSARAELQSSPLVNLSDAFPSAFPSAGANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRTPCGRQEPGSLRRPRQATTRERVTACTPSDGPGGGAAA
477044,P97266,MVEIALIQEDSFAK-QXUSSCGESA-N,Kd,1513.56,nM,ChEMBL,CHEMBL4354,CHEMBL2028967,16942034,CHEMBL2028967,70689891.0,C42H49N5O6,719.883,"benzyl N-[(5S)-5-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-6-(benzylamino)-6-oxohexyl]carbamate",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)OCC4=CC=CC=C4)C(=O)NCC5=CC=CC=C5)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)N[C@@H](CCCCNC(=O)OCC4=CC=CC=C4)C(=O)NCC5=CC=CC=C5)N)C)O,"InChI=1S/C42H49N5O6/c1-28-21-34(48)22-29(2)35(28)24-36(43)41(51)47-26-33-18-10-9-17-32(33)23-38(47)40(50)46-37(39(49)45-25-30-13-5-3-6-14-30)19-11-12-20-44-42(52)53-27-31-15-7-4-8-16-31/h3-10,13-18,21-22,36-38,48H,11-12,19-20,23-27,43H2,1-2H3,(H,44,52)(H,45,49)(H,46,50)/t36-,37-,38-/m0/s1",5.2,5.0,7.0,Mu-type opioid receptor,OPRM1,Cavia porcellus (Guinea pig),YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
477083,P97266,ZBEAXZAFQYRZBS-YJIIWGRFSA-N,Kd,2.512,nM,ChEMBL,CHEMBL4354,CHEMBL3797228,27234885,CHEMBL3797228,127046953.0,C27H30N2O2,414.549,"3-[(1R,9R,13R)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]-N-naphthalen-1-ylpropanamide",CC1C2CC3=C(C1(CCN2CCC(=O)NC4=CC=CC5=CC=CC=C54)C)C=C(C=C3)O,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CCC(=O)NC4=CC=CC5=CC=CC=C54)C)C=C(C=C3)O,"InChI=1S/C27H30N2O2/c1-18-25-16-20-10-11-21(30)17-23(20)27(18,2)13-15-29(25)14-12-26(31)28-24-9-5-7-19-6-3-4-8-22(19)24/h3-11,17-18,25,30H,12-16H2,1-2H3,(H,28,31)/t18-,25+,27+/m0/s1",3.9,2.0,3.0,Mu-type opioid receptor,OPRM1,Cavia porcellus (Guinea pig),YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
478160,P97266,DZIVFTSZIVQCKX-QBGQUKIHSA-N,Kd,4667,nM,ChEMBL,CHEMBL4354,CHEMBL430475,10571174,CHEMBL430475,44334383.0,C26H35N3O,405.586,"N,N-diethyl-4-(N-[(4S)-3-methyl-1-prop-2-enylpiperidin-4-yl]anilino)benzamide",CCN(CC)C(=O)C1=CC=C(C=C1)N(C2CCN(CC2C)CC=C)C3=CC=CC=C3,CCN(CC)C(=O)C1=CC=C(C=C1)N([C@H]2CCN(CC2C)CC=C)C3=CC=CC=C3,"InChI=1S/C26H35N3O/c1-5-18-27-19-17-25(21(4)20-27)29(23-11-9-8-10-12-23)24-15-13-22(14-16-24)26(30)28(6-2)7-3/h5,8-16,21,25H,1,6-7,17-20H2,2-4H3/t21?,25-/m0/s1",5.5,0.0,3.0,Mu-type opioid receptor,OPRM1,Cavia porcellus (Guinea pig),YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
478162,P97266,DZIVFTSZIVQCKX-QBGQUKIHSA-N,Kd,3500,nM,ChEMBL,CHEMBL4354,CHEMBL430475,10571174,CHEMBL430475,44334383.0,C26H35N3O,405.586,"N,N-diethyl-4-(N-[(4S)-3-methyl-1-prop-2-enylpiperidin-4-yl]anilino)benzamide",CCN(CC)C(=O)C1=CC=C(C=C1)N(C2CCN(CC2C)CC=C)C3=CC=CC=C3,CCN(CC)C(=O)C1=CC=C(C=C1)N([C@H]2CCN(CC2C)CC=C)C3=CC=CC=C3,"InChI=1S/C26H35N3O/c1-5-18-27-19-17-25(21(4)20-27)29(23-11-9-8-10-12-23)24-15-13-22(14-16-24)26(30)28(6-2)7-3/h5,8-16,21,25H,1,6-7,17-20H2,2-4H3/t21?,25-/m0/s1",5.5,0.0,3.0,Mu-type opioid receptor,OPRM1,Cavia porcellus (Guinea pig),YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
479890,P97266,OLHDSEHCXLLTLE-QKDODKLFSA-N,Kd,125.89,nM,ChEMBL,CHEMBL4354,CHEMBL111028,11212102,CHEMBL111028,44340096.0,C32H45N5O7,611.74,"(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-(2,6-dimethylphenyl)propanoyl]amino]-4-methylpentanoic acid",CC1=C(C(=CC=C1)C)CC(C(=O)NC(CC(C)C)C(=O)O)NC(=O)CNC(=O)CNC(=O)C(CC2=C(C=C(C=C2C)O)C)N,CC1=C(C(=CC=C1)C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=C(C=C(C=C2C)O)C)N,"InChI=1S/C32H45N5O7/c1-17(2)10-27(32(43)44)37-31(42)26(14-24-18(3)8-7-9-19(24)4)36-29(40)16-34-28(39)15-35-30(41)25(33)13-23-20(5)11-22(38)12-21(23)6/h7-9,11-12,17,25-27,38H,10,13-16,33H2,1-6H3,(H,34,39)(H,35,41)(H,36,40)(H,37,42)(H,43,44)/t25-,26-,27-/m0/s1",0.8,7.0,8.0,Mu-type opioid receptor,OPRM1,Cavia porcellus (Guinea pig),YTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKTVNVCNWI
487189,P41143,SQZBAUUHDXMUTO-FNHZYXHNSA-N,Kd,20,nM,ChEMBL,CHEMBL236,CHEMBL104042,20055417,CHEMBL104042,44336365.0,C19H25NO2,299.414,"(4aR,7aS,12bS)-3-(cyclopropylmethyl)-1,2,4,4a,5,6,7,7a-octahydro-[1]benzofuro[3,2-e]isoquinolin-9-ol",C1CC2CN(CCC23C(C1)OC4=C3C=CC=C4O)CC5CC5,C1C[C@H]2CN(CC[C@]23[C@H](C1)OC4=C3C=CC=C4O)CC5CC5,"InChI=1S/C19H25NO2/c21-16-5-2-4-15-18(16)22-17-6-1-3-14-12-20(11-13-7-8-13)10-9-19(14,15)17/h2,4-5,13-14,17,21H,1,3,6-12H2/t14-,17-,19-/m0/s1",3.5,1.0,3.0,Delta-type opioid receptor,OPRD1,Homo sapiens (Human),MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA
497000,P42866,JQERUKPESNWSQA-UIOOFZCWSA-N,Kd,0.912,nM,ChEMBL,CHEMBL2858,CHEMBL501451,11806723,H-Dmt-Tic-Gly-NH-Ph,11016572.0,C29H32N4O4,500.599,"(3S)-2-[(2S)-2-amino-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]-N-(2-anilino-2-oxoethyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide",CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NC4=CC=CC=C4)N)C)O,CC1=CC(=CC(=C1C[C@@H](C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)NCC(=O)NC4=CC=CC=C4)N)C)O,"InChI=1S/C29H32N4O4/c1-18-12-23(34)13-19(2)24(18)15-25(30)29(37)33-17-21-9-7-6-8-20(21)14-26(33)28(36)31-16-27(35)32-22-10-4-3-5-11-22/h3-13,25-26,34H,14-17,30H2,1-2H3,(H,31,36)(H,32,35)/t25-,26-/m0/s1",3.0,4.0,5.0,Mu-type opioid receptor,Oprm1,Mus musculus (Mouse),MDSSAGPGNISDCSDPLAPASCSPAPGSWLNLSHVDGNQSDPCGPNRTGLGGSHSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGNILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSARIRQNTREHPSTANTVDRTNHQLENLEAETAPLP
497291,P42866,FLBOXTBSDMMGNU-UJLGHMMASA-N,Kd,18.2,nM,ChEMBL,CHEMBL2858,CHEMBL469027,18637671,CHEMBL469027,24949687.0,C30H32N2O3,468.597,"(1S,2S,16R,24R)-25-(cyclopropylmethyl)-17-oxa-14,25-diazaoctacyclo[16.9.1.15,9.01,16.02,24.04,15.022,28.014,29]nonacosa-4(15),5,7,9(29),18,20,22(28)-heptaene-2,19-diol",C1CCN2C3=C(CC4(C5CC6=C7C4(C3OC7=C(C=C6)O)CCN5CC8CC8)O)C9=C2C(=CC=C9)C1,C1CCN2C3=C(C[C@]4([C@H]5CC6=C7[C@]4([C@H]3OC7=C(C=C6)O)CCN5CC8CC8)O)C9=C2C(=CC=C9)C1,"InChI=1S/C30H32N2O3/c33-22-10-9-19-14-23-30(34)15-21-20-6-3-5-18-4-1-2-12-32(25(18)20)26(21)28-29(30,24(19)27(22)35-28)11-13-31(23)16-17-7-8-17/h3,5-6,9-10,17,23,28,33-34H,1-2,4,7-8,11-16H2/t23-,28+,29+,30-/m1/s1",3.9,2.0,4.0,Mu-type opioid receptor,Oprm1,Mus musculus (Mouse),MDSSAGPGNISDCSDPLAPASCSPAPGSWLNLSHVDGNQSDPCGPNRTGLGGSHSLCPQTGSPSMVTAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGNILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIVNVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSARIRQNTREHPSTANTVDRTNHQLENLEAETAPLP
498374,P33534,FLBOXTBSDMMGNU-UJLGHMMASA-N,Kd,51.29,nM,ChEMBL,CHEMBL4329,CHEMBL469027,18637671,CHEMBL469027,24949687.0,C30H32N2O3,468.597,"(1S,2S,16R,24R)-25-(cyclopropylmethyl)-17-oxa-14,25-diazaoctacyclo[16.9.1.15,9.01,16.02,24.04,15.022,28.014,29]nonacosa-4(15),5,7,9(29),18,20,22(28)-heptaene-2,19-diol",C1CCN2C3=C(CC4(C5CC6=C7C4(C3OC7=C(C=C6)O)CCN5CC8CC8)O)C9=C2C(=CC=C9)C1,C1CCN2C3=C(C[C@]4([C@H]5CC6=C7[C@]4([C@H]3OC7=C(C=C6)O)CCN5CC8CC8)O)C9=C2C(=CC=C9)C1,"InChI=1S/C30H32N2O3/c33-22-10-9-19-14-23-30(34)15-21-20-6-3-5-18-4-1-2-12-32(25(18)20)26(21)28-29(30,24(19)27(22)35-28)11-13-31(23)16-17-7-8-17/h3,5-6,9-10,17,23,28,33-34H,1-2,4,7-8,11-16H2/t23-,28+,29+,30-/m1/s1",3.9,2.0,4.0,Kappa-type opioid receptor,Oprk1,Mus musculus (Mouse),MESPIQIFRGDPGPTCSPSACLLPNSSSWFPNWAESDSNGSVGSEDQQLESAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSAVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLASSVGISAIVLGGTKVREDVDVIECSLQFPDDEYSWWDLFMKICVFVFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITKLVLVVVAVFIICWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPVLYAFLDENFKRCFRDFCFPIKMRMERQSTNRVRNTVQDPASMRDVGGMNKPV
504234,P35372,SQZBAUUHDXMUTO-FNHZYXHNSA-N,Kd,0.22,nM,ChEMBL,CHEMBL233,CHEMBL104042,20055417,CHEMBL104042,44336365.0,C19H25NO2,299.414,"(4aR,7aS,12bS)-3-(cyclopropylmethyl)-1,2,4,4a,5,6,7,7a-octahydro-[1]benzofuro[3,2-e]isoquinolin-9-ol",C1CC2CN(CCC23C(C1)OC4=C3C=CC=C4O)CC5CC5,C1C[C@H]2CN(CC[C@]23[C@H](C1)OC4=C3C=CC=C4O)CC5CC5,"InChI=1S/C19H25NO2/c21-16-5-2-4-15-18(16)22-17-6-1-3-14-12-20(11-13-7-8-13)10-9-19(14,15)17/h2,4-5,13-14,17,21H,1,3,6-12H2/t14-,17-,19-/m0/s1",3.5,1.0,3.0,Mu-type opioid receptor,OPRM1,Homo sapiens (Human),MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
506270,P35372,VIYHDCFGTLGXJX-RTOPKKFASA-N,Kd,0.1905,nM,ChEMBL,CHEMBL233,CHEMBL476600,19217280,CHEMBL476600,25256790.0,C26H26N2O5,446.503,"[(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl] pyridine-2-carboxylate",C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)OC(=O)C7=CC=CC=N7,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)OC(=O)C7=CC=CC=N7,"InChI=1S/C26H26N2O5/c29-18-7-6-16-13-20-26(33-24(31)17-3-1-2-11-27-17)9-8-19(30)23-25(26,21(16)22(18)32-23)10-12-28(20)14-15-4-5-15/h1-3,6-7,11,15,20,23,29H,4-5,8-10,12-14H2/t20-,23+,25+,26-/m1/s1",3.4,1.0,7.0,Mu-type opioid receptor,OPRM1,Homo sapiens (Human),MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
509021,P35372,WRHNLIOZZWRRPX-HFXSLSFNSA-N,Kd,0.4571,nM,ChEMBL,CHEMBL233,CHEMBL443326,18298057,CHEMBL443326,24822965.0,C26H30N2O4S,466.596,"N-[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-2-thiophen-2-ylacetamide",C1CC1CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)NC(=O)CC7=CC=CS7,C1C[C@]2([C@H]3CC4=C5[C@@]2(CCN3CC6CC6)[C@H]([C@@H]1NC(=O)CC7=CC=CS7)OC5=C(C=C4)O)O,"InChI=1S/C26H30N2O4S/c29-19-6-5-16-12-20-26(31)8-7-18(27-21(30)13-17-2-1-11-33-17)24-25(26,22(16)23(19)32-24)9-10-28(20)14-15-3-4-15/h1-2,5-6,11,15,18,20,24,29,31H,3-4,7-10,12-14H2,(H,27,30)/t18-,20-,24+,25+,26-/m1/s1",0.9,3.0,6.0,Mu-type opioid receptor,OPRM1,Homo sapiens (Human),MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
524513,P79350,DHHKGYXJJAWJDM-FIYJTVGMSA-N,Kd,0.4,nM,ChEMBL,CHEMBL3041,CHEMBL2304424,"Bioorg. Med. Chem. Lett., (1995) 5:15:1695",CHEMBL2304424,71720326.0,C46H54N4O8S2,855.078,"N-[(4R,4aS,7aR,12bR)-3-(cyclopropylmethyl)-9-hydroxy-7a-methyl-7-oxo-1,2,4,5,6,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl]-2-[[2-[[(4R,4aS,7aR,12bR)-3-(cyclopropylmethyl)-9-hydroxy-7a-methyl-7-oxo-1,2,4,5,6,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl]amino]-2-oxoethyl]disulfanyl]acetamide",CC12C(=O)CCC3(C14CCN(C3CC5=C4C(=C(C=C5)O)O2)CC6CC6)NC(=O)CSSCC(=O)NC78CCC(=O)C9(C71CCN(C8CC2=C1C(=C(C=C2)O)O9)CC1CC1)C,C[C@]12C(=O)CC[C@@]3([C@]14CCN([C@@H]3CC5=C4C(=C(C=C5)O)O2)CC6CC6)NC(=O)CSSCC(=O)N[C@@]78CCC(=O)[C@]9([C@@]71CCN([C@@H]8CC2=C1C(=C(C=C2)O)O9)CC1CC1)C,"InChI=1S/C46H54N4O8S2/c1-41-33(53)11-13-45(31-19-27-7-9-29(51)39(57-41)37(27)43(41,45)15-17-49(31)21-25-3-4-25)47-35(55)23-59-60-24-36(56)48-46-14-12-34(54)42(2)44(46)16-18-50(22-26-5-6-26)32(46)20-28-8-10-30(52)40(58-42)38(28)44/h7-10,25-26,31-32,51-52H,3-6,11-24H2,1-2H3,(H,47,55)(H,48,56)/t31-,32-,41+,42+,43+,44+,45-,46-/m1/s1",4.0,4.0,12.0,Mu-type opioid receptor,OPRM1,Bos taurus (Bovine),MDSGAVPTNASNCTDPFTHPSSCSPAPSPSSWVNFSHLEGNLSDPCGPNRTELGGSDRLCPSAGSPSMITAIIIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDLRTPRNAKIINICNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPILIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALITIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSTIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETTPLP
539434,P25101,LKWYYULZSFFLFK-CQGCQBSQSA-N,Kd,0.158 - 0.25,nM,IUPHAR,219,1002,9489609,[125I]PD164333,10724142.0,C39H38INO11,821.634,"(Z)-2-(1,3-benzodioxol-5-yl)-3-[[3-[4-[2-(4-hydroxy-3-(125I)iodanylphenyl)ethylamino]-4-oxobutoxy]-4,5-dimethoxyphenyl]methyl]-4-(4-methoxyphenyl)-4-oxobut-2-enoic acid",COC1=CC=C(C=C1)C(=O)C(=C(C2=CC3=C(C=C2)OCO3)C(=O)O)CC4=CC(=C(C(=C4)OCCCC(=O)NCCC5=CC(=C(C=C5)O)I)OC)OC,COC1=CC=C(C=C1)C(=O)/C(=C(/C2=CC3=C(C=C2)OCO3)\C(=O)O)/CC4=CC(=C(C(=C4)OCCCC(=O)NCCC5=CC(=C(C=C5)O)[125I])OC)OC,"InChI=1S/C39H38INO11/c1-47-27-10-7-25(8-11-27)37(44)28(36(39(45)46)26-9-13-31-32(21-26)52-22-51-31)17-24-19-33(48-2)38(49-3)34(20-24)50-16-4-5-35(43)41-15-14-23-6-12-30(42)29(40)18-23/h6-13,18-21,42H,4-5,14-17,22H2,1-3H3,(H,41,43)(H,45,46)/b36-28-/i40-2",6.5,3.0,11.0,Endothelin-1 receptor,EDNRA,Homo sapiens (Human),METLCLRASFWLALVGCVISDNPERYSTNLSNHVDDFTTFRGTELSFLVTTHQPTNLVLPSNGSMHNYCPQQTKITSAFKYINTVISCTIFIVGMVGNATLLRIIYQNKCMRNGPNALIASLALGDLIYVVIDLPINVFKLLAGRWPFDHNDFGVFLCKLFPFLQKSSVGITVLNLCALSVDRYRAVASWSRVQGIGIPLVTAIEIVSIWILSFILAIPEAIGFVMVPFEYRGEQHKTCMLNATSKFMEFYQDVKDWWLFGFYFCMPLVCTAIFYTLMTCEMLNRRNGSLRIALSEHLKQRREVAKTVFCLVVIFALCWFPLHLSRILKKTVYNEMDKNRCELLSFLLLMDYIGINLATMNSCINPIALYFVSKKFKNCFQSCLCCCCYQSKSLMTSVPMNGTSIQWKNHDQNNHNTDRSSHKDSMN
540390,P30556,ZUJNXQOZVCUJHC-ATWPTAMPSA-N,Kd,>10000,nM,ChEMBL,CHEMBL227,CHEMBL410812,8709104,CHEMBL410812,44325480.0,C47H64N14O11,1001.116,"(2S)-2-[[(3R,6R,10R,12R)-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-imidazol-5-ylmethyl)-2,5,8-trioxo-1,4,9-triazabicyclo[8.2.1]tridecane-12-carbonyl]amino]-3-phenylpropanoic acid",CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC2CC(=O)NC3CC(N(C3)C(=O)C(NC2=O)CC4=CN=CN4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)CNC,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H]2CC(=O)N[C@@H]3C[C@@H](N(C3)C(=O)[C@H](NC2=O)CC4=CN=CN4)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC,"InChI=1S/C47H64N14O11/c1-25(2)39(60-40(65)31(55-38(64)22-50-3)10-7-15-52-47(48)49)44(69)57-32(16-27-11-13-30(62)14-12-27)41(66)56-33-20-37(63)54-29-19-36(43(68)59-35(46(71)72)17-26-8-5-4-6-9-26)61(23-29)45(70)34(58-42(33)67)18-28-21-51-24-53-28/h4-6,8-9,11-14,21,24-25,29,31-36,39,50,62H,7,10,15-20,22-23H2,1-3H3,(H,51,53)(H,54,63)(H,55,64)(H,56,66)(H,57,69)(H,58,67)(H,59,68)(H,60,65)(H,71,72)(H4,48,49,52)/t29-,31+,32+,33-,34-,35+,36-,39+/m1/s1",-3.6,13.0,14.0,Type-1 angiotensin II receptor,AGTR1,Homo sapiens (Human),MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
541087,P30556,XLXMXFXXYBNHJV-UHFFFAOYSA-N,Kd,3.162,nM,ChEMBL,CHEMBL227,CHEMBL12909,21071232,CHEMBL12909,9823146.0,C24H29N7,415.545,"5-[2-[4-[(2,5-dibutyl-1,2,4-triazol-3-yl)methyl]phenyl]phenyl]-2H-tetrazole",CCCCC1=NN(C(=N1)CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CCCC,CCCCC1=NN(C(=N1)CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CCCC,"InChI=1S/C24H29N7/c1-3-5-11-22-25-23(31(28-22)16-6-4-2)17-18-12-14-19(15-13-18)20-9-7-8-10-21(20)24-26-29-30-27-24/h7-10,12-15H,3-6,11,16-17H2,1-2H3,(H,26,27,29,30)",5.7,1.0,5.0,Type-1 angiotensin II receptor,AGTR1,Homo sapiens (Human),MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE
543431,P61169,OZVBMTJYIDMWIL-AYFBDAFISA-N,Kd,8,nM,ChEMBL,CHEMBL339,CHEMBL493,10956209,bromocriptine,31101.0,C32H40BrN5O5,654.606,"(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,"InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1",3.8,3.0,6.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
543432,P61169,OZVBMTJYIDMWIL-AYFBDAFISA-N,Kd,17,nM,ChEMBL,CHEMBL339,CHEMBL493,10956209,bromocriptine,31101.0,C32H40BrN5O5,654.606,"(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,"InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1",3.8,3.0,6.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
543434,P61169,OZVBMTJYIDMWIL-AYFBDAFISA-N,Kd,4,nM,ChEMBL,CHEMBL339,CHEMBL493,10956209,bromocriptine,31101.0,C32H40BrN5O5,654.606,"(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide",CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,"InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1",3.8,3.0,6.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
545771,P61169,GHWJEDJMOVUXEC-CYBMUJFWSA-N,Kd,3000,nM,ChEMBL,CHEMBL339,CHEMBL1160787,10956209,Biomol-NT_000029,12668019.0,C16H16ClNO2,289.759,"(5R)-9-chloro-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol",C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=CC=C3,C1CNC[C@@H](C2=CC(=C(C(=C21)Cl)O)O)C3=CC=CC=C3,"InChI=1S/C16H16ClNO2/c17-15-11-6-7-18-9-13(10-4-2-1-3-5-10)12(11)8-14(19)16(15)20/h1-5,8,13,18-20H,6-7,9H2/t13-/m1/s1",2.7,3.0,3.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
545772,P61169,GHWJEDJMOVUXEC-CYBMUJFWSA-N,Kd,13000,nM,ChEMBL,CHEMBL339,CHEMBL1160787,10956209,Biomol-NT_000029,12668019.0,C16H16ClNO2,289.759,"(5R)-9-chloro-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol",C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=CC=C3,C1CNC[C@@H](C2=CC(=C(C(=C21)Cl)O)O)C3=CC=CC=C3,"InChI=1S/C16H16ClNO2/c17-15-11-6-7-18-9-13(10-4-2-1-3-5-10)12(11)8-14(19)16(15)20/h1-5,8,13,18-20H,6-7,9H2/t13-/m1/s1",2.7,3.0,3.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
547598,P61169,HJWHHQIVUHOBQN-MRXNPFEDSA-N,Kd,500,nM,ChEMBL,CHEMBL339,CHEMBL317741,10956209,CHEMBL317741,44331310.0,C19H20ClNO2,329.824,"(5R)-9-chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol",C=CCN1CCC2=C(C(=C(C=C2C(C1)C3=CC=CC=C3)O)O)Cl,C=CCN1CCC2=C(C(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)O)Cl,"InChI=1S/C19H20ClNO2/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13/h2-7,11,16,22-23H,1,8-10,12H2/t16-/m1/s1",3.9,2.0,3.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
547602,P61169,HJWHHQIVUHOBQN-MRXNPFEDSA-N,Kd,400,nM,ChEMBL,CHEMBL339,CHEMBL317741,10956209,CHEMBL317741,44331310.0,C19H20ClNO2,329.824,"(5R)-9-chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol",C=CCN1CCC2=C(C(=C(C=C2C(C1)C3=CC=CC=C3)O)O)Cl,C=CCN1CCC2=C(C(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)O)Cl,"InChI=1S/C19H20ClNO2/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13/h2-7,11,16,22-23H,1,8-10,12H2/t16-/m1/s1",3.9,2.0,3.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
547604,P61169,HJWHHQIVUHOBQN-MRXNPFEDSA-N,Kd,1100,nM,ChEMBL,CHEMBL339,CHEMBL317741,10956209,CHEMBL317741,44331310.0,C19H20ClNO2,329.824,"(5R)-9-chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol",C=CCN1CCC2=C(C(=C(C=C2C(C1)C3=CC=CC=C3)O)O)Cl,C=CCN1CCC2=C(C(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)O)Cl,"InChI=1S/C19H20ClNO2/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13/h2-7,11,16,22-23H,1,8-10,12H2/t16-/m1/s1",3.9,2.0,3.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
547605,P61169,HJWHHQIVUHOBQN-MRXNPFEDSA-N,Kd,1600,nM,ChEMBL,CHEMBL339,CHEMBL317741,10956209,CHEMBL317741,44331310.0,C19H20ClNO2,329.824,"(5R)-9-chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol",C=CCN1CCC2=C(C(=C(C=C2C(C1)C3=CC=CC=C3)O)O)Cl,C=CCN1CCC2=C(C(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)O)Cl,"InChI=1S/C19H20ClNO2/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13/h2-7,11,16,22-23H,1,8-10,12H2/t16-/m1/s1",3.9,2.0,3.0,D(2) dopamine receptor,Drd2,Rattus norvegicus (Rat),MDPLNLSWYDDDLERQNWSRPFNGSEGKADRPHYNYYAMLLTLLIFIIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMIAIVWVLSFTISCPLLFGLNNTDQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRKRRKRVNTKRSSRAFRANLKTPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRMDAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSNPDSPAKPEKNGHAKIVNPRIAKFFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFMKILHC
558044,P29371,KIWPQCODGUAEAZ-IBGZPJMESA-N,Kd,16.22,nM,ChEMBL,CHEMBL4429,CHEMBL2203704,22574973,CHEMBL2203704,44241723.0,C31H33F7N4O3S,674.679,"2-[3,5-bis(trifluoromethyl)phenyl]-N-[4-(4-fluoro-2-methylphenyl)-6-[(3S)-3-methyl-4-methylsulfonylpiperazin-1-yl]pyridin-3-yl]-N,2-dimethylpropanamide",CC1CN(CCN1S(=O)(=O)C)C2=NC=C(C(=C2)C3=C(C=C(C=C3)F)C)N(C)C(=O)C(C)(C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,C[C@H]1CN(CCN1S(=O)(=O)C)C2=NC=C(C(=C2)C3=C(C=C(C=C3)F)C)N(C)C(=O)C(C)(C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,"InChI=1S/C31H33F7N4O3S/c1-18-11-23(32)7-8-24(18)25-15-27(41-9-10-42(19(2)17-41)46(6,44)45)39-16-26(25)40(5)28(43)29(3,4)20-12-21(30(33,34)35)14-22(13-20)31(36,37)38/h7-8,11-16,19H,9-10,17H2,1-6H3/t19-/m0/s1",6.5,0.0,13.0,Neuromedin-K receptor,TACR3,Homo sapiens (Human),MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGLPVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVTNYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIAVDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEGPKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKMMIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLNKRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADTTRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS
558400,P29371,HCGIROBRNBTDFG-NRFANRHFSA-N,Kd,120.23,nM,ChEMBL,CHEMBL4429,CHEMBL2203706,22574973,CHEMBL2203706,71453994.0,C29H28F7N3O2,583.551,"2-[3,5-bis(trifluoromethyl)phenyl]-N-[4-(4-fluoro-2-methylphenyl)-6-[(3S)-3-hydroxypyrrolidin-1-yl]pyridin-3-yl]-N,2-dimethylpropanamide",CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCC(C4)O,CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CC[C@@H](C4)O,"InChI=1S/C29H28F7N3O2/c1-16-9-20(30)5-6-22(16)23-13-25(39-8-7-21(40)15-39)37-14-24(23)38(4)26(41)27(2,3)17-10-18(28(31,32)33)12-19(11-17)29(34,35)36/h5-6,9-14,21,40H,7-8,15H2,1-4H3/t21-/m0/s1",6.6,1.0,11.0,Neuromedin-K receptor,TACR3,Homo sapiens (Human),MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGLPVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVTNYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIAVDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEGPKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKMMIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLNKRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADTTRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS
571125,P30543,YFOHBZPJQXLDMO-UHFFFAOYSA-N,Kd,158.49,nM,ChEMBL,CHEMBL302,CHEMBL262332,18226909,CHEMBL262332,44451283.0,C26H27N5O4,473.533,"1,3-dimethyl-6-[4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]phenyl]-5H-pyrrolo[3,2-d]pyrimidine-2,4-dione",CN1C2=C(C(=O)N(C1=O)C)NC(=C2)C3=CC=C(C=C3)OCC(=O)N4CCN(CC4)C5=CC=CC=C5,CN1C2=C(C(=O)N(C1=O)C)NC(=C2)C3=CC=C(C=C3)OCC(=O)N4CCN(CC4)C5=CC=CC=C5,"InChI=1S/C26H27N5O4/c1-28-22-16-21(27-24(22)25(33)29(2)26(28)34)18-8-10-20(11-9-18)35-17-23(32)31-14-12-30(13-15-31)19-6-4-3-5-7-19/h3-11,16,27H,12-15,17H2,1-2H3",2.7,1.0,5.0,Adenosine receptor A2a,Adora2a,Rattus norvegicus (Rat),MGSSVYITVELAIAVLAILGNVLVCWAVWINSNLQNVTNFFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGVRAKGIIAICWVLSFAIGLTPMLGWNNCSQKDGNSTKTCGEGRVTCLFEDVVPMNYMVYYNFFAFVLLPLLLMLAIYLRIFLAARRQLKQMESQPLPGERTRSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCSTCRHAPPWLMYLAIILSHSNSVVNPFIYAYRIREFRQTFRKIIRTHVLRRQEPFQAGGSSAWALAAHSTEGEQVSLRLNGHPLGVWANGSATHSGRRPNGYTLGLGGGGSAQGSPRDVELPTQERQEGQEHPGLRGHLVQARVGASSWSSEFAPS
575548,P30543,RVECQPQWOUQTSZ-QZIRHQCUSA-N,Kd,0.630957344480194,nM,IUPHAR,19,430,8848012,[125I]ZM-241385,73754992.0,C16H14IN7O2,461.24,"4-[2-[[7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino]ethyl]-2-(125I)iodanylphenol",C1=COC(=C1)C2=NN3C(=NC(=NC3=N2)NCCC4=CC(=C(C=C4)O)I)N,C1=COC(=C1)C2=NN3C(=NC(=NC3=N2)NCCC4=CC(=C(C=C4)O)[125I])N,"InChI=1S/C16H14IN7O2/c17-10-8-9(3-4-11(10)25)5-6-19-15-21-14(18)24-16(22-15)20-13(23-24)12-2-1-7-26-12/h1-4,7-8,25H,5-6H2,(H3,18,19,20,21,22,23)/i17-2",2.9,3.0,8.0,Adenosine receptor A2a,Adora2a,Rattus norvegicus (Rat),MGSSVYITVELAIAVLAILGNVLVCWAVWINSNLQNVTNFFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGVRAKGIIAICWVLSFAIGLTPMLGWNNCSQKDGNSTKTCGEGRVTCLFEDVVPMNYMVYYNFFAFVLLPLLLMLAIYLRIFLAARRQLKQMESQPLPGERTRSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCSTCRHAPPWLMYLAIILSHSNSVVNPFIYAYRIREFRQTFRKIIRTHVLRRQEPFQAGGSSAWALAAHSTEGEQVSLRLNGHPLGVWANGSATHSGRRPNGYTLGLGGGGSAQGSPRDVELPTQERQEGQEHPGLRGHLVQARVGASSWSSEFAPS
598234,P21462,VISXVQCNOWJSIZ-ZOHVZMGWSA-N,Kd,180,nM,ChEMBL,CHEMBL3359,CHEMBL3311293,25035262,CHEMBL3311293,118707161.0,C42H63N5O9,781.992,(2S)-2-[[(2R)-4-methyl-2-[[(2S)-2-[[(2R)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-[(2-methylpropan-2-yl)oxy]propanoic acid,CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(COC(C)(C)C)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C,CC(C)C[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](COC(C)(C)C)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OC(C)(C)C,"InChI=1S/C42H63N5O9/c1-26(2)21-30(44-38(51)33(24-29-19-15-12-16-20-29)47-40(54)56-42(8,9)10)35(48)45-32(23-28-17-13-11-14-18-28)37(50)43-31(22-27(3)4)36(49)46-34(39(52)53)25-55-41(5,6)7/h11-20,26-27,30-34H,21-25H2,1-10H3,(H,43,50)(H,44,51)(H,45,48)(H,46,49)(H,47,54)(H,52,53)/t30-,31-,32+,33+,34+/m1/s1",6.2,6.0,9.0,fMet-Leu-Phe receptor,FPR1,Homo sapiens (Human),METNSSLPTNISGGTPAVSAGYLFLDIITYLVFAVTFVLGVLGNGLVIWVAGFRMTHTVTTISYLNLAVADFCFTSTLPFFMVRKAMGGHWPFGWFLCKFVFTIVDINLFGSVFLIALIALDRCVCVLHPVWTQNHRTVSLAKKVIIGPWVMALLLTLPVIIRVTTVPGKTGTVACTFNFSPWTNDPKERINVAVAMLTVRGIIRFIIGFSAPMSIVAVSYGLIATKIHKQGLIKSSRPLRVLSFVAAAFFLCWSPYQVVALIATVRIRELLQGMYKEIGIAVDVTSALAFFNSCLNPMLYVFMGQDFRERLIHALPASLERALTEDSTQTSDTATNSTLPSAEVELQAK
598893,P21462,FLDXQDRQBMEWJC-WWBXDGBDSA-N,Kd,830,nM,ChEMBL,CHEMBL3359,CHEMBL3311288,25035262,CHEMBL3311288,118707155.0,C43H65N5O9,796.019,"(2S)-2-[[(2R)-4-methyl-2-[[(2S,3R)-2-[[(2R)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-[(2-methylpropan-2-yl)oxy]butanoyl]amino]pentanoyl]amino]-3-phenylpropanoic acid",CC(C)CC(C(=O)NC(C(C)OC(C)(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C,C[C@H]([C@@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OC(C)(C)C)OC(C)(C)C,"InChI=1S/C43H65N5O9/c1-26(2)22-31(36(49)46-34(40(53)54)25-30-20-16-13-17-21-30)45-39(52)35(28(5)56-42(6,7)8)48-38(51)32(23-27(3)4)44-37(50)33(24-29-18-14-12-15-19-29)47-41(55)57-43(9,10)11/h12-21,26-28,31-35H,22-25H2,1-11H3,(H,44,50)(H,45,52)(H,46,49)(H,47,55)(H,48,51)(H,53,54)/t28-,31-,32-,33+,34+,35+/m1/s1",6.6,6.0,9.0,fMet-Leu-Phe receptor,FPR1,Homo sapiens (Human),METNSSLPTNISGGTPAVSAGYLFLDIITYLVFAVTFVLGVLGNGLVIWVAGFRMTHTVTTISYLNLAVADFCFTSTLPFFMVRKAMGGHWPFGWFLCKFVFTIVDINLFGSVFLIALIALDRCVCVLHPVWTQNHRTVSLAKKVIIGPWVMALLLTLPVIIRVTTVPGKTGTVACTFNFSPWTNDPKERINVAVAMLTVRGIIRFIIGFSAPMSIVAVSYGLIATKIHKQGLIKSSRPLRVLSFVAAAFFLCWSPYQVVALIATVRIRELLQGMYKEIGIAVDVTSALAFFNSCLNPMLYVFMGQDFRERLIHALPASLERALTEDSTQTSDTATNSTLPSAEVELQAK
599101,P21462,PZKACXCYTPRRSR-DWCHZDDLSA-N,Kd,77,nM,ChEMBL,CHEMBL3359,CHEMBL3311295,25035262,CHEMBL3311295,118707163.0,C44H65N5O8,792.031,(2S)-3-cyclohexyl-2-[[(2R)-4-methyl-2-[[(2S)-2-[[(2R)-4-methyl-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]pentanoyl]amino]propanoic acid,CC(C)CC(C(=O)NC(CC1CCCCC1)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C,CC(C)C[C@H](C(=O)N[C@@H](CC1CCCCC1)C(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)OC(C)(C)C,"InChI=1S/C44H65N5O8/c1-28(2)23-33(46-41(53)36(26-31-19-13-9-14-20-31)49-43(56)57-44(5,6)7)38(50)47-35(25-30-17-11-8-12-18-30)40(52)45-34(24-29(3)4)39(51)48-37(42(54)55)27-32-21-15-10-16-22-32/h8-9,11-14,17-20,28-29,32-37H,10,15-16,21-27H2,1-7H3,(H,45,52)(H,46,53)(H,47,50)(H,48,51)(H,49,56)(H,54,55)/t33-,34-,35+,36+,37+/m1/s1",8.5,6.0,8.0,fMet-Leu-Phe receptor,FPR1,Homo sapiens (Human),METNSSLPTNISGGTPAVSAGYLFLDIITYLVFAVTFVLGVLGNGLVIWVAGFRMTHTVTTISYLNLAVADFCFTSTLPFFMVRKAMGGHWPFGWFLCKFVFTIVDINLFGSVFLIALIALDRCVCVLHPVWTQNHRTVSLAKKVIIGPWVMALLLTLPVIIRVTTVPGKTGTVACTFNFSPWTNDPKERINVAVAMLTVRGIIRFIIGFSAPMSIVAVSYGLIATKIHKQGLIKSSRPLRVLSFVAAAFFLCWSPYQVVALIATVRIRELLQGMYKEIGIAVDVTSALAFFNSCLNPMLYVFMGQDFRERLIHALPASLERALTEDSTQTSDTATNSTLPSAEVELQAK
599472,P30989,DYLJVOXRWLXDIG-UHFFFAOYSA-N,Kd,8.9,nM,ChEMBL,CHEMBL4123,CHEMBL506981,18809332,Meclinertant,119192.0,C32H31ClN4O5,587.073,"2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid",COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O,COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O,"InChI=1S/C32H31ClN4O5/c1-41-27-4-3-5-28(42-2)29(27)26-16-24(36-37(26)25-8-9-34-23-15-21(33)6-7-22(23)25)30(38)35-32(31(39)40)19-11-17-10-18(13-19)14-20(32)12-17/h3-9,15-20H,10-14H2,1-2H3,(H,35,38)(H,39,40)",5.8,2.0,7.0,Neurotensin receptor type 1,NTSR1,Homo sapiens (Human),MRLNSSAPGTPGTPAADPFQRAQAGLEEALLAPGFGNASGNASERVLAAPSSELDVNTDIYSKVLVTAVYLALFVVGTVGNTVTAFTLARKKSLQSLQSTVHYHLGSLALSDLLTLLLAMPVELYNFIWVHHPWAFGDAGCRGYYFLRDACTYATALNVASLSVERYLAICHPFKAKTLMSRSRTKKFISAIWLASALLAVPMLFTMGEQNRSADGQHAGGLVCTPTIHTATVKVVIQVNTFMSFIFPMVVISVLNTIIANKLTVMVRQAAEQGQVCTVGGEHSTFSMAIEPGRVQALRHGVRVLRAVVIAFVVCWLPYHVRRLMFCYISDEQWTPFLYDFYHYFYMVTNALFYVSSTINPILYNLVSANFRHIFLATLACLCPVWRRRRKRPAFSRKADSVSSNHTLSSNATRETLY
613617,P56450,LSXYNCPPYBOAHI-DYRRNQNHSA-N,Kd,158.49,nM,ChEMBL,CHEMBL3719,CHEMBL3577988,25898270,CHEMBL3577988,122178159.0,C56H68N12O9,1053.235,"2-[(3R,9S,12S,15S,18S,21S,24S,27S)-9,21-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-12-methyl-2,8,11,14,17,20,23,26-octaoxo-18-[(4-phenylphenyl)methyl]-1,7,10,13,16,19,22,25-octazatricyclo[25.3.0.03,7]triacontan-15-yl]acetamide",CC1C(=O)NC(C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CC4=CC=C(C=C4)C5=CC=CC=C5)CC6=CC=CC=C6)CCCN=C(N)N)CC7=CC=CC=C7,C[C@H]1C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CC4=CC=C(C=C4)C5=CC=CC=C5)CC6=CC=CC=C6)CCCN=C(N)N)CC7=CC=CC=C7,"InChI=1S/C56H68N12O9/c1-34-48(70)66-44(32-36-16-7-3-8-17-36)54(76)68-29-13-22-46(68)55(77)67-28-12-21-45(67)53(75)62-40(20-11-27-60-56(58)59)49(71)63-41(30-35-14-5-2-6-15-35)51(73)64-42(52(74)65-43(33-47(57)69)50(72)61-34)31-37-23-25-39(26-24-37)38-18-9-4-10-19-38/h2-10,14-19,23-26,34,40-46H,11-13,20-22,27-33H2,1H3,(H2,57,69)(H,61,72)(H,62,75)(H,63,71)(H,64,73)(H,65,74)(H,66,70)(H4,58,59,60)/t34-,40-,41-,42-,43-,44-,45-,46+/m0/s1",2.3,9.0,10.0,Melanocortin receptor 4,Mc4r,Mus musculus (Mouse),MNSTHHHGMYTSLHLWNRSSYGLHGNASESLGKGHPDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVRRVGIIISCIWAACTVSGVLFIIYSDSSAVIICLISMFFTMLVLMASLYVHMFLMARLHIKRIAVLPGTGTIRQGTNMKGAITLTILIGVFVVCWAPFFLHLLFYISCPQNPYCVCFMSHFNLYLILIMCNAVIDPLIYALRSQELRKTFKEIICFYPLGGICELSSRY
613777,P56450,NXFNNHLGYYKVIN-DYLMPHRMSA-N,Kd,501.19,nM,ChEMBL,CHEMBL3719,CHEMBL3422428,25699138,CHEMBL3422428,118735605.0,C43H48IN9O5,897.819,(2S)-2-[[(2R)-2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-3-(4-iodophenyl)propanoyl]amino]-N-[(2S)-1-amino-1-oxo-3-(4-phenylphenyl)propan-2-yl]-5-(diaminomethylideneamino)pentanamide,CC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=C(C=C3)I)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)C5=CC=CC=C5)C(=O)N,CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CC=C(C=C3)I)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC4=CC=C(C=C4)C5=CC=CC=C5)C(=O)N,"InChI=1S/C43H48IN9O5/c1-26(54)50-38(24-31-25-49-34-11-6-5-10-33(31)34)42(58)53-37(23-28-15-19-32(44)20-16-28)41(57)51-35(12-7-21-48-43(46)47)40(56)52-36(39(45)55)22-27-13-17-30(18-14-27)29-8-3-2-4-9-29/h2-6,8-11,13-20,25,35-38,49H,7,12,21-24H2,1H3,(H2,45,55)(H,50,54)(H,51,57)(H,52,56)(H,53,58)(H4,46,47,48)/t35-,36-,37+,38-/m0/s1",3.8,8.0,6.0,Melanocortin receptor 4,Mc4r,Mus musculus (Mouse),MNSTHHHGMYTSLHLWNRSSYGLHGNASESLGKGHPDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVRRVGIIISCIWAACTVSGVLFIIYSDSSAVIICLISMFFTMLVLMASLYVHMFLMARLHIKRIAVLPGTGTIRQGTNMKGAITLTILIGVFVVCWAPFFLHLLFYISCPQNPYCVCFMSHFNLYLILIMCNAVIDPLIYALRSQELRKTFKEIICFYPLGGICELSSRY
614517,P33033,LSXYNCPPYBOAHI-DYRRNQNHSA-N,Kd,>100000,nM,ChEMBL,CHEMBL4774,CHEMBL3577988,25898270,CHEMBL3577988,122178159.0,C56H68N12O9,1053.235,"2-[(3R,9S,12S,15S,18S,21S,24S,27S)-9,21-dibenzyl-24-[3-(diaminomethylideneamino)propyl]-12-methyl-2,8,11,14,17,20,23,26-octaoxo-18-[(4-phenylphenyl)methyl]-1,7,10,13,16,19,22,25-octazatricyclo[25.3.0.03,7]triacontan-15-yl]acetamide",CC1C(=O)NC(C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CC4=CC=C(C=C4)C5=CC=CC=C5)CC6=CC=CC=C6)CCCN=C(N)N)CC7=CC=CC=C7,C[C@H]1C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CC4=CC=C(C=C4)C5=CC=CC=C5)CC6=CC=CC=C6)CCCN=C(N)N)CC7=CC=CC=C7,"InChI=1S/C56H68N12O9/c1-34-48(70)66-44(32-36-16-7-3-8-17-36)54(76)68-29-13-22-46(68)55(77)67-28-12-21-45(67)53(75)62-40(20-11-27-60-56(58)59)49(71)63-41(30-35-14-5-2-6-15-35)51(73)64-42(52(74)65-43(33-47(57)69)50(72)61-34)31-37-23-25-39(26-24-37)38-18-9-4-10-19-38/h2-10,14-19,23-26,34,40-46H,11-13,20-22,27-33H2,1H3,(H2,57,69)(H,61,72)(H,62,75)(H,63,71)(H,64,73)(H,65,74)(H,66,70)(H4,58,59,60)/t34-,40-,41-,42-,43-,44-,45-,46+/m0/s1",2.3,9.0,10.0,Melanocortin receptor 3,Mc3r,Mus musculus (Mouse),MNSSCCLSSVSPMLPNLSEHPAAPPASNRSGSGFCEQVFIKPEVFLALGIVSLMENILVILAVVRNGNLHSPMYFFLCSLAAADMLVSLSNSLETIMIAVINSDSLTLEDQFIQHMDNIFDSMICISLVASICNLLAIAIDRYVTIFYALRYHSIMTVRKALTLIGVIWVCCGICGVMFIIYSESKMVIVCLITMFFAMVLLMGTLYIHMFLFARLHVQRIAVLPPAGVVAPQQHSCMKGAVTITILLGVFIFCWAPFFLHLVLIITCPTNPYCICYTAHFNTYLVLIMCNSVIDPLIYAFRSLELRNTFKEILCGCNSMNLG
615194,P34998,ANNRUWYFVIGKHA-UHFFFAOYSA-N,Kd,0.303,nM,ChEMBL,CHEMBL1800,CHEMBL309138,21889333,195055-03-9,9821250.0,C22H32N6,380.54,"3-[6-(dimethylamino)-4-methylpyridin-3-yl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine",CCCN(CCC)C1=CC(=NC2=C(C(=NN12)C)C3=CN=C(C=C3C)N(C)C)C,CCCN(CCC)C1=CC(=NC2=C(C(=NN12)C)C3=CN=C(C=C3C)N(C)C)C,"InChI=1S/C22H32N6/c1-8-10-27(11-9-2)20-13-16(4)24-22-21(17(5)25-28(20)22)18-14-23-19(26(6)7)12-15(18)3/h12-14H,8-11H2,1-7H3",4.7,0.0,5.0,Corticotropin-releasing factor receptor 1,CRHR1,Homo sapiens (Human),MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPEVHQSNVGWCRLVTAAYNYFHVTNFFWMFGEGCYLHTAIVLTYSTDRLRKWMFICIGWGVPFPIIVAWAIGKLYYDNEKCWFGKRPGVYTDYIYQGPMILVLLINFIFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGEDEVSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKRWHRWQDKHSIRARVARAMSIPTSPTRVSFHSIKQSTAV
617916,P34998,DXVNLEPWBPMCOF-UHFFFAOYSA-N,Kd,14,nM,ChEMBL,CHEMBL1800,CHEMBL568606,21889333,CHEMBL568606,45485040.0,C21H29N5O2,383.496,"N-(2-methoxyethyl)-1-(4-methoxy-2-methylphenyl)-3,6-dimethyl-N-propylpyrazolo[3,4-d]pyrimidin-4-amine",CCCN(CCOC)C1=NC(=NC2=C1C(=NN2C3=C(C=C(C=C3)OC)C)C)C,CCCN(CCOC)C1=NC(=NC2=C1C(=NN2C3=C(C=C(C=C3)OC)C)C)C,"InChI=1S/C21H29N5O2/c1-7-10-25(11-12-27-5)20-19-15(3)24-26(21(19)23-16(4)22-20)18-9-8-17(28-6)13-14(18)2/h8-9,13H,7,10-12H2,1-6H3",4.2,0.0,6.0,Corticotropin-releasing factor receptor 1,CRHR1,Homo sapiens (Human),MGGHPQLRLVKALLLLGLNPVSASLQDQHCESLSLASNISGLQCNASVDLIGTCWPRSPAGQLVVRPCPAFFYGVRYNTTNNGYRECLANGSWAARVNYSECQEILNEEKKSKVHYHVAVIINYLGHCISLVALLVAFVLFLRLRPGCTHWGDQADGALEVGAPWSGAPFQVRRSIRCLRNIIHWNLISAFILRNATWFVVQLTMSPEVHQSNVGWCRLVTAAYNYFHVTNFFWMFGEGCYLHTAIVLTYSTDRLRKWMFICIGWGVPFPIIVAWAIGKLYYDNEKCWFGKRPGVYTDYIYQGPMILVLLINFIFLFNIVRILMTKLRASTTSETIQYRKAVKATLVLLPLLGITYMLFFVNPGEDEVSRVVFIYFNSFLESFQGFFVSVFYCFLNSEVRSAIRKRWHRWQDKHSIRARVARAMSIPTSPTRVSFHSIKQSTAV
622498,P25103,UCDYNHPOUAKORZ-QLKFWGTOSA-O,Kd,540,nM,ChEMBL,CHEMBL249,CHEMBL294452,"Bioorg. Med. Chem. Lett., (1997) 7:14:1921",CHEMBL294452,44300055.0,C45H68N5O+,695.073,"tributyl-[[4-[[(2S)-2-[(N,N'-dicyclohexylcarbamimidoyl)amino]-3-naphthalen-2-ylpropanoyl]amino]phenyl]methyl]azanium",CCCC[N+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=NC4CCCCC4)NC5CCCCC5,CCCC[N+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)[C@H](CC2=CC3=CC=CC=C3C=C2)NC(=NC4CCCCC4)NC5CCCCC5,"InChI=1S/C45H67N5O/c1-4-7-30-50(31-8-5-2,32-9-6-3)35-36-25-28-42(29-26-36)46-44(51)43(34-37-24-27-38-18-16-17-19-39(38)33-37)49-45(47-40-20-12-10-13-21-40)48-41-22-14-11-15-23-41/h16-19,24-29,33,40-41,43H,4-15,20-23,30-32,34-35H2,1-3H3,(H2-,46,47,48,49,51)/p+1/t43-/m0/s1",10.8,3.0,2.0,Substance-P receptor,TACR1,Homo sapiens (Human),MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGAHEEEPEDGPKATPSSLDLTSNCSSRSDSKTMTESFSFSSNVLS
624467,P25103,ZYXOHIFOHNDXGD-VOKJVERTSA-N,Kd,7.943,nM,ChEMBL,CHEMBL249,CHEMBL203111,16289817,CHEMBL203111,44408033.0,C26H26F6N4O2,540.51,"[3,5-bis(trifluoromethyl)phenyl]-[(2R)-2-(1H-indol-3-ylmethyl)-4-[(2Z)-2-methoxyiminopropyl]piperazin-1-yl]methanone",CC(=NOC)CN1CCN(C(C1)CC2=CNC3=CC=CC=C32)C(=O)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,C/C(=N/OC)/CN1CCN([C@@H](C1)CC2=CNC3=CC=CC=C32)C(=O)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,"InChI=1S/C26H26F6N4O2/c1-16(34-38-2)14-35-7-8-36(21(15-35)11-18-13-33-23-6-4-3-5-22(18)23)24(37)17-9-19(25(27,28)29)12-20(10-17)26(30,31)32/h3-6,9-10,12-13,21,33H,7-8,11,14-15H2,1-2H3/b34-16-/t21-/m1/s1",5.4,1.0,10.0,Substance-P receptor,TACR1,Homo sapiens (Human),MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGAHEEEPEDGPKATPSSLDLTSNCSSRSDSKTMTESFSFSSNVLS
625003,P25103,LMKMRFFYQLXLLE-UHFFFAOYSA-N,Kd,1.585,nM,ChEMBL,CHEMBL249,CHEMBL151289,12431064,CHEMBL151289,44366743.0,C25H35Cl2N3O2,480.474,"1-(cyclopropylmethyl)-5-(3,4-dichlorophenyl)-5-[2-[3-(4-hydroxypiperidin-1-yl)azetidin-1-yl]ethyl]piperidin-2-one",C1CC1CN2CC(CCC2=O)(CCN3CC(C3)N4CCC(CC4)O)C5=CC(=C(C=C5)Cl)Cl,C1CC1CN2CC(CCC2=O)(CCN3CC(C3)N4CCC(CC4)O)C5=CC(=C(C=C5)Cl)Cl,"InChI=1S/C25H35Cl2N3O2/c26-22-4-3-19(13-23(22)27)25(8-5-24(32)30(17-25)14-18-1-2-18)9-12-28-15-20(16-28)29-10-6-21(31)7-11-29/h3-4,13,18,20-21,31H,1-2,5-12,14-17H2",3.7,1.0,4.0,Substance-P receptor,TACR1,Homo sapiens (Human),MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGAHEEEPEDGPKATPSSLDLTSNCSSRSDSKTMTESFSFSSNVLS
626287,P25103,VBUIWYPUKKMBDJ-HKBQPEDESA-N,Kd,1100,nM,ChEMBL,CHEMBL249,CHEMBL293804,"Bioorg. Med. Chem. Lett., (1997) 7:14:1921",CHEMBL293804,44300138.0,C34H45N7O,567.782,"(2S)-N-[4-[(diaminomethylideneamino)methyl]phenyl]-2-[(N,N'-dicyclohexylcarbamimidoyl)amino]-3-naphthalen-2-ylpropanamide",C1CCC(CC1)NC(=NC2CCCCC2)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NC5=CC=C(C=C5)CN=C(N)N,C1CCC(CC1)NC(=NC2CCCCC2)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NC5=CC=C(C=C5)CN=C(N)N,"InChI=1S/C34H45N7O/c35-33(36)37-23-24-16-19-30(20-17-24)38-32(42)31(22-25-15-18-26-9-7-8-10-27(26)21-25)41-34(39-28-11-3-1-4-12-28)40-29-13-5-2-6-14-29/h7-10,15-21,28-29,31H,1-6,11-14,22-23H2,(H,38,42)(H4,35,36,37)(H2,39,40,41)/t31-/m0/s1",5.6,5.0,3.0,Substance-P receptor,TACR1,Homo sapiens (Human),MDNVLPVDSDLSPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPSRVVCMIEWPEHPNKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAGDYEGLEMKSTRYLQTQGSVYKVSRLETTISTVVGAHEEEPEDGPKATPSSLDLTSNCSSRSDSKTMTESFSFSSNVLS
627156,P30547,RBAMYRNPYOAKGB-JBBXVCRQSA-N,Kd,10,nM,ChEMBL,CHEMBL3942,CHEMBL66441,12127519,CHEMBL66441,44307757.0,C35H43Cl4N5O5,755.559,"3,5-dichloro-N-[(2Z,3R)-3-(3,4-dichlorophenyl)-5-[4-[3-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-2-oxopiperidin-1-yl]piperidin-1-yl]-2-methoxyiminopentyl]-N-methylbenzamide",CN(CC(=NOC)C(CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N3CC(C3)O)C4=CC(=C(C=C4)Cl)Cl)C(=O)C5=CC(=CC(=C5)Cl)Cl,CN(C/C(=N\OC)/[C@H](CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N3CC(C3)O)C4=CC(=C(C=C4)Cl)Cl)C(=O)C5=CC(=CC(=C5)Cl)Cl,"InChI=1S/C35H43Cl4N5O5/c1-41(34(47)24-14-25(36)18-26(37)15-24)21-32(40-49-2)29(22-5-6-30(38)31(39)16-22)9-13-42-11-7-27(8-12-42)44-10-3-4-23(35(44)48)17-33(46)43-19-28(45)20-43/h5-6,14-16,18,23,27-29,45H,3-4,7-13,17,19-21H2,1-2H3/b40-32+/t23?,29-/m1/s1",5.3,1.0,7.0,Substance-P receptor,TACR1,Cavia porcellus (Guinea pig),MDNVLPVDSDLFPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPGRVVCMIEWPSHPDKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAADYEGLEMKSTRYFQTQGSVYKVSRLETTISTVVGAHEEDPEEGPKATPSSLDLTSNGSSRSNSKTVTESSSFYSNMLS
627360,P30547,AZJXZOMJEDHZHJ-JVCQONLDSA-N,Kd,19.95,nM,ChEMBL,CHEMBL3942,CHEMBL66635,12127519,CHEMBL66635,44307758.0,C32H39Cl4N5O4,699.495,"N-[(2Z,3S)-5-[4-[3-(2-amino-2-oxoethyl)-2-oxopiperidin-1-yl]piperidin-1-yl]-3-(3,4-dichlorophenyl)-2-methoxyiminopentyl]-3,5-dichloro-N-methylbenzamide",CN(CC(=NOC)C(CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC(=CC(=C4)Cl)Cl,CN(C/C(=N\OC)/[C@@H](CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC(=CC(=C4)Cl)Cl,"InChI=1S/C32H39Cl4N5O4/c1-39(31(43)22-14-23(33)18-24(34)15-22)19-29(38-45-2)26(20-5-6-27(35)28(36)16-20)9-13-40-11-7-25(8-12-40)41-10-3-4-21(32(41)44)17-30(37)42/h5-6,14-16,18,21,25-26H,3-4,7-13,17,19H2,1-2H3,(H2,37,42)/b38-29+/t21?,26-/m0/s1",5.6,1.0,6.0,Substance-P receptor,TACR1,Cavia porcellus (Guinea pig),MDNVLPVDSDLFPNISTNTSEPNQFVQPAWQIVLWAAAYTVIVVTSVVGNVVVMWIILAHKRMRTVTNYFLVNLAFAEASMAAFNTVVNFTYAVHNEWYYGLFYCKFHNFFPIAAVFASIYSMTAVAFDRYMAIIHPLQPRLSATATKVVICVIWVLALLLAFPQGYYSTTETMPGRVVCMIEWPSHPDKIYEKVYHICVTVLIYFLPLLVIGYAYTVVGITLWASEIPGDSSDRYHEQVSAKRKVVKMMIVVVCTFAICWLPFHIFFLLPYINPDLYLKKFIQQVYLAIMWLAMSSTMYNPIIYCCLNDRFRLGFKHAFRCCPFISAADYEGLEMKSTRYFQTQGSVYKVSRLETTISTVVGAHEEDPEEGPKATPSSLDLTSNGSSRSNSKTVTESSSFYSNMLS
628060,P21452,PLLWRXKRZRSORW-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL2327,CHEMBL100297,12270180,CHEMBL100297,10232566.0,C36H41N5O2S,607.817,"1-N,2-N-bis[2-(1H-indol-3-yl)ethyl]-1-N-methyl-2-N-(3-thiomorpholin-4-ylpropyl)benzene-1,2-dicarboxamide",CN(CCC1=CNC2=CC=CC=C21)C(=O)C3=CC=CC=C3C(=O)N(CCCN4CCSCC4)CCC5=CNC6=CC=CC=C65,CN(CCC1=CNC2=CC=CC=C21)C(=O)C3=CC=CC=C3C(=O)N(CCCN4CCSCC4)CCC5=CNC6=CC=CC=C65,"InChI=1S/C36H41N5O2S/c1-39(19-15-27-25-37-33-13-6-4-9-29(27)33)35(42)31-11-2-3-12-32(31)36(43)41(18-8-17-40-21-23-44-24-22-40)20-16-28-26-38-34-14-7-5-10-30(28)34/h2-7,9-14,25-26,37-38H,8,15-24H2,1H3",5.8,2.0,4.0,Substance-K receptor,TACR2,Homo sapiens (Human),MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRRAVPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKLELTPTTSLSTRVNRCHTKETLFMAGDTAPSEATSGEAGRPQDGSGLWFGYGLLAPTKTHVEI
629192,P21452,BANYJBHWTOJQDU-GDLZYMKVSA-N,Kd,0.316227766016838 - 15.8489249640273,nM,IUPHAR,361,2115,"7682062,7562907,7713168",GR-159897,9953599.0,C23H27FN2O2S,414.539,5-fluoro-3-[2-[4-methoxy-4-[[(R)-phenylsulfinyl]methyl]piperidin-1-yl]ethyl]-1H-indole,COC1(CCN(CC1)CCC2=CNC3=C2C=C(C=C3)F)CS(=O)C4=CC=CC=C4,COC1(CCN(CC1)CCC2=CNC3=C2C=C(C=C3)F)C[S@@](=O)C4=CC=CC=C4,"InChI=1S/C23H27FN2O2S/c1-28-23(17-29(27)20-5-3-2-4-6-20)10-13-26(14-11-23)12-9-18-16-25-22-8-7-19(24)15-21(18)22/h2-8,15-16,25H,9-14,17H2,1H3/t29-/m1/s1",3.4,1.0,5.0,Substance-K receptor,TACR2,Homo sapiens (Human),MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRRAVPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKLELTPTTSLSTRVNRCHTKETLFMAGDTAPSEATSGEAGRPQDGSGLWFGYGLLAPTKTHVEI
629338,P21452,WNKRABSIBSPIHJ-HHHXNRCGSA-N,Kd,0.631,nM,ChEMBL,CHEMBL2327,CHEMBL182600,16039119,CHEMBL182600,9959481.0,C28H38Cl2F3N3O,560.527,"(5S)-5-(3,4-dichlorophenyl)-1-[(4,4-difluorocyclohexyl)methyl]-5-[2-[3-(4-fluoropiperidin-1-yl)azetidin-1-yl]ethyl]piperidin-2-one",C1CC(CCC1CN2CC(CCC2=O)(CCN3CC(C3)N4CCC(CC4)F)C5=CC(=C(C=C5)Cl)Cl)(F)F,C1CC(CCC1CN2C[C@@](CCC2=O)(CCN3CC(C3)N4CCC(CC4)F)C5=CC(=C(C=C5)Cl)Cl)(F)F,"InChI=1S/C28H38Cl2F3N3O/c29-24-2-1-21(15-25(24)30)27(11-14-34-17-23(18-34)35-12-6-22(31)7-13-35)8-5-26(37)36(19-27)16-20-3-9-28(32,33)10-4-20/h1-2,15,20,22-23H,3-14,16-19H2/t27-/m1/s1",6.1,0.0,6.0,Substance-K receptor,TACR2,Homo sapiens (Human),MGTCDIVTEANISSGPESNTTGITAFSMPSWQLALWATAYLALVLVAVTGNAIVIWIILAHRRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPSTKAVIAGIWLVALALASPQCFYSTVTMDQGATKCVVAWPEDSGGKTLLLYHLVVIALIYFLPLAVMFVAYSVIGLTLWRRAVPGHQAHGANLRHLQAMKKFVKTMVLVVLTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTKEDKLELTPTTSLSTRVNRCHTKETLFMAGDTAPSEATSGEAGRPQDGSGLWFGYGLLAPTKTHVEI
630479,P79218,DWPNGIXRJQQAFI-LTWKBGODSA-N,Kd,112.2,nM,ChEMBL,CHEMBL3433,CHEMBL421062,7932590,CHEMBL421062,44347003.0,C40H56N8O6,744.938,"3-[(2R,5S,8R,11S,14R)-14-benzyl-11-(1H-indol-3-ylmethyl)-2,5-bis(2-methylpropyl)-6,9,12,15,19-pentaoxo-1,4,7,10,13,16-hexazacyclononadec-8-yl]propanamide",CC(C)CC1CNC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CC(C)C,CC(C)C[C@@H]1CN[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CC(C)C,"InChI=1S/C40H56N8O6/c1-24(2)18-28-23-44-32(19-25(3)4)39(53)46-31(14-15-35(41)49)38(52)48-34(21-27-22-43-30-13-9-8-12-29(27)30)40(54)47-33(20-26-10-6-5-7-11-26)37(51)42-17-16-36(50)45-28/h5-13,22,24-25,28,31-34,43-44H,14-21,23H2,1-4H3,(H2,41,49)(H,42,51)(H,45,50)(H,46,53)(H,47,54)(H,48,52)/t28-,31-,32+,33-,34+/m1/s1",3.0,8.0,7.0,Substance-K receptor,TACR2,Oryctolagus cuniculus (Rabbit),MGACDIVTEANISSDIDSNATGVTAFSMPGWQLALWATAYLALVLVAVVGNATVIWIILAHRRMRTVTNYFIVNLALADLCMATFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSGPGTKAVIAGIWLVALALAFPQCFYSTITMDQGATKCVVAWPEDSGGKMLLLYHLTVIALIYFLPLVVMFVAYSVIGFKLWRRTVPGHQTHGANLRHLRAKKKFVKTMVLVVVTFAVCWLPYHLYFLLGHFQDDIYCRKFIQQVYLVLFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDKLELTHTPSLSVRVNRCHTKETLFLVGDVAPSEAANGQAGGPQDGGAYDF
630598,P79218,LYIZVKRYLGRVLP-ZIBKNMLNSA-N,Kd,223.87,nM,ChEMBL,CHEMBL3433,CHEMBL121571,7932590,CHEMBL121571,44347083.0,C39H54N8O6S,762.971,"3-[(2R,5S,8R,11S,14R)-14-benzyl-11-(1H-indol-3-ylmethyl)-2-(2-methylpropyl)-5-(2-methylsulfanylethyl)-6,9,12,15,19-pentaoxo-1,4,7,10,13,16-hexazacyclononadec-8-yl]propanamide",CC(C)CC1CNC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CCSC,CC(C)C[C@@H]1CN[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CCSC,"InChI=1S/C39H54N8O6S/c1-24(2)19-27-23-43-30(16-18-54-3)37(51)45-31(13-14-34(40)48)38(52)47-33(21-26-22-42-29-12-8-7-11-28(26)29)39(53)46-32(20-25-9-5-4-6-10-25)36(50)41-17-15-35(49)44-27/h4-12,22,24,27,30-33,42-43H,13-21,23H2,1-3H3,(H2,40,48)(H,41,50)(H,44,49)(H,45,51)(H,46,53)(H,47,52)/t27-,30+,31-,32-,33+/m1/s1",2.3,8.0,8.0,Substance-K receptor,TACR2,Oryctolagus cuniculus (Rabbit),MGACDIVTEANISSDIDSNATGVTAFSMPGWQLALWATAYLALVLVAVVGNATVIWIILAHRRMRTVTNYFIVNLALADLCMATFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSGPGTKAVIAGIWLVALALAFPQCFYSTITMDQGATKCVVAWPEDSGGKMLLLYHLTVIALIYFLPLVVMFVAYSVIGFKLWRRTVPGHQTHGANLRHLRAKKKFVKTMVLVVVTFAVCWLPYHLYFLLGHFQDDIYCRKFIQQVYLVLFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDKLELTHTPSLSVRVNRCHTKETLFLVGDVAPSEAANGQAGGPQDGGAYDF
639135,P43140,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.3388,nM,ChEMBL,CHEMBL319,CHEMBL836,9379432,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
639140,P43140,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.3388,nM,ChEMBL,CHEMBL319,CHEMBL836,11384242,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
639444,P43140,LLUFTDXWFHPSPE-UHFFFAOYSA-N,Kd,38.02,nM,ChEMBL,CHEMBL319,CHEMBL144224,9822553,CHEMBL144224,10072518.0,C25H33N5O3,451.571,"N-[6-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]hexyl]-N-methylbenzamide",CN(CCCCCCN(C)C(=O)C1=CC=CC=C1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CN(CCCCCCN(C)C(=O)C1=CC=CC=C1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C25H33N5O3/c1-29(24(31)18-12-8-7-9-13-18)14-10-5-6-11-15-30(2)25-27-20-17-22(33-4)21(32-3)16-19(20)23(26)28-25/h7-9,12-13,16-17H,5-6,10-11,14-15H2,1-4H3,(H2,26,27,28)",4.2,1.0,7.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
639776,P43140,WNMJYKCGWZFFKR-UHFFFAOYSA-N,Kd,24.55,nM,ChEMBL,CHEMBL319,CHEMBL709,11384242,alfuzosin,2092.0,C19H27N5O4,389.456,"N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide",CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)",1.7,2.0,8.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640287,P43140,UVEKKXRFQCNLQE-ZEQRLZLVSA-N,Kd,5.888,nM,ChEMBL,CHEMBL319,CHEMBL297106,11931617,CHEMBL297106,44289262.0,C25H27NO5,421.493,"2-(2,6-dimethoxyphenoxy)-N-[[(2S,3S)-3-phenyl-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]ethanamine",COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2[C@@H](OC3=CC=CC=C3O2)C4=CC=CC=C4,"InChI=1S/C25H27NO5/c1-27-21-13-8-14-22(28-2)25(21)29-16-15-26-17-23-24(18-9-4-3-5-10-18)31-20-12-7-6-11-19(20)30-23/h3-14,23-24,26H,15-17H2,1-2H3/t23-,24-/m0/s1",4.4,1.0,6.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640288,P43140,UVEKKXRFQCNLQE-ZEQRLZLVSA-N,Kd,5.754,nM,ChEMBL,CHEMBL319,CHEMBL297106,11931617,CHEMBL297106,44289262.0,C25H27NO5,421.493,"2-(2,6-dimethoxyphenoxy)-N-[[(2S,3S)-3-phenyl-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]ethanamine",COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2[C@@H](OC3=CC=CC=C3O2)C4=CC=CC=C4,"InChI=1S/C25H27NO5/c1-27-21-13-8-14-22(28-2)25(21)29-16-15-26-17-23-24(18-9-4-3-5-10-18)31-20-12-7-6-11-19(20)30-23/h3-14,23-24,26H,15-17H2,1-2H3/t23-,24-/m0/s1",4.4,1.0,6.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640477,P43140,GVRSOZBKXDJGAJ-UHFFFAOYSA-N,Kd,54.95,nM,ChEMBL,CHEMBL319,CHEMBL3415015,25874333,CHEMBL3415015,73437675.0,C23H28N4O3,408.502,5-hydroxy-N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]-1H-indole-2-carboxamide,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(N3)C=CC(=C4)O,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(N3)C=CC(=C4)O,"InChI=1S/C23H28N4O3/c1-30-22-6-3-2-5-21(22)27-13-11-26(12-14-27)10-4-9-24-23(29)20-16-17-15-18(28)7-8-19(17)25-20/h2-3,5-8,15-16,25,28H,4,9-14H2,1H3,(H,24,29)",3.3,3.0,5.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640617,P43140,PDKZRJZOEVFDRV-UHFFFAOYSA-N,Kd,12.59,nM,ChEMBL,CHEMBL319,CHEMBL3415014,25874333,CHEMBL3415014,73437674.0,C26H34N4O2,434.584,4-(1H-indol-3-yl)-N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]butanamide,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CCCC3=CNC4=CC=CC=C43,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CCCC3=CNC4=CC=CC=C43,"InChI=1S/C26H34N4O2/c1-32-25-12-5-4-11-24(25)30-18-16-29(17-19-30)15-7-14-27-26(31)13-6-8-21-20-28-23-10-3-2-9-22(21)23/h2-5,9-12,20,28H,6-8,13-19H2,1H3,(H,27,31)",3.9,2.0,4.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640712,P43140,VDSSOFQYDAIUHS-UHFFFAOYSA-N,Kd,8.913,nM,ChEMBL,CHEMBL319,CHEMBL144000,9822553,CHEMBL144000,10531768.0,C34H53N7O3,607.844,"N-[6-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]hexyl]-N-methyl-3-[[methyl-[6-(methylamino)hexyl]amino]methyl]benzamide",CNCCCCCCN(C)CC1=CC=CC(=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CNCCCCCCN(C)CC1=CC=CC(=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C34H53N7O3/c1-36-18-11-7-8-12-19-39(2)25-26-16-15-17-27(22-26)33(42)40(3)20-13-9-10-14-21-41(4)34-37-29-24-31(44-6)30(43-5)23-28(29)32(35)38-34/h15-17,22-24,36H,7-14,18-21,25H2,1-6H3,(H2,35,37,38)",5.0,2.0,9.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640776,P43140,UVRWMAUASFDRIT-UHFFFAOYSA-N,Kd,5.623,nM,ChEMBL,CHEMBL319,CHEMBL146481,8523408,CHEMBL146481,10694582.0,C18H20N8O6,444.408,"4-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carbonyl]-2-oxido-1,2,5-oxadiazol-2-ium-3-carboxamide",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=NO[N+](=C4C(=O)N)[O-])N)OC,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=NO[N+](=C4C(=O)N)[O-])N)OC,"InChI=1S/C18H20N8O6/c1-30-11-7-9-10(8-12(11)31-2)21-18(22-15(9)19)25-5-3-24(4-6-25)17(28)13-14(16(20)27)26(29)32-23-13/h7-8H,3-6H2,1-2H3,(H2,20,27)(H2,19,21,22)",0.8,2.0,11.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640968,P43140,UOWWWPYFAPQMPE-HNNXBMFYSA-N,Kd,4.898,nM,ChEMBL,CHEMBL319,CHEMBL2419765,23902232,CHEMBL2419765,71817545.0,C20H22N2O4,354.406,"N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-2-[(6-methoxy-1H-indol-7-yl)oxy]ethanamine",COC1=C(C2=C(C=C1)C=CN2)OCCNCC3COC4=CC=CC=C4O3,COC1=C(C2=C(C=C1)C=CN2)OCCNC[C@H]3COC4=CC=CC=C4O3,"InChI=1S/C20H22N2O4/c1-23-18-7-6-14-8-9-22-19(14)20(18)24-11-10-21-12-15-13-25-16-4-2-3-5-17(16)26-15/h2-9,15,21-22H,10-13H2,1H3/t15-/m0/s1",3.0,2.0,5.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
640969,P43140,UOWWWPYFAPQMPE-HNNXBMFYSA-N,Kd,13.18,nM,ChEMBL,CHEMBL319,CHEMBL2419765,23902232,CHEMBL2419765,71817545.0,C20H22N2O4,354.406,"N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-2-[(6-methoxy-1H-indol-7-yl)oxy]ethanamine",COC1=C(C2=C(C=C1)C=CN2)OCCNCC3COC4=CC=CC=C4O3,COC1=C(C2=C(C=C1)C=CN2)OCCNC[C@H]3COC4=CC=CC=C4O3,"InChI=1S/C20H22N2O4/c1-23-18-7-6-14-8-9-22-19(14)20(18)24-11-10-21-12-15-13-25-16-4-2-3-5-17(16)26-15/h2-9,15,21-22H,10-13H2,1H3/t15-/m0/s1",3.0,2.0,5.0,Alpha-1A adrenergic receptor,Adra1a,Rattus norvegicus (Rat),MVLLSENASEGSNCTHPPAPVNISKAILLGVILGGLIIFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIMGLCIISIDRYIGVSYPLRYPTIVTQRRGVRALLCVWVLSLVISIGPLFGWRQPAPEDETICQINEEPGYVLFSALGSFYVPLAIILVMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNVPAEGGGVSSAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPSETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLRIQCLRRRQSSKHALGYTLHPPSQALEGQHRDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPQGSARITVPKDQSACTTARVRSKSFLQVCCCVGSSAPRPEENHQVPTIKIHTISLGENGEEV
641167,P15823,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.2042,nM,ChEMBL,CHEMBL315,CHEMBL836,11384242,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641168,P15823,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.2042,nM,ChEMBL,CHEMBL315,CHEMBL836,9379432,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641305,P15823,LLUFTDXWFHPSPE-UHFFFAOYSA-N,Kd,0.4467,nM,ChEMBL,CHEMBL315,CHEMBL144224,9822553,CHEMBL144224,10072518.0,C25H33N5O3,451.571,"N-[6-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]hexyl]-N-methylbenzamide",CN(CCCCCCN(C)C(=O)C1=CC=CC=C1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CN(CCCCCCN(C)C(=O)C1=CC=CC=C1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C25H33N5O3/c1-29(24(31)18-12-8-7-9-13-18)14-10-5-6-11-15-30(2)25-27-20-17-22(33-4)21(32-3)16-19(20)23(26)28-25/h7-9,12-13,16-17H,5-6,10-11,14-15H2,1-4H3,(H2,26,27,28)",4.2,1.0,7.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641460,P15823,WNMJYKCGWZFFKR-UHFFFAOYSA-N,Kd,4.898,nM,ChEMBL,CHEMBL315,CHEMBL709,11384242,alfuzosin,2092.0,C19H27N5O4,389.456,"N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide",CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)",1.7,2.0,8.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641695,P15823,UVEKKXRFQCNLQE-ZEQRLZLVSA-N,Kd,2511.89,nM,ChEMBL,CHEMBL315,CHEMBL297106,11931617,CHEMBL297106,44289262.0,C25H27NO5,421.493,"2-(2,6-dimethoxyphenoxy)-N-[[(2S,3S)-3-phenyl-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]ethanamine",COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2[C@@H](OC3=CC=CC=C3O2)C4=CC=CC=C4,"InChI=1S/C25H27NO5/c1-27-21-13-8-14-22(28-2)25(21)29-16-15-26-17-23-24(18-9-4-3-5-10-18)31-20-12-7-6-11-19(20)30-23/h3-14,23-24,26H,15-17H2,1-2H3/t23-,24-/m0/s1",4.4,1.0,6.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641766,P15823,GVRSOZBKXDJGAJ-UHFFFAOYSA-N,Kd,154.88,nM,ChEMBL,CHEMBL315,CHEMBL3415015,25874333,CHEMBL3415015,73437675.0,C23H28N4O3,408.502,5-hydroxy-N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]-1H-indole-2-carboxamide,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(N3)C=CC(=C4)O,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(N3)C=CC(=C4)O,"InChI=1S/C23H28N4O3/c1-30-22-6-3-2-5-21(22)27-13-11-26(12-14-27)10-4-9-24-23(29)20-16-17-15-18(28)7-8-19(17)25-20/h2-3,5-8,15-16,25,28H,4,9-14H2,1H3,(H,24,29)",3.3,3.0,5.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641810,P15823,PDKZRJZOEVFDRV-UHFFFAOYSA-N,Kd,95.5,nM,ChEMBL,CHEMBL315,CHEMBL3415014,25874333,CHEMBL3415014,73437674.0,C26H34N4O2,434.584,4-(1H-indol-3-yl)-N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]butanamide,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CCCC3=CNC4=CC=CC=C43,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CCCC3=CNC4=CC=CC=C43,"InChI=1S/C26H34N4O2/c1-32-25-12-5-4-11-24(25)30-18-16-29(17-19-30)15-7-14-27-26(31)13-6-8-21-20-28-23-10-3-2-9-22(21)23/h2-5,9-12,20,28H,6-8,13-19H2,1H3,(H,27,31)",3.9,2.0,4.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641851,P15823,VDSSOFQYDAIUHS-UHFFFAOYSA-N,Kd,19.5,nM,ChEMBL,CHEMBL315,CHEMBL144000,9822553,CHEMBL144000,10531768.0,C34H53N7O3,607.844,"N-[6-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]hexyl]-N-methyl-3-[[methyl-[6-(methylamino)hexyl]amino]methyl]benzamide",CNCCCCCCN(C)CC1=CC=CC(=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CNCCCCCCN(C)CC1=CC=CC(=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C34H53N7O3/c1-36-18-11-7-8-12-19-39(2)25-26-16-15-17-27(22-26)33(42)40(3)20-13-9-10-14-21-41(4)34-37-29-24-31(44-6)30(43-5)23-28(29)32(35)38-34/h15-17,22-24,36H,7-14,18-21,25H2,1-6H3,(H2,35,37,38)",5.0,2.0,9.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641864,P15823,DWUSTUPZNLOYSI-CYBMUJFWSA-N,Kd,13803.84,nM,ChEMBL,CHEMBL315,CHEMBL2261355,"Med Chem Res, (2004) 13:3:134",CHEMBL2261355,76326541.0,C15H19N3O2S,305.396,"N-[(5R)-5-(1H-imidazol-5-yl)-5,6,7,8-tetrahydronaphthalen-1-yl]ethanesulfonamide",CCS(=O)(=O)NC1=CC=CC2=C1CCCC2C3=CN=CN3,CCS(=O)(=O)NC1=CC=CC2=C1CCC[C@H]2C3=CN=CN3,"InChI=1S/C15H19N3O2S/c1-2-21(19,20)18-14-8-4-5-11-12(14)6-3-7-13(11)15-9-16-10-17-15/h4-5,8-10,13,18H,2-3,6-7H2,1H3,(H,16,17)/t13-/m1/s1",2.1,2.0,4.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
641938,P15823,UOWWWPYFAPQMPE-HNNXBMFYSA-N,Kd,16.98,nM,ChEMBL,CHEMBL315,CHEMBL2419765,23902232,CHEMBL2419765,71817545.0,C20H22N2O4,354.406,"N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-2-[(6-methoxy-1H-indol-7-yl)oxy]ethanamine",COC1=C(C2=C(C=C1)C=CN2)OCCNCC3COC4=CC=CC=C4O3,COC1=C(C2=C(C=C1)C=CN2)OCCNC[C@H]3COC4=CC=CC=C4O3,"InChI=1S/C20H22N2O4/c1-23-18-7-6-14-8-9-22-19(14)20(18)24-11-10-21-12-15-13-25-16-4-2-3-5-17(16)26-15/h2-9,15,21-22H,10-13H2,1H3/t15-/m0/s1",3.0,2.0,5.0,Alpha-1B adrenergic receptor,Adra1b,Rattus norvegicus (Rat),MNPDLDTGHNTSAPAHWGELKDDNFTGPNQTSSNSTLPQLDVTRAISVGLVLGAFILFAIVGNILVILSVACNRHLRTPTNYFIVNLAIADLLLSFTVLPFSATLEVLGYWVLGRIFCDIWAAVDVLCCTASILSLCAISIDRYIGVRYSLQYPTLVTRRKAILALLSVWVLSTVISIGPLLGWKEPAPNDDKECGVTEEPFYALFSSLGSFYIPLAVILVMYCRVYIVAKRTTKNLEAGVMKEMSNSKELTLRIHSKNFHEDTLSSTKAKGHNPRSSIAVKLFKFSREKKAAKTLGIVVGMFILCWLPFFIALPLGSLFSTLKPPDAVFKVVFWLGYFNSCLNPIIYPCSSKEFKRAFMRILGCQCRGGRRRRRRRRLGACAYTYRPWTRGGSLERSQSRKDSLDDSGSCMSGTQRTLPSASPSPGYLGRGTQPPVELCAFPEWKPGALLSLPEPPGRRGRLDSGPLFTFKLLGDPESPGTEGDTSNGGCDTTTDLANGQPGFKSNMPLAPGHF
644344,P14842,DLVXCUGDQCNSLY-UHFFFAOYSA-N,Kd,63.1,nM,ChEMBL,CHEMBL322,CHEMBL111509,11754579,CHEMBL111509,10810641.0,C24H27FN2O2,394.49,"3-[[4-[4-(4-fluorophenyl)-4-oxobutyl]piperazin-1-yl]methyl]-2,3-dihydroinden-1-one",C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)CC3CC(=O)C4=CC=CC=C34,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)CC3CC(=O)C4=CC=CC=C34,"InChI=1S/C24H27FN2O2/c25-20-9-7-18(8-10-20)23(28)6-3-11-26-12-14-27(15-13-26)17-19-16-24(29)22-5-2-1-4-21(19)22/h1-2,4-5,7-10,19H,3,6,11-17H2",3.1,0.0,5.0,5-hydroxytryptamine receptor 2A,Htr2a,Rattus norvegicus (Rat),MEILCEDNISLSSIPNSLMQLGDGPRLYHNDFNSRDANTSEASNWTIDAENRTNLSCEGYLPPTCLSILHLQEKNWSALLTTVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAIWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVAFFIPLTIMVITYFLTIKSLQKEATLCVSDLSTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYAGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNENVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENRKPLQLILVNTIPALAYKSSQLQVGQKKNSQEDAEQTVDDCSMVTLGKQQSEENCTDNIETVNEKVSCV
645734,P14842,QKOGDLJCRXBSED-UHFFFAOYSA-N,Kd,0.5623,nM,ChEMBL,CHEMBL322,CHEMBL164471,11754579,CHEMBL164471,10022781.0,C22H23FN2O3,382.435,"5-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-6,7-dihydro-5H-1-benzofuran-4-one",C1CC2=C(C=CO2)C(=O)C1CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,C1CC2=C(C=CO2)C(=O)C1CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"InChI=1S/C22H23FN2O3/c23-16-2-3-17-20(13-16)28-24-21(17)14-5-9-25(10-6-14)11-7-15-1-4-19-18(22(15)26)8-12-27-19/h2-3,8,12-15H,1,4-7,9-11H2",3.7,0.0,6.0,5-hydroxytryptamine receptor 2A,Htr2a,Rattus norvegicus (Rat),MEILCEDNISLSSIPNSLMQLGDGPRLYHNDFNSRDANTSEASNWTIDAENRTNLSCEGYLPPTCLSILHLQEKNWSALLTTVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAIWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVAFFIPLTIMVITYFLTIKSLQKEATLCVSDLSTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYAGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNENVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENRKPLQLILVNTIPALAYKSSQLQVGQKKNSQEDAEQTVDDCSMVTLGKQQSEENCTDNIETVNEKVSCV
646058,P14842,ABERUOJGWHYBJL-UHFFFAOYSA-N,Kd,524.81,nM,ChEMBL,CHEMBL322,CHEMBL148189,"Bioorg. Med. Chem. Lett., (1995) 5:7:667",4-(4-Fluorobenzoyl)piperidine,2724440.0,C12H14FNO,207.248,(4-fluorophenyl)-piperidin-4-ylmethanone,C1CNCCC1C(=O)C2=CC=C(C=C2)F,C1CNCCC1C(=O)C2=CC=C(C=C2)F,"InChI=1S/C12H14FNO/c13-11-3-1-9(2-4-11)12(15)10-5-7-14-8-6-10/h1-4,10,14H,5-8H2",1.7,1.0,3.0,5-hydroxytryptamine receptor 2A,Htr2a,Rattus norvegicus (Rat),MEILCEDNISLSSIPNSLMQLGDGPRLYHNDFNSRDANTSEASNWTIDAENRTNLSCEGYLPPTCLSILHLQEKNWSALLTTVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAIWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVAFFIPLTIMVITYFLTIKSLQKEATLCVSDLSTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYAGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNENVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENRKPLQLILVNTIPALAYKSSQLQVGQKKNSQEDAEQTVDDCSMVTLGKQQSEENCTDNIETVNEKVSCV
662967,Q9H3N8,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,3.98107170553497 - 39.8107170553497,nM,IUPHAR,265,1247,"11179434,11179435,11561071,11181941,10973974,16432504",histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H4 receptor,HRH4,Homo sapiens (Human),MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTTDYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASFHSERQRRKSSLMFSSRTKMNSNTIASKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLPSQHSRSVSS
664972,Q9H3N8,WCCSMIHUOXEBSQ-SNVBAGLBSA-N,Kd,0.5012,nM,ChEMBL,CHEMBL3759,CHEMBL1770979,21458260,CHEMBL1770979,24745337.0,C13H24N6,264.377,"6-[(3R)-3-(methylamino)pyrrolidin-1-yl]-4-N-(2-methylpropyl)pyrimidine-2,4-diamine",CC(C)CNC1=NC(=NC(=C1)N2CCC(C2)NC)N,CC(C)CNC1=NC(=NC(=C1)N2CC[C@H](C2)NC)N,"InChI=1S/C13H24N6/c1-9(2)7-16-11-6-12(18-13(14)17-11)19-5-4-10(8-19)15-3/h6,9-10,15H,4-5,7-8H2,1-3H3,(H3,14,16,17,18)/t10-/m1/s1",1.7,3.0,6.0,Histamine H4 receptor,HRH4,Homo sapiens (Human),MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTTDYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASFHSERQRRKSSLMFSSRTKMNSNTIASKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLPSQHSRSVSS
665844,Q9H3N8,XHDYYUNTHULNFJ-UHFFFAOYSA-N,Kd,6.31,nM,ChEMBL,CHEMBL3759,CHEMBL129436,16366610,CHEMBL129436,11066922.0,C14H15Cl2N3O,312.194,"(4,5-dichloro-1H-indol-2-yl)-(4-methylpiperazin-1-yl)methanone",CN1CCN(CC1)C(=O)C2=CC3=C(N2)C=CC(=C3Cl)Cl,CN1CCN(CC1)C(=O)C2=CC3=C(N2)C=CC(=C3Cl)Cl,"InChI=1S/C14H15Cl2N3O/c1-18-4-6-19(7-5-18)14(20)12-8-9-11(17-12)3-2-10(15)13(9)16/h2-3,8,17H,4-7H2,1H3",2.9,1.0,2.0,Histamine H4 receptor,HRH4,Homo sapiens (Human),MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTTDYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASFHSERQRRKSSLMFSSRTKMNSNTIASKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLPSQHSRSVSS
666458,Q9H3N8,WWLWSAHRMZWXPB-YPMHNXCESA-N,Kd,0.1,nM,ChEMBL,CHEMBL3759,CHEMBL3236561,24495018,CHEMBL3236561,59777258.0,C15H23N5,273.384,"4-[(3aR,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrol-5-yl]-6-cyclopentylpyrimidin-2-amine",C1CCC(C1)C2=CC(=NC(=N2)N)N3CC4CCNC4C3,C1CCC(C1)C2=CC(=NC(=N2)N)N3C[C@H]4CCN[C@H]4C3,"InChI=1S/C15H23N5/c16-15-18-12(10-3-1-2-4-10)7-14(19-15)20-8-11-5-6-17-13(11)9-20/h7,10-11,13,17H,1-6,8-9H2,(H2,16,18,19)/t11-,13+/m1/s1",1.8,2.0,5.0,Histamine H4 receptor,HRH4,Homo sapiens (Human),MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTTDYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASFHSERQRRKSSLMFSSRTKMNSNTIASKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLPSQHSRSVSS
666533,Q9H3N8,YSAYBGMJMWXFOR-UHFFFAOYSA-N,Kd,1.995,nM,ChEMBL,CHEMBL3759,CHEMBL505061,21458260,CHEMBL505061,25130912.0,C13H22N6,262.361,4-(4-methylpiperazin-1-yl)-6-pyrrolidin-1-ylpyrimidin-2-amine,CN1CCN(CC1)C2=NC(=NC(=C2)N3CCCC3)N,CN1CCN(CC1)C2=NC(=NC(=C2)N3CCCC3)N,"InChI=1S/C13H22N6/c1-17-6-8-19(9-7-17)12-10-11(15-13(14)16-12)18-4-2-3-5-18/h10H,2-9H2,1H3,(H2,14,15,16)",1.1,1.0,6.0,Histamine H4 receptor,HRH4,Homo sapiens (Human),MPDTNSTINLSLSTRVTLAFFMSLVAFAIMLGNALVILAFVVDKNLRHRSSYFFLNLAISDFFVGVISIPLYIPHTLFEWDFGKEICVFWLTTDYLLCTASVYNIVLISYDRYLSVSNAVSYRTQHTGVLKIVTLMVAVWVLAFLVNGPMILVSESWKDEGSECEPGFFSEWYILAITSFLEFVIPVILVAYFNMNIYWSLWKRDHLSRCQSHPGLTAVSSNICGHSFRGRLSSRRSLSASTEVPASFHSERQRRKSSLMFSSRTKMNSNTIASKMGSFSQSDSVALHQREHVELLRARRLAKSLAILLGVFAVCWAPYSLFTIVLSFYSSATGPKSVWYRIAFWLQWFNSFVNPLLYPLCHKRFQKAFLKIFCIKKQPLPSQHSRSVSS
667337,P31389,BCIVIRNJAROBHW-UHFFFAOYSA-N,Kd,9772.37,nM,ChEMBL,CHEMBL3943,CHEMBL499301,18950149,CHEMBL499301,25150700.0,C21H23N5O,361.449,"N-[N'-[2-(1H-imidazol-5-yl)ethyl]carbamimidoyl]-3,3-diphenylpropanamide",C1=CC=C(C=C1)C(CC(=O)NC(=NCCC2=CN=CN2)N)C3=CC=CC=C3,C1=CC=C(C=C1)C(CC(=O)NC(=NCCC2=CN=CN2)N)C3=CC=CC=C3,"InChI=1S/C21H23N5O/c22-21(24-12-11-18-14-23-15-25-18)26-20(27)13-19(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-10,14-15,19H,11-13H2,(H,23,25)(H3,22,24,26,27)",2.9,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667411,P31389,GVGOZYJHWUIVHV-UHFFFAOYSA-N,Kd,2187.76,nM,ChEMBL,CHEMBL3943,CHEMBL486965,18950149,UR-AK57,11956130.0,C17H29N5O,319.453,3-cyclohexyl-N-[N'-[3-(1H-imidazol-5-yl)propyl]carbamimidoyl]butanamide,CC(CC(=O)NC(=NCCCC1=CN=CN1)N)C2CCCCC2,CC(CC(=O)NC(=NCCCC1=CN=CN1)N)C2CCCCC2,"InChI=1S/C17H29N5O/c1-13(14-6-3-2-4-7-14)10-16(23)22-17(18)20-9-5-8-15-11-19-12-21-15/h11-14H,2-10H2,1H3,(H,19,21)(H3,18,20,22,23)",3.4,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667481,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,1,nM,ChEMBL,CHEMBL3943,CHEMBL90,14640554,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667482,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,0.7762,nM,ChEMBL,CHEMBL3943,CHEMBL90,10737740,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667486,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,0.8511,nM,ChEMBL,CHEMBL3943,CHEMBL90,10737740,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667490,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,0.7762,nM,ChEMBL,CHEMBL3943,CHEMBL90,9873585,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667494,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,0.8511,nM,ChEMBL,CHEMBL3943,CHEMBL90,9873585,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667496,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL3943,CHEMBL90,10737740,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667503,P31389,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,1,nM,ChEMBL,CHEMBL3943,CHEMBL90,10737740,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667540,P31389,SGQYOPBUMICDBU-UHFFFAOYSA-N,Kd,4677.35,nM,ChEMBL,CHEMBL3943,CHEMBL472441,18950149,CHEMBL472441,25149613.0,C19H22N6OS,382.486,"N-[N'-[3-(1H-imidazol-5-yl)propyl]carbamimidoyl]-3-phenyl-3-(1,3-thiazol-2-yl)propanamide",C1=CC=C(C=C1)C(CC(=O)NC(=NCCCC2=CN=CN2)N)C3=NC=CS3,C1=CC=C(C=C1)C(CC(=O)NC(=NCCCC2=CN=CN2)N)C3=NC=CS3,"InChI=1S/C19H22N6OS/c20-19(23-8-4-7-15-12-21-13-24-15)25-17(26)11-16(18-22-9-10-27-18)14-5-2-1-3-6-14/h1-3,5-6,9-10,12-13,16H,4,7-8,11H2,(H,21,24)(H3,20,23,25,26)",2.3,3.0,5.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667622,P31389,JJCFRYNCJDLXIK-UHFFFAOYSA-N,Kd,1,nM,ChEMBL,CHEMBL3943,CHEMBL516,7650688,CYPROHEPTADINE,2913.0,C21H21N,287.406,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine",CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,"InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3",4.7,0.0,1.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
667790,P31389,WOFSEDMIUMNYEJ-UHFFFAOYSA-N,Kd,89.13,nM,ChEMBL,CHEMBL3943,CHEMBL58922,2569042,CHEMBL58922,14660359.0,C21H25ClN6,396.923,1-[3-(3-chlorophenyl)-3-pyridin-2-ylpropyl]-2-[3-(1H-imidazol-5-yl)propyl]guanidine,C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=CC=C3)Cl,C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=CC=C3)Cl,"InChI=1S/C21H25ClN6/c22-17-6-3-5-16(13-17)19(20-8-1-2-10-25-20)9-12-27-21(23)26-11-4-7-18-14-24-15-28-18/h1-3,5-6,8,10,13-15,19H,4,7,9,11-12H2,(H,24,28)(H3,23,26,27)",2.9,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668094,P31389,BFIAWQUMMUHFNN-UHFFFAOYSA-N,Kd,158.49,nM,ChEMBL,CHEMBL3943,CHEMBL61675,2569042,CHEMBL61675,14660357.0,C21H25FN6,380.471,1-[3-(3-fluorophenyl)-3-pyridin-2-ylpropyl]-2-[3-(1H-imidazol-5-yl)propyl]guanidine,C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=CC=C3)F,C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=CC=C3)F,"InChI=1S/C21H25FN6/c22-17-6-3-5-16(13-17)19(20-8-1-2-10-25-20)9-12-27-21(23)26-11-4-7-18-14-24-15-28-18/h1-3,5-6,8,10,13-15,19H,4,7,9,11-12H2,(H,24,28)(H3,23,26,27)",2.4,3.0,4.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668156,P31389,FPRPVYZMIDKJLA-UHFFFAOYSA-N,Kd,2238.72,nM,ChEMBL,CHEMBL3943,CHEMBL73994,1613748,CHEMBL73994,15179508.0,C26H33IN6O2,588.494,N-[2-[[N-cyano-N'-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]carbamimidoyl]amino]ethyl]-3-iodobenzamide,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=CC(=CC=C3)I)NC#N,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=CC(=CC=C3)I)NC#N,"InChI=1S/C26H33IN6O2/c27-23-9-5-8-22(18-23)25(34)29-12-13-31-26(32-20-28)30-11-6-16-35-24-10-4-7-21(17-24)19-33-14-2-1-3-15-33/h4-5,7-10,17-18H,1-3,6,11-16,19H2,(H,29,34)(H2,30,31,32)",3.9,3.0,5.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668526,P31389,IECPJVGHHUNYNJ-UHFFFAOYSA-N,Kd,3.236,nM,ChEMBL,CHEMBL3943,CHEMBL264491,14640554,CHEMBL264491,11741669.0,C25H29N5,399.542,"N-[2-[2-(3,3-diphenylpropyl)-1H-imidazol-5-yl]ethyl]-2-(1H-imidazol-5-yl)ethanamine",C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCC3=CN=CN3)C4=CC=CC=C4,C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCC3=CN=CN3)C4=CC=CC=C4,"InChI=1S/C25H29N5/c1-3-7-20(8-4-1)24(21-9-5-2-6-10-21)11-12-25-28-18-23(30-25)14-16-26-15-13-22-17-27-19-29-22/h1-10,17-19,24,26H,11-16H2,(H,27,29)(H,28,30)",4.1,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668564,P31389,LLBZLFNYOYVBFX-UHFFFAOYSA-N,Kd,3.802,nM,ChEMBL,CHEMBL3943,CHEMBL1910386,21944853,CHEMBL1910386,57393730.0,C34H38FN7O,579.724,[4-[2-[4-[[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]piperazin-1-yl]-(1H-indol-2-yl)methanone,C1CN(CCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)CCN5CCN(CC5)C(=O)C6=CC7=CC=CC=C7N6,C1CN(CCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)CCN5CCN(CC5)C(=O)C6=CC7=CC=CC=C7N6,"InChI=1S/C34H38FN7O/c35-27-11-9-25(10-12-27)24-42-32-8-4-3-7-30(32)38-34(42)36-28-13-15-39(16-14-28)17-18-40-19-21-41(22-20-40)33(43)31-23-26-5-1-2-6-29(26)37-31/h1-12,23,28,37H,13-22,24H2,(H,36,38)",5.5,2.0,6.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668615,P31389,GXILWBIQFGWJQN-UHFFFAOYSA-N,Kd,>1000,nM,ChEMBL,CHEMBL3943,CHEMBL239975,18052318,CHEMBL239975,15986917.0,C25H30FN3O3,439.531,4-(4-fluorobenzoyl)-1-[4-(3-piperidin-1-ylpropoxy)phenyl]piperazin-2-one,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F,"InChI=1S/C25H30FN3O3/c26-21-7-5-20(6-8-21)25(31)28-16-17-29(24(30)19-28)22-9-11-23(12-10-22)32-18-4-15-27-13-2-1-3-14-27/h5-12H,1-4,13-19H2",3.6,0.0,5.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668693,P31389,WKXIZVSDLMORMY-UHFFFAOYSA-N,Kd,741.31,nM,ChEMBL,CHEMBL3943,CHEMBL486746,18950149,UR-AK64,25149515.0,C17H29N5O,319.453,4-cyclohexyl-N-[N'-[3-(1H-imidazol-5-yl)propyl]carbamimidoyl]butanamide,C1CCC(CC1)CCCC(=O)NC(=NCCCC2=CN=CN2)N,C1CCC(CC1)CCCC(=O)NC(=NCCCC2=CN=CN2)N,"InChI=1S/C17H29N5O/c18-17(20-11-5-9-15-12-19-13-21-15)22-16(23)10-4-8-14-6-2-1-3-7-14/h12-14H,1-11H2,(H,19,21)(H3,18,20,22,23)",3.5,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668839,P31389,GHJQICOITUKHSP-UHFFFAOYSA-N,Kd,79.43,nM,ChEMBL,CHEMBL3943,CHEMBL58740,2569042,CHEMBL58740,10094258.0,C21H24Cl2N6,431.365,"1-[3-(3,4-dichlorophenyl)-3-pyridin-2-ylpropyl]-2-[3-(1H-imidazol-5-yl)propyl]guanidine",C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=C(C=C3)Cl)Cl,C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC(=C(C=C3)Cl)Cl,"InChI=1S/C21H24Cl2N6/c22-18-7-6-15(12-19(18)23)17(20-5-1-2-9-26-20)8-11-28-21(24)27-10-3-4-16-13-25-14-29-16/h1-2,5-7,9,12-14,17H,3-4,8,10-11H2,(H,25,29)(H3,24,27,28)",3.6,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
668986,P31389,IBPWGZKZWJYGLA-UHFFFAOYSA-N,Kd,10000,nM,ChEMBL,CHEMBL3943,CHEMBL15056,11855993,CHEMBL15056,11004759.0,C29H37N3O,443.635,"N-[2-[4-(3-piperidin-1-ylpropoxy)phenyl]ethyl]-1,2,3,4-tetrahydroacridin-9-amine",C1CCN(CC1)CCCOC2=CC=C(C=C2)CCNC3=C4CCCCC4=NC5=CC=CC=C53,C1CCN(CC1)CCCOC2=CC=C(C=C2)CCNC3=C4CCCCC4=NC5=CC=CC=C53,"InChI=1S/C29H37N3O/c1-6-19-32(20-7-1)21-8-22-33-24-15-13-23(14-16-24)17-18-30-29-25-9-2-4-11-27(25)31-28-12-5-3-10-26(28)29/h2,4,9,11,13-16H,1,3,5-8,10,12,17-22H2,(H,30,31)",6.5,1.0,4.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
669082,P31389,NJDNYPJEXDZZKT-UHFFFAOYSA-N,Kd,1819.7,nM,ChEMBL,CHEMBL3943,CHEMBL486962,18950149,UR-AK67,25149427.0,C17H23N5O,313.405,N-[N'-[3-(1H-imidazol-5-yl)propyl]carbamimidoyl]-4-phenylbutanamide,C1=CC=C(C=C1)CCCC(=O)NC(=NCCCC2=CN=CN2)N,C1=CC=C(C=C1)CCCC(=O)NC(=NCCCC2=CN=CN2)N,"InChI=1S/C17H23N5O/c18-17(20-11-5-9-15-12-19-13-21-15)22-16(23)10-4-8-14-6-2-1-3-7-14/h1-3,6-7,12-13H,4-5,8-11H2,(H,19,21)(H3,18,20,22,23)",2.1,3.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
669186,P31389,KIKDYOMNMIMECQ-UHFFFAOYSA-N,Kd,229.09,nM,ChEMBL,CHEMBL3943,CHEMBL58620,2569042,CHEMBL58620,14660391.0,C15H17FN4,272.327,2-[3-(4-fluorophenyl)-3-pyridin-2-ylpropyl]guanidine,C1=CC=NC(=C1)C(CCN=C(N)N)C2=CC=C(C=C2)F,C1=CC=NC(=C1)C(CCN=C(N)N)C2=CC=C(C=C2)F,"InChI=1S/C15H17FN4/c16-12-6-4-11(5-7-12)13(8-10-20-15(17)18)14-3-1-2-9-19-14/h1-7,9,13H,8,10H2,(H4,17,18,20)",1.3,2.0,3.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
669211,P31389,UMNFRBCAPUJRHJ-UHFFFAOYSA-N,Kd,5.012,nM,ChEMBL,CHEMBL3943,CHEMBL277850,12657255,CHEMBL277850,44274583.0,C45H48N4O7,756.9,2-(3-hydroxy-6-oxoxanthen-9-yl)-4-[8-[2-[(4-methoxyphenyl)methyl-pyridin-2-ylamino]ethyl-methylamino]octylcarbamoyl]benzoic acid,CN(CCCCCCCCNC(=O)C1=CC(=C(C=C1)C(=O)O)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)O)CCN(CC5=CC=C(C=C5)OC)C6=CC=CC=N6,CN(CCCCCCCCNC(=O)C1=CC(=C(C=C1)C(=O)O)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)O)CCN(CC5=CC=C(C=C5)OC)C6=CC=CC=N6,"InChI=1S/C45H48N4O7/c1-48(25-26-49(42-11-7-9-22-46-42)30-31-12-17-35(55-2)18-13-31)24-10-6-4-3-5-8-23-47-44(52)32-14-19-36(45(53)54)39(27-32)43-37-20-15-33(50)28-40(37)56-41-29-34(51)16-21-38(41)43/h7,9,11-22,27-29,50H,3-6,8,10,23-26,30H2,1-2H3,(H,47,52)(H,53,54)",4.5,3.0,10.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
669535,P31389,SWSSTSABKSUKHP-UHFFFAOYSA-N,Kd,12.59,nM,ChEMBL,CHEMBL3943,CHEMBL264756,6208360,CHEMBL264756,54710799.0,C23H25N3O6,439.468,7-[3-(4-benzylpiperazin-1-yl)propoxy]-4-hydroxy-3-nitrochromen-2-one,C1CN(CCN1CCCOC2=CC3=C(C=C2)C(=C(C(=O)O3)[N+](=O)[O-])O)CC4=CC=CC=C4,C1CN(CCN1CCCOC2=CC3=C(C=C2)C(=C(C(=O)O3)[N+](=O)[O-])O)CC4=CC=CC=C4,"InChI=1S/C23H25N3O6/c27-22-19-8-7-18(15-20(19)32-23(28)21(22)26(29)30)31-14-4-9-24-10-12-25(13-11-24)16-17-5-2-1-3-6-17/h1-3,5-8,15,27H,4,9-14,16H2",3.5,1.0,8.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
669729,P31389,GAVZCGTYRWKKDV-UHFFFAOYSA-N,Kd,154.88,nM,ChEMBL,CHEMBL3943,CHEMBL3401455,25752982,CHEMBL3401455,102596130.0,C22H20ClN5O,405.886,"[4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidin-1-yl]-(1,2,4-triazol-1-yl)methanone",C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)C(=O)N4C=NC=N4)C5=C1C=CC=N5,C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)C(=O)N4C=NC=N4)C5=C1C=CC=N5,"InChI=1S/C22H20ClN5O/c23-18-5-6-19-17(12-18)4-3-16-2-1-9-25-21(16)20(19)15-7-10-27(11-8-15)22(29)28-14-24-13-26-28/h1-2,5-6,9,12-14H,3-4,7-8,10-11H2",4.6,0.0,4.0,Histamine H1 receptor,HRH1,Cavia porcellus (Guinea pig),MSFLPGMTPVTLSNFSWALEDRMLEGNSTTTPTRQLMPLVVVLSSVSLVTVALNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMSILYLHRSAWILGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWLLSFLWVIPILGWHHFMAPTSEPREKKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYIRIYKAVRRHCQHRQLINSSLPSFSEMKLKLENAKVDTRRMGKESPWEDPKRCSKDASGVHTPMPSSQHLVDMPCAAVLSEDEGGEVGTRQMPMLAVGDGRCCEALNHMHSQLELSGQSRATHSISARPEEWTVVDGQSFPITDSDTSTEAAPMGGQPRSGSNSGLDYIKFTWRRLRSHSRQYTSGLHLNRERKAAKQLGCIMAAFILCWIPYFVFFMVIAFCKSCSNEPVHMFTIWLGYLNSTLNPLIYPLCNENFRKTFKRILRIPP
670240,Q9Y5N1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,10,nM,IUPHAR,264,1247,"11179434,11179435",histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
670574,Q9Y5N1,DUEGUAACJDOGIN-UHFFFAOYSA-N,Kd,0.3311,nM,ChEMBL,CHEMBL264,CHEMBL193934,15771465,CHEMBL193934,9880698.0,C20H32N2O2,332.488,1-[[4-(1-propan-2-ylpiperidin-4-yl)oxyphenyl]methyl]piperidin-4-ol,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)CN3CCC(CC3)O,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)CN3CCC(CC3)O,"InChI=1S/C20H32N2O2/c1-16(2)22-13-9-20(10-14-22)24-19-5-3-17(4-6-19)15-21-11-7-18(23)8-12-21/h3-6,16,18,20,23H,7-15H2,1-2H3",3.0,1.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
670821,Q9Y5N1,UFTSHWLSGKIRED-UHFFFAOYSA-N,Kd,0.7244,nM,ChEMBL,CHEMBL264,CHEMBL247062,17307358,CHEMBL247062,15983456.0,C22H29N3O,351.494,"4-phenyl-7-(3-piperidin-1-ylpropoxy)-1,2,3,4-tetrahydro-2,6-naphthyridine",C1CCN(CC1)CCCOC2=NC=C3C(CNCC3=C2)C4=CC=CC=C4,C1CCN(CC1)CCCOC2=NC=C3C(CNCC3=C2)C4=CC=CC=C4,"InChI=1S/C22H29N3O/c1-3-8-18(9-4-1)20-16-23-15-19-14-22(24-17-21(19)20)26-13-7-12-25-10-5-2-6-11-25/h1,3-4,8-9,14,17,20,23H,2,5-7,10-13,15-16H2",3.3,1.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
672020,Q9Y5N1,XXHIGGQEZHTJEU-UHFFFAOYSA-N,Kd,0.1479,nM,ChEMBL,CHEMBL264,CHEMBL496366,18922693,CHEMBL496366,44581099.0,C22H34N2O2,358.526,4-cyclopentyl-2-[[4-(piperidin-1-ylmethyl)phenoxy]methyl]morpholine,C1CCN(CC1)CC2=CC=C(C=C2)OCC3CN(CCO3)C4CCCC4,C1CCN(CC1)CC2=CC=C(C=C2)OCC3CN(CCO3)C4CCCC4,"InChI=1S/C22H34N2O2/c1-4-12-23(13-5-1)16-19-8-10-21(11-9-19)26-18-22-17-24(14-15-25-22)20-6-2-3-7-20/h8-11,20,22H,1-7,12-18H2",3.6,0.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
673373,Q9Y5N1,DEHKDVJSSBSAEQ-UHFFFAOYSA-N,Kd,0.1259,nM,ChEMBL,CHEMBL264,CHEMBL194441,15771465,CHEMBL194441,9966707.0,C20H32N2O,316.489,4-[4-(piperidin-1-ylmethyl)phenoxy]-1-propan-2-ylpiperidine,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)CN3CCCCC3,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)CN3CCCCC3,"InChI=1S/C20H32N2O/c1-17(2)22-14-10-20(11-15-22)23-19-8-6-18(7-9-19)16-21-12-4-3-5-13-21/h6-9,17,20H,3-5,10-16H2,1-2H3",4.0,0.0,3.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
674194,Q9Y5N1,NAZKNCWBUXRZAC-UHFFFAOYSA-N,Kd,0.5012,nM,ChEMBL,CHEMBL264,CHEMBL1270864,20843691,CHEMBL1270864,25061924.0,C22H32N4O,368.525,[3-(piperidin-1-ylmethyl)-1H-indol-6-yl]-(4-propan-2-ylpiperazin-1-yl)methanone,CC(C)N1CCN(CC1)C(=O)C2=CC3=C(C=C2)C(=CN3)CN4CCCCC4,CC(C)N1CCN(CC1)C(=O)C2=CC3=C(C=C2)C(=CN3)CN4CCCCC4,"InChI=1S/C22H32N4O/c1-17(2)25-10-12-26(13-11-25)22(27)18-6-7-20-19(15-23-21(20)14-18)16-24-8-4-3-5-9-24/h6-7,14-15,17,23H,3-5,8-13,16H2,1-2H3",2.8,1.0,3.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
674371,Q9Y5N1,YKCOYIKIANOWTN-UHFFFAOYSA-N,Kd,7.586,nM,ChEMBL,CHEMBL264,CHEMBL391074,17616397,CHEMBL391074,23625757.0,C24H29FN2OS,412.567,1-[5-[4-(4-fluoropiperidin-1-yl)but-1-ynyl]-2-(4-methylsulfanylphenoxy)phenyl]-N-methylmethanamine,CNCC1=C(C=CC(=C1)C#CCCN2CCC(CC2)F)OC3=CC=C(C=C3)SC,CNCC1=C(C=CC(=C1)C#CCCN2CCC(CC2)F)OC3=CC=C(C=C3)SC,"InChI=1S/C24H29FN2OS/c1-26-18-20-17-19(5-3-4-14-27-15-12-21(25)13-16-27)6-11-24(20)28-22-7-9-23(29-2)10-8-22/h6-11,17,21,26H,4,12-16,18H2,1-2H3",4.9,1.0,5.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
675041,Q9Y5N1,QSLOOQBYTWFYSN-UHFFFAOYSA-N,Kd,0.6026,nM,ChEMBL,CHEMBL264,CHEMBL394861,17127059,CHEMBL394861,11668368.0,C25H34N2O2,394.559,"4-(4-methoxyphenyl)-2-methyl-7-(3-piperidin-1-ylpropoxy)-3,4-dihydro-1H-isoquinoline",CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCCCC3)C4=CC=C(C=C4)OC,CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCCCC3)C4=CC=C(C=C4)OC,"InChI=1S/C25H34N2O2/c1-26-18-21-17-23(29-16-6-15-27-13-4-3-5-14-27)11-12-24(21)25(19-26)20-7-9-22(28-2)10-8-20/h7-12,17,25H,3-6,13-16,18-19H2,1-2H3",4.4,0.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
675272,Q9Y5N1,FWJKAQILVAFVQQ-UHFFFAOYSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL264,CHEMBL237512,17616397,CHEMBL237512,44434165.0,C23H28N2OS,380.55,N-methyl-N-[4-[3-(methylaminomethyl)-4-(4-methylsulfanylphenoxy)phenyl]but-3-ynyl]cyclopropanamine,CNCC1=C(C=CC(=C1)C#CCCN(C)C2CC2)OC3=CC=C(C=C3)SC,CNCC1=C(C=CC(=C1)C#CCCN(C)C2CC2)OC3=CC=C(C=C3)SC,"InChI=1S/C23H28N2OS/c1-24-17-19-16-18(6-4-5-15-25(2)20-8-9-20)7-14-23(19)26-21-10-12-22(27-3)13-11-21/h7,10-14,16,20,24H,5,8-9,15,17H2,1-3H3",4.6,1.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
675303,Q9Y5N1,RLMPFTWBCJRGCF-UHFFFAOYSA-N,Kd,3.981,nM,ChEMBL,CHEMBL264,CHEMBL480245,19119007,CHEMBL480245,44570656.0,C16H22ClN3OS,339.882,(4-chlorophenyl)-[2-[3-(dimethylamino)propylsulfanyl]-3-methylimidazol-4-yl]methanol,CN1C(=CN=C1SCCCN(C)C)C(C2=CC=C(C=C2)Cl)O,CN1C(=CN=C1SCCCN(C)C)C(C2=CC=C(C=C2)Cl)O,"InChI=1S/C16H22ClN3OS/c1-19(2)9-4-10-22-16-18-11-14(20(16)3)15(21)12-5-7-13(17)8-6-12/h5-8,11,15,21H,4,9-10H2,1-3H3",2.7,1.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
677080,Q9Y5N1,SBAQYPMYNRQKBF-UHFFFAOYSA-N,Kd,7.943,nM,ChEMBL,CHEMBL264,CHEMBL402644,18060777,CHEMBL402644,24890939.0,C22H25Cl2N3O2,434.361,"(4-cyclopropylpiperazin-1-yl)-[4-(3,4-dichlorophenoxy)-3-(methylaminomethyl)phenyl]methanone",CNCC1=C(C=CC(=C1)C(=O)N2CCN(CC2)C3CC3)OC4=CC(=C(C=C4)Cl)Cl,CNCC1=C(C=CC(=C1)C(=O)N2CCN(CC2)C3CC3)OC4=CC(=C(C=C4)Cl)Cl,"InChI=1S/C22H25Cl2N3O2/c1-25-14-16-12-15(22(28)27-10-8-26(9-11-27)17-3-4-17)2-7-21(16)29-18-5-6-19(23)20(24)13-18/h2,5-7,12-13,17,25H,3-4,8-11,14H2,1H3",3.9,1.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
677370,Q9Y5N1,OWINJKNPCPHOEX-UHFFFAOYSA-N,Kd,8.913,nM,ChEMBL,CHEMBL264,CHEMBL126904,12930154,CHEMBL126904,9926445.0,C19H30N2O,302.462,1-[[4-(2-piperidin-1-ylethoxy)phenyl]methyl]piperidine,C1CCN(CC1)CCOC2=CC=C(C=C2)CN3CCCCC3,C1CCN(CC1)CCOC2=CC=C(C=C2)CN3CCCCC3,"InChI=1S/C19H30N2O/c1-3-11-20(12-4-1)15-16-22-19-9-7-18(8-10-19)17-21-13-5-2-6-14-21/h7-10H,1-6,11-17H2",3.5,0.0,3.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
678021,Q9Y5N1,VYEDDDWXKRDQRX-NHCUHLMSSA-N,Kd,3.162,nM,ChEMBL,CHEMBL264,CHEMBL247136,17583504,CHEMBL247136,44441084.0,C22H29N3O2S,399.553,"4-[3-[[(6S,10bR)-6-(1,3-thiazol-5-yl)-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinolin-9-yl]oxy]propyl]morpholine",C1CC2C3=C(C=CC(=C3)OCCCN4CCOCC4)C(CN2C1)C5=CN=CS5,C1C[C@@H]2C3=C(C=CC(=C3)OCCCN4CCOCC4)[C@@H](CN2C1)C5=CN=CS5,"InChI=1S/C22H29N3O2S/c1-3-21-19-13-17(27-10-2-6-24-8-11-26-12-9-24)4-5-18(19)20(15-25(21)7-1)22-14-23-16-28-22/h4-5,13-14,16,20-21H,1-3,6-12,15H2/t20-,21-/m1/s1",2.8,0.0,6.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
678083,Q9Y5N1,DZMJATAIFBTELK-LEWJYISDSA-N,Kd,0.7079,nM,ChEMBL,CHEMBL264,CHEMBL1097883,20382018,CHEMBL1097883,46887995.0,C22H30N4O2,382.508,"4-[(3S,5R)-5-(4-cyclopentyl-1,4-diazepane-1-carbonyl)pyrrolidin-3-yl]oxybenzonitrile",C1CCC(C1)N2CCCN(CC2)C(=O)C3CC(CN3)OC4=CC=C(C=C4)C#N,C1CCC(C1)N2CCCN(CC2)C(=O)[C@H]3C[C@@H](CN3)OC4=CC=C(C=C4)C#N,"InChI=1S/C22H30N4O2/c23-15-17-6-8-19(9-7-17)28-20-14-21(24-16-20)22(27)26-11-3-10-25(12-13-26)18-4-1-2-5-18/h6-9,18,20-21,24H,1-5,10-14,16H2/t20-,21+/m0/s1",2.4,1.0,5.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
678122,Q9Y5N1,WWSHLNJFRHBFML-UHFFFAOYSA-N,Kd,6.166,nM,ChEMBL,CHEMBL264,CHEMBL246331,17127059,CHEMBL246331,11539608.0,C25H32ClFN2O2,446.991,"4-(3-chloro-4-methoxyphenyl)-7-[3-(4-fluoropiperidin-1-yl)propoxy]-2-methyl-3,4-dihydro-1H-isoquinoline",CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCC(CC3)F)C4=CC(=C(C=C4)OC)Cl,CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCC(CC3)F)C4=CC(=C(C=C4)OC)Cl,"InChI=1S/C25H32ClFN2O2/c1-28-16-19-14-21(31-13-3-10-29-11-8-20(27)9-12-29)5-6-22(19)23(17-28)18-4-7-25(30-2)24(26)15-18/h4-7,14-15,20,23H,3,8-13,16-17H2,1-2H3",5.1,0.0,5.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
678362,Q9Y5N1,CCLHRWBVZOMXEV-NRFANRHFSA-N,Kd,0.3802,nM,ChEMBL,CHEMBL264,CHEMBL497192,18922693,CHEMBL497192,25211254.0,C21H32N2O3,360.498,(2S)-4-cyclopentyl-2-[[4-(morpholin-4-ylmethyl)phenoxy]methyl]morpholine,C1CCC(C1)N2CCOC(C2)COC3=CC=C(C=C3)CN4CCOCC4,C1CCC(C1)N2CCO[C@@H](C2)COC3=CC=C(C=C3)CN4CCOCC4,"InChI=1S/C21H32N2O3/c1-2-4-19(3-1)23-11-14-25-21(16-23)17-26-20-7-5-18(6-8-20)15-22-9-12-24-13-10-22/h5-8,19,21H,1-4,9-17H2/t21-/m0/s1",2.4,0.0,5.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
678661,Q9Y5N1,VECSKFSGEBXSKE-UHFFFAOYSA-N,Kd,0.257,nM,ChEMBL,CHEMBL264,CHEMBL372471,15771465,CHEMBL372471,10131633.0,C20H33N3O,331.504,1-methyl-4-[[4-(1-propan-2-ylpiperidin-4-yl)oxyphenyl]methyl]piperazine,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)CN3CCN(CC3)C,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)CN3CCN(CC3)C,"InChI=1S/C20H33N3O/c1-17(2)23-10-8-20(9-11-23)24-19-6-4-18(5-7-19)16-22-14-12-21(3)13-15-22/h4-7,17,20H,8-16H2,1-3H3",2.9,0.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
678860,Q9Y5N1,GBZPNPQJVWRRPZ-UHFFFAOYSA-N,Kd,0.5012,nM,ChEMBL,CHEMBL264,CHEMBL481745,19119007,CHEMBL481745,10134089.0,C20H26ClN3O2,375.897,(4-chlorophenyl)-[3-methyl-2-[(1-propan-2-ylpiperidin-4-yl)methoxy]imidazol-4-yl]methanone,CC(C)N1CCC(CC1)COC2=NC=C(N2C)C(=O)C3=CC=C(C=C3)Cl,CC(C)N1CCC(CC1)COC2=NC=C(N2C)C(=O)C3=CC=C(C=C3)Cl,"InChI=1S/C20H26ClN3O2/c1-14(2)24-10-8-15(9-11-24)13-26-20-22-12-18(23(20)3)19(25)16-4-6-17(21)7-5-16/h4-7,12,14-15H,8-11,13H2,1-3H3",4.2,0.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
679237,Q9Y5N1,PBMWBJNBIVVHNL-UHFFFAOYSA-N,Kd,0.3311,nM,ChEMBL,CHEMBL264,CHEMBL496167,18922693,CHEMBL496167,44581098.0,C21H32N2O2,344.499,4-cyclopentyl-2-[[4-(pyrrolidin-1-ylmethyl)phenoxy]methyl]morpholine,C1CCC(C1)N2CCOC(C2)COC3=CC=C(C=C3)CN4CCCC4,C1CCC(C1)N2CCOC(C2)COC3=CC=C(C=C3)CN4CCCC4,"InChI=1S/C21H32N2O2/c1-2-6-19(5-1)23-13-14-24-21(16-23)17-25-20-9-7-18(8-10-20)15-22-11-3-4-12-22/h7-10,19,21H,1-6,11-17H2",3.2,0.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
679363,Q9Y5N1,QARLWQQWNLVURD-UHFFFAOYSA-N,Kd,0.4898,nM,ChEMBL,CHEMBL264,CHEMBL1783905,19577344,CHEMBL1783905,25126154.0,C19H30N4O,330.476,[5-(piperidin-1-ylmethyl)pyridin-2-yl]-(4-propan-2-ylpiperazin-1-yl)methanone,CC(C)N1CCN(CC1)C(=O)C2=NC=C(C=C2)CN3CCCCC3,CC(C)N1CCN(CC1)C(=O)C2=NC=C(C=C2)CN3CCCCC3,"InChI=1S/C19H30N4O/c1-16(2)22-10-12-23(13-11-22)19(24)18-7-6-17(14-20-18)15-21-8-4-3-5-9-21/h6-7,14,16H,3-5,8-13,15H2,1-2H3",1.9,0.0,4.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
679628,Q9Y5N1,YSPPECQFRDJSGQ-ISKFKSNPSA-N,Kd,3.162,nM,ChEMBL,CHEMBL264,CHEMBL247335,17583504,CHEMBL247335,44441073.0,C24H31N3O2,393.531,"4-[3-[[(6S,10bR)-6-pyridin-2-yl-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinolin-9-yl]oxy]propyl]morpholine",C1CC2C3=C(C=CC(=C3)OCCCN4CCOCC4)C(CN2C1)C5=CC=CC=N5,C1C[C@@H]2C3=C(C=CC(=C3)OCCCN4CCOCC4)[C@@H](CN2C1)C5=CC=CC=N5,"InChI=1S/C24H31N3O2/c1-2-9-25-23(5-1)22-18-27-11-3-6-24(27)21-17-19(7-8-20(21)22)29-14-4-10-26-12-15-28-16-13-26/h1-2,5,7-9,17,22,24H,3-4,6,10-16,18H2/t22-,24-/m1/s1",2.7,0.0,5.0,Histamine H3 receptor,HRH3,Homo sapiens (Human),MERAPPDGPLNASGALAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSAFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMLLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGAREAAGPEPPPEAQPSPPPPPGCWGCWQKGHGEAMPLHRYGVGEAAVGAEAGEATLGGGGGGGSVASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSFTQRFRLSRDRKVAKSLAVIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHHSFRRAFTKLLCPQKLKIQPHSSLEHCWK
680556,P47747,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,69183.1,nM,ChEMBL,CHEMBL2882,CHEMBL90,1507209,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681159,P47747,XCPYYRGRBRZJBY-UHFFFAOYSA-N,Kd,181.97,nM,ChEMBL,CHEMBL2882,CHEMBL47917,12729649,CHEMBL47917,44292729.0,C33H37N7O2,563.706,N-[2-[[N-cyano-N'-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]carbamimidoyl]amino]ethyl]acridine-9-carboxamide,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=C4C=CC=CC4=NC5=CC=CC=C53)NC#N,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=C4C=CC=CC4=NC5=CC=CC=C53)NC#N,"InChI=1S/C33H37N7O2/c34-24-38-33(36-16-9-21-42-26-11-8-10-25(22-26)23-40-19-6-1-7-20-40)37-18-17-35-32(41)31-27-12-2-4-14-29(27)39-30-15-5-3-13-28(30)31/h2-5,8,10-15,22H,1,6-7,9,16-21,23H2,(H,35,41)(H2,36,37,38)",4.8,3.0,6.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681229,P47747,VAHSNCINYMWAGT-UHFFFAOYSA-N,Kd,1698.24,nM,ChEMBL,CHEMBL2882,CHEMBL312601,1352351,CHEMBL312601,14514734.0,C23H28F3N3O2,435.491,1-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-3-[4-(trifluoromethyl)phenyl]urea,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC=C(C=C3)C(F)(F)F,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC=C(C=C3)C(F)(F)F,"InChI=1S/C23H28F3N3O2/c24-23(25,26)19-8-10-20(11-9-19)28-22(30)27-12-5-15-31-21-7-4-6-18(16-21)17-29-13-2-1-3-14-29/h4,6-11,16H,1-3,5,12-15,17H2,(H2,27,28,30)",4.4,2.0,6.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681402,P47747,CALTUROEFHQVRN-UHFFFAOYSA-N,Kd,154.88,nM,ChEMBL,CHEMBL2882,CHEMBL309401,1352351,CHEMBL309401,14883414.0,C22H30N4O2,382.508,1-(3-aminophenyl)-3-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]urea,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC=CC(=C3)N,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC=CC(=C3)N,"InChI=1S/C22H30N4O2/c23-19-8-5-9-20(16-19)25-22(27)24-11-6-14-28-21-10-4-7-18(15-21)17-26-12-2-1-3-13-26/h4-5,7-10,15-16H,1-3,6,11-14,17,23H2,(H2,24,25,27)",2.9,3.0,4.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681610,P47747,UHWSOPLLSOYYQA-UHFFFAOYSA-N,Kd,37.15,nM,ChEMBL,CHEMBL2882,CHEMBL295682,12729649,CHEMBL295682,44293002.0,C26H33N9O4,535.609,"1-cyano-3-[3-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]propyl]-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]guanidine",C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCCNC3=CC=C(C4=NON=C34)[N+](=O)[O-])NC#N,C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCCNC3=CC=C(C4=NON=C34)[N+](=O)[O-])NC#N,"InChI=1S/C26H33N9O4/c27-19-31-26(29-12-5-11-28-22-9-10-23(35(36)37)25-24(22)32-39-33-25)30-13-6-16-38-21-8-4-7-20(17-21)18-34-14-2-1-3-15-34/h4,7-10,17,28H,1-3,5-6,11-16,18H2,(H2,29,30,31)",3.9,3.0,10.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681665,P47747,IBPWGZKZWJYGLA-UHFFFAOYSA-N,Kd,31622.78,nM,ChEMBL,CHEMBL2882,CHEMBL15056,11855993,CHEMBL15056,11004759.0,C29H37N3O,443.635,"N-[2-[4-(3-piperidin-1-ylpropoxy)phenyl]ethyl]-1,2,3,4-tetrahydroacridin-9-amine",C1CCN(CC1)CCCOC2=CC=C(C=C2)CCNC3=C4CCCCC4=NC5=CC=CC=C53,C1CCN(CC1)CCCOC2=CC=C(C=C2)CCNC3=C4CCCCC4=NC5=CC=CC=C53,"InChI=1S/C29H37N3O/c1-6-19-32(20-7-1)21-8-22-33-24-15-13-23(14-16-24)17-18-30-29-25-9-2-4-11-27(25)31-28-12-5-3-10-26(28)29/h2,4,9,11,13-16H,1,3,5-8,10,12,17-22H2,(H,30,31)",6.5,1.0,4.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681702,P47747,CMMPYSSGZCXFRL-UHFFFAOYSA-N,Kd,177.83,nM,ChEMBL,CHEMBL2882,CHEMBL81859,1352351,CHEMBL81859,14514743.0,C22H28N4O4,412.49,1-(4-nitrophenyl)-3-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]urea,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC=C(C=C3)[N+](=O)[O-],C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC=C(C=C3)[N+](=O)[O-],"InChI=1S/C22H28N4O4/c27-22(24-19-8-10-20(11-9-19)26(28)29)23-12-5-15-30-21-7-4-6-18(16-21)17-25-13-2-1-3-14-25/h4,6-11,16H,1-3,5,12-15,17H2,(H2,23,24,27)",3.4,2.0,5.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
681993,P47747,NCHFMUPYWCKMIZ-UHFFFAOYSA-N,Kd,269.15,nM,ChEMBL,CHEMBL2882,CHEMBL311978,1352351,CHEMBL311978,14514742.0,C22H28N4O4,412.49,1-(3-nitrophenyl)-3-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]urea,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC(=CC=C3)[N+](=O)[O-],C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)NC3=CC(=CC=C3)[N+](=O)[O-],"InChI=1S/C22H28N4O4/c27-22(24-19-8-5-9-20(16-19)26(28)29)23-11-6-14-30-21-10-4-7-18(15-21)17-25-12-2-1-3-13-25/h4-5,7-10,15-16H,1-3,6,11-14,17H2,(H2,23,24,27)",3.4,2.0,5.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
682111,P47747,QDGYDRMUJVIATQ-UHFFFAOYSA-N,Kd,1949.84,nM,ChEMBL,CHEMBL2882,CHEMBL295252,12729649,CHEMBL295252,44292619.0,C31H41N7O3S,591.775,1-cyano-3-[2-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]ethyl]-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]guanidine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCNC(=NCCCOC3=CC=CC(=C3)CN4CCCCC4)NC#N,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCNC(=NCCCOC3=CC=CC(=C3)CN4CCCCC4)NC#N,"InChI=1S/C31H41N7O3S/c1-37(2)29-14-7-13-28-27(29)12-8-15-30(28)42(39,40)36-18-17-34-31(35-24-32)33-16-9-21-41-26-11-6-10-25(22-26)23-38-19-4-3-5-20-38/h6-8,10-15,22,36H,3-5,9,16-21,23H2,1-2H3,(H2,33,34,35)",4.3,3.0,8.0,Histamine H2 receptor,HRH2,Cavia porcellus (Guinea pig),MAFNGTVPSFCMDFTVYKVTISVILIILILVTVAGNVVVCLAVGLNRRLRSLTNCFIVSLAVTDLLLGLLVLPFSAIYQLSCKWSFSKVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLITPARVAISLVFIWVISITLSFLSIHLGWNSRNETSKDNDTIVKCKVQVNEVYGLVDGLVTFYLPLLIMCITYFRIFKIAREQARRINHIGSWKAATIREHKATVTLAAVMGAFIICWFPYFTVFVYRGLKGDDAVNEVFEDVVLWLGYANSALNPILYAALNRDFRTAYHQLFCCRLASHNSHETSLRLNNSQLNRSQCQEPRWQEDKPLNLQVWSGTEVTAPQGATNR
682506,Q9JI35,ISYZXIQFYBYIKC-UHFFFAOYSA-N,Kd,>316.23,nM,ChEMBL,CHEMBL5076,CHEMBL153468,14640554,CHEMBL153468,11166893.0,C30H36N4,452.646,"N-[2-[2-(3,3-diphenylpropyl)-1H-imidazol-5-yl]ethyl]-5-pyridin-2-ylpentan-1-amine",C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCCCCC3=CC=CC=N3)C4=CC=CC=C4,C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCCCCC3=CC=CC=N3)C4=CC=CC=C4,"InChI=1S/C30H36N4/c1-4-12-25(13-5-1)29(26-14-6-2-7-15-26)18-19-30-33-24-28(34-30)20-23-31-21-10-3-8-16-27-17-9-11-22-32-27/h1-2,4-7,9,11-15,17,22,24,29,31H,3,8,10,16,18-21,23H2,(H,33,34)",6.0,2.0,3.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682509,Q9JI35,ASYPSYLJDLVBFQ-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL5076,CHEMBL2437432,24050887,CHEMBL2437432,72375119.0,C28H31FN8O2,530.608,1-[1-[1-[(2-aminopyridin-4-yl)methyl]piperidine-4-carbonyl]piperidin-4-yl]-5-fluoro-3-pyrimidin-2-ylbenzimidazol-2-one,C1CN(CCC1C(=O)N2CCC(CC2)N3C4=C(C=C(C=C4)F)N(C3=O)C5=NC=CC=N5)CC6=CC(=NC=C6)N,C1CN(CCC1C(=O)N2CCC(CC2)N3C4=C(C=C(C=C4)F)N(C3=O)C5=NC=CC=N5)CC6=CC(=NC=C6)N,"InChI=1S/C28H31FN8O2/c29-21-2-3-23-24(17-21)37(27-32-9-1-10-33-27)28(39)36(23)22-7-14-35(15-8-22)26(38)20-5-12-34(13-6-20)18-19-4-11-31-25(30)16-19/h1-4,9-11,16-17,20,22H,5-8,12-15,18H2,(H2,30,31)",1.8,1.0,8.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682653,Q9JI35,OFLWRNCEFSGWJL-UHFFFAOYSA-N,Kd,117.49,nM,ChEMBL,CHEMBL5076,CHEMBL421350,9258364,CHEMBL421350,10018468.0,C15H15N5OS,313.379,4-[2-[2-(1H-imidazol-5-yl)ethylsulfanyl]-1H-imidazol-5-yl]benzamide,C1=CC(=CC=C1C2=CN=C(N2)SCCC3=CN=CN3)C(=O)N,C1=CC(=CC=C1C2=CN=C(N2)SCCC3=CN=CN3)C(=O)N,"InChI=1S/C15H15N5OS/c16-14(21)11-3-1-10(2-4-11)13-8-18-15(20-13)22-6-5-12-7-17-9-19-12/h1-4,7-9H,5-6H2,(H2,16,21)(H,17,19)(H,18,20)",1.6,3.0,4.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682685,Q9JI35,GPLGAQQQNWMVMM-MYAJQUOBSA-N,Kd,281.84,nM,ChEMBL,CHEMBL5076,CHEMBL191703,18683917,conessine,441082.0,C24H40N2,356.598,"(1R,2S,5S,6S,9R,12S,13R,16S)-N,N,6,7,13-pentamethyl-7-azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-en-16-amine",CC1C2CCC3C2(CCC4C3CC=C5C4(CCC(C5)N(C)C)C)CN1C,C[C@H]1[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)N(C)C)C)CN1C,"InChI=1S/C24H40N2/c1-16-20-8-9-22-19-7-6-17-14-18(25(3)4)10-12-23(17,2)21(19)11-13-24(20,22)15-26(16)5/h6,16,18-22H,7-15H2,1-5H3/t16-,18-,19+,20+,21-,22-,23-,24-/m0/s1",4.9,0.0,2.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682708,Q9JI35,QEXOFWNDNHZFRD-UHFFFAOYSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL5076,CHEMBL1222798,20685118,CHEMBL1222798,49864988.0,C32H37N5O3,539.68,1-(2-phenoxyethyl)-3-[1-[1-(pyridin-4-ylmethyl)piperidine-4-carbonyl]piperidin-4-yl]benzimidazol-2-one,C1CN(CCC1C(=O)N2CCC(CC2)N3C4=CC=CC=C4N(C3=O)CCOC5=CC=CC=C5)CC6=CC=NC=C6,C1CN(CCC1C(=O)N2CCC(CC2)N3C4=CC=CC=C4N(C3=O)CCOC5=CC=CC=C5)CC6=CC=NC=C6,"InChI=1S/C32H37N5O3/c38-31(26-12-18-34(19-13-26)24-25-10-16-33-17-11-25)35-20-14-27(15-21-35)37-30-9-5-4-8-29(30)36(32(37)39)22-23-40-28-6-2-1-3-7-28/h1-11,16-17,26-27H,12-15,18-24H2",3.6,0.0,5.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682859,Q9JI35,IECPJVGHHUNYNJ-UHFFFAOYSA-N,Kd,>1000,nM,ChEMBL,CHEMBL5076,CHEMBL264491,14640554,CHEMBL264491,11741669.0,C25H29N5,399.542,"N-[2-[2-(3,3-diphenylpropyl)-1H-imidazol-5-yl]ethyl]-2-(1H-imidazol-5-yl)ethanamine",C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCC3=CN=CN3)C4=CC=CC=C4,C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCC3=CN=CN3)C4=CC=CC=C4,"InChI=1S/C25H29N5/c1-3-7-20(8-4-1)24(21-9-5-2-6-10-21)11-12-25-28-18-23(30-25)14-16-26-15-13-22-17-27-19-29-22/h1-10,17-19,24,26H,11-16H2,(H,27,29)(H,28,30)",4.1,3.0,3.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682868,Q9JI35,IXZDLPYKIIELLK-UHFFFAOYSA-N,Kd,1000,nM,ChEMBL,CHEMBL5076,CHEMBL90063,7830269,CHEMBL90063,10420190.0,C11H21N3,195.31,8-(1H-imidazol-5-yl)octan-1-amine,C1=C(NC=N1)CCCCCCCCN,C1=C(NC=N1)CCCCCCCCN,"InChI=1S/C11H21N3/c12-8-6-4-2-1-3-5-7-11-9-13-10-14-11/h9-10H,1-8,12H2,(H,13,14)",2.1,2.0,2.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
682911,Q9JI35,GXILWBIQFGWJQN-UHFFFAOYSA-N,Kd,3.981,nM,ChEMBL,CHEMBL5076,CHEMBL239975,18052318,CHEMBL239975,15986917.0,C25H30FN3O3,439.531,4-(4-fluorobenzoyl)-1-[4-(3-piperidin-1-ylpropoxy)phenyl]piperazin-2-one,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F,"InChI=1S/C25H30FN3O3/c26-21-7-5-20(6-8-21)25(31)28-16-17-29(24(30)19-28)22-9-11-23(12-10-22)32-18-4-15-27-13-2-1-3-14-27/h5-12H,1-4,13-19H2",3.6,0.0,5.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683151,Q9JI35,XQWKLOMHNQDDHP-UHFFFAOYSA-N,Kd,61.66,nM,ChEMBL,CHEMBL5076,CHEMBL412882,10794692,CHEMBL412882,10806687.0,C16H19ClN4S,334.866,N-[(4-chlorophenyl)methyl]-4-(1H-imidazol-5-yl)piperidine-1-carbothioamide,C1CN(CCC1C2=CN=CN2)C(=S)NCC3=CC=C(C=C3)Cl,C1CN(CCC1C2=CN=CN2)C(=S)NCC3=CC=C(C=C3)Cl,"InChI=1S/C16H19ClN4S/c17-14-3-1-12(2-4-14)9-19-16(22)21-7-5-13(6-8-21)15-10-18-11-20-15/h1-4,10-11,13H,5-9H2,(H,18,20)(H,19,22)",2.7,2.0,2.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683153,Q9JI35,XQWKLOMHNQDDHP-UHFFFAOYSA-N,Kd,61.66,nM,ChEMBL,CHEMBL5076,CHEMBL412882,11356102,CHEMBL412882,10806687.0,C16H19ClN4S,334.866,N-[(4-chlorophenyl)methyl]-4-(1H-imidazol-5-yl)piperidine-1-carbothioamide,C1CN(CCC1C2=CN=CN2)C(=S)NCC3=CC=C(C=C3)Cl,C1CN(CCC1C2=CN=CN2)C(=S)NCC3=CC=C(C=C3)Cl,"InChI=1S/C16H19ClN4S/c17-14-3-1-12(2-4-14)9-19-16(22)21-7-5-13(6-8-21)15-10-18-11-20-15/h1-4,10-11,13H,5-9H2,(H,18,20)(H,19,22)",2.7,2.0,2.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683193,Q9JI35,IBPWGZKZWJYGLA-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL5076,CHEMBL15056,11855993,CHEMBL15056,11004759.0,C29H37N3O,443.635,"N-[2-[4-(3-piperidin-1-ylpropoxy)phenyl]ethyl]-1,2,3,4-tetrahydroacridin-9-amine",C1CCN(CC1)CCCOC2=CC=C(C=C2)CCNC3=C4CCCCC4=NC5=CC=CC=C53,C1CCN(CC1)CCCOC2=CC=C(C=C2)CCNC3=C4CCCCC4=NC5=CC=CC=C53,"InChI=1S/C29H37N3O/c1-6-19-32(20-7-1)21-8-22-33-24-15-13-23(14-16-24)17-18-30-29-25-9-2-4-11-27(25)31-28-12-5-3-10-26(28)29/h2,4,9,11,13-16H,1,3,5-8,10,12,17-22H2,(H,30,31)",6.5,1.0,4.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683244,Q9JI35,ILGIWHFMFHNSOO-UHFFFAOYSA-N,Kd,15.85,nM,ChEMBL,CHEMBL5076,CHEMBL2437431,24050887,CHEMBL2437431,72375001.0,C29H32FN7O2,529.62,1-[1-[1-[(2-aminopyridin-4-yl)methyl]piperidine-4-carbonyl]piperidin-4-yl]-5-fluoro-3-pyridin-2-ylbenzimidazol-2-one,C1CN(CCC1C(=O)N2CCC(CC2)N3C4=C(C=C(C=C4)F)N(C3=O)C5=CC=CC=N5)CC6=CC(=NC=C6)N,C1CN(CCC1C(=O)N2CCC(CC2)N3C4=C(C=C(C=C4)F)N(C3=O)C5=CC=CC=N5)CC6=CC(=NC=C6)N,"InChI=1S/C29H32FN7O2/c30-22-4-5-24-25(18-22)37(27-3-1-2-11-33-27)29(39)36(24)23-9-15-35(16-10-23)28(38)21-7-13-34(14-8-21)19-20-6-12-32-26(31)17-20/h1-6,11-12,17-18,21,23H,7-10,13-16,19H2,(H2,31,32)",2.5,1.0,7.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683422,Q9JI35,MPCYZPCWSYUWMJ-UHFFFAOYSA-N,Kd,>1000000,nM,ChEMBL,CHEMBL5076,CHEMBL92694,7830269,(1H-IMIDAZOL-4-YL)METHANAMINE,12408174.0,C4H7N3,97.121,1H-imidazol-5-ylmethanamine,C1=C(NC=N1)CN,C1=C(NC=N1)CN,"InChI=1S/C4H7N3/c5-1-4-2-6-3-7-4/h2-3H,1,5H2,(H,6,7)",-1.0,2.0,2.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683587,Q9JI35,CMUOXPNQSSULRS-UHFFFAOYSA-N,Kd,50.12,nM,ChEMBL,CHEMBL5076,CHEMBL88048,9258364,CHEMBL88048,23277107.0,C20H18N4O3S2,426.509,[4-[2-[2-(1H-imidazol-5-yl)ethylsulfanyl]-1H-imidazol-5-yl]phenyl] benzenesulfonate,C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)C3=CN=C(N3)SCCC4=CN=CN4,C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)C3=CN=C(N3)SCCC4=CN=CN4,"InChI=1S/C20H18N4O3S2/c25-29(26,18-4-2-1-3-5-18)27-17-8-6-15(7-9-17)19-13-22-20(24-19)28-11-10-16-12-21-14-23-16/h1-9,12-14H,10-11H2,(H,21,23)(H,22,24)",3.8,2.0,6.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683612,Q9JI35,DZBSGIZPIZEWAW-UHFFFAOYSA-N,Kd,165.96,nM,ChEMBL,CHEMBL5076,CHEMBL442958,10794692,CHEMBL442958,10002565.0,C16H19IN4S,426.32,4-(1H-imidazol-5-yl)-N-[(4-iodophenyl)methyl]piperidine-1-carbothioamide,C1CN(CCC1C2=CN=CN2)C(=S)NCC3=CC=C(C=C3)I,C1CN(CCC1C2=CN=CN2)C(=S)NCC3=CC=C(C=C3)I,"InChI=1S/C16H19IN4S/c17-14-3-1-12(2-4-14)9-19-16(22)21-7-5-13(6-8-21)15-10-18-11-20-15/h1-4,10-11,13H,5-9H2,(H,18,20)(H,19,22)",2.7,2.0,2.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
683731,Q9JI35,XTLNKZYASKPMLL-UHFFFAOYSA-N,Kd,1.259,nM,ChEMBL,CHEMBL5076,CHEMBL1222863,20685118,CHEMBL1222863,44215838.0,C31H42N6O2,530.717,1-(2-piperidin-1-ylethyl)-3-[1-[1-(pyridin-4-ylmethyl)piperidine-4-carbonyl]piperidin-4-yl]benzimidazol-2-one,C1CCN(CC1)CCN2C3=CC=CC=C3N(C2=O)C4CCN(CC4)C(=O)C5CCN(CC5)CC6=CC=NC=C6,C1CCN(CC1)CCN2C3=CC=CC=C3N(C2=O)C4CCN(CC4)C(=O)C5CCN(CC5)CC6=CC=NC=C6,"InChI=1S/C31H42N6O2/c38-30(26-10-18-34(19-11-26)24-25-8-14-32-15-9-25)35-20-12-27(13-21-35)37-29-7-3-2-6-28(29)36(31(37)39)23-22-33-16-4-1-5-17-33/h2-3,6-9,14-15,26-27H,1,4-5,10-13,16-24H2",2.8,0.0,5.0,Histamine H3 receptor,HRH3,Cavia porcellus (Guinea pig),MERAPPDGLMNASGALAGEAAAAAGGARTFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGVFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCTSSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMVLVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGAREAGPDPLPEAQSSPPQPPPGCWGCWPKGQGESMPLHRYGVGEAGPGAEAGEAALGGGSGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGHCVPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHSSLEHCWK
695881,P30411,COEYQHHSXLKKSG-DEOSSOPVSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL3157,CHEMBL267493,17266207,CHEMBL267493,10418701.0,C35H46Cl2N8O5S,761.764,"2-[(4S)-4-amino-6-[4-[1-[[2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]phenyl]sulfonylamino]cyclopentanecarbonyl]piperazin-1-yl]-6-oxohexyl]guanidine",CC1=CC(=NC2=C1C=CC=C2OCC3=C(C=CC(=C3Cl)S(=O)(=O)NC4(CCCC4)C(=O)N5CCN(CC5)C(=O)CC(CCCN=C(N)N)N)Cl)C,CC1=CC(=NC2=C1C=CC=C2OCC3=C(C=CC(=C3Cl)S(=O)(=O)NC4(CCCC4)C(=O)N5CCN(CC5)C(=O)C[C@H](CCCN=C(N)N)N)Cl)C,"InChI=1S/C35H46Cl2N8O5S/c1-22-19-23(2)42-32-25(22)8-5-9-28(32)50-21-26-27(36)10-11-29(31(26)37)51(48,49)43-35(12-3-4-13-35)33(47)45-17-15-44(16-18-45)30(46)20-24(38)7-6-14-41-34(39)40/h5,8-11,19,24,43H,3-4,6-7,12-18,20-21,38H2,1-2H3,(H4,39,40,41)/t24-/m0/s1",2.7,4.0,9.0,B2 bradykinin receptor,BDKRB2,Homo sapiens (Human),MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQVEWLGWLNTIQPPFLWVLFVLATLENIFVLSVFCLHKSSCTVAEIYLGNLAAADLILACGLPFWAITISNNFDWLFGETLCRVVNAIISMNLYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLVIWGCTLLLSSPMLVFRTMKEYSDEGHNVTACVISYPSLIWEVFTNMLLNVVGFLLPLSVITFCTMQIMQVLRNNEMQKFKEIQTERRATVLVLVVLLLFIICWLPFQISTFLDTLHRLGILSSCQDERIIDVITQIASFMAYSNSCLNPLVYVIVGKRFRKKSWEVYQGVCQKGGCRSEPIQMENSMGTLRTSISVERQIHKLQDWAGSRQ
707688,P50406,YZWVCKIHPIIMEV-UHFFFAOYSA-N,Kd,5.012,nM,ChEMBL,CHEMBL3371,CHEMBL3786693,26876931,CHEMBL3786693,44240753.0,C17H25N5O2S,363.48,"N-(4-aminophenyl)sulfonyl-N'-ethyl-2,3-diazaspiro[4.5]dec-3-ene-2-carboximidamide",CCN=C(NS(=O)(=O)C1=CC=C(C=C1)N)N2CC3(CCCCC3)C=N2,CCN=C(NS(=O)(=O)C1=CC=C(C=C1)N)N2CC3(CCCCC3)C=N2,"InChI=1S/C17H25N5O2S/c1-2-19-16(21-25(23,24)15-8-6-14(18)7-9-15)22-13-17(12-20-22)10-4-3-5-11-17/h6-9,12H,2-5,10-11,13,18H2,1H3,(H,19,21)",1.9,2.0,5.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
708460,P50406,ZNRJXSHXWJKTGJ-UHFFFAOYSA-N,Kd,100,nM,ChEMBL,CHEMBL3371,CHEMBL328816,12825922,CHEMBL328816,10356663.0,C15H14N2O2S,286.349,4-(3-methylindol-1-yl)sulfonylaniline,CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=C(C=C3)N,CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=C(C=C3)N,"InChI=1S/C15H14N2O2S/c1-11-10-17(15-5-3-2-4-14(11)15)20(18,19)13-8-6-12(16)7-9-13/h2-10H,16H2,1H3",2.9,1.0,3.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
709222,P50406,MKGZFKFZQDUADL-UHFFFAOYSA-N,Kd,5.012,nM,ChEMBL,CHEMBL3371,CHEMBL1834226,21866910,CHEMBL1834226,56595402.0,C14H19ClN4O2S,342.842,"N-(3-chlorophenyl)sulfonyl-N',4-diethyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,"InChI=1S/C14H19ClN4O2S/c1-3-11-9-17-19(10-11)14(16-4-2)18-22(20,21)13-7-5-6-12(15)8-13/h5-9,11H,3-4,10H2,1-2H3,(H,16,18)",2.2,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
709223,P50406,MKGZFKFZQDUADL-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL3371,CHEMBL1834226,21866910,CHEMBL1834226,56595402.0,C14H19ClN4O2S,342.842,"N-(3-chlorophenyl)sulfonyl-N',4-diethyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,"InChI=1S/C14H19ClN4O2S/c1-3-11-9-17-19(10-11)14(16-4-2)18-22(20,21)13-7-5-6-12(15)8-13/h5-9,11H,3-4,10H2,1-2H3,(H,16,18)",2.2,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
709224,P50406,MKGZFKFZQDUADL-UHFFFAOYSA-N,Kd,5.012,nM,ChEMBL,CHEMBL3371,CHEMBL1834226,26876931,CHEMBL1834226,56595402.0,C14H19ClN4O2S,342.842,"N-(3-chlorophenyl)sulfonyl-N',4-diethyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,"InChI=1S/C14H19ClN4O2S/c1-3-11-9-17-19(10-11)14(16-4-2)18-22(20,21)13-7-5-6-12(15)8-13/h5-9,11H,3-4,10H2,1-2H3,(H,16,18)",2.2,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
709228,P50406,MKGZFKFZQDUADL-UHFFFAOYSA-N,Kd,31.62,nM,ChEMBL,CHEMBL3371,CHEMBL1834226,21866910,CHEMBL1834226,56595402.0,C14H19ClN4O2S,342.842,"N-(3-chlorophenyl)sulfonyl-N',4-diethyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC(=CC=C2)Cl,"InChI=1S/C14H19ClN4O2S/c1-3-11-9-17-19(10-11)14(16-4-2)18-22(20,21)13-7-5-6-12(15)8-13/h5-9,11H,3-4,10H2,1-2H3,(H,16,18)",2.2,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
709901,P50406,RGYUHWISLHLCCL-UHFFFAOYSA-N,Kd,12.59,nM,ChEMBL,CHEMBL3371,CHEMBL3786087,26876931,CHEMBL3786087,58158707.0,C17H22N6O2S,374.463,"N'-ethyl-N-(1H-indazol-5-ylsulfonyl)-2,3-diazaspiro[4.4]non-3-ene-2-carboximidamide",CCN=C(NS(=O)(=O)C1=CC2=C(C=C1)NN=C2)N3CC4(CCCC4)C=N3,CCN=C(NS(=O)(=O)C1=CC2=C(C=C1)NN=C2)N3CC4(CCCC4)C=N3,"InChI=1S/C17H22N6O2S/c1-2-18-16(23-12-17(11-20-23)7-3-4-8-17)22-26(24,25)14-5-6-15-13(9-14)10-19-21-15/h5-6,9-11H,2-4,7-8,12H2,1H3,(H,18,22)(H,19,21)",1.7,2.0,5.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
710190,P50406,UTCBGRDLKHYAOT-UHFFFAOYSA-N,Kd,2.512,nM,ChEMBL,CHEMBL3371,CHEMBL1834338,21866910,CHEMBL1834338,56593646.0,C18H22N4O2S,358.46,"N',4-diethyl-N-naphthalen-1-ylsulfonyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC=CC3=CC=CC=C32,CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC=CC3=CC=CC=C32,"InChI=1S/C18H22N4O2S/c1-3-14-12-20-22(13-14)18(19-4-2)21-25(23,24)17-11-7-9-15-8-5-6-10-16(15)17/h5-12,14H,3-4,13H2,1-2H3,(H,19,21)",2.8,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
711825,P50406,FAHHQHKCTQQKDO-UHFFFAOYSA-N,Kd,79.43,nM,ChEMBL,CHEMBL3371,CHEMBL1834231,21866910,CHEMBL1834231,56595407.0,C12H15ClN4O2S,314.788,"N-(3-chlorophenyl)sulfonyl-N'-ethyl-3,4-dihydropyrazole-2-carboximidamide",CCN=C(NS(=O)(=O)C1=CC(=CC=C1)Cl)N2CCC=N2,CCN=C(NS(=O)(=O)C1=CC(=CC=C1)Cl)N2CCC=N2,"InChI=1S/C12H15ClN4O2S/c1-2-14-12(17-8-4-7-15-17)16-20(18,19)11-6-3-5-10(13)9-11/h3,5-7,9H,2,4,8H2,1H3,(H,14,16)",1.3,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
712036,P50406,QGNIIKFYMGOEGK-UHFFFAOYSA-N,Kd,100,nM,ChEMBL,CHEMBL3371,CHEMBL1834332,21866910,CHEMBL1834332,56595670.0,C15H22N4O3S,338.426,"N',4-diethyl-N-(3-methoxyphenyl)sulfonyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC=CC(=C2)OC,CCC1CN(N=C1)C(=NCC)NS(=O)(=O)C2=CC=CC(=C2)OC,"InChI=1S/C15H22N4O3S/c1-4-12-10-17-19(11-12)15(16-5-2)18-23(20,21)14-8-6-7-13(9-14)22-3/h6-10,12H,4-5,11H2,1-3H3,(H,16,18)",1.5,1.0,5.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
714379,P50406,QEGIPVVTDFUDRC-UHFFFAOYSA-N,Kd,>1000,nM,ChEMBL,CHEMBL3371,CHEMBL1834223,21866910,CID 70878684,70878684.0,C18H19ClN4O2S,390.886,"N'-(2-chlorophenyl)sulfonyl-4-ethyl-N-phenyl-3,4-dihydropyrazole-2-carboximidamide",CCC1CN(N=C1)C(=NS(=O)(=O)C2=CC=CC=C2Cl)NC3=CC=CC=C3,CCC1CN(N=C1)C(=NS(=O)(=O)C2=CC=CC=C2Cl)NC3=CC=CC=C3,"InChI=1S/C18H19ClN4O2S/c1-2-14-12-20-23(13-14)18(21-15-8-4-3-5-9-15)22-26(24,25)17-11-7-6-10-16(17)19/h3-12,14H,2,13H2,1H3,(H,21,22)",4.1,1.0,4.0,5-hydroxytryptamine receptor 6,HTR6,Homo sapiens (Human),MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN
719367,P30968,ZLHDBMSLLLDWAB-PLLCQXJGSA-N,Kd,1,nM,ChEMBL,CHEMBL1855,CHEMBL413698,11462984,CHEMBL413698,44361468.0,C86H106ClN19O18,1729.359,"(4R)-N-[4-[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[4-[[(4R)-2,6-dioxo-1,3-diazinane-4-carbonyl]amino]phenyl]propanoyl]amino]-3-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide",CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C3CC(=O)NC(=O)N3)NC(=O)C(CC4=CC=C(C=C4)NC(=O)C5CC(=O)NC(=O)N5)NC(=O)C(CO)NC(=O)C(CC6=CN=CC=C6)NC(=O)C(CC7=CC=C(C=C7)Cl)NC(=O)C(CC8=CC9=CC=CC=C9C=C8)NC(=O)C,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)[C@H]3CC(=O)NC(=O)N3)NC(=O)[C@H](CC4=CC=C(C=C4)NC(=O)[C@H]5CC(=O)NC(=O)N5)NC(=O)[C@H](CO)NC(=O)[C@@H](CC6=CN=CC=C6)NC(=O)[C@@H](CC7=CC=C(C=C7)Cl)NC(=O)[C@@H](CC8=CC9=CC=CC=C9C=C8)NC(=O)C,"InChI=1S/C86H106ClN19O18/c1-46(2)35-61(76(114)95-60(16-9-10-33-90-47(3)4)84(122)106-34-12-17-70(106)83(121)91-48(5)73(88)111)96-78(116)64(38-51-21-28-58(29-22-51)93-74(112)67-42-71(109)104-85(123)102-67)98-80(118)65(39-52-23-30-59(31-24-52)94-75(113)68-43-72(110)105-86(124)103-68)100-82(120)69(45-107)101-81(119)66(41-54-13-11-32-89-44-54)99-79(117)63(37-50-19-26-57(87)27-20-50)97-77(115)62(92-49(6)108)40-53-18-25-55-14-7-8-15-56(55)36-53/h7-8,11,13-15,18-32,36,44,46-48,60-70,90,107H,9-10,12,16-17,33-35,37-43,45H2,1-6H3,(H2,88,111)(H,91,121)(H,92,108)(H,93,112)(H,94,113)(H,95,114)(H,96,116)(H,97,115)(H,98,118)(H,99,117)(H,100,120)(H,101,119)(H2,102,104,109,123)(H2,103,105,110,124)/t48-,60+,61+,62-,63-,64-,65+,66-,67-,68-,69+,70+/m1/s1",2.8,18.0,20.0,Gonadotropin-releasing hormone receptor,GNRHR,Homo sapiens (Human),MANSASPEQNQNHCSAINNSIPLMQGNLPTLTLSGKIRVTVTFFLFLLSATFNASFLLKLQKWTQKKEKGKKLSRMKLLLKHLTLANLLETLIVMPLDGMWNITVQWYAGELLCKVLSYLKLFSMYAPAFMMVVISLDRSLAITRPLALKSNSKVGQSMVGLAWILSSVFAGPQLYIFRMIHLADSSGQTKVFSQCVTHCSFSQWWHQAFYNFFTFSCLFIIPLFIMLICNAKIIFTLTRVLHQDPHELQLNQSKNNIPRARLKTLKMTVAFATSFTVCWTPYYVLGIWYWFDPEMLNRLSDPVNHFFFLFAFLNPCFDPLIYGYFSL
720950,P32239,VLKJKVMACAESPP-MRDSYVANSA-N,Kd,2.951,nM,ChEMBL,CHEMBL298,CHEMBL515288,19271701,[125I]-BDZ2,44572147.0,C23H19IN4O2,508.336,"1-(3-(125I)iodanylphenyl)-3-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]urea",CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC(=CC=C3)I)C4=CC=CC=C4,CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)NC3=CC(=CC=C3)[125I])C4=CC=CC=C4,"InChI=1S/C23H19IN4O2/c1-28-19-13-6-5-12-18(19)20(15-8-3-2-4-9-15)26-21(22(28)29)27-23(30)25-17-11-7-10-16(24)14-17/h2-14,21H,1H3,(H2,25,27,30)/t21-/m0/s1/i24-2",4.1,2.0,3.0,Gastrin/cholecystokinin type B receptor,CCKBR,Homo sapiens (Human),MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG
724394,P30553,RAOPPBQATVHDJR-UHFFFAOYSA-N,Kd,91.2,nM,ChEMBL,CHEMBL3508,CHEMBL205831,16570921,CHEMBL205831,11663565.0,C30H39N5O3,517.674,"2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(dimethylamino)phenyl]acetamide",CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NN(C1=O)CC(=O)NC3=CC(=CC=C3)N(C)C)C4CCCCC4,CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NN(C1=O)CC(=O)NC3=CC(=CC=C3)N(C)C)C4CCCCC4,"InChI=1S/C30H39N5O3/c1-30(2,3)26(36)19-34-25-17-10-9-16-24(25)28(21-12-7-6-8-13-21)32-35(29(34)38)20-27(37)31-22-14-11-15-23(18-22)33(4)5/h9-11,14-18,21H,6-8,12-13,19-20H2,1-5H3,(H,31,37)",5.4,1.0,5.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
724465,P30553,NFNSLUVCTGTZGY-XMMPIXPASA-N,Kd,28.84,nM,ChEMBL,CHEMBL3508,CHEMBL379902,16570921,CHEMBL379902,11555166.0,C30H38N4O3,502.659,"2-[(3R)-5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-3H-1,4-benzodiazepin-3-yl]-N-[3-(methylamino)phenyl]acetamide",CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NC(C1=O)CC(=O)NC3=CC(=CC=C3)NC)C4CCCCC4,CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=N[C@@H](C1=O)CC(=O)NC3=CC(=CC=C3)NC)C4CCCCC4,"InChI=1S/C30H38N4O3/c1-30(2,3)26(35)19-34-25-16-9-8-15-23(25)28(20-11-6-5-7-12-20)33-24(29(34)37)18-27(36)32-22-14-10-13-21(17-22)31-4/h8-10,13-17,20,24,31H,5-7,11-12,18-19H2,1-4H3,(H,32,36)/t24-/m1/s1",5.0,2.0,5.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
724478,P30553,ODMAYKFSTPTMKE-UHFFFAOYSA-N,Kd,4.467,nM,ChEMBL,CHEMBL3508,CHEMBL258863,18289857,CHEMBL258863,44451581.0,C31H38N4O6S,594.727,"2-[3-[[2-[5-cycloheptyl-1-(3,3-dimethyl-2-oxobutyl)-2,4-dioxo-1,3,5-benzotriazepin-3-yl]acetyl]amino]phenyl]sulfanylacetic acid",CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C(=O)N(C1=O)CC(=O)NC3=CC(=CC=C3)SCC(=O)O)C4CCCCCC4,CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C(=O)N(C1=O)CC(=O)NC3=CC(=CC=C3)SCC(=O)O)C4CCCCCC4,"InChI=1S/C31H38N4O6S/c1-31(2,3)26(36)18-33-24-15-8-9-16-25(24)35(22-12-6-4-5-7-13-22)30(41)34(29(33)40)19-27(37)32-21-11-10-14-23(17-21)42-20-28(38)39/h8-11,14-17,22H,4-7,12-13,18-20H2,1-3H3,(H,32,37)(H,38,39)",5.2,2.0,7.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
724536,P30553,HKBYMWFROSMGAG-UHFFFAOYSA-N,Kd,10.96,nM,ChEMBL,CHEMBL3508,CHEMBL197370,16250639,CHEMBL197370,11568611.0,C27H35N3O3,449.595,3-[[5-[2-(1-adamantyl)ethyl]-2-tert-butyl-1H-imidazole-4-carbonyl]amino]benzoic acid,CC(C)(C)C1=NC(=C(N1)CCC23CC4CC(C2)CC(C4)C3)C(=O)NC5=CC=CC(=C5)C(=O)O,CC(C)(C)C1=NC(=C(N1)CCC23CC4CC(C2)CC(C4)C3)C(=O)NC5=CC=CC(=C5)C(=O)O,"InChI=1S/C27H35N3O3/c1-26(2,3)25-29-21(7-8-27-13-16-9-17(14-27)11-18(10-16)15-27)22(30-25)23(31)28-20-6-4-5-19(12-20)24(32)33/h4-6,12,16-18H,7-11,13-15H2,1-3H3,(H,28,31)(H,29,30)(H,32,33)",6.6,3.0,4.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
724871,P30553,SENALJXYBWJQJJ-UHFFFAOYSA-N,Kd,1.622,nM,ChEMBL,CHEMBL3508,CHEMBL373050,16250639,CHEMBL373050,11571142.0,C30H39N3O3,489.66,3-[[5-[2-(1-adamantyl)ethyl]-2-(1-methylcyclohexyl)-1H-imidazole-4-carbonyl]amino]benzoic acid,CC1(CCCCC1)C2=NC(=C(N2)CCC34CC5CC(C3)CC(C5)C4)C(=O)NC6=CC=CC(=C6)C(=O)O,CC1(CCCCC1)C2=NC(=C(N2)CCC34CC5CC(C3)CC(C5)C4)C(=O)NC6=CC=CC(=C6)C(=O)O,"InChI=1S/C30H39N3O3/c1-29(9-3-2-4-10-29)28-32-24(8-11-30-16-19-12-20(17-30)14-21(13-19)18-30)25(33-28)26(34)31-23-7-5-6-22(15-23)27(35)36/h5-7,15,19-21H,2-4,8-14,16-18H2,1H3,(H,31,34)(H,32,33)(H,35,36)",7.6,3.0,4.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
725091,P30553,ATEVJIZSYFNEAX-UHFFFAOYSA-N,Kd,144.54,nM,ChEMBL,CHEMBL3508,CHEMBL380907,16570921,CHEMBL380907,11613982.0,C32H41N5O3,543.712,"2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-(3-pyrrolidin-1-ylphenyl)acetamide",CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NN(C1=O)CC(=O)NC3=CC=CC(=C3)N4CCCC4)C5CCCCC5,CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NN(C1=O)CC(=O)NC3=CC=CC(=C3)N4CCCC4)C5CCCCC5,"InChI=1S/C32H41N5O3/c1-32(2,3)28(38)21-36-27-17-8-7-16-26(27)30(23-12-5-4-6-13-23)34-37(31(36)40)22-29(39)33-24-14-11-15-25(20-24)35-18-9-10-19-35/h7-8,11,14-17,20,23H,4-6,9-10,12-13,18-19,21-22H2,1-3H3,(H,33,39)",5.9,1.0,5.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
725257,P30553,BXSYWNFICYSSKM-UHFFFAOYSA-N,Kd,2.455,nM,ChEMBL,CHEMBL3508,CHEMBL199091,16250639,CHEMBL199091,11513177.0,C31H39N3O3,501.671,3-[[5-[2-(1-adamantyl)ethyl]-2-(1-bicyclo[2.2.2]octanyl)-1H-imidazole-4-carbonyl]amino]benzoic acid,C1CC2(CCC1CC2)C3=NC(=C(N3)CCC45CC6CC(C4)CC(C6)C5)C(=O)NC7=CC=CC(=C7)C(=O)O,C1CC2(CCC1CC2)C3=NC(=C(N3)CCC45CC6CC(C4)CC(C6)C5)C(=O)NC7=CC=CC(=C7)C(=O)O,"InChI=1S/C31H39N3O3/c35-27(32-24-3-1-2-23(15-24)28(36)37)26-25(33-29(34-26)31-9-4-19(5-10-31)6-11-31)7-8-30-16-20-12-21(17-30)14-22(13-20)18-30/h1-3,15,19-22H,4-14,16-18H2,(H,32,35)(H,33,34)(H,36,37)",7.5,3.0,4.0,Gastrin/cholecystokinin type B receptor,Cckbr,Rattus norvegicus (Rat),MELLKLNRSVQGPGPGSGSSLCRPGVSLLNSSSAGNLSCDPPRIRGTGTRELEMAIRITLYAVIFLMSVGGNVLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAISYLMGVSVSVSTLNLVAIALERYSAICRPLQARVWQTRSHAARVILATWLLSGLLMVPYPVYTMVQPVGPRVLQCMHRWPSARVQQTWSVLLLLLLFFIPGVVIAVAYGLISRELYLGLHFDGENDSETQSRARNQGGLPGGAAPGPVHQNGGCRPVTSVAGEDSDGCCVQLPRSRLEMTTLTTPTPGPVPGPRPNQAKLLAKKRVVRMLLVIVLLFFLCWLPVYSVNTWRAFDGPGAQRALSGAPISFIHLLSYVSACVNPLVYCFMHRRFRQACLDTCARCCPRPPRARPQPLPDEDPPTPSIASLSRLSYTTISTLGPG
726565,Q63931,BDVFAVBKAXMDIW-OALUTQOASA-N,Kd,6.31,nM,ChEMBL,CHEMBL3501,CHEMBL277661,"Bioorg. Med. Chem. Lett., (1992) 2:10:1251",CHEMBL277661,44458112.0,C22H18N2O4,374.396,"(3S,4S)-4-(naphthalene-2-carbonylamino)-5-oxo-1-phenylpyrrolidine-3-carboxylic acid",C1C(C(C(=O)N1C2=CC=CC=C2)NC(=O)C3=CC4=CC=CC=C4C=C3)C(=O)O,C1[C@@H]([C@@H](C(=O)N1C2=CC=CC=C2)NC(=O)C3=CC4=CC=CC=C4C=C3)C(=O)O,"InChI=1S/C22H18N2O4/c25-20(16-11-10-14-6-4-5-7-15(14)12-16)23-19-18(22(27)28)13-24(21(19)26)17-8-2-1-3-9-17/h1-12,18-19H,13H2,(H,23,25)(H,27,28)/t18-,19-/m0/s1",3.4,2.0,4.0,Cholecystokinin receptor type A,CCKAR,Cavia porcellus (Guinea pig),MDVVDSLFVNGSNITSACELGFENETLFCLDRPRPSKEWQPAVQILLYSLIFLLSVLGNTLVITVLIRNKRMRTVTNIFLLSLAVSDLMLCLFCMPFNLIPSLLKDFIFGSAVCKTTTYFMGTSVSVSTFNLVAISLERYGAICKPLQSRVWQTKSHALKVIAATWCLSFTIMTPYPIYSNLVPFTKNNNQTGNMCRFLLPNDVMQQTWHTFLLLILFLIPGIVMMVAYGLISLELYQGIKFDAIQKKSAKERKTSTGSSGPMEDSDGCYLQKSRHPRKLELRQLSPSSSGSNRINRIRSSSSTANLMAKKRVIRMLIVIVVLFFLCWMPIFSANAWRAYDTVSAERHLSGTPISFILLLSYTSSCVNPIIYCFMNKRFRLGFMATFPCCPNPGTPGVRGEMGEEEEGRTTGASLSRYSYSHMSTSAPPP
728991,Q9NS75,YRCPIXCRSAKRGM-UHFFFAOYSA-N,Kd,6309.57344480193,nM,IUPHAR,270,3414,1329767,Ici 198615,115219.0,C28H28N4O6S,548.614,cyclopentyl N-[1-[[4-(benzenesulfonylcarbamoyl)-2-methoxyphenyl]methyl]indazol-6-yl]carbamate,COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3,COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3,"InChI=1S/C28H28N4O6S/c1-37-26-15-19(27(33)31-39(35,36)24-9-3-2-4-10-24)11-12-21(26)18-32-25-16-22(14-13-20(25)17-29-32)30-28(34)38-23-7-5-6-8-23/h2-4,9-17,23H,5-8,18H2,1H3,(H,30,34)(H,31,33)",4.4,2.0,7.0,Cysteinyl leukotriene receptor 2,CYSLTR2,Homo sapiens (Human),MERKFMSLQPSISVSEMEPNGTFSNNNSRNCTIENFKREFFPIVYLIIFFWGVLGNGLSIYVFLQPYKKSTSVNVFMLNLAISDLLFISTLPFRADYYLRGSNWIFGDLACRIMSYSLYVNMYSSIYFLTVLSVVRFLAMVHPFRLLHVTSIRSAWILCGIIWILIMASSIMLLDSGSEQNGSVTSCLELNLYKIAKLQTMNYIALVVGCLLPFFTLSICYLLIIRVLLKVEVPESGLRVSHRKALTTIIITLIIFFLCFLPYHTLRTVHLTTWKVGLCKDRLHKALVITLALAAANACFNPLLYYFAGENFKDRLKSALRKGHPQKAKTKCVFPVSVWLRKETRV
729369,Q2NNR5,YRCPIXCRSAKRGM-UHFFFAOYSA-N,Kd,30100,nM,ChEMBL,CHEMBL5645,CHEMBL22033,"Bioorg. Med. Chem. Lett., (1997) 7:10:1331",Ici 198615,115219.0,C28H28N4O6S,548.614,cyclopentyl N-[1-[[4-(benzenesulfonylcarbamoyl)-2-methoxyphenyl]methyl]indazol-6-yl]carbamate,COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3,COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3,"InChI=1S/C28H28N4O6S/c1-37-26-15-19(27(33)31-39(35,36)24-9-3-2-4-10-24)11-12-21(26)18-32-25-16-22(14-13-20(25)17-29-32)30-28(34)38-23-7-5-6-8-23/h2-4,9-17,23H,5-8,18H2,1H3,(H,30,34)(H,31,33)",4.4,2.0,7.0,Cysteinyl leukotriene receptor 1,CYSLTR1,Cavia porcellus (Guinea pig),MDETGNPTIPPASNNTCYDSIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLVKTYHEKSAFQVYMINLAVADLLCVCTLPLRVAYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCVAIVFPVQNISLVTQKKARLVCIAIWMFVILTSSPFLMANTYKDEKNNTKCFEPPQDNQAKNYVLILHYVSLFIGFIIPFITIIVCYTMIIFTLLKSSMKKNLSSRKRAIGMIIVVTAAFLVSFMPYHIQRTIHLHFLHNKTKPCDSILRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRRRLSTIRKYSLSSMTYIPKKKTSLPQKGKDICKE
729442,Q2NNR5,YKSLUJQRTVEPOZ-DHZHZOJOSA-N,Kd,408,nM,ChEMBL,CHEMBL5645,CHEMBL33329,9554876,CHEMBL33329,10598159.0,C27H17NO4,419.436,4-oxo-2-[3-[(E)-2-quinolin-2-ylethenyl]phenyl]chromene-6-carboxylic acid,C1=CC=C2C(=C1)C=CC(=N2)C=CC3=CC=CC(=C3)C4=CC(=O)C5=C(O4)C=CC(=C5)C(=O)O,C1=CC=C2C(=C1)C=CC(=N2)/C=C/C3=CC=CC(=C3)C4=CC(=O)C5=C(O4)C=CC(=C5)C(=O)O,"InChI=1S/C27H17NO4/c29-24-16-26(32-25-13-10-20(27(30)31)15-22(24)25)19-6-3-4-17(14-19)8-11-21-12-9-18-5-1-2-7-23(18)28-21/h1-16H,(H,30,31)/b11-8+",5.3,1.0,5.0,Cysteinyl leukotriene receptor 1,CYSLTR1,Cavia porcellus (Guinea pig),MDETGNPTIPPASNNTCYDSIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLVKTYHEKSAFQVYMINLAVADLLCVCTLPLRVAYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCVAIVFPVQNISLVTQKKARLVCIAIWMFVILTSSPFLMANTYKDEKNNTKCFEPPQDNQAKNYVLILHYVSLFIGFIIPFITIIVCYTMIIFTLLKSSMKKNLSSRKRAIGMIIVVTAAFLVSFMPYHIQRTIHLHFLHNKTKPCDSILRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRRRLSTIRKYSLSSMTYIPKKKTSLPQKGKDICKE
729764,Q2NNR5,CPQMZGGGIONSEK-UHFFFAOYSA-N,Kd,526,nM,ChEMBL,CHEMBL5645,CHEMBL33294,9554876,CHEMBL33294,11796528.0,C26H17NO5,423.424,4-oxo-2-[4-(quinolin-2-ylmethoxy)phenyl]chromene-8-carboxylic acid,C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=C(C=C3)C4=CC(=O)C5=C(O4)C(=CC=C5)C(=O)O,C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=C(C=C3)C4=CC(=O)C5=C(O4)C(=CC=C5)C(=O)O,"InChI=1S/C26H17NO5/c28-23-14-24(32-25-20(23)5-3-6-21(25)26(29)30)17-9-12-19(13-10-17)31-15-18-11-8-16-4-1-2-7-22(16)27-18/h1-14H,15H2,(H,29,30)",4.5,1.0,6.0,Cysteinyl leukotriene receptor 1,CYSLTR1,Cavia porcellus (Guinea pig),MDETGNPTIPPASNNTCYDSIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLVKTYHEKSAFQVYMINLAVADLLCVCTLPLRVAYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCVAIVFPVQNISLVTQKKARLVCIAIWMFVILTSSPFLMANTYKDEKNNTKCFEPPQDNQAKNYVLILHYVSLFIGFIIPFITIIVCYTMIIFTLLKSSMKKNLSSRKRAIGMIIVVTAAFLVSFMPYHIQRTIHLHFLHNKTKPCDSILRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRRRLSTIRKYSLSSMTYIPKKKTSLPQKGKDICKE
730376,Q2NNR5,GRXPSBPMPHAFEI-CSKARUKUSA-N,Kd,17,nM,ChEMBL,CHEMBL5645,CHEMBL32136,9554876,CHEMBL32136,10767627.0,C27H16BrNO4,498.332,6-bromo-4-oxo-2-[3-[(E)-2-quinolin-2-ylethenyl]phenyl]chromene-8-carboxylic acid,C1=CC=C2C(=C1)C=CC(=N2)C=CC3=CC=CC(=C3)C4=CC(=O)C5=CC(=CC(=C5O4)C(=O)O)Br,C1=CC=C2C(=C1)C=CC(=N2)/C=C/C3=CC=CC(=C3)C4=CC(=O)C5=CC(=CC(=C5O4)C(=O)O)Br,"InChI=1S/C27H16BrNO4/c28-19-13-21-24(30)15-25(33-26(21)22(14-19)27(31)32)18-6-3-4-16(12-18)8-10-20-11-9-17-5-1-2-7-23(17)29-20/h1-15H,(H,31,32)/b10-8+",6.0,1.0,5.0,Cysteinyl leukotriene receptor 1,CYSLTR1,Cavia porcellus (Guinea pig),MDETGNPTIPPASNNTCYDSIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLVKTYHEKSAFQVYMINLAVADLLCVCTLPLRVAYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCVAIVFPVQNISLVTQKKARLVCIAIWMFVILTSSPFLMANTYKDEKNNTKCFEPPQDNQAKNYVLILHYVSLFIGFIIPFITIIVCYTMIIFTLLKSSMKKNLSSRKRAIGMIIVVTAAFLVSFMPYHIQRTIHLHFLHNKTKPCDSILRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRRRLSTIRKYSLSSMTYIPKKKTSLPQKGKDICKE
730624,Q9Y271,YRCPIXCRSAKRGM-UHFFFAOYSA-N,Kd,0.025,nM,IUPHAR,269,3414,1329767,Ici 198615,115219.0,C28H28N4O6S,548.614,cyclopentyl N-[1-[[4-(benzenesulfonylcarbamoyl)-2-methoxyphenyl]methyl]indazol-6-yl]carbamate,COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3,COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3,"InChI=1S/C28H28N4O6S/c1-37-26-15-19(27(33)31-39(35,36)24-9-3-2-4-10-24)11-12-21(26)18-32-25-16-22(14-13-20(25)17-29-32)30-28(34)38-23-7-5-6-8-23/h2-4,9-17,23H,5-8,18H2,1H3,(H,30,34)(H,31,33)",4.4,2.0,7.0,Cysteinyl leukotriene receptor 1,CYSLTR1,Homo sapiens (Human),MDETGNLTVSSATCHDTIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLIKTYHKKSAFQVYMINLAVADLLCVCTLPLRVVYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCIAIVFPVQNINLVTQKKARFVCVGIWIFVILTSSPFLMAKPQKDEKNNTKCFEPPQDNQTKNHVLVLHYVSLFVGFIIPFVIIIVCYTMIILTLLKKSMKKNLSSHKKAIGMIMVVTAAFLVSFMPYHIQRTIHLHFLHNETKPCDSVLRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRKRLSTFRKHSLSSVTYVPRKKASLPEKGEEICKV
736318,P47746,BUZAJRPLUGXRAB-VEFBWTBNSA-N,Kd,0.251188643150958,nM,IUPHAR,56,744,9335234,[123I]AM251,10506880.0,C22H21Cl2IN4O,551.243,"1-(2,4-dichlorophenyl)-5-(4-(123I)iodanylphenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide",CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)[123I],"InChI=1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)/i25-4",6.5,1.0,3.0,Cannabinoid receptor 1,Cnr1,Mus musculus (Mouse),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNSPLVPAGDTTNITEFYNKSLSSFKENEDNIQCGENFMDMECFMILNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFVDFHVFHRKDSPNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCKKLQSVCSDIFPLIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNTASMHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
736370,P47746,YNAFMBOYEHPUJL-UHFFFAOYSA-N,Kd,208.93,nM,ChEMBL,CHEMBL3037,CHEMBL241774,17870539,CHEMBL241774,16666375.0,C21H29ClN4O3S,452.998,"5-(4-chlorophenyl)-6-hexyl-1,1-dioxo-N-piperidin-1-yl-1,2,6-thiadiazine-3-carboxamide",CCCCCCN1C(=CC(=NS1(=O)=O)C(=O)NN2CCCCC2)C3=CC=C(C=C3)Cl,CCCCCCN1C(=CC(=NS1(=O)=O)C(=O)NN2CCCCC2)C3=CC=C(C=C3)Cl,"InChI=1S/C21H29ClN4O3S/c1-2-3-4-8-15-26-20(17-9-11-18(22)12-10-17)16-19(24-30(26,28)29)21(27)23-25-13-6-5-7-14-25/h9-12,16H,2-8,13-15H2,1H3,(H,23,27)",4.5,1.0,6.0,Cannabinoid receptor 1,Cnr1,Mus musculus (Mouse),MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNSPLVPAGDTTNITEFYNKSLSSFKENEDNIQCGENFMDMECFMILNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFVDFHVFHRKDSPNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCKKLQSVCSDIFPLIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNTASMHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
743507,P25929,UTHXFGJCCVQERK-FFIDFHKDSA-N,Kd,100,nM,ChEMBL,CHEMBL4777,CHEMBL415353,1433176,CID 44346892,44346892.0,C154H231N47O41,3396.83,"(3S)-4-[[(3R,8S,11S,14R,17S,20R,23S,26R,29S,32R,35S,38R,41S,44R)-8-[[(2S)-4-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]carbamoyl]-17,35-bis[3-(diaminomethylideneamino)propyl]-26-(hydroxymethyl)-11,29,32-tris[(4-hydroxyphenyl)methyl]-14-(1H-imidazol-4-ylmethyl)-8,23,38,41-tetramethyl-20-(2-methylpropyl)-2,6,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaoxo-1,7,9,12,15,18,21,24,27,30,33,36,39,42-tetradecazabicyclo[42.3.0]heptatetracontan-3-yl]amino]-3-[[(2R)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid",CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C2(NC(=O)CCC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC4=CC=C(C=C4)O)CC5=CNC=N5)CCCN=C(N)N)CC(C)C)C)CO)CC6=CC=C(C=C6)O)CC7=CC=C(C=C7)O)CCCN=C(N)N)C)C)NC(=O)C(CC(=O)O)NC(=O)C8CCCN8C(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C9CCCN9C(=O)C(CC1=CC=C(C=C1)O)N)C,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@]2(NC(=O)CC[C@H](C(=O)N3CCC[C@@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2)CC4=CC=C(C=C4)O)CC5=CNC=N5)CCCN=C(N)N)CC(C)C)C)CO)CC6=CC=C(C=C6)O)CC7=CC=C(C=C7)O)CCCN=C(N)N)C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]8CCCN8C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]9CCCN9C(=O)[C@H](CC1=CC=C(C=C1)O)N)C,"InChI=1S/C154H231N47O41/c1-12-78(6)120(144(237)196-121(82(10)204)145(238)181-98(26-18-58-172-153(166)167)126(219)180-99(50-52-116(157)210)130(223)178-96(24-16-56-170-151(162)163)127(220)184-102(122(159)215)65-84-32-42-90(206)43-33-84)195-137(230)104(63-77(4)5)186-135(228)109(70-117(158)211)194-149(242)154(11)197-118(212)53-51-101(183-136(229)110(71-119(213)214)191-142(235)115-29-21-61-201(115)147(240)100(22-13-14-54-155)182-139(232)112(74-203)193-143(236)114-28-19-59-199(114)146(239)94(156)64-83-30-40-89(205)41-31-83)148(241)200-60-20-27-113(200)141(234)176-79(7)123(216)174-80(8)124(217)177-95(23-15-55-169-150(160)161)128(221)187-105(66-85-34-44-91(207)45-35-85)132(225)188-106(67-86-36-46-92(208)47-37-86)133(226)192-111(73-202)138(231)175-81(9)125(218)185-103(62-76(2)3)131(224)179-97(25-17-57-171-152(164)165)129(222)190-108(69-88-72-168-75-173-88)134(227)189-107(140(233)198-154)68-87-38-48-93(209)49-39-87/h30-49,72,75-82,94-115,120-121,202-209H,12-29,50-71,73-74,155-156H2,1-11H3,(H2,157,210)(H2,158,211)(H2,159,215)(H,168,173)(H,174,216)(H,175,231)(H,176,234)(H,177,217)(H,178,223)(H,179,224)(H,180,219)(H,181,238)(H,182,232)(H,183,229)(H,184,220)(H,185,218)(H,186,228)(H,187,221)(H,188,225)(H,189,227)(H,190,222)(H,191,235)(H,192,226)(H,193,236)(H,194,242)(H,195,230)(H,196,237)(H,197,212)(H,198,233)(H,213,214)(H4,160,161,169)(H4,162,163,170)(H4,164,165,171)(H4,166,167,172)/t78-,79-,80+,81-,82+,94-,95-,96-,97-,98-,99-,100-,101+,102-,103+,104-,105+,106-,107-,108+,109-,110-,111+,112-,113+,114-,115+,120-,121-,154-/m0/s1",-11.5,48.0,48.0,Neuropeptide Y receptor type 1,NPY1R,Homo sapiens (Human),MNSTLFSQVENHSVHSNFSEKNAQLLAFENDDCHLPLAMIFTLALAYGAVIILGVSGNLALIIIILKQKEMRNVTNILIVNLSFSDLLVAIMCLPFTFVYTLMDHWVFGEAMCKLNPFVQCVSITVSIFSLVLIAVERHQLIINPRGWRPNNRHAYVGIAVIWVLAVASSLPFLIYQVMTDEPFQNVTLDAYKDKYVCFDQFPSDSHRLSYTTLLLVLQYFGPLCFIFICYFKIYIRLKRRNNMMDKMRDNKYRSSETKRINIMLLSIVVAFAVCWLPLTIFNTVFDWNHQIIATCNHNLLFLLCHLTAMISTCVNPIFYGFLNKNFQRDLQFFFNFCDFRSRDDDYETIAMSTMHTDVSKTSLKQASPVAFKKINNNDDNEKI
753030,P08908,UEQUQVLFIPOEMF-UHFFFAOYSA-N,Kd,398.11,nM,ChEMBL,CHEMBL214,CHEMBL6437,19754201,mianserin,4184.0,C18H20N2,264.372,"5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene",CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,"InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3",3.4,0.0,2.0,5-hydroxytryptamine receptor 1A,HTR1A,Homo sapiens (Human),MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
757529,P08908,YJZYDPRMWYWYCG-UHFFFAOYSA-N,Kd,3.98107170553497,nM,IUPHAR,1,81,15628665,155204-26-5,6603915.0,C25H27FN4O2,434.515,4-fluoro-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylbenzamide,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4=CC=C(C=C4)F,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4=CC=C(C=C4)F,"InChI=1S/C25H27FN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3",3.9,0.0,6.0,5-hydroxytryptamine receptor 1A,HTR1A,Homo sapiens (Human),MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
758351,P08908,HPUKPOAWHHZLIX-ZIAGYGMSSA-N,Kd,0.1995,nM,ChEMBL,CHEMBL214,CHEMBL284585,19754201,CHEMBL284585,10332127.0,C16H23NO,245.366,"(3aR,9bS)-9-methoxy-3-propyl-1,2,3a,4,5,9b-hexahydrobenzo[e]indole",CCCN1CCC2C1CCC3=C2C(=CC=C3)OC,CCCN1CC[C@@H]2[C@H]1CCC3=C2C(=CC=C3)OC,"InChI=1S/C16H23NO/c1-3-10-17-11-9-13-14(17)8-7-12-5-4-6-15(18-2)16(12)13/h4-6,13-14H,3,7-11H2,1-2H3/t13-,14-/m1/s1",3.5,0.0,2.0,5-hydroxytryptamine receptor 1A,HTR1A,Homo sapiens (Human),MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
760613,P08908,GZQMSNKBMQEZJK-HNNXBMFYSA-N,Kd,1.995,nM,ChEMBL,CHEMBL214,CHEMBL568077,19754201,CHEMBL568077,45483993.0,C17H25N3O,287.407,"(11S)-11-(dipropylamino)-1,3-diazatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-2-one",CCCN(CCC)C1CC2=C3C(=CC=C2)CNC(=O)N3C1,CCCN(CCC)[C@H]1CC2=C3C(=CC=C2)CNC(=O)N3C1,"InChI=1S/C17H25N3O/c1-3-8-19(9-4-2)15-10-13-6-5-7-14-11-18-17(21)20(12-15)16(13)14/h5-7,15H,3-4,8-12H2,1-2H3,(H,18,21)/t15-/m0/s1",2.6,1.0,2.0,5-hydroxytryptamine receptor 1A,HTR1A,Homo sapiens (Human),MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
762502,P08908,MQTUXRKNJYPMCG-FZQCOGARSA-N,Kd,0.158,nM,IUPHAR,1,82,9851589,[3H]robalzotan,10591800.0,C18H23FN2O2,320.4,"(3R)-3-[di(cyclobutyl)amino]-8-fluoro-6-tritio-3,4-dihydro-2H-chromene-5-carboxamide",C1CC(C1)N(C2CCC2)C3CC4=C(C=CC(=C4OC3)F)C(=O)N,[3H]C1=CC(=C2C(=C1C(=O)N)C[C@H](CO2)N(C3CCC3)C4CCC4)F,"InChI=1S/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1/i7T",2.8,1.0,4.0,5-hydroxytryptamine receptor 1A,HTR1A,Homo sapiens (Human),MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ
764492,P31390,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL4701,CHEMBL90,14640554,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H1 receptor,Hrh1,Rattus norvegicus (Rat),MSFANTSSTFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFFSFLWVIPILGWHHFMPPAPELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRRHCQHRQLTNGSLPSFSELKLRSDDTKEGAKKPGRESPWGVLKRPSRDPSVGLDQKSTSEDPKMTSPTVFSQEGERETRPCFRLDIMQKQSVAEGDVRGSKANDQALSQPKMDEQSLNTCRRISETSEDQTLVDQQSFSRTTDSDTSIEPGPGRVKSRSGSNSGLDYIKITWKRLRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCSEPMHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
764760,P31390,IECPJVGHHUNYNJ-UHFFFAOYSA-N,Kd,9.55,nM,ChEMBL,CHEMBL4701,CHEMBL264491,14640554,CHEMBL264491,11741669.0,C25H29N5,399.542,"N-[2-[2-(3,3-diphenylpropyl)-1H-imidazol-5-yl]ethyl]-2-(1H-imidazol-5-yl)ethanamine",C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCC3=CN=CN3)C4=CC=CC=C4,C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCNCCC3=CN=CN3)C4=CC=CC=C4,"InChI=1S/C25H29N5/c1-3-7-20(8-4-1)24(21-9-5-2-6-10-21)11-12-25-28-18-23(30-25)14-16-26-15-13-22-17-27-19-29-22/h1-10,17-19,24,26H,11-16H2,(H,27,29)(H,28,30)",4.1,3.0,3.0,Histamine H1 receptor,Hrh1,Rattus norvegicus (Rat),MSFANTSSTFEDKMCEGNRTAMASPQLLPLVVVLSSISLVTVGLNLLVLYAVHSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLIMTKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLRYRTKTRASATILGAWFFSFLWVIPILGWHHFMPPAPELREDKCETDFYNVTWFKIMTAIINFYLPTLLMLWFYVKIYKAVRRHCQHRQLTNGSLPSFSELKLRSDDTKEGAKKPGRESPWGVLKRPSRDPSVGLDQKSTSEDPKMTSPTVFSQEGERETRPCFRLDIMQKQSVAEGDVRGSKANDQALSQPKMDEQSLNTCRRISETSEDQTLVDQQSFSRTTDSDTSIEPGPGRVKSRSGSNSGLDYIKITWKRLRSHSRQYVSGLHLNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKSCCSEPMHMFTIWLGYINSTLNPLIYPLCNENFKKTFKKILHIRS
767961,P28221,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,112.2,nM,ChEMBL,CHEMBL1983,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,5-hydroxytryptamine receptor 1D,HTR1D,Homo sapiens (Human),MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS
784416,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,0.528,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
784417,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,0.679,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
784418,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,0.391,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
784425,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,3.69,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
784430,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,0.381,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
784434,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,0.271,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
784435,P29274,NJQVZARFMYPNOT-UHFFFAOYSA-N,Kd,1.64,nM,ChEMBL,CHEMBL251,CHEMBL184061,DOI: http://dx.doi.org/10.6019/CHEMBL3885741,CHEMBL184061,44394716.0,C20H21F2N9O,441.447,"5-N-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine",C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,C1CN(CCN1CCNC2=NC3=NC(=NN3C(=N2)N)C4=CC=CO4)C5=C(C=C(C=C5)F)F,"InChI=1S/C20H21F2N9O/c21-13-3-4-15(14(22)12-13)30-9-7-29(8-10-30)6-5-24-19-26-18(23)31-20(27-19)25-17(28-31)16-2-1-11-32-16/h1-4,11-12H,5-10H2,(H3,23,24,25,26,27,28)",2.4,2.0,11.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
788035,P29274,IBCSETAMVUUPMW-PVURQLNPSA-N,Kd,27000,nM,ChEMBL,CHEMBL251,CHEMBL3423408,25969169,CHEMBL3423408,118736410.0,C42H57FN8O5,772.967,"(3S,12bR)-N-[6-[[(2S)-1-[[(2S)-1-[(2S,4S)-4-amino-2-carbamoylpyrrolidin-1-yl]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)N2CC(CC2C(=O)N)N)NC(=O)CCCCCNC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)N2C[C@H](C[C@H]2C(=O)N)N)NC(=O)CCCCCNC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C42H57FN8O5/c1-2-3-10-33(41(55)49-34(22-26-13-16-28(43)17-14-26)42(56)51-25-29(44)23-36(51)39(45)53)47-37(52)12-5-4-8-20-46-40(54)27-15-18-35-38-31(19-21-50(35)24-27)30-9-6-7-11-32(30)48-38/h6-7,9,11,13-14,16-17,27,29,33-36,48H,2-5,8,10,12,15,18-25,44H2,1H3,(H2,45,53)(H,46,54)(H,47,52)(H,49,55)/t27-,29-,33-,34-,35+,36-/m0/s1",3.1,6.0,8.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
788364,P29274,PVDILSXPBZQZOY-UHFFFAOYSA-N,Kd,1000,nM,ChEMBL,CHEMBL251,CHEMBL1800357,21661720,CHEMBL1800357,136026130.0,C17H14FN5O,323.331,"2-[4-amino-6-(5-fluoro-1,3-dihydroisoindol-2-yl)-1,3,5-triazin-2-yl]phenol",C1C2=C(CN1C3=NC(=NC(=N3)C4=CC=CC=C4O)N)C=C(C=C2)F,C1C2=C(CN1C3=NC(=NC(=N3)C4=CC=CC=C4O)N)C=C(C=C2)F,"InChI=1S/C17H14FN5O/c18-12-6-5-10-8-23(9-11(10)7-12)17-21-15(20-16(19)22-17)13-3-1-2-4-14(13)24/h1-7,24H,8-9H2,(H2,19,20,21,22)",2.6,2.0,7.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
794966,P29274,BUSZPEZABSAFAL-YWNCIPKLSA-N,Kd,10000,nM,ChEMBL,CHEMBL251,CHEMBL3423406,25969169,CHEMBL3423406,118736408.0,C39H52N8O4,696.897,"(3S,12bR)-N-[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)N)NC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C39H52N8O4/c1-2-3-12-32(45-37(49)24-16-17-34-35-28(18-20-47(34)23-24)27-11-5-7-14-30(27)43-35)38(50)46-33(21-25-22-42-29-13-6-4-10-26(25)29)39(51)44-31(36(41)48)15-8-9-19-40/h4-7,10-11,13-14,22,24,31-34,42-43H,2-3,8-9,12,15-21,23,40H2,1H3,(H2,41,48)(H,44,51)(H,45,49)(H,46,50)/t24-,31-,32-,33-,34+/m0/s1",3.5,7.0,6.0,Adenosine receptor A2a,ADORA2A,Homo sapiens (Human),MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
802147,P51681,GSNHKUDZZFZSJB-HLMSNRGBSA-N,Kd,0.794328234724282,nM,IUPHAR,62,803,16298345,Maraviroc,3002977.0,C29H41F2N5O,513.678,"4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide",CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1",5.1,1.0,6.0,C-C chemokine receptor type 5,CCR5,Homo sapiens (Human),MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSSHFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTIMIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
802633,P51681,POCCWDXEMQOTQF-UHFFFAOYSA-N,Kd,49000,nM,ChEMBL,CHEMBL274,CHEMBL1621896,21765967,CHEMBL1621896,3373405.0,C19H27BrN2O2,395.341,[1-[(5-bromo-2-methoxyphenyl)methyl]piperidin-3-yl]-piperidin-1-ylmethanone,COC1=C(C=C(C=C1)Br)CN2CCCC(C2)C(=O)N3CCCCC3,COC1=C(C=C(C=C1)Br)CN2CCCC(C2)C(=O)N3CCCCC3,"InChI=1S/C19H27BrN2O2/c1-24-18-8-7-17(20)12-16(18)14-21-9-5-6-15(13-21)19(23)22-10-3-2-4-11-22/h7-8,12,15H,2-6,9-11,13-14H2,1H3",3.2,0.0,3.0,C-C chemokine receptor type 5,CCR5,Homo sapiens (Human),MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSSHFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTIMIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
803167,O43614,FEEAYUXIGFRTRF-JOCHJYFZSA-N,Kd,2,nM,ChEMBL,CHEMBL4792,CHEMBL2413517,23891187,CHEMBL2413517,59475183.0,C26H31N3O3,433.552,N-[(3S)-3-[(3-ethoxybenzoyl)-methylamino]-4-phenylbutyl]-1-methylpyrrole-2-carboxamide,CCOC1=CC=CC(=C1)C(=O)N(C)C(CCNC(=O)C2=CC=CN2C)CC3=CC=CC=C3,CCOC1=CC=CC(=C1)C(=O)N(C)[C@H](CCNC(=O)C2=CC=CN2C)CC3=CC=CC=C3,"InChI=1S/C26H31N3O3/c1-4-32-23-13-8-12-21(19-23)26(31)29(3)22(18-20-10-6-5-7-11-20)15-16-27-25(30)24-14-9-17-28(24)2/h5-14,17,19,22H,4,15-16,18H2,1-3H3,(H,27,30)/t22-/m1/s1",4.1,1.0,3.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
803269,O43614,QVQBRELNCAXZCF-UHFFFAOYSA-N,Kd,755,nM,ChEMBL,CHEMBL4792,CHEMBL3669441,None,SCHEMBL2023334,53259457.0,C27H28N4O,424.548,"9-(1H-benzimidazol-2-yl)-2-(naphthalen-1-ylmethyl)-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N3)C(=O)N(C1)CC5=CC=CC6=CC=CC=C65,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N3)C(=O)N(C1)CC5=CC=CC6=CC=CC=C65,"InChI=1S/C27H28N4O/c32-25-27(14-17-30(18-15-27)26-28-23-11-3-4-12-24(23)29-26)13-6-16-31(25)19-21-9-5-8-20-7-1-2-10-22(20)21/h1-5,7-12H,6,13-19H2,(H,28,29)",5.0,1.0,3.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
803467,O43614,UQDZEOCEKHULPR-UHFFFAOYSA-N,Kd,115,nM,ChEMBL,CHEMBL4792,CHEMBL3669470,None,SCHEMBL2022233,53259790.0,C26H27N7O,453.55,"9-quinoxalin-2-yl-2-[[2-(triazol-2-yl)phenyl]methyl]-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC=C5N6N=CC=N6,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC=C5N6N=CC=N6,"InChI=1S/C26H27N7O/c34-25-26(11-16-31(17-12-26)24-18-27-21-7-2-3-8-22(21)30-24)10-5-15-32(25)19-20-6-1-4-9-23(20)33-28-13-14-29-33/h1-4,6-9,13-14,18H,5,10-12,15-17,19H2",3.4,0.0,6.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
803838,O43614,CWYFTFBSOGXBMH-UHFFFAOYSA-N,Kd,98,nM,ChEMBL,CHEMBL4792,CHEMBL3669436,None,SCHEMBL2025010,53259278.0,C29H29N5O,463.585,"2-[(3-pyridin-3-ylphenyl)methyl]-9-quinoxalin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC(=C5)C6=CN=CC=C6,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC(=C5)C6=CN=CC=C6,"InChI=1S/C29H29N5O/c35-28-29(12-16-33(17-13-29)27-20-31-25-9-1-2-10-26(25)32-27)11-5-15-34(28)21-22-6-3-7-23(18-22)24-8-4-14-30-19-24/h1-4,6-10,14,18-20H,5,11-13,15-17,21H2",4.0,0.0,5.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
803962,O43614,JQEYMZFGKKZWLJ-INIZCTEOSA-N,Kd,30,nM,ChEMBL,CHEMBL4792,CHEMBL3665712,None,SCHEMBL6845175,69915167.0,C25H24F2N4O2,450.49,"2-[4-(difluoromethyl)-1-methyl-3-phenylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C(F)F)C(=NN3C)C4=CC=CC=C4,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C(F)F)C(=NN3C)C4=CC=CC=C4,"InChI=1S/C25H24F2N4O2/c1-15-9-11-17(12-10-15)16(2)28-20(32)14-33-21-13-19(24(26)27)22-23(18-7-5-4-6-8-18)30-31(3)25(22)29-21/h4-13,16,24H,14H2,1-3H3,(H,28,32)/t16-/m0/s1",5.0,1.0,6.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
804008,O43614,RDHXDMAVHATBQH-INIZCTEOSA-N,Kd,240,nM,ChEMBL,CHEMBL4792,CHEMBL3665733,None,SCHEMBL6845156,69915151.0,C25H22F3N3O2,453.465,"2-[1-methyl-3-phenyl-4-(trifluoromethyl)pyrrolo[2,3-b]pyridin-6-yl]oxy-N-[(1S)-1-phenylethyl]acetamide",CC(C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=CN3C)C4=CC=CC=C4,C[C@@H](C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=CN3C)C4=CC=CC=C4,"InChI=1S/C25H22F3N3O2/c1-16(17-9-5-3-6-10-17)29-21(32)15-33-22-13-20(25(26,27)28)23-19(14-31(2)24(23)30-22)18-11-7-4-8-12-18/h3-14,16H,15H2,1-2H3,(H,29,32)/t16-/m0/s1",5.3,1.0,6.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
804683,O43614,ZNASAJGWPUTONJ-AWEZNQCLSA-N,Kd,79,nM,ChEMBL,CHEMBL4792,CHEMBL3665671,None,SCHEMBL6845120,69915132.0,C24H20F4N4O2,472.444,"2-[3-(2-fluorophenyl)-1-methyl-4-(trifluoromethyl)pyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-phenylethyl]acetamide",CC(C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=NN3C)C4=CC=CC=C4F,C[C@@H](C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=NN3C)C4=CC=CC=C4F,"InChI=1S/C24H20F4N4O2/c1-14(15-8-4-3-5-9-15)29-19(33)13-34-20-12-17(24(26,27)28)21-22(31-32(2)23(21)30-20)16-10-6-7-11-18(16)25/h3-12,14H,13H2,1-2H3,(H,29,33)/t14-/m0/s1",5.0,1.0,8.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
804800,O43614,RSXGQEFCZXHYTD-UHFFFAOYSA-N,Kd,123,nM,ChEMBL,CHEMBL4792,CHEMBL3669573,None,SCHEMBL2028719,67253332.0,C26H27N5O,425.536,"2-(1H-indol-3-ylmethyl)-9-quinazolin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4C=N3)C(=O)N(C1)CC5=CNC6=CC=CC=C65,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4C=N3)C(=O)N(C1)CC5=CNC6=CC=CC=C65,"InChI=1S/C26H27N5O/c32-24-26(10-5-13-31(24)18-20-17-27-23-9-4-2-7-21(20)23)11-14-30(15-12-26)25-28-16-19-6-1-3-8-22(19)29-25/h1-4,6-9,16-17,27H,5,10-15,18H2",3.9,1.0,4.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
806534,O43614,YDZDZQBHJHYWCU-UHFFFAOYSA-N,Kd,1369,nM,ChEMBL,CHEMBL4792,CHEMBL3669512,None,SCHEMBL2020778,67250574.0,C27H28N6O2,468.561,"2-[[3-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]methyl]-9-quinoxalin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",CC1=NOC(=N1)C2=CC(=CC=C2)CN3CCCC4(C3=O)CCN(CC4)C5=NC6=CC=CC=C6N=C5,CC1=NOC(=N1)C2=CC(=CC=C2)CN3CCCC4(C3=O)CCN(CC4)C5=NC6=CC=CC=C6N=C5,"InChI=1S/C27H28N6O2/c1-19-29-25(35-31-19)21-7-4-6-20(16-21)18-33-13-5-10-27(26(33)34)11-14-32(15-12-27)24-17-28-22-8-2-3-9-23(22)30-24/h2-4,6-9,16-17H,5,10-15,18H2,1H3",3.7,0.0,7.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
806599,O43614,GDBCAXYOLOFJIR-UHFFFAOYSA-N,Kd,364,nM,ChEMBL,CHEMBL4792,CHEMBL3669498,None,SCHEMBL2022271,67251111.0,C26H27N7O,453.55,"2-[(6-pyrazol-1-ylpyridin-2-yl)methyl]-9-quinoxalin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=NC(=CC=C5)N6C=CC=N6,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=NC(=CC=C5)N6C=CC=N6,"InChI=1S/C26H27N7O/c34-25-26(11-16-31(17-12-26)24-18-27-21-7-1-2-8-22(21)30-24)10-4-14-32(25)19-20-6-3-9-23(29-20)33-15-5-13-28-33/h1-3,5-9,13,15,18H,4,10-12,14,16-17,19H2",2.7,0.0,6.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
806855,O43614,KSZRPNZKQXWNEQ-UHFFFAOYSA-N,Kd,410,nM,ChEMBL,CHEMBL4792,CHEMBL3634017,None,SCHEMBL1915574,67209610.0,C24H21F3N4O3,470.452,"N-[(4-methoxyphenyl)methyl]-2-[1-methyl-3-phenyl-4-(trifluoromethyl)pyrazolo[3,4-b]pyridin-6-yl]oxyacetamide",CN1C2=C(C(=CC(=N2)OCC(=O)NCC3=CC=C(C=C3)OC)C(F)(F)F)C(=N1)C4=CC=CC=C4,CN1C2=C(C(=CC(=N2)OCC(=O)NCC3=CC=C(C=C3)OC)C(F)(F)F)C(=N1)C4=CC=CC=C4,"InChI=1S/C24H21F3N4O3/c1-31-23-21(22(30-31)16-6-4-3-5-7-16)18(24(25,26)27)12-20(29-23)34-14-19(32)28-13-15-8-10-17(33-2)11-9-15/h3-12H,13-14H2,1-2H3,(H,28,32)",4.5,1.0,8.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
806933,O43614,XSUIGCPNDJKEIF-KRWDZBQOSA-N,Kd,14,nM,ChEMBL,CHEMBL4792,CHEMBL3665725,None,CHEMBL3665725,70816819.0,C23H24F2N4O3,442.467,"2-[3-cyclopropyl-4-(difluoromethyl)-1-methylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-5-methoxy-2,3-dihydro-1H-inden-1-yl]acetamide",CN1C2=C(C(=CC(=N2)OCC(=O)NC3CCC4=C3C=CC(=C4)OC)C(F)F)C(=N1)C5CC5,CN1C2=C(C(=CC(=N2)OCC(=O)N[C@H]3CCC4=C3C=CC(=C4)OC)C(F)F)C(=N1)C5CC5,"InChI=1S/C23H24F2N4O3/c1-29-23-20(21(28-29)12-3-4-12)16(22(24)25)10-19(27-23)32-11-18(30)26-17-8-5-13-9-14(31-2)6-7-15(13)17/h6-7,9-10,12,17,22H,3-5,8,11H2,1-2H3,(H,26,30)/t17-/m0/s1",3.6,1.0,7.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
807173,O43614,CWQYLWVLAFHETG-KRWDZBQOSA-N,Kd,143,nM,ChEMBL,CHEMBL4792,CHEMBL3665674,None,SCHEMBL6845155,69915150.0,C24H24N4O2,400.482,"2-(1,4-dimethyl-3-phenylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-[(1S)-1-phenylethyl]acetamide",CC1=CC(=NC2=C1C(=NN2C)C3=CC=CC=C3)OCC(=O)NC(C)C4=CC=CC=C4,CC1=CC(=NC2=C1C(=NN2C)C3=CC=CC=C3)OCC(=O)N[C@@H](C)C4=CC=CC=C4,"InChI=1S/C24H24N4O2/c1-16-14-21(30-15-20(29)25-17(2)18-10-6-4-7-11-18)26-24-22(16)23(27-28(24)3)19-12-8-5-9-13-19/h4-14,17H,15H2,1-3H3,(H,25,29)/t17-/m0/s1",4.4,1.0,4.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
807849,O43614,VHPHJZXOLJJSPJ-INIZCTEOSA-N,Kd,22,nM,ChEMBL,CHEMBL4792,CHEMBL3665692,None,CHEMBL3665692,70817062.0,C24H24FN5O2,433.487,"2-[3-(3-fluoropyridin-2-yl)-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,"InChI=1S/C24H24FN5O2/c1-14-7-9-17(10-8-14)16(3)27-19(31)13-32-20-12-15(2)21-23(29-30(4)24(21)28-20)22-18(25)6-5-11-26-22/h5-12,16H,13H2,1-4H3,(H,27,31)/t16-/m0/s1",3.8,1.0,6.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
807850,O43614,VHPHJZXOLJJSPJ-INIZCTEOSA-N,Kd,6,nM,ChEMBL,CHEMBL4792,CHEMBL3665692,None,CHEMBL3665692,70817062.0,C24H24FN5O2,433.487,"2-[3-(3-fluoropyridin-2-yl)-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,"InChI=1S/C24H24FN5O2/c1-14-7-9-17(10-8-14)16(3)27-19(31)13-32-20-12-15(2)21-23(29-30(4)24(21)28-20)22-18(25)6-5-11-26-22/h5-12,16H,13H2,1-4H3,(H,27,31)/t16-/m0/s1",3.8,1.0,6.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
808322,O43614,CITUDCOPJFTZRP-INIZCTEOSA-N,Kd,76,nM,ChEMBL,CHEMBL4792,CHEMBL3665716,None,CHEMBL3665716,70817109.0,C22H28N4O2,380.492,"2-(1,4-dimethyl-3-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C(C)C,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C(C)C,"InChI=1S/C22H28N4O2/c1-13(2)21-20-15(4)11-19(24-22(20)26(6)25-21)28-12-18(27)23-16(5)17-9-7-14(3)8-10-17/h7-11,13,16H,12H2,1-6H3,(H,23,27)/t16-/m0/s1",4.3,1.0,4.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
808343,O43614,HGSOFDAPWKEOJR-IBGZPJMESA-N,Kd,271,nM,ChEMBL,CHEMBL4792,CHEMBL3665722,None,CHEMBL3665722,70817289.0,C25H25F2N5O3,481.504,"2-[4-(difluoromethyl)-3-(2,5-dimethylfuran-3-yl)-1-methylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(5S)-2-methyl-6,7-dihydro-5H-cyclopenta[b]pyridin-5-yl]acetamide",CC1=NC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C(F)F)C(=NN4C)C5=C(OC(=C5)C)C,CC1=NC2=C(C=C1)[C@H](CC2)NC(=O)COC3=NC4=C(C(=C3)C(F)F)C(=NN4C)C5=C(OC(=C5)C)C,"InChI=1S/C25H25F2N5O3/c1-12-5-6-15-18(28-12)7-8-19(15)29-20(33)11-34-21-10-17(24(26)27)22-23(31-32(4)25(22)30-21)16-9-13(2)35-14(16)3/h5-6,9-10,19,24H,7-8,11H2,1-4H3,(H,29,33)/t19-/m0/s1",3.9,1.0,8.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
809488,O43614,LADVEYKZADVBJM-UHFFFAOYSA-N,Kd,225,nM,ChEMBL,CHEMBL4792,CHEMBL3665724,None,SCHEMBL1914960,67209310.0,C23H26N4O2,390.487,"2-(3-cyclopropyl-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-(5-methyl-2,3-dihydro-1H-inden-1-yl)acetamide",CC1=CC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,CC1=CC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,"InChI=1S/C23H26N4O2/c1-13-4-8-17-16(10-13)7-9-18(17)24-19(28)12-29-20-11-14(2)21-22(15-5-6-15)26-27(3)23(21)25-20/h4,8,10-11,15,18H,5-7,9,12H2,1-3H3,(H,24,28)",3.7,1.0,4.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
810658,O43614,HYQGCUGXXGKSFM-MRXNPFEDSA-N,Kd,76,nM,ChEMBL,CHEMBL4792,CHEMBL3665673,None,CHEMBL3665673,70817358.0,C25H23F3N4O2,468.48,"2-[1-methyl-3-phenyl-4-(trifluoromethyl)pyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(2S)-2-phenylpropyl]acetamide",CC(CNC(=O)COC1=NC2=C(C(=C1)C(F)(F)F)C(=NN2C)C3=CC=CC=C3)C4=CC=CC=C4,C[C@H](CNC(=O)COC1=NC2=C(C(=C1)C(F)(F)F)C(=NN2C)C3=CC=CC=C3)C4=CC=CC=C4,"InChI=1S/C25H23F3N4O2/c1-16(17-9-5-3-6-10-17)14-29-20(33)15-34-21-13-19(25(26,27)28)22-23(18-11-7-4-8-12-18)31-32(2)24(22)30-21/h3-13,16H,14-15H2,1-2H3,(H,29,33)/t16-/m1/s1",5.3,1.0,7.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
810999,O43614,OJFITYODHBZMLE-IBGZPJMESA-N,Kd,317,nM,ChEMBL,CHEMBL4792,CHEMBL3665731,None,CHEMBL3665731,70816879.0,C24H28N4O3,420.513,"2-(3-cyclopropyl-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-[(1S)-5-ethoxy-2,3-dihydro-1H-inden-1-yl]acetamide",CCOC1=CC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,CCOC1=CC2=C(C=C1)[C@H](CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,"InChI=1S/C24H28N4O3/c1-4-30-17-8-9-18-16(12-17)7-10-19(18)25-20(29)13-31-21-11-14(2)22-23(15-5-6-15)27-28(3)24(22)26-21/h8-9,11-12,15,19H,4-7,10,13H2,1-3H3,(H,25,29)/t19-/m0/s1",3.7,1.0,5.0,Orexin receptor type 2,HCRTR2,Homo sapiens (Human),MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW
812561,O43613,FEEAYUXIGFRTRF-JOCHJYFZSA-N,Kd,696,nM,ChEMBL,CHEMBL5113,CHEMBL2413517,23891187,CHEMBL2413517,59475183.0,C26H31N3O3,433.552,N-[(3S)-3-[(3-ethoxybenzoyl)-methylamino]-4-phenylbutyl]-1-methylpyrrole-2-carboxamide,CCOC1=CC=CC(=C1)C(=O)N(C)C(CCNC(=O)C2=CC=CN2C)CC3=CC=CC=C3,CCOC1=CC=CC(=C1)C(=O)N(C)[C@H](CCNC(=O)C2=CC=CN2C)CC3=CC=CC=C3,"InChI=1S/C26H31N3O3/c1-4-32-23-13-8-12-21(19-23)26(31)29(3)22(18-20-10-6-5-7-11-20)15-16-27-25(30)24-14-9-17-28(24)2/h5-14,17,19,22H,4,15-16,18H2,1-3H3,(H,27,30)/t22-/m1/s1",4.1,1.0,3.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
812659,O43613,QVQBRELNCAXZCF-UHFFFAOYSA-N,Kd,>10000,nM,ChEMBL,CHEMBL5113,CHEMBL3669441,None,SCHEMBL2023334,53259457.0,C27H28N4O,424.548,"9-(1H-benzimidazol-2-yl)-2-(naphthalen-1-ylmethyl)-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N3)C(=O)N(C1)CC5=CC=CC6=CC=CC=C65,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N3)C(=O)N(C1)CC5=CC=CC6=CC=CC=C65,"InChI=1S/C27H28N4O/c32-25-27(14-17-30(18-15-27)26-28-23-11-3-4-12-24(23)29-26)13-6-16-31(25)19-21-9-5-8-20-7-1-2-10-22(20)21/h1-5,7-12H,6,13-19H2,(H,28,29)",5.0,1.0,3.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
812862,O43613,UQDZEOCEKHULPR-UHFFFAOYSA-N,Kd,3255,nM,ChEMBL,CHEMBL5113,CHEMBL3669470,None,SCHEMBL2022233,53259790.0,C26H27N7O,453.55,"9-quinoxalin-2-yl-2-[[2-(triazol-2-yl)phenyl]methyl]-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC=C5N6N=CC=N6,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC=C5N6N=CC=N6,"InChI=1S/C26H27N7O/c34-25-26(11-16-31(17-12-26)24-18-27-21-7-2-3-8-22(21)30-24)10-5-15-32(25)19-20-6-1-4-9-23(20)33-28-13-14-29-33/h1-4,6-9,13-14,18H,5,10-12,15-17,19H2",3.4,0.0,6.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
813237,O43613,CWYFTFBSOGXBMH-UHFFFAOYSA-N,Kd,426,nM,ChEMBL,CHEMBL5113,CHEMBL3669436,None,SCHEMBL2025010,53259278.0,C29H29N5O,463.585,"2-[(3-pyridin-3-ylphenyl)methyl]-9-quinoxalin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC(=C5)C6=CN=CC=C6,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=CC=CC(=C5)C6=CN=CC=C6,"InChI=1S/C29H29N5O/c35-28-29(12-16-33(17-13-29)27-20-31-25-9-1-2-10-26(25)32-27)11-5-15-34(28)21-22-6-3-7-23(18-22)24-8-4-14-30-19-24/h1-4,6-10,14,18-20H,5,11-13,15-17,21H2",4.0,0.0,5.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
813364,O43613,JQEYMZFGKKZWLJ-INIZCTEOSA-N,Kd,37,nM,ChEMBL,CHEMBL5113,CHEMBL3665712,None,SCHEMBL6845175,69915167.0,C25H24F2N4O2,450.49,"2-[4-(difluoromethyl)-1-methyl-3-phenylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C(F)F)C(=NN3C)C4=CC=CC=C4,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C(F)F)C(=NN3C)C4=CC=CC=C4,"InChI=1S/C25H24F2N4O2/c1-15-9-11-17(12-10-15)16(2)28-20(32)14-33-21-13-19(24(26)27)22-23(18-7-5-4-6-8-18)30-31(3)25(22)29-21/h4-13,16,24H,14H2,1-3H3,(H,28,32)/t16-/m0/s1",5.0,1.0,6.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
813411,O43613,RDHXDMAVHATBQH-INIZCTEOSA-N,Kd,501,nM,ChEMBL,CHEMBL5113,CHEMBL3665733,None,SCHEMBL6845156,69915151.0,C25H22F3N3O2,453.465,"2-[1-methyl-3-phenyl-4-(trifluoromethyl)pyrrolo[2,3-b]pyridin-6-yl]oxy-N-[(1S)-1-phenylethyl]acetamide",CC(C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=CN3C)C4=CC=CC=C4,C[C@@H](C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=CN3C)C4=CC=CC=C4,"InChI=1S/C25H22F3N3O2/c1-16(17-9-5-3-6-10-17)29-21(32)15-33-22-13-20(25(26,27)28)23-19(14-31(2)24(23)30-22)18-11-7-4-8-12-18/h3-14,16H,15H2,1-2H3,(H,29,32)/t16-/m0/s1",5.3,1.0,6.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
814075,O43613,ZNASAJGWPUTONJ-AWEZNQCLSA-N,Kd,185,nM,ChEMBL,CHEMBL5113,CHEMBL3665671,None,SCHEMBL6845120,69915132.0,C24H20F4N4O2,472.444,"2-[3-(2-fluorophenyl)-1-methyl-4-(trifluoromethyl)pyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-phenylethyl]acetamide",CC(C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=NN3C)C4=CC=CC=C4F,C[C@@H](C1=CC=CC=C1)NC(=O)COC2=NC3=C(C(=C2)C(F)(F)F)C(=NN3C)C4=CC=CC=C4F,"InChI=1S/C24H20F4N4O2/c1-14(15-8-4-3-5-9-15)29-19(33)13-34-20-12-17(24(26,27)28)21-22(31-32(2)23(21)30-20)16-10-6-7-11-18(16)25/h3-12,14H,13H2,1-2H3,(H,29,33)/t14-/m0/s1",5.0,1.0,8.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
814197,O43613,RSXGQEFCZXHYTD-UHFFFAOYSA-N,Kd,926,nM,ChEMBL,CHEMBL5113,CHEMBL3669573,None,SCHEMBL2028719,67253332.0,C26H27N5O,425.536,"2-(1H-indol-3-ylmethyl)-9-quinazolin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4C=N3)C(=O)N(C1)CC5=CNC6=CC=CC=C65,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4C=N3)C(=O)N(C1)CC5=CNC6=CC=CC=C65,"InChI=1S/C26H27N5O/c32-24-26(10-5-13-31(24)18-20-17-27-23-9-4-2-7-21(20)23)11-14-30(15-12-26)25-28-16-19-6-1-3-8-22(19)29-25/h1-4,6-9,16-17,27H,5,10-15,18H2",3.9,1.0,4.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
815927,O43613,YDZDZQBHJHYWCU-UHFFFAOYSA-N,Kd,4579,nM,ChEMBL,CHEMBL5113,CHEMBL3669512,None,SCHEMBL2020778,67250574.0,C27H28N6O2,468.561,"2-[[3-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]methyl]-9-quinoxalin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",CC1=NOC(=N1)C2=CC(=CC=C2)CN3CCCC4(C3=O)CCN(CC4)C5=NC6=CC=CC=C6N=C5,CC1=NOC(=N1)C2=CC(=CC=C2)CN3CCCC4(C3=O)CCN(CC4)C5=NC6=CC=CC=C6N=C5,"InChI=1S/C27H28N6O2/c1-19-29-25(35-31-19)21-7-4-6-20(16-21)18-33-13-5-10-27(26(33)34)11-14-32(15-12-27)24-17-28-22-8-2-3-9-23(22)30-24/h2-4,6-9,16-17H,5,10-15,18H2,1H3",3.7,0.0,7.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
815987,O43613,GDBCAXYOLOFJIR-UHFFFAOYSA-N,Kd,2756,nM,ChEMBL,CHEMBL5113,CHEMBL3669498,None,SCHEMBL2022271,67251111.0,C26H27N7O,453.55,"2-[(6-pyrazol-1-ylpyridin-2-yl)methyl]-9-quinoxalin-2-yl-2,9-diazaspiro[5.5]undecan-1-one",C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=NC(=CC=C5)N6C=CC=N6,C1CC2(CCN(CC2)C3=NC4=CC=CC=C4N=C3)C(=O)N(C1)CC5=NC(=CC=C5)N6C=CC=N6,"InChI=1S/C26H27N7O/c34-25-26(11-16-31(17-12-26)24-18-27-21-7-1-2-8-22(21)30-24)10-4-14-32(25)19-20-6-3-9-23(29-20)33-15-5-13-28-33/h1-3,5-9,13,15,18H,4,10-12,14,16-17,19H2",2.7,0.0,6.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
816236,O43613,KSZRPNZKQXWNEQ-UHFFFAOYSA-N,Kd,1240,nM,ChEMBL,CHEMBL5113,CHEMBL3634017,None,SCHEMBL1915574,67209610.0,C24H21F3N4O3,470.452,"N-[(4-methoxyphenyl)methyl]-2-[1-methyl-3-phenyl-4-(trifluoromethyl)pyrazolo[3,4-b]pyridin-6-yl]oxyacetamide",CN1C2=C(C(=CC(=N2)OCC(=O)NCC3=CC=C(C=C3)OC)C(F)(F)F)C(=N1)C4=CC=CC=C4,CN1C2=C(C(=CC(=N2)OCC(=O)NCC3=CC=C(C=C3)OC)C(F)(F)F)C(=N1)C4=CC=CC=C4,"InChI=1S/C24H21F3N4O3/c1-31-23-21(22(30-31)16-6-4-3-5-7-16)18(24(25,26)27)12-20(29-23)34-14-19(32)28-13-15-8-10-17(33-2)11-9-15/h3-12H,13-14H2,1-2H3,(H,28,32)",4.5,1.0,8.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
816309,O43613,XSUIGCPNDJKEIF-KRWDZBQOSA-N,Kd,63,nM,ChEMBL,CHEMBL5113,CHEMBL3665725,None,CHEMBL3665725,70816819.0,C23H24F2N4O3,442.467,"2-[3-cyclopropyl-4-(difluoromethyl)-1-methylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-5-methoxy-2,3-dihydro-1H-inden-1-yl]acetamide",CN1C2=C(C(=CC(=N2)OCC(=O)NC3CCC4=C3C=CC(=C4)OC)C(F)F)C(=N1)C5CC5,CN1C2=C(C(=CC(=N2)OCC(=O)N[C@H]3CCC4=C3C=CC(=C4)OC)C(F)F)C(=N1)C5CC5,"InChI=1S/C23H24F2N4O3/c1-29-23-20(21(28-29)12-3-4-12)16(22(24)25)10-19(27-23)32-11-18(30)26-17-8-5-13-9-14(31-2)6-7-15(13)17/h6-7,9-10,12,17,22H,3-5,8,11H2,1-2H3,(H,26,30)/t17-/m0/s1",3.6,1.0,7.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
816558,O43613,CWQYLWVLAFHETG-KRWDZBQOSA-N,Kd,45,nM,ChEMBL,CHEMBL5113,CHEMBL3665674,None,SCHEMBL6845155,69915150.0,C24H24N4O2,400.482,"2-(1,4-dimethyl-3-phenylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-[(1S)-1-phenylethyl]acetamide",CC1=CC(=NC2=C1C(=NN2C)C3=CC=CC=C3)OCC(=O)NC(C)C4=CC=CC=C4,CC1=CC(=NC2=C1C(=NN2C)C3=CC=CC=C3)OCC(=O)N[C@@H](C)C4=CC=CC=C4,"InChI=1S/C24H24N4O2/c1-16-14-21(30-15-20(29)25-17(2)18-10-6-4-7-11-18)26-24-22(16)23(27-28(24)3)19-12-8-5-9-13-19/h4-14,17H,15H2,1-3H3,(H,25,29)/t17-/m0/s1",4.4,1.0,4.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
817225,O43613,VHPHJZXOLJJSPJ-INIZCTEOSA-N,Kd,27,nM,ChEMBL,CHEMBL5113,CHEMBL3665692,None,CHEMBL3665692,70817062.0,C24H24FN5O2,433.487,"2-[3-(3-fluoropyridin-2-yl)-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,"InChI=1S/C24H24FN5O2/c1-14-7-9-17(10-8-14)16(3)27-19(31)13-32-20-12-15(2)21-23(29-30(4)24(21)28-20)22-18(25)6-5-11-26-22/h5-12,16H,13H2,1-4H3,(H,27,31)/t16-/m0/s1",3.8,1.0,6.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
817228,O43613,VHPHJZXOLJJSPJ-INIZCTEOSA-N,Kd,5,nM,ChEMBL,CHEMBL5113,CHEMBL3665692,None,CHEMBL3665692,70817062.0,C24H24FN5O2,433.487,"2-[3-(3-fluoropyridin-2-yl)-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C4=C(C=CC=N4)F,"InChI=1S/C24H24FN5O2/c1-14-7-9-17(10-8-14)16(3)27-19(31)13-32-20-12-15(2)21-23(29-30(4)24(21)28-20)22-18(25)6-5-11-26-22/h5-12,16H,13H2,1-4H3,(H,27,31)/t16-/m0/s1",3.8,1.0,6.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
817711,O43613,CITUDCOPJFTZRP-INIZCTEOSA-N,Kd,119,nM,ChEMBL,CHEMBL5113,CHEMBL3665716,None,CHEMBL3665716,70817109.0,C22H28N4O2,380.492,"2-(1,4-dimethyl-3-propan-2-ylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-[(1S)-1-(4-methylphenyl)ethyl]acetamide",CC1=CC=C(C=C1)C(C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C(C)C,CC1=CC=C(C=C1)[C@H](C)NC(=O)COC2=NC3=C(C(=C2)C)C(=NN3C)C(C)C,"InChI=1S/C22H28N4O2/c1-13(2)21-20-15(4)11-19(24-22(20)26(6)25-21)28-12-18(27)23-16(5)17-9-7-14(3)8-10-17/h7-11,13,16H,12H2,1-6H3,(H,23,27)/t16-/m0/s1",4.3,1.0,4.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
817731,O43613,HGSOFDAPWKEOJR-IBGZPJMESA-N,Kd,123,nM,ChEMBL,CHEMBL5113,CHEMBL3665722,None,CHEMBL3665722,70817289.0,C25H25F2N5O3,481.504,"2-[4-(difluoromethyl)-3-(2,5-dimethylfuran-3-yl)-1-methylpyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(5S)-2-methyl-6,7-dihydro-5H-cyclopenta[b]pyridin-5-yl]acetamide",CC1=NC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C(F)F)C(=NN4C)C5=C(OC(=C5)C)C,CC1=NC2=C(C=C1)[C@H](CC2)NC(=O)COC3=NC4=C(C(=C3)C(F)F)C(=NN4C)C5=C(OC(=C5)C)C,"InChI=1S/C25H25F2N5O3/c1-12-5-6-15-18(28-12)7-8-19(15)29-20(33)11-34-21-10-17(24(26)27)22-23(31-32(4)25(22)30-21)16-9-13(2)35-14(16)3/h5-6,9-10,19,24H,7-8,11H2,1-4H3,(H,29,33)/t19-/m0/s1",3.9,1.0,8.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
818793,O43613,LADVEYKZADVBJM-UHFFFAOYSA-N,Kd,908,nM,ChEMBL,CHEMBL5113,CHEMBL3665724,None,SCHEMBL1914960,67209310.0,C23H26N4O2,390.487,"2-(3-cyclopropyl-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-(5-methyl-2,3-dihydro-1H-inden-1-yl)acetamide",CC1=CC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,CC1=CC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,"InChI=1S/C23H26N4O2/c1-13-4-8-17-16(10-13)7-9-18(17)24-19(28)12-29-20-11-14(2)21-22(15-5-6-15)26-27(3)23(21)25-20/h4,8,10-11,15,18H,5-7,9,12H2,1-3H3,(H,24,28)",3.7,1.0,4.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
819899,O43613,HYQGCUGXXGKSFM-MRXNPFEDSA-N,Kd,1151,nM,ChEMBL,CHEMBL5113,CHEMBL3665673,None,CHEMBL3665673,70817358.0,C25H23F3N4O2,468.48,"2-[1-methyl-3-phenyl-4-(trifluoromethyl)pyrazolo[3,4-b]pyridin-6-yl]oxy-N-[(2S)-2-phenylpropyl]acetamide",CC(CNC(=O)COC1=NC2=C(C(=C1)C(F)(F)F)C(=NN2C)C3=CC=CC=C3)C4=CC=CC=C4,C[C@H](CNC(=O)COC1=NC2=C(C(=C1)C(F)(F)F)C(=NN2C)C3=CC=CC=C3)C4=CC=CC=C4,"InChI=1S/C25H23F3N4O2/c1-16(17-9-5-3-6-10-17)14-29-20(33)15-34-21-13-19(25(26,27)28)22-23(18-11-7-4-8-12-18)31-32(2)24(22)30-21/h3-13,16H,14-15H2,1-2H3,(H,29,33)/t16-/m1/s1",5.3,1.0,7.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
820214,O43613,OJFITYODHBZMLE-IBGZPJMESA-N,Kd,52,nM,ChEMBL,CHEMBL5113,CHEMBL3665731,None,CHEMBL3665731,70816879.0,C24H28N4O3,420.513,"2-(3-cyclopropyl-1,4-dimethylpyrazolo[3,4-b]pyridin-6-yl)oxy-N-[(1S)-5-ethoxy-2,3-dihydro-1H-inden-1-yl]acetamide",CCOC1=CC2=C(C=C1)C(CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,CCOC1=CC2=C(C=C1)[C@H](CC2)NC(=O)COC3=NC4=C(C(=C3)C)C(=NN4C)C5CC5,"InChI=1S/C24H28N4O3/c1-4-30-17-8-9-18-16(12-17)7-10-19(18)25-20(29)13-31-21-11-14(2)22-23(15-5-6-15)27-28(3)24(22)26-21/h8-9,11-12,15,19H,4-7,10,13H2,1-3H3,(H,25,29)/t19-/m0/s1",3.7,1.0,5.0,Orexin receptor type 1,HCRTR1,Homo sapiens (Human),MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP
824882,Q9QYN8,XXHIGGQEZHTJEU-UHFFFAOYSA-N,Kd,1.549,nM,ChEMBL,CHEMBL4124,CHEMBL496366,18922693,CHEMBL496366,44581099.0,C22H34N2O2,358.526,4-cyclopentyl-2-[[4-(piperidin-1-ylmethyl)phenoxy]methyl]morpholine,C1CCN(CC1)CC2=CC=C(C=C2)OCC3CN(CCO3)C4CCCC4,C1CCN(CC1)CC2=CC=C(C=C2)OCC3CN(CCO3)C4CCCC4,"InChI=1S/C22H34N2O2/c1-4-12-23(13-5-1)16-19-8-10-21(11-9-19)26-18-22-17-24(14-15-25-22)20-6-2-3-7-20/h8-11,20,22H,1-7,12-18H2",3.6,0.0,4.0,Histamine H3 receptor,Hrh3,Rattus norvegicus (Rat),MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
826300,Q9QYN8,UWFACTDPNOOPFV-HNNXBMFYSA-N,Kd,0.6,nM,IUPHAR,264,3960,7834183,[125I]IODOPHENPROPIT,5311186.0,C15H21IN4S,416.325,(1S)-1-[3-(1H-imidazol-5-yl)propylsulfanyl]-N'-[2-(4-iodophenyl)ethyl]methanediamine,C1=CC(=CC=C1CCNC(N)SCCCC2=CN=CN2)I,C1=CC(=CC=C1CCN[C@H](N)SCCCC2=CN=CN2)I,"InChI=1S/C15H21IN4S/c16-13-5-3-12(4-6-13)7-8-19-15(17)21-9-1-2-14-10-18-11-20-14/h3-6,10-11,15,19H,1-2,7-9,17H2,(H,18,20)/t15-/m0/s1",2.9,3.0,4.0,Histamine H3 receptor,Hrh3,Rattus norvegicus (Rat),MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
827478,Q9QYN8,DZMJATAIFBTELK-LEWJYISDSA-N,Kd,3.09,nM,ChEMBL,CHEMBL4124,CHEMBL1097883,20382018,CHEMBL1097883,46887995.0,C22H30N4O2,382.508,"4-[(3S,5R)-5-(4-cyclopentyl-1,4-diazepane-1-carbonyl)pyrrolidin-3-yl]oxybenzonitrile",C1CCC(C1)N2CCCN(CC2)C(=O)C3CC(CN3)OC4=CC=C(C=C4)C#N,C1CCC(C1)N2CCCN(CC2)C(=O)[C@H]3C[C@@H](CN3)OC4=CC=C(C=C4)C#N,"InChI=1S/C22H30N4O2/c23-15-17-6-8-19(9-7-17)28-20-14-21(24-16-20)22(27)26-11-3-10-25(12-13-26)18-4-1-2-5-18/h6-9,18,20-21,24H,1-5,10-14,16H2/t20-,21+/m0/s1",2.4,1.0,5.0,Histamine H3 receptor,Hrh3,Rattus norvegicus (Rat),MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
827555,Q9QYN8,CCLHRWBVZOMXEV-NRFANRHFSA-N,Kd,2.138,nM,ChEMBL,CHEMBL4124,CHEMBL497192,18922693,CHEMBL497192,25211254.0,C21H32N2O3,360.498,(2S)-4-cyclopentyl-2-[[4-(morpholin-4-ylmethyl)phenoxy]methyl]morpholine,C1CCC(C1)N2CCOC(C2)COC3=CC=C(C=C3)CN4CCOCC4,C1CCC(C1)N2CCO[C@@H](C2)COC3=CC=C(C=C3)CN4CCOCC4,"InChI=1S/C21H32N2O3/c1-2-4-19(3-1)23-11-14-25-21(16-23)17-26-20-7-5-18(6-8-20)15-22-9-12-24-13-10-22/h5-8,19,21H,1-4,9-17H2/t21-/m0/s1",2.4,0.0,5.0,Histamine H3 receptor,Hrh3,Rattus norvegicus (Rat),MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
827756,Q9QYN8,GBZPNPQJVWRRPZ-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL4124,CHEMBL481745,19119007,CHEMBL481745,10134089.0,C20H26ClN3O2,375.897,(4-chlorophenyl)-[3-methyl-2-[(1-propan-2-ylpiperidin-4-yl)methoxy]imidazol-4-yl]methanone,CC(C)N1CCC(CC1)COC2=NC=C(N2C)C(=O)C3=CC=C(C=C3)Cl,CC(C)N1CCC(CC1)COC2=NC=C(N2C)C(=O)C3=CC=C(C=C3)Cl,"InChI=1S/C20H26ClN3O2/c1-14(2)24-10-8-15(9-11-24)13-26-20-22-12-18(23(20)3)19(25)16-4-6-17(21)7-5-16/h4-7,12,14-15H,8-11,13H2,1-3H3",4.2,0.0,4.0,Histamine H3 receptor,Hrh3,Rattus norvegicus (Rat),MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
827913,Q9QYN8,PBMWBJNBIVVHNL-UHFFFAOYSA-N,Kd,1.585,nM,ChEMBL,CHEMBL4124,CHEMBL496167,18922693,CHEMBL496167,44581098.0,C21H32N2O2,344.499,4-cyclopentyl-2-[[4-(pyrrolidin-1-ylmethyl)phenoxy]methyl]morpholine,C1CCC(C1)N2CCOC(C2)COC3=CC=C(C=C3)CN4CCCC4,C1CCC(C1)N2CCOC(C2)COC3=CC=C(C=C3)CN4CCCC4,"InChI=1S/C21H32N2O2/c1-2-6-19(5-1)23-13-14-24-21(16-23)17-25-20-9-7-18(8-10-20)15-22-11-3-4-12-22/h7-10,19,21H,1-6,11-17H2",3.2,0.0,4.0,Histamine H3 receptor,Hrh3,Rattus norvegicus (Rat),MERAPPDGLMNASGTLAGEAAAAGGARGFSAAWTAVLAALMALLIVATVLGNALVMLAFVADSSLRTQNNFFLLNLAISDFLVGAFCIPLYVPYVLTGRWTFGRGLCKLWLVVDYLLCASSVFNIVLISYDRFLSVTRAVSYRAQQGDTRRAVRKMALVWVLAFLLYGPAILSWEYLSGGSSIPEGHCYAEFFYNWYFLITASTLEFFTPFLSVTFFNLSIYLNIQRRTRLRLDGGREAGPEPPPDAQPSPPPAPPSCWGCWPKGHGEAMPLHRYGVGEAGPGVEAGEAALGGGSGGGAAASPTSSSGSSSRGTERPRSLKRGSKPSASSASLEKRMKMVSQSITQRFRLSRDKKVAKSLAIIVSIFGLCWAPYTLLMIIRAACHGRCIPDYWYETSFWLLWANSAVNPVLYPLCHYSFRRAFTKLLCPQKLKVQPHGSLEQCWK
829304,P23944,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.02512,nM,ChEMBL,CHEMBL326,CHEMBL836,9379432,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
829426,P23944,LLUFTDXWFHPSPE-UHFFFAOYSA-N,Kd,6.918,nM,ChEMBL,CHEMBL326,CHEMBL144224,9822553,CHEMBL144224,10072518.0,C25H33N5O3,451.571,"N-[6-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]hexyl]-N-methylbenzamide",CN(CCCCCCN(C)C(=O)C1=CC=CC=C1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CN(CCCCCCN(C)C(=O)C1=CC=CC=C1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C25H33N5O3/c1-29(24(31)18-12-8-7-9-13-18)14-10-5-6-11-15-30(2)25-27-20-17-22(33-4)21(32-3)16-19(20)23(26)28-25/h7-9,12-13,16-17H,5-6,10-11,14-15H2,1-4H3,(H2,26,27,28)",4.2,1.0,7.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
829956,P23944,UVEKKXRFQCNLQE-ZEQRLZLVSA-N,Kd,32.36,nM,ChEMBL,CHEMBL326,CHEMBL297106,11931617,CHEMBL297106,44289262.0,C25H27NO5,421.493,"2-(2,6-dimethoxyphenoxy)-N-[[(2S,3S)-3-phenyl-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]ethanamine",COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3O2)C4=CC=CC=C4,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2[C@@H](OC3=CC=CC=C3O2)C4=CC=CC=C4,"InChI=1S/C25H27NO5/c1-27-21-13-8-14-22(28-2)25(21)29-16-15-26-17-23-24(18-9-4-3-5-10-18)31-20-12-7-6-11-19(20)30-23/h3-14,23-24,26H,15-17H2,1-2H3/t23-,24-/m0/s1",4.4,1.0,6.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830091,P23944,GVRSOZBKXDJGAJ-UHFFFAOYSA-N,Kd,26.92,nM,ChEMBL,CHEMBL326,CHEMBL3415015,25874333,CHEMBL3415015,73437675.0,C23H28N4O3,408.502,5-hydroxy-N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]-1H-indole-2-carboxamide,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(N3)C=CC(=C4)O,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(N3)C=CC(=C4)O,"InChI=1S/C23H28N4O3/c1-30-22-6-3-2-5-21(22)27-13-11-26(12-14-27)10-4-9-24-23(29)20-16-17-15-18(28)7-8-19(17)25-20/h2-3,5-8,15-16,25,28H,4,9-14H2,1H3,(H,24,29)",3.3,3.0,5.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830201,P23944,PDKZRJZOEVFDRV-UHFFFAOYSA-N,Kd,5.129,nM,ChEMBL,CHEMBL326,CHEMBL3415014,25874333,CHEMBL3415014,73437674.0,C26H34N4O2,434.584,4-(1H-indol-3-yl)-N-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl]butanamide,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CCCC3=CNC4=CC=CC=C43,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CCCC3=CNC4=CC=CC=C43,"InChI=1S/C26H34N4O2/c1-32-25-12-5-4-11-24(25)30-18-16-29(17-19-30)15-7-14-27-26(31)13-6-8-21-20-28-23-10-3-2-9-22(21)23/h2-5,9-12,20,28H,6-8,13-19H2,1H3,(H,27,31)",3.9,2.0,4.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830284,P23944,VDSSOFQYDAIUHS-UHFFFAOYSA-N,Kd,14.45,nM,ChEMBL,CHEMBL326,CHEMBL144000,9822553,CHEMBL144000,10531768.0,C34H53N7O3,607.844,"N-[6-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]hexyl]-N-methyl-3-[[methyl-[6-(methylamino)hexyl]amino]methyl]benzamide",CNCCCCCCN(C)CC1=CC=CC(=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,CNCCCCCCN(C)CC1=CC=CC(=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,"InChI=1S/C34H53N7O3/c1-36-18-11-7-8-12-19-39(2)25-26-16-15-17-27(22-26)33(42)40(3)20-13-9-10-14-21-41(4)34-37-29-24-31(44-6)30(43-5)23-28(29)32(35)38-34/h15-17,22-24,36H,7-14,18-21,25H2,1-6H3,(H2,35,37,38)",5.0,2.0,9.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830305,P23944,DWUSTUPZNLOYSI-CYBMUJFWSA-N,Kd,7244.36,nM,ChEMBL,CHEMBL326,CHEMBL2261355,"Med Chem Res, (2004) 13:3:134",CHEMBL2261355,76326541.0,C15H19N3O2S,305.396,"N-[(5R)-5-(1H-imidazol-5-yl)-5,6,7,8-tetrahydronaphthalen-1-yl]ethanesulfonamide",CCS(=O)(=O)NC1=CC=CC2=C1CCCC2C3=CN=CN3,CCS(=O)(=O)NC1=CC=CC2=C1CCC[C@H]2C3=CN=CN3,"InChI=1S/C15H19N3O2S/c1-2-21(19,20)18-14-8-4-5-11-12(14)6-3-7-13(11)15-9-16-10-17-15/h4-5,8-10,13,18H,2-3,6-7H2,1H3,(H,16,17)/t13-/m1/s1",2.1,2.0,4.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830315,P23944,ASVLTVMZMRWUDI-UHFFFAOYSA-N,Kd,100,nM,ChEMBL,CHEMBL326,CHEMBL91989,9276013,CHEMBL91989,10815708.0,C27H32F3N5O2,515.581,"N,N-dimethyl-4-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propylamino]quinoline-3-carboxamide",CN(C)C(=O)C1=C(C2=CC=CC=C2N=C1)NCCCN3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F,CN(C)C(=O)C1=C(C2=CC=CC=C2N=C1)NCCCN3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F,"InChI=1S/C27H32F3N5O2/c1-33(2)26(36)21-18-32-22-9-4-3-8-20(22)25(21)31-12-7-13-34-14-16-35(17-15-34)23-10-5-6-11-24(23)37-19-27(28,29)30/h3-6,8-11,18H,7,12-17,19H2,1-2H3,(H,31,32)",5.3,1.0,9.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830401,P23944,PLJCELRWRGZCMC-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL326,CHEMBL88435,9276013,CHEMBL88435,10833725.0,C22H31N5O,381.524,"N,N-dimethyl-2-[3-[4-(2-methylphenyl)piperazin-1-yl]propylamino]pyridine-3-carboxamide",CC1=CC=CC=C1N2CCN(CC2)CCCNC3=C(C=CC=N3)C(=O)N(C)C,CC1=CC=CC=C1N2CCN(CC2)CCCNC3=C(C=CC=N3)C(=O)N(C)C,"InChI=1S/C22H31N5O/c1-18-8-4-5-10-20(18)27-16-14-26(15-17-27)13-7-12-24-21-19(9-6-11-23-21)22(28)25(2)3/h4-6,8-11H,7,12-17H2,1-3H3,(H,23,24)",3.5,1.0,5.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830518,P23944,UOWWWPYFAPQMPE-HNNXBMFYSA-N,Kd,3.02,nM,ChEMBL,CHEMBL326,CHEMBL2419765,23902232,CHEMBL2419765,71817545.0,C20H22N2O4,354.406,"N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]-2-[(6-methoxy-1H-indol-7-yl)oxy]ethanamine",COC1=C(C2=C(C=C1)C=CN2)OCCNCC3COC4=CC=CC=C4O3,COC1=C(C2=C(C=C1)C=CN2)OCCNC[C@H]3COC4=CC=CC=C4O3,"InChI=1S/C20H22N2O4/c1-23-18-7-6-14-8-9-22-19(14)20(18)24-11-10-21-12-15-13-25-16-4-2-3-5-17(16)26-15/h2-9,15,21-22H,10-13H2,1H3/t15-/m0/s1",3.0,2.0,5.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830539,P23944,IUHSDXDFPGLZMT-UHFFFAOYSA-N,Kd,63.1,nM,ChEMBL,CHEMBL326,CHEMBL88820,9276013,CHEMBL88820,10716502.0,C23H30N4O3,410.518,"2-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propanoylamino]-N,N-dimethylbenzamide",CN(C)C(=O)C1=CC=CC=C1NC(=O)CCN2CCN(CC2)C3=CC=CC=C3OC,CN(C)C(=O)C1=CC=CC=C1NC(=O)CCN2CCN(CC2)C3=CC=CC=C3OC,"InChI=1S/C23H30N4O3/c1-25(2)23(29)18-8-4-5-9-19(18)24-22(28)12-13-26-14-16-27(17-15-26)20-10-6-7-11-21(20)30-3/h4-11H,12-17H2,1-3H3,(H,24,28)",2.6,1.0,5.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830630,P23944,GMYYIJWKRJLTMK-UHFFFAOYSA-N,Kd,50.12,nM,ChEMBL,CHEMBL326,CHEMBL88633,9276013,CHEMBL88633,44323803.0,C21H30N6O2,398.511,"5-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-N,N-dimethylpyrimidine-4-carboxamide",CN(C)C(=O)C1=NC=NC=C1NCCCN2CCN(CC2)C3=CC=CC=C3OC,CN(C)C(=O)C1=NC=NC=C1NCCCN2CCN(CC2)C3=CC=CC=C3OC,"InChI=1S/C21H30N6O2/c1-25(2)21(28)20-17(15-22-16-24-20)23-9-6-10-26-11-13-27(14-12-26)18-7-4-5-8-19(18)29-3/h4-5,7-8,15-16,23H,6,9-14H2,1-3H3",2.5,1.0,7.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830646,P23944,LIKJINLMRISDIC-UHFFFAOYSA-N,Kd,63.1,nM,ChEMBL,CHEMBL326,CHEMBL90869,9276013,CHEMBL90869,10552164.0,C23H29F3N4O3,466.505,"N,N-dimethyl-2-[4-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]piperidin-1-yl]pyridine-3-carboxamide",CN(C)C(=O)C1=C(N=CC=C1)N2CCC(CC2)NCCOC3=CC=CC=C3OCC(F)(F)F,CN(C)C(=O)C1=C(N=CC=C1)N2CCC(CC2)NCCOC3=CC=CC=C3OCC(F)(F)F,"InChI=1S/C23H29F3N4O3/c1-29(2)22(31)18-6-5-11-28-21(18)30-13-9-17(10-14-30)27-12-15-32-19-7-3-4-8-20(19)33-16-23(24,25)26/h3-8,11,17,27H,9-10,12-16H2,1-2H3",3.6,1.0,9.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
830684,P23944,CSOCCMKODQKNLN-UHFFFAOYSA-N,Kd,15.85,nM,ChEMBL,CHEMBL326,CHEMBL330579,9276013,CHEMBL330579,10552132.0,C23H30F3N5O2,465.521,"N,N-dimethyl-2-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propylamino]pyridine-3-carboxamide",CN(C)C(=O)C1=C(N=CC=C1)NCCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,CN(C)C(=O)C1=C(N=CC=C1)NCCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,"InChI=1S/C23H30F3N5O2/c1-29(2)22(32)18-7-5-10-27-21(18)28-11-6-12-30-13-15-31(16-14-30)19-8-3-4-9-20(19)33-17-23(24,25)26/h3-5,7-10H,6,11-17H2,1-2H3,(H,27,28)",4.3,1.0,9.0,Alpha-1D adrenergic receptor,Adra1d,Rattus norvegicus (Rat),MTFRDILSVTFEGPRSSSSTGGSGAGGGAGTVGPEGGAVGGVPGATGGGAVVGTGSGEDNQSSTGEPGAAASGEVNGSAAVGGLVVSAQGVGVGVFLAAFILTAVAGNLLVILSVACNRHLQTVTNYFIVNLAVADLLLSAAVLPFSATMEVLGFWAFGRTFCDVWAAVDVLCCTASILSLCTISVDRYVGVRHSLKYPAIMTERKAAAILALLWAVALVVSVGPLLGWKEPVPPDERFCGITEEVGYAIFSSVCSFYLPMAVIVVMYCRVYVVARSTTRSLEAGIKREPGKASEVVLRIHCRGAATSAKGYPGTQSSKGHTLRSSLSVRLLKFSREKKAAKTLAIVVGVFVLCWFPFFFVLPLGSLFPQLKPSEGVFKVIFWLGYFNSCVNPLIYPCSSREFKRAFLRLLRCQCRRRRRRLWAVYGHHWRASTGDARSDCAPSPRIAPPGAPLALTAHPGAGSADTPETQDSVSSSRKPASALREWRLLGPLQRPTTQLRAKVSSLSHKIRSGARRAETACALRSEVEAVSLNVPQDGAEAVICQAYEPGDYSNLRETDI
831247,O02824,DRHKJLXJIQTDTD-OAHLLOKOSA-N,Kd,0.1585,nM,ChEMBL,CHEMBL3637,CHEMBL836,9276013,TAMSULOSIN,129211.0,C20H28N2O5S,408.513,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",2.7,2.0,7.0,Alpha-1A adrenergic receptor,ADRA1A,Oryctolagus cuniculus (Rabbit),MVFLSGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPGYVLFSALGSFYVPLTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGVASAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKHALGYTLHAPSQALEGQHKDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPRGSARITVPKDQSACTTARVRSKSFLQVCCCVGPSTPNPGENHQVPTIKIHTISLSENGEEV
831376,O02824,ASVLTVMZMRWUDI-UHFFFAOYSA-N,Kd,3.981,nM,ChEMBL,CHEMBL3637,CHEMBL91989,9276013,CHEMBL91989,10815708.0,C27H32F3N5O2,515.581,"N,N-dimethyl-4-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propylamino]quinoline-3-carboxamide",CN(C)C(=O)C1=C(C2=CC=CC=C2N=C1)NCCCN3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F,CN(C)C(=O)C1=C(C2=CC=CC=C2N=C1)NCCCN3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F,"InChI=1S/C27H32F3N5O2/c1-33(2)26(36)21-18-32-22-9-4-3-8-20(22)25(21)31-12-7-13-34-14-16-35(17-15-34)23-10-5-6-11-24(23)37-19-27(28,29)30/h3-6,8-11,18H,7,12-17,19H2,1-2H3,(H,31,32)",5.3,1.0,9.0,Alpha-1A adrenergic receptor,ADRA1A,Oryctolagus cuniculus (Rabbit),MVFLSGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPGYVLFSALGSFYVPLTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGVASAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKHALGYTLHAPSQALEGQHKDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPRGSARITVPKDQSACTTARVRSKSFLQVCCCVGPSTPNPGENHQVPTIKIHTISLSENGEEV
831383,O02824,PLJCELRWRGZCMC-UHFFFAOYSA-N,Kd,1.995,nM,ChEMBL,CHEMBL3637,CHEMBL88435,9276013,CHEMBL88435,10833725.0,C22H31N5O,381.524,"N,N-dimethyl-2-[3-[4-(2-methylphenyl)piperazin-1-yl]propylamino]pyridine-3-carboxamide",CC1=CC=CC=C1N2CCN(CC2)CCCNC3=C(C=CC=N3)C(=O)N(C)C,CC1=CC=CC=C1N2CCN(CC2)CCCNC3=C(C=CC=N3)C(=O)N(C)C,"InChI=1S/C22H31N5O/c1-18-8-4-5-10-20(18)27-16-14-26(15-17-27)13-7-12-24-21-19(9-6-11-23-21)22(28)25(2)3/h4-6,8-11H,7,12-17H2,1-3H3,(H,23,24)",3.5,1.0,5.0,Alpha-1A adrenergic receptor,ADRA1A,Oryctolagus cuniculus (Rabbit),MVFLSGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPGYVLFSALGSFYVPLTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGVASAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKHALGYTLHAPSQALEGQHKDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPRGSARITVPKDQSACTTARVRSKSFLQVCCCVGPSTPNPGENHQVPTIKIHTISLSENGEEV
831409,O02824,GMYYIJWKRJLTMK-UHFFFAOYSA-N,Kd,3.981,nM,ChEMBL,CHEMBL3637,CHEMBL88633,9276013,CHEMBL88633,44323803.0,C21H30N6O2,398.511,"5-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-N,N-dimethylpyrimidine-4-carboxamide",CN(C)C(=O)C1=NC=NC=C1NCCCN2CCN(CC2)C3=CC=CC=C3OC,CN(C)C(=O)C1=NC=NC=C1NCCCN2CCN(CC2)C3=CC=CC=C3OC,"InChI=1S/C21H30N6O2/c1-25(2)21(28)20-17(15-22-16-24-20)23-9-6-10-26-11-13-27(14-12-26)18-7-4-5-8-19(18)29-3/h4-5,7-8,15-16,23H,6,9-14H2,1-3H3",2.5,1.0,7.0,Alpha-1A adrenergic receptor,ADRA1A,Oryctolagus cuniculus (Rabbit),MVFLSGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPGYVLFSALGSFYVPLTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGVASAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKHALGYTLHAPSQALEGQHKDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPRGSARITVPKDQSACTTARVRSKSFLQVCCCVGPSTPNPGENHQVPTIKIHTISLSENGEEV
831416,O02824,LIKJINLMRISDIC-UHFFFAOYSA-N,Kd,1.585,nM,ChEMBL,CHEMBL3637,CHEMBL90869,9276013,CHEMBL90869,10552164.0,C23H29F3N4O3,466.505,"N,N-dimethyl-2-[4-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]piperidin-1-yl]pyridine-3-carboxamide",CN(C)C(=O)C1=C(N=CC=C1)N2CCC(CC2)NCCOC3=CC=CC=C3OCC(F)(F)F,CN(C)C(=O)C1=C(N=CC=C1)N2CCC(CC2)NCCOC3=CC=CC=C3OCC(F)(F)F,"InChI=1S/C23H29F3N4O3/c1-29(2)22(31)18-6-5-11-28-21(18)30-13-9-17(10-14-30)27-12-15-32-19-7-3-4-8-20(19)33-16-23(24,25)26/h3-8,11,17,27H,9-10,12-16H2,1-2H3",3.6,1.0,9.0,Alpha-1A adrenergic receptor,ADRA1A,Oryctolagus cuniculus (Rabbit),MVFLSGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPGYVLFSALGSFYVPLTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGVASAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKHALGYTLHAPSQALEGQHKDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPRGSARITVPKDQSACTTARVRSKSFLQVCCCVGPSTPNPGENHQVPTIKIHTISLSENGEEV
831420,O02824,CSOCCMKODQKNLN-UHFFFAOYSA-N,Kd,0.1,nM,ChEMBL,CHEMBL3637,CHEMBL330579,9276013,CHEMBL330579,10552132.0,C23H30F3N5O2,465.521,"N,N-dimethyl-2-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propylamino]pyridine-3-carboxamide",CN(C)C(=O)C1=C(N=CC=C1)NCCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,CN(C)C(=O)C1=C(N=CC=C1)NCCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,"InChI=1S/C23H30F3N5O2/c1-29(2)22(32)18-7-5-10-27-21(18)28-11-6-12-30-13-15-31(16-14-30)19-8-3-4-9-20(19)33-17-23(24,25)26/h3-5,7-10H,6,11-17H2,1-2H3,(H,27,28)",4.3,1.0,9.0,Alpha-1A adrenergic receptor,ADRA1A,Oryctolagus cuniculus (Rabbit),MVFLSGNASDSSNCTHPPAPVNISKAILLGVILGGLILFGVLGNILVILSVACHRHLHSVTHYYIVNLAVADLLLTSTVLPFSAIFEILGYWAFGRVFCNIWAAVDVLCCTASIISLCVISIDRYIGVSYPLRYPTIVTQRRGLRALLCVWAFSLVISVGPLFGWRQPAPDDETICQINEEPGYVLFSALGSFYVPLTIILAMYCRVYVVAKRESRGLKSGLKTDKSDSEQVTLRIHRKNAPAGGSGVASAKNKTHFSVRLLKFSREKKAAKTLGIVVGCFVLCWLPFFLVMPIGSFFPDFKPPETVFKIVFWLGYLNSCINPIIYPCSSQEFKKAFQNVLKIQCLRRKQSSKHALGYTLHAPSQALEGQHKDMVRIPVGSGETFYKISKTDGVCEWKFFSSMPRGSARITVPKDQSACTTARVRSKSFLQVCCCVGPSTPNPGENHQVPTIKIHTISLSENGEEV
835523,P41968,CZCIDYFBUVIGBB-KVVACOCFSA-N,Kd,398.11,nM,ChEMBL,CHEMBL4644,CHEMBL1161321,12431055,CHEMBL1161321,44366213.0,C58H73N13O9,1096.304,"(3'S,6'R,9'S,15'R,23'S)-15'-[[(2R)-2-acetamidohexanoyl]amino]-6'-[3-(diaminomethylideneamino)propyl]-3'-(1H-indol-3-ylmethyl)-9'-(naphthalen-2-ylmethyl)-2',5',8',11',14',17'-hexaoxospiro[1,3-dihydroindene-2,12'-1,4,7,10,13,18-hexazacyclotricosane]-23'-carboxamide",CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2(CC3=CC=CC=C3C2)NC1=O)CC4=CC5=CC=CC=C5C=C4)CCCN=C(N)N)CC6=CNC7=CC=CC=C76)C(=O)N)NC(=O)C,CCCC[C@H](C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)C2(CC3=CC=CC=C3C2)NC1=O)CC4=CC5=CC=CC=C5C=C4)CCCN=C(N)N)CC6=CNC7=CC=CC=C76)C(=O)N)NC(=O)C,"InChI=1S/C58H73N13O9/c1-3-4-19-44(65-34(2)72)51(75)69-48-30-49(73)62-25-12-11-21-43(50(59)74)66-54(78)47(29-40-33-64-42-20-10-9-18-41(40)42)68-52(76)45(22-13-26-63-57(60)61)67-53(77)46(28-35-23-24-36-14-5-6-15-37(36)27-35)70-56(80)58(71-55(48)79)31-38-16-7-8-17-39(38)32-58/h5-10,14-18,20,23-24,27,33,43-48,64H,3-4,11-13,19,21-22,25-26,28-32H2,1-2H3,(H2,59,74)(H,62,73)(H,65,72)(H,66,78)(H,67,77)(H,68,76)(H,69,75)(H,70,80)(H,71,79)(H4,60,61,63)/t43-,44+,45+,46-,47-,48+/m0/s1",3.0,12.0,10.0,Melanocortin receptor 3,MC3R,Homo sapiens (Human),MNASCCLPSVQPTLPNGSEHLQAPFFSNQSSSAFCEQVFIKPEVFLSLGIVSLLENILVILAVVRNGNLHSPMYFFLCSLAVADMLVSVSNALETIMIAIVHSDYLTFEDQFIQHMDNIFDSMICISLVASICNLLAIAVDRYVTIFYALRYHSIMTVRKALTLIVAIWVCCGVCGVVFIVYSESKMVIVCLITMFFAMMLLMGTLYVHMFLFARLHVKRIAALPPADGVAPQQHSCMKGAVTITILLGVFIFCWAPFFLHLVLIITCPTNPYCICYTAHFNTYLVLIMCNSVIDPLIYAFRSLELRNTFREILCGCNGMNLG
838101,P41968,NEVVXMYOTHZJES-BYMRNIKTSA-N,Kd,25.12,nM,ChEMBL,CHEMBL4644,CHEMBL1161320,12431055,CHEMBL1161320,44366187.0,C52H69N13O9,1020.206,"(6R,14S,17S,20R,23S)-6-[[(2R)-2-acetamidohexanoyl]amino]-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-23-(naphthalen-2-ylmethyl)-5,8,16,19,22,25-hexaoxo-4,9,15,18,21,24-hexazaspiro[2.22]pentacosane-14-carboxamide",CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2(CC2)NC1=O)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C,CCCC[C@H](C(=O)N[C@@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)C2(CC2)NC1=O)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C,"InChI=1S/C52H69N13O9/c1-3-4-15-38(59-30(2)66)45(69)63-42-28-43(67)56-23-10-9-17-37(44(53)68)60-48(72)41(27-34-29-58-36-16-8-7-14-35(34)36)62-46(70)39(18-11-24-57-51(54)55)61-47(71)40(64-50(74)52(21-22-52)65-49(42)73)26-31-19-20-32-12-5-6-13-33(32)25-31/h5-8,12-14,16,19-20,25,29,37-42,58H,3-4,9-11,15,17-18,21-24,26-28H2,1-2H3,(H2,53,68)(H,56,67)(H,59,66)(H,60,72)(H,61,71)(H,62,70)(H,63,69)(H,64,74)(H,65,73)(H4,54,55,57)/t37-,38+,39+,40-,41-,42+/m0/s1",1.5,12.0,10.0,Melanocortin receptor 3,MC3R,Homo sapiens (Human),MNASCCLPSVQPTLPNGSEHLQAPFFSNQSSSAFCEQVFIKPEVFLSLGIVSLLENILVILAVVRNGNLHSPMYFFLCSLAVADMLVSVSNALETIMIAIVHSDYLTFEDQFIQHMDNIFDSMICISLVASICNLLAIAVDRYVTIFYALRYHSIMTVRKALTLIVAIWVCCGVCGVVFIVYSESKMVIVCLITMFFAMMLLMGTLYVHMFLFARLHVKRIAALPPADGVAPQQHSCMKGAVTITILLGVFIFCWAPFFLHLVLIITCPTNPYCICYTAHFNTYLVLIMCNSVIDPLIYAFRSLELRNTFREILCGCNGMNLG
838161,P41968,VFKSOTPIQWLTBE-DIEXDCLBSA-N,Kd,0.02512,nM,ChEMBL,CHEMBL4644,CHEMBL253364,18088090,CHEMBL253364,44445109.0,C47H60N14O7,933.088,"(2S,5S,8S,11R,14S,23S)-23-amino-8-[3-(diaminomethylideneamino)propyl]-2-(1H-imidazol-5-ylmethyl)-11-(1H-indol-3-ylmethyl)-5-(naphthalen-2-ylmethyl)-3,6,9,12,20,24-hexaoxo-1,4,7,10,13,19-hexazacyclotetracosane-14-carboxamide",C1CCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CC6=CN=CN6)N,C1CCNC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CC6=CN=CN6)N,"InChI=1S/C47H60N14O7/c48-33-16-17-40(62)53-18-6-5-12-35(41(49)63)57-45(67)38(22-30-24-55-34-11-4-3-10-32(30)34)61-43(65)36(13-7-19-54-47(50)51)58-44(66)37(21-27-14-15-28-8-1-2-9-29(28)20-27)60-46(68)39(59-42(33)64)23-31-25-52-26-56-31/h1-4,8-11,14-15,20,24-26,33,35-39,55H,5-7,12-13,16-19,21-23,48H2,(H2,49,63)(H,52,56)(H,53,62)(H,57,67)(H,58,66)(H,59,64)(H,60,68)(H,61,65)(H4,50,51,54)/t33-,35-,36-,37-,38+,39-/m0/s1",0.2,12.0,10.0,Melanocortin receptor 3,MC3R,Homo sapiens (Human),MNASCCLPSVQPTLPNGSEHLQAPFFSNQSSSAFCEQVFIKPEVFLSLGIVSLLENILVILAVVRNGNLHSPMYFFLCSLAVADMLVSVSNALETIMIAIVHSDYLTFEDQFIQHMDNIFDSMICISLVASICNLLAIAVDRYVTIFYALRYHSIMTVRKALTLIVAIWVCCGVCGVVFIVYSESKMVIVCLITMFFAMMLLMGTLYVHMFLFARLHVKRIAALPPADGVAPQQHSCMKGAVTITILLGVFIFCWAPFFLHLVLIITCPTNPYCICYTAHFNTYLVLIMCNSVIDPLIYAFRSLELRNTFREILCGCNGMNLG
841547,P43116,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,12.5 - 19.9,nM,IUPHAR,341,1916,"16604093,10634944",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP2 subtype,PTGER2,Homo sapiens (Human),MGNASNDSQSEDCETRQWLPPGESPAISSVMFSAGVLGNLIALALLARRWRGDVGCSAGRRSSLSLFHVLVTELVFTDLLGTCLISPVVLASYARNQTLVALAPESRACTYFAFAMTFFSLATMLMLFAMALERYLSIGHPYFYQRRVSRSGGLAVLPVIYAVSLLFCSLPLLDYGQYVQYCPGTWCFIRHGRTAYLQLYATLLLLLIVSVLACNFSVILNLIRMHRRSRRSRCGPSLGSGRGGPGARRRGERVSMAEETDHLILLAIMTITFAVCSLPFTIFAYMNETSSRKEKWDLQALRFLSINSIIDPWVFAILRPPVLRLMRSVLCCRISLRTQDATQTSCSTQSDASKQADL
843627,P43115,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,0.8 - 6,nM,IUPHAR,342,1883,"16604093,22480736,18632791",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,PTGER3,Homo sapiens (Human),MKETRGYGGDAPFCTRLNHSYTGMWAPERSAEARGNLTRPPGSGEDCGSVSVAFPITMLLTGFVGNALAMLLVSRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTTPVVIVVYLSKQRWEHIDPSGRLCTFFGLTMTVFGLSSLFIASAMAVERALAIRAPHWYASHMKTRATRAVLLGVWLAVLAFALLPVLGVGQYTVQWPGTWCFISTGRGGNGTSSSHNWGNLFFASAFAFLGLLALTVTFSCNLATIKALVSRCRAKATASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQTSVEHCKTHTEKQKECNFFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRYHTNNYASSSTSLPCQCSSTLMWSDHLER
843633,P43115,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,0.300000011920929 - 7,nM,IUPHAR,342,1916,"16604093,10634944",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,PTGER3,Homo sapiens (Human),MKETRGYGGDAPFCTRLNHSYTGMWAPERSAEARGNLTRPPGSGEDCGSVSVAFPITMLLTGFVGNALAMLLVSRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTTPVVIVVYLSKQRWEHIDPSGRLCTFFGLTMTVFGLSSLFIASAMAVERALAIRAPHWYASHMKTRATRAVLLGVWLAVLAFALLPVLGVGQYTVQWPGTWCFISTGRGGNGTSSSHNWGNLFFASAFAFLGLLALTVTFSCNLATIKALVSRCRAKATASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQTSVEHCKTHTEKQKECNFFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRYHTNNYASSSTSLPCQCSSTLMWSDHLER
843640,P43115,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,2.1,nM,IUPHAR,342,1883,18632791,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,PTGER3,Homo sapiens (Human),MKETRGYGGDAPFCTRLNHSYTGMWAPERSAEARGNLTRPPGSGEDCGSVSVAFPITMLLTGFVGNALAMLLVSRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTTPVVIVVYLSKQRWEHIDPSGRLCTFFGLTMTVFGLSSLFIASAMAVERALAIRAPHWYASHMKTRATRAVLLGVWLAVLAFALLPVLGVGQYTVQWPGTWCFISTGRGGNGTSSSHNWGNLFFASAFAFLGLLALTVTFSCNLATIKALVSRCRAKATASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQTSVEHCKTHTEKQKECNFFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRYHTNNYASSSTSLPCQCSSTLMWSDHLER
848815,P30559,LWXMEDXFGOLDEE-CBTNKBIDSA-N,Kd,1917.7,nM,ChEMBL,CHEMBL2049,CHEMBL2110297,10201826,CHEMBL2110297,70693566.0,C43H66N14O11S2,1019.208,"(4S,7R,10S,13R,16R)-7-(2-amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-N-methyl-6,9,12,15,18-pentaoxospiro[1,2-dithia-5,8,11,14,17-pentazacycloicosane-16,3'-2,4-dihydro-1H-naphthalene]-4-carboxamide",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC2(CCC3=CC=CC=C3C2)C(=O)N1)C(=O)N(C)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,CC[C@H](C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](CSSCCC(=O)N[C@@]2(CCC3=CC=CC=C3C2)C(=O)N1)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,"InChI=1S/C43H66N14O11S2/c1-4-23(2)35-39(66)52-27(11-12-30(44)58)37(64)53-28(18-31(45)59)38(65)54-29(40(67)57(3)21-34(62)51-26(10-7-16-49-42(47)48)36(63)50-20-32(46)60)22-70-69-17-14-33(61)56-43(41(68)55-35)15-13-24-8-5-6-9-25(24)19-43/h5-6,8-9,23,26-29,35H,4,7,10-22H2,1-3H3,(H2,44,58)(H2,45,59)(H2,46,60)(H,50,63)(H,51,62)(H,52,66)(H,53,64)(H,54,65)(H,55,68)(H,56,61)(H4,47,48,49)/t23-,26-,27-,28+,29+,35+,43+/m0/s1",-4.2,12.0,14.0,Oxytocin receptor,OXTR,Homo sapiens (Human),MEGALAANWSAEAANASAAPPGAEGNRTAGPPRRNEALARVEVAVLCLILLLALSGNACVLLALRTTRQKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQVVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLATWLGCLVASAPQVHIFSLREVADGVFDCWAVFIQPWGPKAYITWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAAAEAPEGAAAGDGGRVALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDANAPKEASAFIIVMLLASLNSCCNPWIYMLFTGHLFHELVQRFLCCSASYLKGRRLGETSASKKSNSSSFVLSHRSSSQRSCSQPSTA
849055,P30559,KAIHIKUAZAISIV-ICEWOMRGSA-N,Kd,6,nM,ChEMBL,CHEMBL2049,CHEMBL264208,10201826,CHEMBL264208,44373714.0,C51H68N14O15S,1149.248,"2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-4-amino-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2R)-3-(1H-indol-3-yl)-2-[(7-methoxy-2-oxochromene-4-carbonyl)amino]propanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-sulfanylpropanoyl]-methylamino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetic acid",CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)N(C)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C3=CC(=O)OC4=C3C=CC(=C4)OC,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)C3=CC(=O)OC4=C3C=CC(=C4)OC,"InChI=1S/C51H68N14O15S/c1-5-25(2)43(64-48(76)34(17-26-21-57-31-10-7-6-9-28(26)31)61-44(72)30-19-42(71)80-37-18-27(79-4)12-13-29(30)37)49(77)60-33(14-15-38(52)66)46(74)62-35(20-39(53)67)47(75)63-36(24-81)50(78)65(3)23-40(68)59-32(11-8-16-56-51(54)55)45(73)58-22-41(69)70/h6-7,9-10,12-13,18-19,21,25,32-36,43,57,81H,5,8,11,14-17,20,22-24H2,1-4H3,(H2,52,66)(H2,53,67)(H,58,73)(H,59,68)(H,60,77)(H,61,72)(H,62,74)(H,63,75)(H,64,76)(H,69,70)(H4,54,55,56)/t25-,32-,33-,34+,35-,36-,43-/m0/s1",-2.4,14.0,17.0,Oxytocin receptor,OXTR,Homo sapiens (Human),MEGALAANWSAEAANASAAPPGAEGNRTAGPPRRNEALARVEVAVLCLILLLALSGNACVLLALRTTRQKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQVVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLATWLGCLVASAPQVHIFSLREVADGVFDCWAVFIQPWGPKAYITWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAAAEAPEGAAAGDGGRVALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDANAPKEASAFIIVMLLASLNSCCNPWIYMLFTGHLFHELVQRFLCCSASYLKGRRLGETSASKKSNSSSFVLSHRSSSQRSCSQPSTA
851621,P41597,OOGWCCRYNCAIBK-QGZVFWFLSA-N,Kd,3.467,nM,ChEMBL,CHEMBL4015,CHEMBL2036782,22608963,CHEMBL2036782,57656833.0,C19H27Cl2N5O2,428.358,"N-(3,4-dichlorophenyl)-4-[(2R)-4-propan-2-ylpiperazine-2-carbonyl]piperazine-1-carboxamide",CC(C)N1CCNC(C1)C(=O)N2CCN(CC2)C(=O)NC3=CC(=C(C=C3)Cl)Cl,CC(C)N1CCN[C@H](C1)C(=O)N2CCN(CC2)C(=O)NC3=CC(=C(C=C3)Cl)Cl,"InChI=1S/C19H27Cl2N5O2/c1-13(2)26-6-5-22-17(12-26)18(27)24-7-9-25(10-8-24)19(28)23-14-3-4-15(20)16(21)11-14/h3-4,11,13,17,22H,5-10,12H2,1-2H3,(H,23,28)/t17-/m1/s1",1.9,2.0,4.0,C-C chemokine receptor type 2,CCR2,Homo sapiens (Human),MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA
857880,Q9Y5Y4,GFPPXZDRVCSVNR-UHFFFAOYSA-N,Kd,1.01999998092651,nM,IUPHAR,339,8995,26916831,Fevipiprant,23582412.0,C19H17F3N2O4S,426.41,"2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid",CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,"InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)",2.8,1.0,8.0,Prostaglandin D2 receptor 2,PTGDR2,Homo sapiens (Human),MSANATLKPLCPILEQMSRLQSHSNTSIRYIDHAAVLLHGLASLLGLVENGVILFVVGCRMRQTVVTTWVLHLALSDLLASASLPFFTYFLAVGHSWELGTTFCKLHSSIFFLNMFASGFLLSAISLDRCLQVVRPVWAQNHRTVAAAHKVCLVLWALAVLNTVPYFVFRDTISRLDGRIMCYYNVLLLNPGPDRDATCNSRQVALAVSKFLLAFLVPLAIIASSHAAVSLRLQHRGRRRPGRFVRLVAAVVAAFALCWGPYHVFSLLEARAHANPGLRPLVWRGLPFVTSLAFFNSVANPVLYVLTCPDMLRKLRRSLRTVLESVLVDDSELGGAGSSRRRRTSSTARSASPLALCSRPEEPRGPARLLGWLLGSCAASPQTGPLNRALSSTSS
863239,P07550,JWZZKOKVBUJMES-UHFFFAOYSA-N,Kd,251.19,nM,ChEMBL,CHEMBL210,CHEMBL434,23954364,isoproterenol,3779.0,C11H17NO3,211.261,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol",CC(C)NCC(C1=CC(=C(C=C1)O)O)O,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",-0.6,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
863267,P07550,JWZZKOKVBUJMES-UHFFFAOYSA-N,Kd,50,nM,ChEMBL,CHEMBL210,CHEMBL434,19168263,isoproterenol,3779.0,C11H17NO3,211.261,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol",CC(C)NCC(C1=CC(=C(C=C1)O)O)O,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",-0.6,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
863677,P07550,LSLYOANBFKQKPT-DIFFPNOSSA-N,Kd,347,nM,ChEMBL,CHEMBL210,CHEMBL388570,None,UNII-5Z64M7W0JM,688468.0,C17H21NO4,303.358,"5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol",CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,C[C@H](CC1=CC=C(C=C1)O)NC[C@@H](C2=CC(=CC(=C2)O)O)O,"InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3/t11-,17+/m1/s1",2.0,5.0,5.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
865909,P07550,BWRYWVZCQTUAKZ-UHFFFAOYSA-N,Kd,1584.89,nM,ChEMBL,CHEMBL210,CHEMBL2348214,23614528,CHEMBL2348214,56599099.0,C26H37N3O5,471.598,1-[2-[[3-[4-(2-cyclopentyloxyethoxy)phenoxy]-2-hydroxypropyl]amino]ethyl]-3-(4-methylphenyl)urea,CC1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=C(C=C2)OCCOC3CCCC3)O,CC1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=C(C=C2)OCCOC3CCCC3)O,"InChI=1S/C26H37N3O5/c1-20-6-8-21(9-7-20)29-26(31)28-15-14-27-18-22(30)19-34-25-12-10-24(11-13-25)33-17-16-32-23-4-2-3-5-23/h6-13,22-23,27,30H,2-5,14-19H2,1H3,(H2,28,29,31)",3.0,4.0,6.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
866827,P07550,LMOINURANNBYCM-UHFFFAOYSA-N,Kd,501.19,nM,ChEMBL,CHEMBL210,CHEMBL776,23954364,metaproterenol,4086.0,C11H17NO3,211.261,"5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol",CC(C)NCC(C1=CC(=CC(=C1)O)O)O,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",0.7,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
866830,P07550,LMOINURANNBYCM-UHFFFAOYSA-N,Kd,4810,nM,IUPHAR,29,7250,19168263,metaproterenol,4086.0,C11H17NO3,211.261,"5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol",CC(C)NCC(C1=CC(=CC(=C1)O)O)O,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",0.7,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
866832,P07550,LMOINURANNBYCM-UHFFFAOYSA-N,Kd,4810,nM,ChEMBL,CHEMBL210,CHEMBL776,19168263,metaproterenol,4086.0,C11H17NO3,211.261,"5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol",CC(C)NCC(C1=CC(=CC(=C1)O)O)O,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",0.7,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
868764,P07550,LSLYOANBFKQKPT-GTNSWQLSSA-N,Kd,3715,nM,ChEMBL,CHEMBL210,CHEMBL229476,None,"(R,S)-(-)-fenoterol",688467.0,C17H21NO4,303.358,"5-[(1R)-1-hydroxy-2-[[(2S)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol",CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,C[C@@H](CC1=CC=C(C=C1)O)NC[C@@H](C2=CC(=CC(=C2)O)O)O,"InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3/t11-,17-/m0/s1",2.0,5.0,5.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
869676,P07550,FEYMRICSONQYOT-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL210,CHEMBL2426777,23954364,N-Cyclopentylbutanephrine,26227.0,C15H23NO3,265.353,"4-[2-(cyclopentylamino)-1-hydroxybutyl]benzene-1,2-diol",CCC(C(C1=CC(=C(C=C1)O)O)O)NC2CCCC2,CCC(C(C1=CC(=C(C=C1)O)O)O)NC2CCCC2,"InChI=1S/C15H23NO3/c1-2-12(16-11-5-3-4-6-11)15(19)10-7-8-13(17)14(18)9-10/h7-9,11-12,15-19H,2-6H2,1H3",2.2,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Homo sapiens (Human),MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL
882077,P0DMS8,KOCIMZNSNPOGOP-IWCJZZDYSA-N,Kd,1,nM,IUPHAR,21,5736,17126322,HEMADO,10981286.0,C17H23N5O4,361.402,"(2R,3R,4S,5R)-2-[2-hex-1-ynyl-6-(methylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",CCCCC#CC1=NC2=C(C(=N1)NC)N=CN2C3C(C(C(O3)CO)O)O,CCCCC#CC1=NC2=C(C(=N1)NC)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,"InChI=1S/C17H23N5O4/c1-3-4-5-6-7-11-20-15(18-2)12-16(21-11)22(9-19-12)17-14(25)13(24)10(8-23)26-17/h9-10,13-14,17,23-25H,3-5,8H2,1-2H3,(H,18,20,21)/t10-,13-,14-,17-/m1/s1",1.9,4.0,8.0,Adenosine receptor A3,ADORA3,Homo sapiens (Human),MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVRYKRVTTHRRIWLALGLCWLVSFLVGLTPMFGWNMKLTSEYHRNVTFLSCQFVSVMRMDYMVYFSFLTWIFIPLVVMCAIYLDIFYIIRNKLSLNLSNSKETGAFYGREFKTAKSLFLVLFLFALSWLPLSIINCIIYFNGEVPQLVLYMGILLSHANSMMNPIVYAYKIKKFKETYLLILKACVVCHPSDSLDTSIEKNSE
889399,P0DMS8,UKMBHSMWAQUBRZ-LSCFUAHRSA-N,Kd,0.1585,nM,ChEMBL,CHEMBL256,CHEMBL2181968,22468757,CHEMBL2181968,11611903.0,C19H20F3N5O4,439.395,"(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[2-(2-phenylethylamino)-6-(trifluoromethyl)purin-9-yl]oxolane-3,4-diol",C1=CC=C(C=C1)CCNC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)C(F)(F)F,C1=CC=C(C=C1)CCNC2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)C(F)(F)F,"InChI=1S/C19H20F3N5O4/c20-19(21,22)15-12-16(26-18(25-15)23-7-6-10-4-2-1-3-5-10)27(9-24-12)17-14(30)13(29)11(8-28)31-17/h1-5,9,11,13-14,17,28-30H,6-8H2,(H,23,25,26)/t11-,13-,14-,17-/m1/s1",1.6,4.0,11.0,Adenosine receptor A3,ADORA3,Homo sapiens (Human),MPNNSTALSLANVTYITMEIFIGLCAIVGNVLVICVVKLNPSLQTTTFYFIVSLALADIAVGVLVMPLAIVVSLGITIHFYSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVKLTVRYKRVTTHRRIWLALGLCWLVSFLVGLTPMFGWNMKLTSEYHRNVTFLSCQFVSVMRMDYMVYFSFLTWIFIPLVVMCAIYLDIFYIIRNKLSLNLSNSKETGAFYGREFKTAKSLFLVLFLFALSWLPLSIINCIIYFNGEVPQLVLYMGILLSHANSMMNPIVYAYKIKKFKETYLLILKACVVCHPSDSLDTSIEKNSE
893330,P30542,XXOVWLRNSMIVHV-UHFFFAOYSA-N,Kd,7.943,nM,ChEMBL,CHEMBL226,CHEMBL461432,18771255,CHEMBL461432,25099163.0,C15H12ClN3O3S,349.789,"ethyl 5-amino-3-(3-chlorophenyl)-4-oxothieno[3,4-d]pyridazine-1-carboxylate",CCOC(=O)C1=NN(C(=O)C2=C(SC=C21)N)C3=CC(=CC=C3)Cl,CCOC(=O)C1=NN(C(=O)C2=C(SC=C21)N)C3=CC(=CC=C3)Cl,"InChI=1S/C15H12ClN3O3S/c1-2-22-15(21)12-10-7-23-13(17)11(10)14(20)19(18-12)9-5-3-4-8(16)6-9/h3-7H,2,17H2,1H3",3.6,1.0,6.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
893333,P30542,XXOVWLRNSMIVHV-UHFFFAOYSA-N,Kd,1.995,nM,ChEMBL,CHEMBL226,CHEMBL461432,18771255,CHEMBL461432,25099163.0,C15H12ClN3O3S,349.789,"ethyl 5-amino-3-(3-chlorophenyl)-4-oxothieno[3,4-d]pyridazine-1-carboxylate",CCOC(=O)C1=NN(C(=O)C2=C(SC=C21)N)C3=CC(=CC=C3)Cl,CCOC(=O)C1=NN(C(=O)C2=C(SC=C21)N)C3=CC(=CC=C3)Cl,"InChI=1S/C15H12ClN3O3S/c1-2-22-15(21)12-10-7-23-13(17)11(10)14(20)19(18-12)9-5-3-4-8(16)6-9/h3-7H,2,17H2,1H3",3.6,1.0,6.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
896272,P30542,IOXKZTKWCOVDBE-UHFFFAOYSA-N,Kd,0.46,nM,ChEMBL,CHEMBL226,CHEMBL3330574,25181013,CHEMBL3330574,101882375.0,C24H22ClNOS,407.956,"[2-amino-4-(2,2-dimethylpropyl)-5-(2-phenylethynyl)thiophen-3-yl]-(4-chlorophenyl)methanone",CC(C)(C)CC1=C(SC(=C1C(=O)C2=CC=C(C=C2)Cl)N)C#CC3=CC=CC=C3,CC(C)(C)CC1=C(SC(=C1C(=O)C2=CC=C(C=C2)Cl)N)C#CC3=CC=CC=C3,"InChI=1S/C24H22ClNOS/c1-24(2,3)15-19-20(14-9-16-7-5-4-6-8-16)28-23(26)21(19)22(27)17-10-12-18(25)13-11-17/h4-8,10-13H,15,26H2,1-3H3",7.8,1.0,3.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
896813,P30542,IBCSETAMVUUPMW-PVURQLNPSA-N,Kd,>100000,nM,ChEMBL,CHEMBL226,CHEMBL3423408,25969169,CHEMBL3423408,118736410.0,C42H57FN8O5,772.967,"(3S,12bR)-N-[6-[[(2S)-1-[[(2S)-1-[(2S,4S)-4-amino-2-carbamoylpyrrolidin-1-yl]-3-(4-fluorophenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-6-oxohexyl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)N2CC(CC2C(=O)N)N)NC(=O)CCCCCNC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)F)C(=O)N2C[C@H](C[C@H]2C(=O)N)N)NC(=O)CCCCCNC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C42H57FN8O5/c1-2-3-10-33(41(55)49-34(22-26-13-16-28(43)17-14-26)42(56)51-25-29(44)23-36(51)39(45)53)47-37(52)12-5-4-8-20-46-40(54)27-15-18-35-38-31(19-21-50(35)24-27)30-9-6-7-11-32(30)48-38/h6-7,9,11,13-14,16-17,27,29,33-36,48H,2-5,8,10,12,15,18-25,44H2,1H3,(H2,45,53)(H,46,54)(H,47,52)(H,49,55)/t27-,29-,33-,34-,35+,36-/m0/s1",3.1,6.0,8.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
901583,P30542,PNTFMBLZDHRWEH-UHFFFAOYSA-N,Kd,1.1,nM,ChEMBL,CHEMBL226,CHEMBL461213,18729349,CHEMBL461213,25068880.0,C22H28ClN3OS,417.996,[2-amino-4-[(4-cyclohexylpiperazin-1-yl)methyl]thiophen-3-yl]-(4-chlorophenyl)methanone,C1CCC(CC1)N2CCN(CC2)CC3=CSC(=C3C(=O)C4=CC=C(C=C4)Cl)N,C1CCC(CC1)N2CCN(CC2)CC3=CSC(=C3C(=O)C4=CC=C(C=C4)Cl)N,"InChI=1S/C22H28ClN3OS/c23-18-8-6-16(7-9-18)21(27)20-17(15-28-22(20)24)14-25-10-12-26(13-11-25)19-4-2-1-3-5-19/h6-9,15,19H,1-5,10-14,24H2",5.2,1.0,5.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
901584,P30542,PNTFMBLZDHRWEH-UHFFFAOYSA-N,Kd,1.9,nM,ChEMBL,CHEMBL226,CHEMBL461213,18729349,CHEMBL461213,25068880.0,C22H28ClN3OS,417.996,[2-amino-4-[(4-cyclohexylpiperazin-1-yl)methyl]thiophen-3-yl]-(4-chlorophenyl)methanone,C1CCC(CC1)N2CCN(CC2)CC3=CSC(=C3C(=O)C4=CC=C(C=C4)Cl)N,C1CCC(CC1)N2CCN(CC2)CC3=CSC(=C3C(=O)C4=CC=C(C=C4)Cl)N,"InChI=1S/C22H28ClN3OS/c23-18-8-6-16(7-9-18)21(27)20-17(15-28-22(20)24)14-25-10-12-26(13-11-25)19-4-2-1-3-5-19/h6-9,15,19H,1-5,10-14,24H2",5.2,1.0,5.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
901868,P30542,AYDQZOJLBAJBEG-XYIJYTLJSA-N,Kd,10715.19,nM,ChEMBL,CHEMBL226,CHEMBL2413110,23200243,CHEMBL2413110,45258970.0,C35H50N8O6S,710.895,"(2S,3S,4R,5R)-5-[6-[11-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]undecylamino]purin-9-yl]-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide",CCNC(=O)C1C(C(C(O1)N2C=NC3=C2N=CN=C3NCCCCCCCCCCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)O)O,CCNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2N=CN=C3NCCCCCCCCCCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)O)O,"InChI=1S/C35H50N8O6S/c1-4-36-34(46)31-29(44)30(45)35(49-31)43-23-40-28-32(38-22-39-33(28)43)37-20-12-10-8-6-5-7-9-11-13-21-41-50(47,48)27-19-15-16-24-25(27)17-14-18-26(24)42(2)3/h14-19,22-23,29-31,35,41,44-45H,4-13,20-21H2,1-3H3,(H,36,46)(H,37,38,39)/t29-,30+,31-,35+/m0/s1",5.3,5.0,12.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
903691,P30542,BUSZPEZABSAFAL-YWNCIPKLSA-N,Kd,>100000,nM,ChEMBL,CHEMBL226,CHEMBL3423406,25969169,CHEMBL3423406,118736408.0,C39H52N8O4,696.897,"(3S,12bR)-N-[(2S)-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine-3-carboxamide",CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)N)NC(=O)C3CCC4C5=C(CCN4C3)C6=CC=CC=C6N5,CCCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)N)NC(=O)[C@H]3CC[C@@H]4C5=C(CCN4C3)C6=CC=CC=C6N5,"InChI=1S/C39H52N8O4/c1-2-3-12-32(45-37(49)24-16-17-34-35-28(18-20-47(34)23-24)27-11-5-7-14-30(27)43-35)38(50)46-33(21-25-22-42-29-13-6-4-10-26(25)29)39(51)44-31(36(41)48)15-8-9-19-40/h4-7,10-11,13-14,22,24,31-34,42-43H,2-3,8-9,12,15-21,23,40H2,1H3,(H2,41,48)(H,44,51)(H,45,49)(H,46,50)/t24-,31-,32-,33-,34+/m0/s1",3.5,7.0,6.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
905725,P30542,MCWZNVZBGFAJDJ-UHFFFAOYSA-N,Kd,123.03,nM,ChEMBL,CHEMBL226,CHEMBL2413246,23200243,CHEMBL2413246,45257564.0,C41H54N8O7S,802.992,"8-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]-N-[2-[[2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetyl]amino]ethyl]octanamide",CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCNC(=O)CCCCCCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCNC(=O)CCCCCCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C,"InChI=1S/C41H54N8O7S/c1-5-26-48-39-37(40(52)49(27-6-2)41(48)53)45-38(46-39)29-19-21-30(22-20-29)56-28-36(51)43-25-24-42-35(50)18-10-8-7-9-11-23-44-57(54,55)34-17-13-14-31-32(34)15-12-16-33(31)47(3)4/h12-17,19-22,44H,5-11,18,23-28H2,1-4H3,(H,42,50)(H,43,51)(H,45,46)",7.1,4.0,10.0,Adenosine receptor A1,ADORA1,Homo sapiens (Human),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD
917301,P70536,XNFZULVFMCTJAC-YKVWRKJBSA-N,Kd,23.44,nM,ChEMBL,CHEMBL3996,CHEMBL3349469,7752199,CHEMBL3349469,10396464.0,C54H79N11O13S2,1154.41,"(2S)-N-[(2S)-5-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-1-[(10R,13S,16S,19S,22S)-13-(2-amino-2-oxoethyl)-19-[(2S)-butan-2-yl]-16-[(1R)-1-hydroxyethyl]-22-[(4-methoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidine-2-carboxamide",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)N1)CC3=CC=C(C=C3)OC)C(=O)N4CCCC4C(=O)NC(CCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N)C(C)O,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC2(CCCCC2)CC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OC)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N)[C@@H](C)O,"InChI=1S/C54H79N11O13S2/c1-5-30(2)44-51(75)64-45(31(3)66)52(76)61-39(27-42(56)68)48(72)62-40(29-79-80-54(21-7-6-8-22-54)28-43(69)58-38(49(73)63-44)26-33-15-19-35(78-4)20-16-33)53(77)65-24-10-12-41(65)50(74)59-36(11-9-23-55)47(71)60-37(46(57)70)25-32-13-17-34(67)18-14-32/h13-20,30-31,36-41,44-45,66-67H,5-12,21-29,55H2,1-4H3,(H2,56,68)(H2,57,70)(H,58,69)(H,59,74)(H,60,71)(H,61,76)(H,62,72)(H,63,73)(H,64,75)/t30-,31+,36-,37-,38-,39-,40-,41-,44-,45-/m0/s1",1.0,12.0,16.0,Oxytocin receptor,Oxtr,Rattus norvegicus (Rat),MEGTPAANWSVELDLGSGVPPGEEGNRTAGPPQRNEALARVEVAVLCLILFLALSGNACVLLALRTTRHKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQVVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLGTWLGCLVASAPQVHIFSLREVADGVFDCWAVFIQPWGPKAYVTWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAAAAEGNDAAGGAGRAALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDVNAPKEASAFIIAMLLASLNSCCNPWIYMLFTGHLFHELVQRFFCCSARYLKGSRPGETSVSKKSNSSTFVLSRRSSSQRSCSQPSSA
917302,P70536,XNFZULVFMCTJAC-YKVWRKJBSA-N,Kd,5.248,nM,ChEMBL,CHEMBL3996,CHEMBL3349469,7752199,CHEMBL3349469,10396464.0,C54H79N11O13S2,1154.41,"(2S)-N-[(2S)-5-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-1-[(10R,13S,16S,19S,22S)-13-(2-amino-2-oxoethyl)-19-[(2S)-butan-2-yl]-16-[(1R)-1-hydroxyethyl]-22-[(4-methoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidine-2-carboxamide",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)N1)CC3=CC=C(C=C3)OC)C(=O)N4CCCC4C(=O)NC(CCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N)C(C)O,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC2(CCCCC2)CC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OC)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N)[C@@H](C)O,"InChI=1S/C54H79N11O13S2/c1-5-30(2)44-51(75)64-45(31(3)66)52(76)61-39(27-42(56)68)48(72)62-40(29-79-80-54(21-7-6-8-22-54)28-43(69)58-38(49(73)63-44)26-33-15-19-35(78-4)20-16-33)53(77)65-24-10-12-41(65)50(74)59-36(11-9-23-55)47(71)60-37(46(57)70)25-32-13-17-34(67)18-14-32/h13-20,30-31,36-41,44-45,66-67H,5-12,21-29,55H2,1-4H3,(H2,56,68)(H2,57,70)(H,58,69)(H,59,74)(H,60,71)(H,61,76)(H,62,72)(H,63,73)(H,64,75)/t30-,31+,36-,37-,38-,39-,40-,41-,44-,45-/m0/s1",1.0,12.0,16.0,Oxytocin receptor,Oxtr,Rattus norvegicus (Rat),MEGTPAANWSVELDLGSGVPPGEEGNRTAGPPQRNEALARVEVAVLCLILFLALSGNACVLLALRTTRHKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQVVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLGTWLGCLVASAPQVHIFSLREVADGVFDCWAVFIQPWGPKAYVTWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAAAAEGNDAAGGAGRAALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDVNAPKEASAFIIAMLLASLNSCCNPWIYMLFTGHLFHELVQRFFCCSARYLKGSRPGETSVSKKSNSSTFVLSRRSSSQRSCSQPSSA
917991,P70536,FEYJPDZSGSDJNY-FPIKYVQKSA-N,Kd,1000000000,nM,ChEMBL,CHEMBL3996,CHEMBL274635,7629809,CHEMBL274635,44324575.0,C50H76N14O12S2,1129.364,"(4R)-5-[[(2S)-4-amino-1-[[(2R)-1-[(2R)-2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-[[(2S,3S)-2-[[(2R)-3-(1H-indol-3-yl)-2-[[2-(1-sulfanylcyclohexyl)acetyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoic acid",CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CC4(CCCCC4)S,CC[C@H](C)[C@@H](C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)CC4(CCCCC4)S,"InChI=1S/C50H76N14O12S2/c1-3-27(2)41(63-45(73)33(21-28-24-56-30-12-6-5-11-29(28)30)58-39(67)23-50(78)17-7-4-8-18-50)47(75)60-32(15-16-40(68)69)43(71)61-34(22-37(51)65)44(72)62-35(26-77)48(76)64-20-10-14-36(64)46(74)59-31(13-9-19-55-49(53)54)42(70)57-25-38(52)66/h5-6,11-12,24,27,31-36,41,56,77-78H,3-4,7-10,13-23,25-26H2,1-2H3,(H2,51,65)(H2,52,66)(H,57,70)(H,58,67)(H,59,74)(H,60,75)(H,61,71)(H,62,72)(H,63,73)(H,68,69)(H4,53,54,55)/t27-,31-,32+,33+,34-,35-,36+,41-/m0/s1",-1.4,15.0,15.0,Oxytocin receptor,Oxtr,Rattus norvegicus (Rat),MEGTPAANWSVELDLGSGVPPGEEGNRTAGPPQRNEALARVEVAVLCLILFLALSGNACVLLALRTTRHKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQVVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLGTWLGCLVASAPQVHIFSLREVADGVFDCWAVFIQPWGPKAYVTWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAAAAEGNDAAGGAGRAALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDVNAPKEASAFIIAMLLASLNSCCNPWIYMLFTGHLFHELVQRFFCCSARYLKGSRPGETSVSKKSNSSTFVLSRRSSSQRSCSQPSSA
918216,P70536,VYJJNCPBSHEQPK-YZRZUMJVSA-N,Kd,72.44,nM,ChEMBL,CHEMBL3996,CHEMBL3245755,423185,CHEMBL3245755,90672306.0,C42H72N12O11S2,985.231,"(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-20,20-dimethyl-16-(2-methylpropyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC(C(C(=O)NC(C(=O)N1)CC(C)C)N)(C)C)C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC([C@@H](C(=O)N[C@H](C(=O)N1)CC(C)C)N)(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,"InChI=1S/C42H72N12O11S2/c1-9-22(6)32-39(63)48-23(12-13-29(43)55)35(59)49-26(17-30(44)56)36(60)52-27(19-66-67-42(7,8)33(46)40(64)51-25(16-21(4)5)37(61)53-32)41(65)54-14-10-11-28(54)38(62)50-24(15-20(2)3)34(58)47-18-31(45)57/h20-28,32-33H,9-19,46H2,1-8H3,(H2,43,55)(H2,44,56)(H2,45,57)(H,47,58)(H,48,63)(H,49,59)(H,50,62)(H,51,64)(H,52,60)(H,53,61)/t22-,23-,24-,25-,26-,27-,28-,32-,33+/m0/s1",-1.9,11.0,14.0,Oxytocin receptor,Oxtr,Rattus norvegicus (Rat),MEGTPAANWSVELDLGSGVPPGEEGNRTAGPPQRNEALARVEVAVLCLILFLALSGNACVLLALRTTRHKHSRLFFFMKHLSIADLVVAVFQVLPQLLWDITFRFYGPDLLCRLVKYLQVVGMFASTYLLLLMSLDRCLAICQPLRSLRRRTDRLAVLGTWLGCLVASAPQVHIFSLREVADGVFDCWAVFIQPWGPKAYVTWITLAVYIVPVIVLAACYGLISFKIWQNLRLKTAAAAAAAEGNDAAGGAGRAALARVSSVKLISKAKIRTVKMTFIIVLAFIVCWTPFFFVQMWSVWDVNAPKEASAFIIAMLLASLNSCCNPWIYMLFTGHLFHELVQRFFCCSARYLKGSRPGETSVSKKSNSSTFVLSRRSSSQRSCSQPSSA
919603,Q00788,LWXMEDXFGOLDEE-CBTNKBIDSA-N,Kd,5340,nM,ChEMBL,CHEMBL3766,CHEMBL2110297,10201826,CHEMBL2110297,70693566.0,C43H66N14O11S2,1019.208,"(4S,7R,10S,13R,16R)-7-(2-amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-N-methyl-6,9,12,15,18-pentaoxospiro[1,2-dithia-5,8,11,14,17-pentazacycloicosane-16,3'-2,4-dihydro-1H-naphthalene]-4-carboxamide",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC2(CCC3=CC=CC=C3C2)C(=O)N1)C(=O)N(C)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,CC[C@H](C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](CSSCCC(=O)N[C@@]2(CCC3=CC=CC=C3C2)C(=O)N1)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,"InChI=1S/C43H66N14O11S2/c1-4-23(2)35-39(66)52-27(11-12-30(44)58)37(64)53-28(18-31(45)59)38(65)54-29(40(67)57(3)21-34(62)51-26(10-7-16-49-42(47)48)36(63)50-20-32(46)60)22-70-69-17-14-33(61)56-43(41(68)55-35)15-13-24-8-5-6-9-25(24)19-43/h5-6,8-9,23,26-29,35H,4,7,10-22H2,1-3H3,(H2,44,58)(H2,45,59)(H2,46,60)(H,50,63)(H,51,62)(H,52,66)(H,53,64)(H,54,65)(H,55,68)(H,56,61)(H4,47,48,49)/t23-,26-,27-,28+,29+,35+,43+/m0/s1",-4.2,12.0,14.0,Vasopressin V2 receptor,Avpr2,Rattus norvegicus (Rat),MLLVSTVSAVPGLFSPPSSPSNSSQEELLDDRDPLLVRAELALLSTIFVAVALSNGLVLGALIRRGRRGRWAPMHVFISHLCLADLAVALFQVLPQLAWDATDRFHGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGGGARWNRPVLVAWAFSLLLSLPQLFIFAQRDVGNGSGVFDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLVPGPSERAGRRRRGRRTGSPSEGAHVSAAMAKTVRMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPLERPPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCAQRHTTHSLGPQDESCATASSSLMKDTPS
919682,Q00788,BKUWCDXZBLWXOP-AECBHFLPSA-N,Kd,100,nM,ChEMBL,CHEMBL3766,CHEMBL2373423,2231609,CHEMBL2373423,44335261.0,C53H75N13O10,1054.264,(2S)-N-[(2S)-6-amino-1-[(2R)-2-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]-2-[[(2S)-2-[[(2S)-2-[[(2R)-3-(4-methoxyphenyl)-2-[(2-phenylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]butanediamide,CC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=C(C=C3)OC)NC(=O)CC4=CC=CC=C4,CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC3=CC=C(C=C3)OC)NC(=O)CC4=CC=CC=C4,"InChI=1S/C53H75N13O10/c1-32(2)45(65-49(72)40(28-33-14-6-4-7-15-33)63-47(70)39(29-35-21-23-36(76-3)24-22-35)60-44(68)30-34-16-8-5-9-17-34)51(74)64-41(31-43(55)67)48(71)62-38(18-10-11-25-54)52(75)66-27-13-20-42(66)50(73)61-37(46(56)69)19-12-26-59-53(57)58/h4-9,14-17,21-24,32,37-42,45H,10-13,18-20,25-31,54H2,1-3H3,(H2,55,67)(H2,56,69)(H,60,68)(H,61,73)(H,62,71)(H,63,70)(H,64,74)(H,65,72)(H4,57,58,59)/t37-,38-,39+,40-,41-,42+,45-/m0/s1",0.4,11.0,12.0,Vasopressin V2 receptor,Avpr2,Rattus norvegicus (Rat),MLLVSTVSAVPGLFSPPSSPSNSSQEELLDDRDPLLVRAELALLSTIFVAVALSNGLVLGALIRRGRRGRWAPMHVFISHLCLADLAVALFQVLPQLAWDATDRFHGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGGGARWNRPVLVAWAFSLLLSLPQLFIFAQRDVGNGSGVFDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLVPGPSERAGRRRRGRRTGSPSEGAHVSAAMAKTVRMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPLERPPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCAQRHTTHSLGPQDESCATASSSLMKDTPS
919782,Q00788,KAIHIKUAZAISIV-ICEWOMRGSA-N,Kd,3,nM,ChEMBL,CHEMBL3766,CHEMBL264208,10201826,CHEMBL264208,44373714.0,C51H68N14O15S,1149.248,"2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-4-amino-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2R)-3-(1H-indol-3-yl)-2-[(7-methoxy-2-oxochromene-4-carbonyl)amino]propanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-sulfanylpropanoyl]-methylamino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetic acid",CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)N(C)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C3=CC(=O)OC4=C3C=CC(=C4)OC,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)C3=CC(=O)OC4=C3C=CC(=C4)OC,"InChI=1S/C51H68N14O15S/c1-5-25(2)43(64-48(76)34(17-26-21-57-31-10-7-6-9-28(26)31)61-44(72)30-19-42(71)80-37-18-27(79-4)12-13-29(30)37)49(77)60-33(14-15-38(52)66)46(74)62-35(20-39(53)67)47(75)63-36(24-81)50(78)65(3)23-40(68)59-32(11-8-16-56-51(54)55)45(73)58-22-41(69)70/h6-7,9-10,12-13,18-19,21,25,32-36,43,57,81H,5,8,11,14-17,20,22-24H2,1-4H3,(H2,52,66)(H2,53,67)(H,58,73)(H,59,68)(H,60,77)(H,61,72)(H,62,74)(H,63,75)(H,64,76)(H,69,70)(H4,54,55,56)/t25-,32-,33-,34+,35-,36-,43-/m0/s1",-2.4,14.0,17.0,Vasopressin V2 receptor,Avpr2,Rattus norvegicus (Rat),MLLVSTVSAVPGLFSPPSSPSNSSQEELLDDRDPLLVRAELALLSTIFVAVALSNGLVLGALIRRGRRGRWAPMHVFISHLCLADLAVALFQVLPQLAWDATDRFHGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGGGARWNRPVLVAWAFSLLLSLPQLFIFAQRDVGNGSGVFDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLVPGPSERAGRRRRGRRTGSPSEGAHVSAAMAKTVRMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPLERPPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCAQRHTTHSLGPQDESCATASSSLMKDTPS
919867,Q00788,FALCSTYLQGBSFB-KMRGNHMASA-N,Kd,43.65,nM,ChEMBL,CHEMBL3766,CHEMBL2373516,2231609,CHEMBL2373516,44335051.0,C54H77N13O10,1068.291,(2S)-N-[(2S)-6-amino-1-[(2R)-2-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]-2-[[(2S)-2-[[(2S)-2-[[(2R)-3-(4-ethoxyphenyl)-2-[(2-phenylacetyl)amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]butanediamide,CCOC1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)CC4=CC=CC=C4,CCOC1=CC=C(C=C1)C[C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)N)NC(=O)CC4=CC=CC=C4,"InChI=1S/C54H77N13O10/c1-4-77-37-24-22-36(23-25-37)30-40(61-45(69)31-35-17-9-6-10-18-35)48(71)64-41(29-34-15-7-5-8-16-34)50(73)66-46(33(2)3)52(75)65-42(32-44(56)68)49(72)63-39(19-11-12-26-55)53(76)67-28-14-21-43(67)51(74)62-38(47(57)70)20-13-27-60-54(58)59/h5-10,15-18,22-25,33,38-43,46H,4,11-14,19-21,26-32,55H2,1-3H3,(H2,56,68)(H2,57,70)(H,61,69)(H,62,74)(H,63,72)(H,64,71)(H,65,75)(H,66,73)(H4,58,59,60)/t38-,39-,40+,41-,42-,43+,46-/m0/s1",0.8,11.0,12.0,Vasopressin V2 receptor,Avpr2,Rattus norvegicus (Rat),MLLVSTVSAVPGLFSPPSSPSNSSQEELLDDRDPLLVRAELALLSTIFVAVALSNGLVLGALIRRGRRGRWAPMHVFISHLCLADLAVALFQVLPQLAWDATDRFHGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGGGARWNRPVLVAWAFSLLLSLPQLFIFAQRDVGNGSGVFDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLVPGPSERAGRRRRGRRTGSPSEGAHVSAAMAKTVRMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPLERPPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCAQRHTTHSLGPQDESCATASSSLMKDTPS
919907,Q00788,FOVGMYFPEVTZEE-UBQWUPTESA-N,Kd,6.3,nM,ChEMBL,CHEMBL3766,CHEMBL438189,1531076,CHEMBL438189,44350544.0,C52H76N14O11S2,1137.387,"(2S)-N-[(2S)-1-(2-aminoethylamino)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(10S,13R,16S,19R,22S)-13-(2-amino-2-oxoethyl)-16-(3-amino-3-oxopropyl)-19-benzyl-22-[(4-hydroxyphenyl)methyl]-23-methyl-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidine-2-carboxamide",CN1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC1=O)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)NCCN)CC(=O)N)CCC(=O)N)CC4=CC=CC=C4)CC5=CC=C(C=C5)O,CN1[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](CSSC2(CCCCC2)CC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCN)CC(=O)N)CCC(=O)N)CC4=CC=CC=C4)CC5=CC=C(C=C5)O,"InChI=1S/C52H76N14O11S2/c1-65-40(27-32-14-16-33(67)17-15-32)49(76)63-36(26-31-10-4-2-5-11-31)46(73)60-35(18-19-41(54)68)45(72)62-37(28-42(55)69)47(74)64-38(30-78-79-52(29-43(65)70)20-6-3-7-21-52)50(77)66-25-9-13-39(66)48(75)61-34(44(71)58-24-22-53)12-8-23-59-51(56)57/h2,4-5,10-11,14-17,34-40,67H,3,6-9,12-13,18-30,53H2,1H3,(H2,54,68)(H2,55,69)(H,58,71)(H,60,73)(H,61,75)(H,62,72)(H,63,76)(H,64,74)(H4,56,57,59)/t34-,35-,36+,37+,38+,39-,40-/m0/s1",-2.1,12.0,15.0,Vasopressin V2 receptor,Avpr2,Rattus norvegicus (Rat),MLLVSTVSAVPGLFSPPSSPSNSSQEELLDDRDPLLVRAELALLSTIFVAVALSNGLVLGALIRRGRRGRWAPMHVFISHLCLADLAVALFQVLPQLAWDATDRFHGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGGGARWNRPVLVAWAFSLLLSLPQLFIFAQRDVGNGSGVFDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLVPGPSERAGRRRRGRRTGSPSEGAHVSAAMAKTVRMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPLERPPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCAQRHTTHSLGPQDESCATASSSLMKDTPS
919986,P30560,XNFZULVFMCTJAC-YKVWRKJBSA-N,Kd,95.5,nM,ChEMBL,CHEMBL2868,CHEMBL3349469,7752199,CHEMBL3349469,10396464.0,C54H79N11O13S2,1154.41,"(2S)-N-[(2S)-5-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]-1-[(10R,13S,16S,19S,22S)-13-(2-amino-2-oxoethyl)-19-[(2S)-butan-2-yl]-16-[(1R)-1-hydroxyethyl]-22-[(4-methoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidine-2-carboxamide",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)N1)CC3=CC=C(C=C3)OC)C(=O)N4CCCC4C(=O)NC(CCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N)C(C)O,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC2(CCCCC2)CC(=O)N[C@H](C(=O)N1)CC3=CC=C(C=C3)OC)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N)[C@@H](C)O,"InChI=1S/C54H79N11O13S2/c1-5-30(2)44-51(75)64-45(31(3)66)52(76)61-39(27-42(56)68)48(72)62-40(29-79-80-54(21-7-6-8-22-54)28-43(69)58-38(49(73)63-44)26-33-15-19-35(78-4)20-16-33)53(77)65-24-10-12-41(65)50(74)59-36(11-9-23-55)47(71)60-37(46(57)70)25-32-13-17-34(67)18-14-32/h13-20,30-31,36-41,44-45,66-67H,5-12,21-29,55H2,1-4H3,(H2,56,68)(H2,57,70)(H,58,69)(H,59,74)(H,60,71)(H,61,76)(H,62,72)(H,63,73)(H,64,75)/t30-,31+,36-,37-,38-,39-,40-,41-,44-,45-/m0/s1",1.0,12.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
920394,P30560,JJKDJJIRIJTKGT-HSLJZQCHSA-N,Kd,1.66,nM,ChEMBL,CHEMBL2868,CHEMBL2115368,1732523,CHEMBL2115368,71454576.0,C55H74N12O13S2,1175.388,"(2S)-N-[(2S)-6-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-19,19-dimethyl-16-[(4-nitrophenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,"InChI=1S/C55H74N12O13S2/c1-31(2)45-52(76)62-41(28-44(57)69)49(73)63-42(53(77)66-24-10-14-43(66)51(75)59-37(13-8-9-23-56)47(71)60-38(46(58)70)25-34-17-21-36(68)22-18-34)29-81-82-30-55(3,4)54(78)64-40(27-33-15-19-35(20-16-33)67(79)80)48(72)61-39(50(74)65-45)26-32-11-6-5-7-12-32/h5-7,11-12,15-22,31,37-43,45,68H,8-10,13-14,23-30,56H2,1-4H3,(H2,57,69)(H2,58,70)(H,59,75)(H,60,71)(H,61,72)(H,62,76)(H,63,73)(H,64,78)(H,65,74)/t37-,38-,39-,40-,41-,42-,43-,45-/m0/s1",1.8,11.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
920395,P30560,JJKDJJIRIJTKGT-HSLJZQCHSA-N,Kd,1.63,nM,ChEMBL,CHEMBL2868,CHEMBL2115368,1732523,CHEMBL2115368,71454576.0,C55H74N12O13S2,1175.388,"(2S)-N-[(2S)-6-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-19,19-dimethyl-16-[(4-nitrophenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,"InChI=1S/C55H74N12O13S2/c1-31(2)45-52(76)62-41(28-44(57)69)49(73)63-42(53(77)66-24-10-14-43(66)51(75)59-37(13-8-9-23-56)47(71)60-38(46(58)70)25-34-17-21-36(68)22-18-34)29-81-82-30-55(3,4)54(78)64-40(27-33-15-19-35(20-16-33)67(79)80)48(72)61-39(50(74)65-45)26-32-11-6-5-7-12-32/h5-7,11-12,15-22,31,37-43,45,68H,8-10,13-14,23-30,56H2,1-4H3,(H2,57,69)(H2,58,70)(H,59,75)(H,60,71)(H,61,72)(H,62,76)(H,63,73)(H,64,78)(H,65,74)/t37-,38-,39-,40-,41-,42-,43-,45-/m0/s1",1.8,11.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
920396,P30560,JJKDJJIRIJTKGT-HSLJZQCHSA-N,Kd,1.82,nM,ChEMBL,CHEMBL2868,CHEMBL2115368,1732523,CHEMBL2115368,71454576.0,C55H74N12O13S2,1175.388,"(2S)-N-[(2S)-6-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-19,19-dimethyl-16-[(4-nitrophenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,"InChI=1S/C55H74N12O13S2/c1-31(2)45-52(76)62-41(28-44(57)69)49(73)63-42(53(77)66-24-10-14-43(66)51(75)59-37(13-8-9-23-56)47(71)60-38(46(58)70)25-34-17-21-36(68)22-18-34)29-81-82-30-55(3,4)54(78)64-40(27-33-15-19-35(20-16-33)67(79)80)48(72)61-39(50(74)65-45)26-32-11-6-5-7-12-32/h5-7,11-12,15-22,31,37-43,45,68H,8-10,13-14,23-30,56H2,1-4H3,(H2,57,69)(H2,58,70)(H,59,75)(H,60,71)(H,61,72)(H,62,76)(H,63,73)(H,64,78)(H,65,74)/t37-,38-,39-,40-,41-,42-,43-,45-/m0/s1",1.8,11.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
920398,P30560,JJKDJJIRIJTKGT-HSLJZQCHSA-N,Kd,1.8,nM,ChEMBL,CHEMBL2868,CHEMBL2115368,1732523,CHEMBL2115368,71454576.0,C55H74N12O13S2,1175.388,"(2S)-N-[(2S)-6-amino-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-19,19-dimethyl-16-[(4-nitrophenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCC(C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])(C)C)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,"InChI=1S/C55H74N12O13S2/c1-31(2)45-52(76)62-41(28-44(57)69)49(73)63-42(53(77)66-24-10-14-43(66)51(75)59-37(13-8-9-23-56)47(71)60-38(46(58)70)25-34-17-21-36(68)22-18-34)29-81-82-30-55(3,4)54(78)64-40(27-33-15-19-35(20-16-33)67(79)80)48(72)61-39(50(74)65-45)26-32-11-6-5-7-12-32/h5-7,11-12,15-22,31,37-43,45,68H,8-10,13-14,23-30,56H2,1-4H3,(H2,57,69)(H2,58,70)(H,59,75)(H,60,71)(H,61,72)(H,62,76)(H,63,73)(H,64,78)(H,65,74)/t37-,38-,39-,40-,41-,42-,43-,45-/m0/s1",1.8,11.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
920896,P30560,LMPRIVBNRCUGFQ-VSANGWNWSA-N,Kd,26.92,nM,ChEMBL,CHEMBL2868,CHEMBL2372420,1732523,CHEMBL2372420,73347179.0,C53H70N12O13S2,1147.334,"(2S)-N-[(2S)-6-amino-1-[[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-16-[(4-nitrophenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,"InChI=1S/C53H70N12O13S2/c1-30(2)45-52(75)61-40(28-43(55)67)49(72)62-41(53(76)64-23-8-12-42(64)51(74)58-36(11-6-7-22-54)47(70)59-37(46(56)69)25-33-15-19-35(66)20-16-33)29-80-79-24-21-44(68)57-38(27-32-13-17-34(18-14-32)65(77)78)48(71)60-39(50(73)63-45)26-31-9-4-3-5-10-31/h3-5,9-10,13-20,30,36-42,45,66H,6-8,11-12,21-29,54H2,1-2H3,(H2,55,67)(H2,56,69)(H,57,68)(H,58,74)(H,59,70)(H,60,71)(H,61,75)(H,62,72)(H,63,73)/t36-,37+,38-,39-,40-,41-,42-,45-/m0/s1",0.9,11.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
920898,P30560,LMPRIVBNRCUGFQ-VSANGWNWSA-N,Kd,27,nM,ChEMBL,CHEMBL2868,CHEMBL2372420,1732523,CHEMBL2372420,73347179.0,C53H70N12O13S2,1147.334,"(2S)-N-[(2S)-6-amino-1-[[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-13-benzyl-16-[(4-nitrophenyl)methyl]-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,CC(C)[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC5=CC=C(C=C5)O)C(=O)N)CC(=O)N,"InChI=1S/C53H70N12O13S2/c1-30(2)45-52(75)61-40(28-43(55)67)49(72)62-41(53(76)64-23-8-12-42(64)51(74)58-36(11-6-7-22-54)47(70)59-37(46(56)69)25-33-15-19-35(66)20-16-33)29-80-79-24-21-44(68)57-38(27-32-13-17-34(18-14-32)65(77)78)48(71)60-39(50(73)63-45)26-31-9-4-3-5-10-31/h3-5,9-10,13-20,30,36-42,45,66H,6-8,11-12,21-29,54H2,1-2H3,(H2,55,67)(H2,56,69)(H,57,68)(H,58,74)(H,59,70)(H,60,71)(H,61,75)(H,62,72)(H,63,73)/t36-,37+,38-,39-,40-,41-,42-,45-/m0/s1",0.9,11.0,16.0,Vasopressin V1a receptor,Avpr1a,Rattus norvegicus (Rat),MSFPRGSQDRSVGNSSPWWPLTTEGSNGSQEAARLGEGDSPLGDVRNEELAKLEIAVLAVIFVVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQLCWDITYRFRGPDWLCRVVKHLQVFAMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIATSWVLSFILSTPQYFIFSVIEIEVNNGTKTQDCWATFIQPWGTRAYVTWMTSGVFVAPVVVLGTCYGFICYHIWRNIRGKTASSRHSKGDKGSGEAVGPFHKGLLVTPCVSSVKSISRAKIRTVKMTFVIVSAYILCWAPFFIVQMWSVWDENFIWTDSENPSITITALLASLNSCCNPWIYMFFSGHLLQDCVQSFPCCHSMAQKFAKDDSDSMSRRQTSYSNNRSPTNSTGMWKDSPKSSKSIRFIPVST
921138,P28190,UASGMORFNUPXFD-UHFFFAOYSA-N,Kd,2860,nM,ChEMBL,CHEMBL4975,CHEMBL353115,3351850,CHEMBL353115,14016359.0,C24H22IN7O5,615.388,"2-[4-[1-[2-(4-azido-3-iodophenyl)ethyl]-2,6-dioxo-3-propyl-7H-purin-8-yl]phenoxy]acetic acid",CCCN1C2=C(C(=O)N(C1=O)CCC3=CC(=C(C=C3)N=[N+]=[N-])I)NC(=N2)C4=CC=C(C=C4)OCC(=O)O,CCCN1C2=C(C(=O)N(C1=O)CCC3=CC(=C(C=C3)N=[N+]=[N-])I)NC(=N2)C4=CC=C(C=C4)OCC(=O)O,"InChI=1S/C24H22IN7O5/c1-2-10-31-22-20(27-21(28-22)15-4-6-16(7-5-15)37-13-19(33)34)23(35)32(24(31)36)11-9-14-3-8-18(29-30-26)17(25)12-14/h3-8,12H,2,9-11,13H2,1H3,(H,27,28)(H,33,34)",6.5,2.0,8.0,Adenosine receptor A1,ADORA1,Bos taurus (Bovine),MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPRTYFHTCLKVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKTVVTPRRAVVAITGCWILSFVVGLTPMFGWNNLSAVERDWLANGSVGEPVIECQFEKVISMEYMVYFNFFVWVLPPLLLMVLIYMEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHMPRILIYIAIFLSHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPVDEDAPAERPDD
927221,Q13304,KNBSYZNKEAWABY-WQUPFYEISA-N,Kd,1256,nM,ChEMBL,CHEMBL1075162,CHEMBL3264006,24900835,CHEMBL3264006,90677009.0,C12H9Cl2NO4,310.139,"3-(2-carboxy-1,1,2,2-tetratritioethyl)-4,6-dichloro-1H-indole-2-carboxylic acid",C1=C(C=C2C(=C1Cl)C(=C(N2)C(=O)O)CCC(=O)O)Cl,[3H]C([3H])(C1=C(NC2=CC(=CC(=C21)Cl)Cl)C(=O)O)C([3H])([3H])C(=O)O,"InChI=1S/C12H9Cl2NO4/c13-5-3-7(14)10-6(1-2-9(16)17)11(12(18)19)15-8(10)4-5/h3-4,15H,1-2H2,(H,16,17)(H,18,19)/i1T2,2T2",2.9,3.0,4.0,Uracil nucleotide/cysteinyl leukotriene receptor,GPR17,Homo sapiens (Human),MSKRSWWAGSRKPPREMLKLSGSDSSQSMNGLEVAPPGLITNFSLATAEQCGQETPLENMLFASFYLLDFILALVGNTLALWLFIRDHKSGTPANVFLMHLAVADLSCVLVLPTRLVYHFSGNHWPFGEIACRLTGFLFYLNMYASIYFLTCISADRFLAIVHPVKSLKLRRPLYAHLACAFLWVVVAVAMAPLLVSPQTVQTNHTVVCLQLYREKASHHALVSLAVAFTFPFITTVTCYLLIIRSLRQGLRVEKRLKTKAVRMIAIVLAIFLVCFVPYHVNRSVYVLHYRSHGASCATQRILALANRITSCLTSLNGALDPIMYFFVAEKFRHALCNLLCGKRLKGPPPSFEGKTNESSLSAKSEL
928420,P08588,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,223.87,nM,ChEMBL,CHEMBL213,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Beta-1 adrenergic receptor,ADRB1,Homo sapiens (Human),MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
928839,P08588,UMQUQWCJKFOUGV-VIFPVBQESA-N,Kd,0.125892541179417 - 251.188643150958,nM,IUPHAR,28,531,15060759,UNII-Z7YP8B158Q,6603756.0,C14H21N3O3,279.34,"4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,3-dihydrobenzimidazol-2-one",CC(C)(C)NCC(COC1=CC=CC2=C1NC(=O)N2)O,CC(C)(C)NC[C@@H](COC1=CC=CC2=C1NC(=O)N2)O,"InChI=1S/C14H21N3O3/c1-14(2,3)15-7-9(18)8-20-11-6-4-5-10-12(11)17-13(19)16-10/h4-6,9,15,18H,7-8H2,1-3H3,(H2,16,17,19)/t9-/m0/s1",0.5,4.0,4.0,Beta-1 adrenergic receptor,ADRB1,Homo sapiens (Human),MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
928840,P08588,UMQUQWCJKFOUGV-VIFPVBQESA-N,Kd,0.630957344480194 - 251.188643150958,nM,IUPHAR,28,531,"15060759,15655528",UNII-Z7YP8B158Q,6603756.0,C14H21N3O3,279.34,"4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,3-dihydrobenzimidazol-2-one",CC(C)(C)NCC(COC1=CC=CC2=C1NC(=O)N2)O,CC(C)(C)NC[C@@H](COC1=CC=CC2=C1NC(=O)N2)O,"InChI=1S/C14H21N3O3/c1-14(2,3)15-7-9(18)8-20-11-6-4-5-10-12(11)17-13(19)16-10/h4-6,9,15,18H,7-8H2,1-3H3,(H2,16,17,19)/t9-/m0/s1",0.5,4.0,4.0,Beta-1 adrenergic receptor,ADRB1,Homo sapiens (Human),MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
929477,P08588,BWRYWVZCQTUAKZ-UHFFFAOYSA-N,Kd,17.38,nM,ChEMBL,CHEMBL213,CHEMBL2348214,23614528,CHEMBL2348214,56599099.0,C26H37N3O5,471.598,1-[2-[[3-[4-(2-cyclopentyloxyethoxy)phenoxy]-2-hydroxypropyl]amino]ethyl]-3-(4-methylphenyl)urea,CC1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=C(C=C2)OCCOC3CCCC3)O,CC1=CC=C(C=C1)NC(=O)NCCNCC(COC2=CC=C(C=C2)OCCOC3CCCC3)O,"InChI=1S/C26H37N3O5/c1-20-6-8-21(9-7-20)29-26(31)28-15-14-27-18-22(30)19-34-25-12-10-24(11-13-25)33-17-16-32-23-4-2-3-5-23/h6-13,22-23,27,30H,2-5,14-19H2,1H3,(H2,28,29,31)",3.0,4.0,6.0,Beta-1 adrenergic receptor,ADRB1,Homo sapiens (Human),MGAGVLVLGASEPGNLSSAAPLPDGAATAARLLVPASPPASLLPPASESPEPLSQQWTAGMGLLMALIVLLIVAGNVLVIVAIAKTPRLQTLTNLFIMSLASADLVMGLLVVPFGATIVVWGRWEYGSFFCELWTSVDVLCVTASIETLCVIALDRYLAITSPFRYQSLLTRARARGLVCTVWAISALVSFLPILMHWWRAESDEARRCYNDPKCCDFVTNRAYAIASSVVSFYVPLCIMAFVYLRVFREAQKQVKKIDSCERRFLGGPARPPSPSPSPVPAPAPPPGPPRPAAAAATAPLANGRAGKRRPSRLVALREQKALKTLGIIMGVFTLCWLPFFLANVVKAFHRELVPDRLFVFFNWLGYANSAFNPIIYCRSPDFRKAFQRLLCCARRAARRRHATHGDRPRASGCLARPGPPPSPGAASDDDDDDVVGATPPARLLEPWAGCNGGAAADSDSSLDEPCRPGFASESKV
936231,P34995,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,1 - 25,nM,IUPHAR,340,1916,"16604093,10634944,11999132",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP1 subtype,PTGER1,Homo sapiens (Human),MSPCGPLNLSLAGEATTCAAPWVPNTSAVPPSGASPALPIFSMTLGAVSNLLALALLAQAAGRLRRRRSAATFLLFVASLLATDLAGHVIPGALVLRLYTAGRAPAGGACHFLGGCMVFFGLCPLLLGCGMAVERCVGVTRPLLHAARVSVARARLALAAVAAVALAVALLPLARVGRYELQYPGTWCFIGLGPPGGWRQALLAGLFASLGLVALLAALVCNTLSGLALLRARWRRRSRRPPPASGPDSRRRWGAHGPRSASASSASSIASASTFFGGSRSSGSARRARAHDVEMVGQLVGIMVVSCICWSPMLVLVALAVGGWSSTSLQRPLFLAVRLASWNQILDPWVYILLRQAVLRQLLRLLPPRAGAKGGPAGLGLTPSAWEASSLRSSRHSGLSHF
936942,P34995,PFODPHDNBFSMOX-UHFFFAOYSA-N,Kd,0.7943,nM,ChEMBL,CHEMBL1811,CHEMBL234940,17084082,GW848687X,10238338.0,C24H18ClF2NO3,441.859,"6-[2-[5-chloro-2-[(2,4-difluorophenyl)methoxy]phenyl]cyclopenten-1-yl]pyridine-2-carboxylic acid",C1CC(=C(C1)C2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)F)F)C4=NC(=CC=C4)C(=O)O,C1CC(=C(C1)C2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)F)F)C4=NC(=CC=C4)C(=O)O,"InChI=1S/C24H18ClF2NO3/c25-15-8-10-23(31-13-14-7-9-16(26)12-20(14)27)19(11-15)17-3-1-4-18(17)21-5-2-6-22(28-21)24(29)30/h2,5-12H,1,3-4,13H2,(H,29,30)",5.4,1.0,6.0,Prostaglandin E2 receptor EP1 subtype,PTGER1,Homo sapiens (Human),MSPCGPLNLSLAGEATTCAAPWVPNTSAVPPSGASPALPIFSMTLGAVSNLLALALLAQAAGRLRRRRSAATFLLFVASLLATDLAGHVIPGALVLRLYTAGRAPAGGACHFLGGCMVFFGLCPLLLGCGMAVERCVGVTRPLLHAARVSVARARLALAAVAAVALAVALLPLARVGRYELQYPGTWCFIGLGPPGGWRQALLAGLFASLGLVALLAALVCNTLSGLALLRARWRRRSRRPPPASGPDSRRRWGAHGPRSASASSASSIASASTFFGGSRSSGSARRARAHDVEMVGQLVGIMVVSCICWSPMLVLVALAVGGWSSTSLQRPLFLAVRLASWNQILDPWVYILLRQAVLRQLLRLLPPRAGAKGGPAGLGLTPSAWEASSLRSSRHSGLSHF
939414,P43119,CTPOHARTNNSRSR-NOQAJONNSA-N,Kd,13,nM,IUPHAR,345,8314,2665758,Esuberaprost,10501053.0,C24H30O5,398.499,"4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S,4S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoic acid",CC#CCC(C)C(C=CC1C(CC2C1C3=C(O2)C(=CC=C3)CCCC(=O)O)O)O,CC#CC[C@H](C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C3=C(O2)C(=CC=C3)CCCC(=O)O)O)O,"InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15-,17-,19+,20+,21-,23-/m0/s1",3.2,3.0,5.0,Prostacyclin receptor,PTGIR,Homo sapiens (Human),MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATDLLGTSFLSPAVFVAYARNSSLLGLARGGPALCDAFAFAMTFFGLASMLILFAMAVERCLALSHPYLYAQLDGPRCARLALPAIYAFCVLFCALPLLGLGQHQQYCPGSWCFLRMRWAQPGGAAFSLAYAGLVALLVAAIFLCNGSVTLSLCRMYRQQKRHQGSLGPRPRTGEDEVDHLILLALMTVVMAVCSLPLTIRCFTQAVAPDSSSEMGDLLAFRFYAFNPILDPWVFILFRKAVFQRLKLWVCCLCLGPAHGDSQTPLSQLASGRRDPRAPSAPVGKEGSCVPLSAWGEGQVEPLPPTQQSSGSAVGTSSKAEASVACSLC
953049,P21731,BZYFYLPNTYTHJE-KPZIQFQPSA-N,Kd,7.943,nM,ChEMBL,CHEMBL2069,CHEMBL161427,"Bioorg. Med. Chem. Lett., (1991) 1:12:689",CHEMBL161427,13560651.0,C29H37NO4,463.618,"(Z)-6-[(1R,2S,5S)-2-[(4-phenylphenyl)methoxy]-5-piperidin-1-ylcyclopentyl]oxyhex-4-enoic acid",C1CCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1CCN(CC1)[C@H]2CC[C@@H]([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H37NO4/c31-28(32)12-6-2-9-21-33-29-26(30-19-7-3-8-20-30)17-18-27(29)34-22-23-13-15-25(16-14-23)24-10-4-1-5-11-24/h1-2,4-5,9-11,13-16,26-27,29H,3,6-8,12,17-22H2,(H,31,32)/b9-2-/t26-,27-,29+/m0/s1",2.6,1.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
953051,P21731,BZYFYLPNTYTHJE-KPZIQFQPSA-N,Kd,10,nM,ChEMBL,CHEMBL2069,CHEMBL161427,"Bioorg. Med. Chem. Lett., (1991) 1:12:689",CHEMBL161427,13560651.0,C29H37NO4,463.618,"(Z)-6-[(1R,2S,5S)-2-[(4-phenylphenyl)methoxy]-5-piperidin-1-ylcyclopentyl]oxyhex-4-enoic acid",C1CCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1CCN(CC1)[C@H]2CC[C@@H]([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H37NO4/c31-28(32)12-6-2-9-21-33-29-26(30-19-7-3-8-20-30)17-18-27(29)34-22-23-13-15-25(16-14-23)24-10-4-1-5-11-24/h1-2,4-5,9-11,13-16,26-27,29H,3,6-8,12,17-22H2,(H,31,32)/b9-2-/t26-,27-,29+/m0/s1",2.6,1.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
953450,P21731,UICLKHCKXGFMBB-UVHMKAGCSA-N,Kd,33.3,nM,ChEMBL,CHEMBL2069,CHEMBL56722,9873463,CHEMBL56722,15462454.0,C31H37N3O4,515.654,"(E)-6-[4-[4-(4-cyclohexylbutylcarbamoyl)-1,3-oxazol-2-yl]phenyl]-6-pyridin-3-ylhex-5-enoic acid",C1CCC(CC1)CCCCNC(=O)C2=COC(=N2)C3=CC=C(C=C3)C(=CCCCC(=O)O)C4=CN=CC=C4,C1CCC(CC1)CCCCNC(=O)C2=COC(=N2)C3=CC=C(C=C3)/C(=C\CCCC(=O)O)/C4=CN=CC=C4,"InChI=1S/C31H37N3O4/c35-29(36)14-5-4-13-27(26-12-8-19-32-21-26)24-15-17-25(18-16-24)31-34-28(22-38-31)30(37)33-20-7-6-11-23-9-2-1-3-10-23/h8,12-13,15-19,21-23H,1-7,9-11,14,20H2,(H,33,37)(H,35,36)/b27-13+",7.2,2.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
953623,P21731,SHQBTFGWYKSCSE-UHFFFAOYSA-N,Kd,0.3,nM,ChEMBL,CHEMBL2069,CHEMBL281959,8496908,CHEMBL281959,19875349.0,C31H36N2O6,532.637,"3-[2-[[3-[4-[4-(4-methoxyphenyl)butylcarbamoyl]-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid",COC1=CC=C(C=C1)CCCCNC(=O)C2=COC(=N2)C3C4CCC(C3CC5=CC=CC=C5CCC(=O)O)O4,COC1=CC=C(C=C1)CCCCNC(=O)C2=COC(=N2)C3C4CCC(C3CC5=CC=CC=C5CCC(=O)O)O4,"InChI=1S/C31H36N2O6/c1-37-23-12-9-20(10-13-23)6-4-5-17-32-30(36)25-19-38-31(33-25)29-24(26-14-15-27(29)39-26)18-22-8-3-2-7-21(22)11-16-28(34)35/h2-3,7-10,12-13,19,24,26-27,29H,4-6,11,14-18H2,1H3,(H,32,36)(H,34,35)",4.9,2.0,7.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
954135,P21731,UYFMSCHBODMWON-HBHIRWTLSA-N,Kd,0.479999989271164 - 1.1599999666214,nM,IUPHAR,346,1938,1830308,I-BOP,5311175.0,C23H29IO5,512.384,"(Z)-7-[(1S,2R,3R,4R)-3-[(E,3R)-3-hydroxy-4-(4-iodophenoxy)but-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid",C1CC2C(C(C1O2)CC=CCCCC(=O)O)C=CC(COC3=CC=C(C=C3)I)O,C1C[C@@H]2[C@@H]([C@H]([C@H]1O2)C/C=C\CCCC(=O)O)/C=C/[C@H](COC3=CC=C(C=C3)I)O,"InChI=1S/C23H29IO5/c24-16-7-10-18(11-8-16)28-15-17(25)9-12-20-19(21-13-14-22(20)29-21)5-3-1-2-4-6-23(26)27/h1,3,7-12,17,19-22,25H,2,4-6,13-15H2,(H,26,27)/b3-1-,12-9+/t17-,19-,20-,21+,22-/m1/s1",4.0,2.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
954552,P21731,DNBSROBEWRUXPM-UHFFFAOYSA-N,Kd,36,nM,ChEMBL,CHEMBL2069,CHEMBL282186,8496908,CHEMBL282186,44280058.0,C32H44N2O5,536.713,"3-[2-[[3-[4-(4-cyclohexylbutylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]-2,2-dimethylpropanoic acid",CC(C)(CC1=CC=CC=C1CC2C3CCC(C2C4=NC(=CO4)C(=O)NCCCCC5CCCCC5)O3)C(=O)O,CC(C)(CC1=CC=CC=C1CC2C3CCC(C2C4=NC(=CO4)C(=O)NCCCCC5CCCCC5)O3)C(=O)O,"InChI=1S/C32H44N2O5/c1-32(2,31(36)37)19-23-14-7-6-13-22(23)18-24-26-15-16-27(39-26)28(24)30-34-25(20-38-30)29(35)33-17-9-8-12-21-10-4-3-5-11-21/h6-7,13-14,20-21,24,26-28H,3-5,8-12,15-19H2,1-2H3,(H,33,35)(H,36,37)",7.2,2.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
954633,P21731,XCXKTQPMCWBJCT-GAFDFGGTSA-N,Kd,7.943,nM,ChEMBL,CHEMBL2069,CHEMBL159814,"Bioorg. Med. Chem. Lett., (1991) 1:12:689",CHEMBL159814,44374550.0,C31H41N3O5,535.685,"(Z)-6-[(1R,2S)-2-(azepan-1-yl)-5-[[4-[2-(carbamoylamino)phenyl]phenyl]methoxy]cyclopentyl]oxyhex-4-enoic acid",C1CCCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4NC(=O)N,C1CCCN(CC1)[C@H]2CCC([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4NC(=O)N,"InChI=1S/C31H41N3O5/c32-31(37)33-26-11-6-5-10-25(26)24-15-13-23(14-16-24)22-39-28-18-17-27(34-19-7-1-2-8-20-34)30(28)38-21-9-3-4-12-29(35)36/h3,5-6,9-11,13-16,27-28,30H,1-2,4,7-8,12,17-22H2,(H,35,36)(H3,32,33,37)/b9-3-/t27-,28?,30+/m0/s1",1.6,3.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
954674,P21731,FMDTZGRGHLMLSW-UHFFFAOYSA-N,Kd,4.8,nM,ChEMBL,CHEMBL2069,CHEMBL281293,8496908,CHEMBL281293,44279891.0,C25H29F3N2O5,494.511,"3-[2-[[3-[4-(5,5,5-trifluoropentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid",C1CC2C(C(C1O2)CC3=CC=CC=C3CCC(=O)O)C4=NC(=CO4)C(=O)NCCCCC(F)(F)F,C1CC2C(C(C1O2)CC3=CC=CC=C3CCC(=O)O)C4=NC(=CO4)C(=O)NCCCCC(F)(F)F,"InChI=1S/C25H29F3N2O5/c26-25(27,28)11-3-4-12-29-23(33)18-14-34-24(30-18)22-17(19-8-9-20(22)35-19)13-16-6-2-1-5-15(16)7-10-21(31)32/h1-2,5-6,14,17,19-20,22H,3-4,7-13H2,(H,29,33)(H,31,32)",4.4,2.0,9.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
954688,P21731,LACPPBQCKQXQIH-IPPBACCNSA-N,Kd,64.3,nM,ChEMBL,CHEMBL2069,CHEMBL150436,9876106,CHEMBL150436,10769084.0,C33H35N3O5,553.659,"(E)-7-[4-[4-(5-phenoxypentylcarbamoyl)-1,3-oxazol-2-yl]phenyl]-7-pyridin-3-ylhept-6-enoic acid",C1=CC=C(C=C1)OCCCCCNC(=O)C2=COC(=N2)C3=CC=C(C=C3)C(=CCCCCC(=O)O)C4=CN=CC=C4,C1=CC=C(C=C1)OCCCCCNC(=O)C2=COC(=N2)C3=CC=C(C=C3)/C(=C\CCCCC(=O)O)/C4=CN=CC=C4,"InChI=1S/C33H35N3O5/c37-31(38)15-7-2-6-14-29(27-11-10-20-34-23-27)25-16-18-26(19-17-25)33-36-30(24-41-33)32(39)35-21-8-3-9-22-40-28-12-4-1-5-13-28/h1,4-5,10-14,16-20,23-24H,2-3,6-9,15,21-22H2,(H,35,39)(H,37,38)/b29-14+",6.5,2.0,7.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955058,P21731,NMJYFIAGWNELHF-SJKZHLFISA-N,Kd,10.47,nM,ChEMBL,CHEMBL2069,CHEMBL63040,"Bioorg. Med. Chem. Lett., (1994) 4:17:2073",CHEMBL63040,44305522.0,C29H31NO4,457.57,"(Z)-7-[(2S,3R,4R)-4-[(4-phenylphenyl)methoxy]-2-pyridin-3-yloxolan-3-yl]hept-4-enoic acid",C1C(C(C(O1)C2=CN=CC=C2)CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1[C@@H]([C@@H]([C@H](O1)C2=CN=CC=C2)CC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H31NO4/c31-28(32)13-7-2-1-6-12-26-27(21-34-29(26)25-11-8-18-30-19-25)33-20-22-14-16-24(17-15-22)23-9-4-3-5-10-23/h1-5,8-11,14-19,26-27,29H,6-7,12-13,20-21H2,(H,31,32)/b2-1-/t26-,27-,29+/m0/s1",4.7,1.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955060,P21731,NMJYFIAGWNELHF-SJKZHLFISA-N,Kd,21.88,nM,ChEMBL,CHEMBL2069,CHEMBL63040,"Bioorg. Med. Chem. Lett., (1994) 4:17:2073",CHEMBL63040,44305522.0,C29H31NO4,457.57,"(Z)-7-[(2S,3R,4R)-4-[(4-phenylphenyl)methoxy]-2-pyridin-3-yloxolan-3-yl]hept-4-enoic acid",C1C(C(C(O1)C2=CN=CC=C2)CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1[C@@H]([C@@H]([C@H](O1)C2=CN=CC=C2)CC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H31NO4/c31-28(32)13-7-2-1-6-12-26-27(21-34-29(26)25-11-8-18-30-19-25)33-20-22-14-16-24(17-15-22)23-9-4-3-5-10-23/h1-5,8-11,14-19,26-27,29H,6-7,12-13,20-21H2,(H,31,32)/b2-1-/t26-,27-,29+/m0/s1",4.7,1.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955061,P21731,NMJYFIAGWNELHF-SJKZHLFISA-N,Kd,70.79,nM,ChEMBL,CHEMBL2069,CHEMBL63040,"Bioorg. Med. Chem. Lett., (1994) 4:17:2073",CHEMBL63040,44305522.0,C29H31NO4,457.57,"(Z)-7-[(2S,3R,4R)-4-[(4-phenylphenyl)methoxy]-2-pyridin-3-yloxolan-3-yl]hept-4-enoic acid",C1C(C(C(O1)C2=CN=CC=C2)CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1[C@@H]([C@@H]([C@H](O1)C2=CN=CC=C2)CC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H31NO4/c31-28(32)13-7-2-1-6-12-26-27(21-34-29(26)25-11-8-18-30-19-25)33-20-22-14-16-24(17-15-22)23-9-4-3-5-10-23/h1-5,8-11,14-19,26-27,29H,6-7,12-13,20-21H2,(H,31,32)/b2-1-/t26-,27-,29+/m0/s1",4.7,1.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955071,P21731,WHSSOYNNHOWWJE-MFKUBSTISA-N,Kd,1000,nM,ChEMBL,CHEMBL2069,CHEMBL422017,"Bioorg. Med. Chem. Lett., (1991) 1:12:699",CHEMBL422017,44375168.0,C26H28N2O4S,464.58,(E)-6-[3-[3-(benzenesulfonamido)propyl]phenyl]-6-pyridin-3-ylhex-5-enoic acid,C1=CC=C(C=C1)S(=O)(=O)NCCCC2=CC=CC(=C2)C(=CCCCC(=O)O)C3=CN=CC=C3,C1=CC=C(C=C1)S(=O)(=O)NCCCC2=CC=CC(=C2)/C(=C\CCCC(=O)O)/C3=CN=CC=C3,"InChI=1S/C26H28N2O4S/c29-26(30)16-5-4-15-25(23-12-8-17-27-20-23)22-11-6-9-21(19-22)10-7-18-28-33(31,32)24-13-2-1-3-14-24/h1-3,6,8-9,11-15,17,19-20,28H,4-5,7,10,16,18H2,(H,29,30)/b25-15+",4.8,2.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955245,P21731,WTEIAUJWYKFJJY-UHFFFAOYSA-N,Kd,3981.07,nM,ChEMBL,CHEMBL2069,CHEMBL177596,"Bioorg. Med. Chem. Lett., (1992) 2:9:979",CHEMBL177596,44385951.0,C31H33FN2O2,484.615,"2-[6-fluoro-9-[[3-(5-pyridin-3-ylpentyl)phenyl]methyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid",C1CC(C2=C(C1)C3=C(N2CC4=CC=CC(=C4)CCCCCC5=CN=CC=C5)C=CC(=C3)F)CC(=O)O,C1CC(C2=C(C1)C3=C(N2CC4=CC=CC(=C4)CCCCCC5=CN=CC=C5)C=CC(=C3)F)CC(=O)O,"InChI=1S/C31H33FN2O2/c32-26-14-15-29-28(19-26)27-13-5-12-25(18-30(35)36)31(27)34(29)21-24-10-4-9-22(17-24)7-2-1-3-8-23-11-6-16-33-20-23/h4,6,9-11,14-17,19-20,25H,1-3,5,7-8,12-13,18,21H2,(H,35,36)",7.0,1.0,4.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955419,P21731,SZNMERGTFJHNSM-JSMWPFPQSA-N,Kd,0.47,nM,IUPHAR,346,3332,1386885,"(Z)-7-[(1R,2S,3S,5S)-3-[(4-iodophenyl)sulfonylamino]-7,7-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid",22524604.0,C22H30INO4S,531.449,"(Z)-7-[(1R,2S,3S,5S)-3-[(4-iodophenyl)sulfonylamino]-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid",CC1(C2CC1C(C(C2)NS(=O)(=O)C3=CC=C(C=C3)I)CC=CCCCC(=O)O)C,CC1([C@H]2C[C@@H]1[C@@H]([C@H](C2)NS(=O)(=O)C3=CC=C(C=C3)I)C/C=C\CCCC(=O)O)C,"InChI=1S/C22H30INO4S/c1-22(2)15-13-19(22)18(7-5-3-4-6-8-21(25)26)20(14-15)24-29(27,28)17-11-9-16(23)10-12-17/h3,5,9-12,15,18-20,24H,4,6-8,13-14H2,1-2H3,(H,25,26)/b5-3-/t15-,18-,19+,20-/m0/s1",5.1,2.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955503,P21731,YKPJTNNQDJFQBF-HLOJMEPRSA-N,Kd,12.59,nM,ChEMBL,CHEMBL2069,CHEMBL433884,"Bioorg. Med. Chem. Lett., (1991) 1:12:695",CHEMBL433884,15024085.0,C29H38N2O4,478.633,"(Z)-6-[(1R,2S,5R)-2-(azepan-1-yl)-5-[(4-pyridin-3-ylphenyl)methoxy]cyclopentyl]oxyhex-4-enoic acid",C1CCCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CN=CC=C4,C1CCCN(CC1)[C@H]2CC[C@H]([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CN=CC=C4,"InChI=1S/C29H38N2O4/c32-28(33)10-4-3-7-20-34-29-26(31-18-5-1-2-6-19-31)15-16-27(29)35-22-23-11-13-24(14-12-23)25-9-8-17-30-21-25/h3,7-9,11-14,17,21,26-27,29H,1-2,4-6,10,15-16,18-20,22H2,(H,32,33)/b7-3-/t26-,27+,29+/m0/s1",1.9,1.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955509,P21731,PMZRHVZFESEBFJ-AUEPDCJTSA-N,Kd,153.1,nM,ChEMBL,CHEMBL2069,CHEMBL291539,9876106,CHEMBL291539,44301194.0,C27H31N3O4,461.562,"(E)-7-[4-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]phenyl]-7-pyridin-3-ylhept-6-enoic acid",CCCCCNC(=O)C1=COC(=N1)C2=CC=C(C=C2)C(=CCCCCC(=O)O)C3=CN=CC=C3,CCCCCNC(=O)C1=COC(=N1)C2=CC=C(C=C2)/C(=C\CCCCC(=O)O)/C3=CN=CC=C3,"InChI=1S/C27H31N3O4/c1-2-3-7-17-29-26(33)24-19-34-27(30-24)21-14-12-20(13-15-21)23(22-9-8-16-28-18-22)10-5-4-6-11-25(31)32/h8-10,12-16,18-19H,2-7,11,17H2,1H3,(H,29,33)(H,31,32)/b23-10+",5.5,2.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955512,P21731,PMZRHVZFESEBFJ-AUEPDCJTSA-N,Kd,153.1,nM,ChEMBL,CHEMBL2069,CHEMBL291539,9873463,CHEMBL291539,44301194.0,C27H31N3O4,461.562,"(E)-7-[4-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]phenyl]-7-pyridin-3-ylhept-6-enoic acid",CCCCCNC(=O)C1=COC(=N1)C2=CC=C(C=C2)C(=CCCCCC(=O)O)C3=CN=CC=C3,CCCCCNC(=O)C1=COC(=N1)C2=CC=C(C=C2)/C(=C\CCCCC(=O)O)/C3=CN=CC=C3,"InChI=1S/C27H31N3O4/c1-2-3-7-17-29-26(33)24-19-34-27(30-24)21-14-12-20(13-15-21)23(22-9-8-16-28-18-22)10-5-4-6-11-25(31)32/h8-10,12-16,18-19H,2-7,11,17H2,1H3,(H,29,33)(H,31,32)/b23-10+",5.5,2.0,6.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955570,P21731,DJPVNHLABTYAMF-LSHDLFTRSA-N,Kd,1000,nM,ChEMBL,CHEMBL2069,CHEMBL164109,"Bioorg. Med. Chem. Lett., (1991) 1:12:699",CHEMBL164109,15684009.0,C25H25N3O6S,495.55,(E)-6-[3-[2-[(2-nitrophenyl)sulfonylamino]ethyl]phenyl]-6-pyridin-3-ylhex-5-enoic acid,C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)NCCC2=CC=CC(=C2)C(=CCCCC(=O)O)C3=CN=CC=C3,C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)NCCC2=CC=CC(=C2)/C(=C\CCCC(=O)O)/C3=CN=CC=C3,"InChI=1S/C25H25N3O6S/c29-25(30)13-4-1-10-22(21-9-6-15-26-18-21)20-8-5-7-19(17-20)14-16-27-35(33,34)24-12-3-2-11-23(24)28(31)32/h2-3,5-12,15,17-18,27H,1,4,13-14,16H2,(H,29,30)/b22-10+",4.2,2.0,8.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955656,P21731,SJOULRAWZZKEMY-UHFFFAOYSA-N,Kd,1,nM,ChEMBL,CHEMBL2069,CHEMBL286978,8496908,CHEMBL286978,44279871.0,C30H39NO6,509.643,"3-[2-[[3-[4-(4-cyclohexylbutoxycarbonyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid",C1CCC(CC1)CCCCOC(=O)C2=COC(=N2)C3C4CCC(C3CC5=CC=CC=C5CCC(=O)O)O4,C1CCC(CC1)CCCCOC(=O)C2=COC(=N2)C3C4CCC(C3CC5=CC=CC=C5CCC(=O)O)O4,"InChI=1S/C30H39NO6/c32-27(33)16-13-21-11-4-5-12-22(21)18-23-25-14-15-26(37-25)28(23)29-31-24(19-36-29)30(34)35-17-7-6-10-20-8-2-1-3-9-20/h4-5,11-12,19-20,23,25-26,28H,1-3,6-10,13-18H2,(H,32,33)",6.8,1.0,7.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955898,P21731,YDJGESKTURUXSO-MRWCJKGFSA-N,Kd,0.4,nM,ChEMBL,CHEMBL2069,CHEMBL2096756,2523485,CHEMBL2096756,52935553.0,C20H32O3S,352.533,(Z)-7-[3-[[(Z)-hex-3-enyl]sulfanylmethyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid,CCC=CCCSCC1C2CCC(C1CC=CCCCC(=O)O)O2,CC/C=C\CCSCC1C2CCC(C1C/C=C\CCCC(=O)O)O2,"InChI=1S/C20H32O3S/c1-2-3-4-9-14-24-15-17-16(18-12-13-19(17)23-18)10-7-5-6-8-11-20(21)22/h3-5,7,16-19H,2,6,8-15H2,1H3,(H,21,22)/b4-3-,7-5-",4.5,1.0,4.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
955901,P21731,MIIIWVNAZRSKJI-UHFFFAOYSA-N,Kd,501.19,nM,ChEMBL,CHEMBL2069,CHEMBL425325,"Bioorg. Med. Chem. Lett., (1992) 2:9:979",CHEMBL425325,44386373.0,C30H31FN2O3,486.587,"2-[6-fluoro-9-[[3-(4-pyridin-3-ylbutoxy)phenyl]methyl]-1,2,3,4-tetrahydrocarbazol-1-yl]acetic acid",C1CC(C2=C(C1)C3=C(N2CC4=CC(=CC=C4)OCCCCC5=CN=CC=C5)C=CC(=C3)F)CC(=O)O,C1CC(C2=C(C1)C3=C(N2CC4=CC(=CC=C4)OCCCCC5=CN=CC=C5)C=CC(=C3)F)CC(=O)O,"InChI=1S/C30H31FN2O3/c31-24-12-13-28-27(18-24)26-11-4-9-23(17-29(34)35)30(26)33(28)20-22-7-3-10-25(16-22)36-15-2-1-6-21-8-5-14-32-19-21/h3,5,7-8,10,12-14,16,18-19,23H,1-2,4,6,9,11,15,17,20H2,(H,34,35)",5.8,1.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
956095,P21731,WBTHGTHFGYAVNF-IHXJLJSNSA-N,Kd,10000,nM,ChEMBL,CHEMBL2069,CHEMBL320461,"Bioorg. Med. Chem. Lett., (1996) 6:3:273",CHEMBL320461,44326663.0,C51H57N5O7,852.045,"(Z)-N-[6-[[(Z)-6-[(2S,4S,5R)-2-(4-cyanophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]hex-4-enoyl]amino]hexyl]-6-[(2S,4S,5R)-2-(4-cyanophenyl)-4-pyridin-3-yl-1,3-dioxan-5-yl]hex-4-enamide",C1C(C(OC(O1)C2=CC=C(C=C2)C#N)C3=CN=CC=C3)CC=CCCC(=O)NCCCCCCNC(=O)CCC=CCC4COC(OC4C5=CC=CC=C5O)C6=CC=C(C=C6)C#N,C1[C@H]([C@H](O[C@H](O1)C2=CC=C(C=C2)C#N)C3=CN=CC=C3)C/C=C\CCC(=O)NCCCCCCNC(=O)CC/C=C\C[C@@H]4CO[C@@H](O[C@@H]4C5=CC=CC=C5O)C6=CC=C(C=C6)C#N,"InChI=1S/C51H57N5O7/c52-32-37-21-25-39(26-22-37)50-60-35-42(48(62-50)41-16-13-29-54-34-41)14-5-3-7-19-46(58)55-30-11-1-2-12-31-56-47(59)20-8-4-6-15-43-36-61-51(40-27-23-38(33-53)24-28-40)63-49(43)44-17-9-10-18-45(44)57/h3-6,9-10,13,16-18,21-29,34,42-43,48-51,57H,1-2,7-8,11-12,14-15,19-20,30-31,35-36H2,(H,55,58)(H,56,59)/b5-3-,6-4-/t42-,43-,48-,49+,50+,51+/m1/s1",6.4,3.0,10.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
956150,P21731,SZNMERGTFJHNSM-NTVCQXSRSA-N,Kd,0.5 - 20,nM,IUPHAR,346,1982,1386885,[125I]SAP,73755024.0,C22H30INO4S,529.45,"(Z)-7-[(1R,2S,3S,5S)-3-[(4-(125I)iodanylphenyl)sulfonylamino]-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]hept-5-enoic acid",CC1(C2CC1C(C(C2)NS(=O)(=O)C3=CC=C(C=C3)I)CC=CCCCC(=O)O)C,CC1([C@H]2C[C@@H]1[C@@H]([C@H](C2)NS(=O)(=O)C3=CC=C(C=C3)[125I])C/C=C\CCCC(=O)O)C,"InChI=1S/C22H30INO4S/c1-22(2)15-13-19(22)18(7-5-3-4-6-8-21(25)26)20(14-15)24-29(27,28)17-11-9-16(23)10-12-17/h3,5,9-12,15,18-20,24H,4,6-8,13-14H2,1-2H3,(H,25,26)/b5-3-/t15-,18-,19+,20-/m0/s1/i23-2",5.1,2.0,5.0,Thromboxane A2 receptor,TBXA2R,Homo sapiens (Human),MWPNGSSLGPCFRPTNITLEERRLIASPWFAASFCVVGLASNLLALSVLAGARQGGSHTRSSFLTFLCGLVLTDFLGLLVTGTIVVSQHAALFEWHAVDPGCRLCRFMGVVMIFFGLSPLLLGAAMASERYLGITRPFSRPAVASQRRAWATVGLVWAAALALGLLPLLGVGRYTVQYPGSWCFLTLGAESGDVAFGLLFSMLGGLSVGLSFLLNTVSVATLCHVYHGQEAAQQRPRDSEVEMMAQLLGIMVVASVCWLPLLVFIAQTVLRNPPAMSPAGQLSRTTEKELLIYLRVATWNQILDPWVYILFRRAVLRRLQPRLSTRPRSLSLQPQLTQRSGLQ
958218,P25116,WNSZHTAQLGVRHC-UWXQCODUSA-N,Kd,0.82,nM,ChEMBL,CHEMBL3974,CHEMBL428311,11297447,CHEMBL428311,9919038.0,C43H47Cl2F2N9O3,846.806,"(2S)-N-benzyl-5-(diaminomethylideneamino)-2-[[(2S)-2-[[1-[(2,6-dichlorophenyl)methyl]-3-(pyrrolidin-1-ylmethyl)indol-6-yl]carbamoylamino]-3-(3,4-difluorophenyl)propanoyl]amino]pentanamide",C1CCN(C1)CC2=CN(C3=C2C=CC(=C3)NC(=O)NC(CC4=CC(=C(C=C4)F)F)C(=O)NC(CCCN=C(N)N)C(=O)NCC5=CC=CC=C5)CC6=C(C=CC=C6Cl)Cl,C1CCN(C1)CC2=CN(C3=C2C=CC(=C3)NC(=O)N[C@@H](CC4=CC(=C(C=C4)F)F)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC5=CC=CC=C5)CC6=C(C=CC=C6Cl)Cl,"InChI=1S/C43H47Cl2F2N9O3/c44-33-10-6-11-34(45)32(33)26-56-25-29(24-55-18-4-5-19-55)31-15-14-30(22-39(31)56)52-43(59)54-38(21-28-13-16-35(46)36(47)20-28)41(58)53-37(12-7-17-50-42(48)49)40(57)51-23-27-8-2-1-3-9-27/h1-3,6,8-11,13-16,20,22,25,37-38H,4-5,7,12,17-19,21,23-24,26H2,(H,51,57)(H,53,58)(H4,48,49,50)(H2,52,54,59)/t37-,38-/m0/s1",5.8,6.0,7.0,Proteinase-activated receptor 1,F2R,Homo sapiens (Human),MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQKQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFGSELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNETLLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYFAYLLCVCVSSISCCIDPLIYYYASSECQRYVYSILCCKESSDPSSYNSSGQLMASKMDTCSSNLNNSIYKKLLT
964632,P30969,AHPAANSMMWNOOM-TXMVLUGGSA-N,Kd,0.24,nM,ChEMBL,CHEMBL3066,CHEMBL407225,3279211,CHEMBL407225,44374471.0,C67H88ClN19O12,1387.012,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-2-pyridin-3-ylacetyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-2-pyridin-3-ylacetyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2S)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(C2=CN=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(C3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,C[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C2=CN=CC=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C3=CN=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C,"InChI=1S/C67H88ClN19O12/c1-37(2)30-49(58(92)81-48(17-10-28-77-67(72)73)65(99)87-29-11-18-53(87)62(96)78-38(3)56(69)90)83-63(97)54(44-14-7-25-74-34-44)85-57(91)47(16-9-27-76-66(70)71)80-61(95)52(36-88)84-64(98)55(45-15-8-26-75-35-45)86-60(94)51(32-40-20-23-46(68)24-21-40)82-59(93)50(79-39(4)89)33-41-19-22-42-12-5-6-13-43(42)31-41/h5-8,12-15,19-26,31,34-35,37-38,47-55,88H,9-11,16-18,27-30,32-33,36H2,1-4H3,(H2,69,90)(H,78,96)(H,79,89)(H,80,95)(H,81,92)(H,82,93)(H,83,97)(H,84,98)(H,85,91)(H,86,94)(H4,70,71,76)(H4,72,73,77)/t38-,47-,48-,49-,50-,51-,52-,53-,54-,55-/m0/s1",0.3,15.0,16.0,Gonadotropin-releasing hormone receptor,Gnrhr,Rattus norvegicus (Rat),MANNASLEQDQNHCSAINNSIPLTQGKLPTLTLSGKIRVTVTFFLFLLSTAFNASFLVKLQRWTQKRKKGKKLSRMKVLLKHLTLANLLETLIVMPLDGMWNITVQWYAGEFLCKVLSYLKLFSMYAPAFMMVVISLDRSLAVTQPLAVQSKSKLERSMTSLAWILSIVFAGPQLYIFRMIYLADGSGPAVFSQCVTHCSFPQWWHEAFYNFFTFSCLFIIPLLIMLICNAKIIFALTRVLHQDPRKLQLNQSKNNIPRARLRTLKMTVAFGTSFVICWTPYYVLGIWYWFDPEMLNRVSEPVNHFFFLFAFLNPCFDPLIYGYFSL
964657,P30969,MBXFWMGSHBYZHX-SZVWHOLFSA-N,Kd,0.24,nM,ChEMBL,CHEMBL3066,CHEMBL414391,1714956,CHEMBL414391,44316939.0,C66H101N23O12,1408.683,(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-6-[(N-cyano-N'-methylcarbamimidoyl)amino]-1-oxohexan-2-yl]amino]-6-[(N-cyano-N'-methylcarbamimidoyl)amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=NC)NC#N)NC(=O)C(CCCCNC(=NC)NC#N)NC(=O)C(CO)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C5CCC(=O)N5,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCCNC(=NC)NC#N)NC(=O)[C@H](CCCCNC(=NC)NC#N)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CN=CN4)NC(=O)[C@@H]5CCC(=O)N5,"InChI=1S/C66H101N23O12/c1-38(2)29-49(59(96)84-48(21-12-13-25-73-39(3)4)64(101)89-28-16-22-53(89)63(100)80-40(5)55(69)92)85-57(94)46(20-11-15-27-75-66(71-7)78-36-68)82-56(93)45(19-10-14-26-74-65(70-6)77-35-67)83-62(99)52(34-90)88-60(97)50(30-41-32-76-44-18-9-8-17-43(41)44)86-61(98)51(31-42-33-72-37-79-42)87-58(95)47-23-24-54(91)81-47/h8-9,17-18,32-33,37-40,45-53,73,76,90H,10-16,19-31,34H2,1-7H3,(H2,69,92)(H,72,79)(H,80,100)(H,81,91)(H,82,93)(H,83,99)(H,84,96)(H,85,94)(H,86,98)(H,87,95)(H,88,97)(H2,70,74,77)(H2,71,75,78)/t40-,45+,46-,47+,48+,49+,50+,51+,52+,53+/m1/s1",-0.4,18.0,18.0,Gonadotropin-releasing hormone receptor,Gnrhr,Rattus norvegicus (Rat),MANNASLEQDQNHCSAINNSIPLTQGKLPTLTLSGKIRVTVTFFLFLLSTAFNASFLVKLQRWTQKRKKGKKLSRMKVLLKHLTLANLLETLIVMPLDGMWNITVQWYAGEFLCKVLSYLKLFSMYAPAFMMVVISLDRSLAVTQPLAVQSKSKLERSMTSLAWILSIVFAGPQLYIFRMIYLADGSGPAVFSQCVTHCSFPQWWHEAFYNFFTFSCLFIIPLLIMLICNAKIIFALTRVLHQDPRKLQLNQSKNNIPRARLRTLKMTVAFGTSFVICWTPYYVLGIWYWFDPEMLNRVSEPVNHFFFLFAFLNPCFDPLIYGYFSL
964709,P30969,CQJZXVCPROCGRM-OYDHUGEGSA-N,Kd,0.64,nM,ChEMBL,CHEMBL3066,CHEMBL441741,3279211,"LHRH, acetyl-2-(2-naphthyl)-ala(1)-4-F-phe(2)-trp(3)-arg(6)-",16131124.0,C72H93FN18O13,1437.647,(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-fluorophenyl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]-N-(2-amino-2-oxoethyl)pyrrolidine-2-carboxamide,CC(C)CC(C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CC=C(C=C5)F)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C,CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@@H](CC5=CC=C(C=C5)F)NC(=O)[C@@H](CC6=CC7=CC=CC=C7C=C6)NC(=O)C,"InChI=1S/C72H93FN18O13/c1-40(2)31-54(63(97)85-53(16-9-29-80-72(77)78)70(104)91-30-10-17-60(91)69(103)82-38-61(74)95)86-62(96)52(15-8-28-79-71(75)76)84-65(99)56(34-43-21-26-49(94)27-22-43)88-68(102)59(39-92)90-67(101)58(36-47-37-81-51-14-7-6-13-50(47)51)89-66(100)57(33-42-19-24-48(73)25-20-42)87-64(98)55(83-41(3)93)35-44-18-23-45-11-4-5-12-46(45)32-44/h4-7,11-14,18-27,32,37,40,52-60,81,92,94H,8-10,15-17,28-31,33-36,38-39H2,1-3H3,(H2,74,95)(H,82,103)(H,83,93)(H,84,99)(H,85,97)(H,86,96)(H,87,98)(H,88,102)(H,89,100)(H,90,101)(H4,75,76,79)(H4,77,78,80)/t52-,53+,54+,55-,56+,57-,58-,59+,60+/m1/s1",2.6,19.0,16.0,Gonadotropin-releasing hormone receptor,Gnrhr,Rattus norvegicus (Rat),MANNASLEQDQNHCSAINNSIPLTQGKLPTLTLSGKIRVTVTFFLFLLSTAFNASFLVKLQRWTQKRKKGKKLSRMKVLLKHLTLANLLETLIVMPLDGMWNITVQWYAGEFLCKVLSYLKLFSMYAPAFMMVVISLDRSLAVTQPLAVQSKSKLERSMTSLAWILSIVFAGPQLYIFRMIYLADGSGPAVFSQCVTHCSFPQWWHEAFYNFFTFSCLFIIPLLIMLICNAKIIFALTRVLHQDPRKLQLNQSKNNIPRARLRTLKMTVAFGTSFVICWTPYYVLGIWYWFDPEMLNRVSEPVNHFFFLFAFLNPCFDPLIYGYFSL
974105,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,20.42,nM,ChEMBL,CHEMBL5494,CHEMBL282199,18800769,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974106,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,12.59,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974107,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,6.31,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974108,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,10.96,nM,ChEMBL,CHEMBL5494,CHEMBL282199,18800769,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974109,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,33.11,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974110,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,14.45,nM,ChEMBL,CHEMBL5494,CHEMBL282199,18800769,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974111,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,33.11,nM,ChEMBL,CHEMBL5494,CHEMBL282199,18800769,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974112,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,14.45,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974113,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,7.943,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974114,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,3.981,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974115,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,8.913,nM,ChEMBL,CHEMBL5494,CHEMBL282199,17649988,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974116,P50407,HWKROQUZSKPIKQ-MRXNPFEDSA-N,Kd,15.85,nM,ChEMBL,CHEMBL5494,CHEMBL282199,18800769,SB-269970,6604889.0,C18H28N2O3S,352.493,3-[(2R)-2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidin-1-yl]sulfonylphenol,CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,"InChI=1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1",2.9,1.0,5.0,5-hydroxytryptamine receptor 7,HTR7,Cavia porcellus (Guinea pig),MMGVNSSGRPDLYGHLHSILLPGRGLPDWSPDGGADPGVSTWTPRLLSGVPEVAASPSPSWDGTWDNVSGCGEQINYGRAEKVVIGSILTLITLLTIAGNCLVVISVCFVKKLRQPSNYLIVSLALADLSVAVAVIPFVSVTDLIGGKWIFGHFFCNVFIAMDVMCCTASIMTLCVISIDRYLGITRPLTYPVRQNGKCMPKMILSVWLLSASITLPPLFGWAQNVNDDKVCLISQDFGYTIYSTAVAFYIPMSVMLFMYYRIYKAARKSAAKHKFPGFPRVQPESIISLNGMVKLQKEVEECANLSRLLKHERKNISIFKREQKAATTLGIIVGAFTVCWLPFFLLSTARPFICGTACSCIPLWVERTCLWLGYANSLINPFIYAFFNRDLRTTYRSLLQCQYRNINRKLSAAGMHEALKLAERPERPECVLQNSDYCRKKGHDS
974564,P50129,ATCJEKKXEJVYOB-UHFFFAOYSA-N,Kd,2.042,nM,ChEMBL,CHEMBL2490,CHEMBL380330,18534847,CHEMBL380330,44408818.0,C19H23NO,281.399,"6-methoxy-11-methyl-11-azatricyclo[12.4.0.03,8]octadeca-1(18),3(8),4,6,14,16-hexaene",CN1CCC2=CC=CC=C2CC3=C(CC1)C=C(C=C3)OC,CN1CCC2=CC=CC=C2CC3=C(CC1)C=C(C=C3)OC,"InChI=1S/C19H23NO/c1-20-11-9-15-5-3-4-6-16(15)13-17-7-8-19(21-2)14-18(17)10-12-20/h3-8,14H,9-13H2,1-2H3",4.1,0.0,2.0,5-hydroxytryptamine receptor 2A,HTR2A,Sus scrofa (Pig),MDVLCEENTSLSSPTNSFMQLNDDTRLYHNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPPCFSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHRRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQTGQKENSKQDDKATENDCTMVALGKQHSEDAPADNSNTVNEKVSCV
975122,Q62758,SKYGATVDBNOBSE-FZMZJTMJSA-N,Kd,7.413,nM,ChEMBL,CHEMBL4317,CHEMBL202434,16451077,SC 53606,133999.0,C16H19ClN4O,318.805,"6-chloro-N-[[(1S,8S)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl]imidazo[1,2-a]pyridine-8-carboxamide",C1CC2C(CCN2C1)CNC(=O)C3=CC(=CN4C3=NC=C4)Cl,C1C[C@H]2[C@@H](CCN2C1)CNC(=O)C3=CC(=CN4C3=NC=C4)Cl,"InChI=1S/C16H19ClN4O/c17-12-8-13(15-18-4-7-21(15)10-12)16(22)19-9-11-3-6-20-5-1-2-14(11)20/h4,7-8,10-11,14H,1-3,5-6,9H2,(H,19,22)/t11-,14-/m0/s1",2.6,1.0,3.0,5-hydroxytryptamine receptor 4,Htr4,Rattus norvegicus (Rat),MDRLDANVSSNEGFGSVEKVVLLTFFAMVILMAILGNLLVMVAVCRDRQLRKIKTNYFIVSLAFADLLVSVLVNAFGAIELVQDIWFYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDVIEKRKFNHNSNSTFCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAQQIQMLQRAGATSESRPQTADQHSTHRMRTETKAAKTLCVIMGCFCFCWAPFFVTNIVDPFIDYTVPEKVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYKRPPILGQTVPCSTTTINGSTHVLRDTVECGGQWESRCHLTATSPLVAAQPVIRRPQDNDLEDSCSLKRSQS
975609,Q62758,HSJJCSVABNNXON-JSGCOSHPSA-N,Kd,2.754,nM,ChEMBL,CHEMBL4317,CHEMBL383577,16451077,CHEMBL383577,11522273.0,C17H21N3O2,299.374,"[(1R,8S)-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl]methyl 1-methylindazole-3-carboxylate",CN1C2=CC=CC=C2C(=N1)C(=O)OCC3CCN4C3CCC4,CN1C2=CC=CC=C2C(=N1)C(=O)OC[C@@H]3CCN4[C@H]3CCC4,"InChI=1S/C17H21N3O2/c1-19-15-6-3-2-5-13(15)16(18-19)17(21)22-11-12-8-10-20-9-4-7-14(12)20/h2-3,5-6,12,14H,4,7-11H2,1H3/t12-,14-/m0/s1",2.7,0.0,4.0,5-hydroxytryptamine receptor 4,Htr4,Rattus norvegicus (Rat),MDRLDANVSSNEGFGSVEKVVLLTFFAMVILMAILGNLLVMVAVCRDRQLRKIKTNYFIVSLAFADLLVSVLVNAFGAIELVQDIWFYGEMFCLVRTSLDVLLTTASIFHLCCISLDRYYAICCQPLVYRNKMTPLRIALMLGGCWVIPMFISFLPIMQGWNNIGIVDVIEKRKFNHNSNSTFCVFMVNKPYAITCSVVAFYIPFLLMVLAYYRIYVTAKEHAQQIQMLQRAGATSESRPQTADQHSTHRMRTETKAAKTLCVIMGCFCFCWAPFFVTNIVDPFIDYTVPEKVWTAFLWLGYINSGLNPFLYAFLNKSFRRAFLIILCCDDERYKRPPILGQTVPCSTTTINGSTHVLRDTVECGGQWESRCHLTATSPLVAAQPVIRRPQDNDLEDSCSLKRSQS
975994,P30994,UVEGZSXIBVSOJB-UHFFFAOYSA-N,Kd,75.86,nM,ChEMBL,CHEMBL323,CHEMBL177800,7411554,CHEMBL177800,44385952.0,C11H17NO2,195.262,5-(2-aminopropyl)-4-methoxy-2-methylphenol,CC1=CC(=C(C=C1O)CC(C)N)OC,CC1=CC(=C(C=C1O)CC(C)N)OC,"InChI=1S/C11H17NO2/c1-7-4-11(14-3)9(5-8(2)12)6-10(7)13/h4,6,8,13H,5,12H2,1-3H3",1.9,2.0,3.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
975995,P30994,UVEGZSXIBVSOJB-UHFFFAOYSA-N,Kd,12.3,nM,ChEMBL,CHEMBL323,CHEMBL177800,7411554,CHEMBL177800,44385952.0,C11H17NO2,195.262,5-(2-aminopropyl)-4-methoxy-2-methylphenol,CC1=CC(=C(C=C1O)CC(C)N)OC,CC1=CC(=C(C=C1O)CC(C)N)OC,"InChI=1S/C11H17NO2/c1-7-4-11(14-3)9(5-8(2)12)6-10(7)13/h4,6,8,13H,5,12H2,1-3H3",1.9,2.0,3.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976116,P30994,DLVXCUGDQCNSLY-UHFFFAOYSA-N,Kd,>10000,nM,ChEMBL,CHEMBL323,CHEMBL111509,11754579,CHEMBL111509,10810641.0,C24H27FN2O2,394.49,"3-[[4-[4-(4-fluorophenyl)-4-oxobutyl]piperazin-1-yl]methyl]-2,3-dihydroinden-1-one",C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)CC3CC(=O)C4=CC=CC=C34,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)CC3CC(=O)C4=CC=CC=C34,"InChI=1S/C24H27FN2O2/c25-20-9-7-18(8-10-20)23(28)6-3-11-26-12-14-27(15-13-26)17-19-16-24(29)22-5-2-1-4-21(19)22/h1-2,4-5,7-10,19H,3,6,11-17H2",3.1,0.0,5.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976208,P30994,QKOGDLJCRXBSED-UHFFFAOYSA-N,Kd,501.19,nM,ChEMBL,CHEMBL323,CHEMBL164471,11754579,CHEMBL164471,10022781.0,C22H23FN2O3,382.435,"5-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-6,7-dihydro-5H-1-benzofuran-4-one",C1CC2=C(C=CO2)C(=O)C1CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,C1CC2=C(C=CO2)C(=O)C1CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"InChI=1S/C22H23FN2O3/c23-16-2-3-17-20(13-16)28-24-21(17)14-5-9-25(10-6-14)11-7-15-1-4-19-18(22(15)26)8-12-27-19/h2-3,8,12-15H,1,4-7,9-11H2",3.7,0.0,6.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976223,P30994,FLXRQZHNCDCQLM-UHFFFAOYSA-N,Kd,1819.7,nM,ChEMBL,CHEMBL323,CHEMBL357517,11101359,CHEMBL357517,10710246.0,C17H20N4O2,312.373,"6-[(4-pyrimidin-2-ylpiperazin-1-yl)methyl]-6,7-dihydro-5H-1-benzofuran-4-one",C1CN(CCN1CC2CC3=C(C=CO3)C(=O)C2)C4=NC=CC=N4,C1CN(CCN1CC2CC3=C(C=CO3)C(=O)C2)C4=NC=CC=N4,"InChI=1S/C17H20N4O2/c22-15-10-13(11-16-14(15)2-9-23-16)12-20-5-7-21(8-6-20)17-18-3-1-4-19-17/h1-4,9,13H,5-8,10-12H2",1.3,0.0,6.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976224,P30994,FLXRQZHNCDCQLM-UHFFFAOYSA-N,Kd,977.24,nM,ChEMBL,CHEMBL323,CHEMBL357517,11754579,CHEMBL357517,10710246.0,C17H20N4O2,312.373,"6-[(4-pyrimidin-2-ylpiperazin-1-yl)methyl]-6,7-dihydro-5H-1-benzofuran-4-one",C1CN(CCN1CC2CC3=C(C=CO3)C(=O)C2)C4=NC=CC=N4,C1CN(CCN1CC2CC3=C(C=CO3)C(=O)C2)C4=NC=CC=N4,"InChI=1S/C17H20N4O2/c22-15-10-13(11-16-14(15)2-9-23-16)12-20-5-7-21(8-6-20)17-18-3-1-4-19-17/h1-4,9,13H,5-8,10-12H2",1.3,0.0,6.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976356,P30994,RPRUYWDHAFSOLB-UHFFFAOYSA-N,Kd,302,nM,ChEMBL,CHEMBL323,CHEMBL174449,7411554,CHEMBL174449,12611615.0,C18H23NO2,285.387,"2-(5-methoxy-2-phenylmethoxyphenyl)-N,N-dimethylethanamine",CN(C)CCC1=C(C=CC(=C1)OC)OCC2=CC=CC=C2,CN(C)CCC1=C(C=CC(=C1)OC)OCC2=CC=CC=C2,"InChI=1S/C18H23NO2/c1-19(2)12-11-16-13-17(20-3)9-10-18(16)21-14-15-7-5-4-6-8-15/h4-10,13H,11-12,14H2,1-3H3",3.7,0.0,3.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976357,P30994,RPRUYWDHAFSOLB-UHFFFAOYSA-N,Kd,3630.78,nM,ChEMBL,CHEMBL323,CHEMBL174449,7411554,CHEMBL174449,12611615.0,C18H23NO2,285.387,"2-(5-methoxy-2-phenylmethoxyphenyl)-N,N-dimethylethanamine",CN(C)CCC1=C(C=CC(=C1)OC)OCC2=CC=CC=C2,CN(C)CCC1=C(C=CC(=C1)OC)OCC2=CC=CC=C2,"InChI=1S/C18H23NO2/c1-19(2)12-11-16-13-17(20-3)9-10-18(16)21-14-15-7-5-4-6-8-15/h4-10,13H,11-12,14H2,1-3H3",3.7,0.0,3.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976393,P30994,VBAHFEPKESUPDE-UHFFFAOYSA-N,Kd,2884.03,nM,ChEMBL,CHEMBL323,CHEMBL16451,7310818,1-(2-methoxyphenyl)propan-2-amine,159755.0,C10H15NO,165.236,1-(2-methoxyphenyl)propan-2-amine,CC(CC1=CC=CC=C1OC)N,CC(CC1=CC=CC=C1OC)N,"InChI=1S/C10H15NO/c1-8(11)7-9-5-3-4-6-10(9)12-2/h3-6,8H,7,11H2,1-2H3",2.1,1.0,2.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976422,P30994,PACCFUOVGUNDLQ-UHFFFAOYSA-N,Kd,138.04,nM,ChEMBL,CHEMBL323,CHEMBL137933,6581313,CHEMBL137933,44359525.0,C14H19N,201.313,6-methyl-1-(3-methylbutyl)indole,CC1=CC2=C(C=C1)C=CN2CCC(C)C,CC1=CC2=C(C=C1)C=CN2CCC(C)C,"InChI=1S/C14H19N/c1-11(2)6-8-15-9-7-13-5-4-12(3)10-14(13)15/h4-5,7,9-11H,6,8H2,1-3H3",4.0,0.0,0.0,5-hydroxytryptamine receptor 2B,Htr2b,Rattus norvegicus (Rat),MASSYKMSEQSTISEHILQKTCDHLILTDRSGLKAESAAEEMKQTAENQGNTVHWAALLIFAVIIPTIGGNILVILAVSLEKRLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEATWPLPLALCPAWLFLDVLFSTASIMHLCAISLDRYIAIKKPIQANQCNSRTTAFVKITVVWLISIGIAIPVPIKGIEADVVNAHNITCELTKDRFGSFMLFGSLAAFFAPLTIMIVTYFLTIHALRKKAYLVRNRPPQRLTRWTVSTVLQREDSSFSSPEKMVMLDGSHKDKILPNSTDETLMRRMSSAGKKPAQTISNEQRASKVLGIVFLFFLLMWCPFFITNVTLALCDSCNQTTLKTLLQIFVWVGYVSSGVNPLIYTLFNKTFREAFGRYITCNYQATKSVKVLRKCSSTLYFGNSMVENSKFFTKHGIRNGINPAMYQSPVRLRSSTIQSSSIILLNTFLTENDGDKVEDQVSYI
976480,P35370,PULGYDLMFSFVBL-SMFNREODSA-N,Kd,0.1,nM,ChEMBL,CHEMBL4503,CHEMBL396460,10782696,BDBM21842,44361543.0,C79H129N27O22,1809.068,"(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoic acid",CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N,C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)O,"InChI=1S/C79H129N27O22/c1-41(2)33-54(72(122)95-44(5)66(116)103-56(36-59(84)110)73(123)102-53(77(127)128)27-28-58(83)109)104-70(120)49(23-13-15-29-80)100-69(119)52(26-18-32-90-79(87)88)99-65(115)43(4)96-75(125)57(40-107)105-71(121)50(24-14-16-30-81)101-68(118)51(25-17-31-89-78(85)86)98-64(114)42(3)94-61(112)39-93-76(126)63(45(6)108)106-74(124)55(35-47-21-11-8-12-22-47)97-62(113)38-91-60(111)37-92-67(117)48(82)34-46-19-9-7-10-20-46/h7-12,19-22,41-45,48-57,63,107-108H,13-18,23-40,80-82H2,1-6H3,(H2,83,109)(H2,84,110)(H,91,111)(H,92,117)(H,93,126)(H,94,112)(H,95,122)(H,96,125)(H,97,113)(H,98,114)(H,99,115)(H,100,119)(H,101,118)(H,102,123)(H,103,116)(H,104,120)(H,105,121)(H,106,124)(H,127,128)(H4,85,86,89)(H4,87,88,90)/t42-,43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-/m0/s1",-11.0,28.0,27.0,Nociceptin receptor,Oprl1,Rattus norvegicus (Rat),MESLFPAPYWEVLYGSHFQGNLSLLNETVPHHLLLNASHSAFLPLGLKVTIVGLYLAVCIGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPAPQDYWGPVFAICIFLFSFIIPVLIISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLVQGLGVQPGSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASSLHREMQVSDRVRSIAKDVGLGCKTSETVPRPA
978320,O70526,HYDMCZYUJWEDCS-XOELGGNHSA-N,Kd,3981.07,nM,ChEMBL,CHEMBL4111,CHEMBL264517,9986712,CHEMBL264517,44354176.0,C46H76N12O8,925.19,"(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[12-[[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]dodecanoylamino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid",C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)CCCCCCCCCCCNC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)O,C1CC[C@H]2[C@@H](C1)C[C@H](N2C(=O)[C@H]3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)CCCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)C(=O)O,"InChI=1S/C46H76N12O8/c47-33(19-14-24-53-45(48)49)40(61)56-34(20-15-25-54-46(50)51)41(62)52-23-13-7-5-3-1-2-4-6-8-22-39(60)55-35(29-59)42(63)57-28-32-18-10-9-16-30(32)26-37(57)43(64)58-36-21-12-11-17-31(36)27-38(58)44(65)66/h9-10,16,18,31,33-38,59H,1-8,11-15,17,19-29,47H2,(H,52,62)(H,55,60)(H,56,61)(H,65,66)(H4,48,49,53)(H4,50,51,54)/t31-,33+,34-,35-,36-,37+,38-/m0/s1",-0.9,10.0,11.0,B2 bradykinin receptor,BDKRB2,Cavia porcellus (Guinea pig),MFNITSQVSALNATLAQGNSCLDAEWWSWLNTIQAPFLWVLFVLAVLENIFVLSVFFLHKSSCTVAEIYLGNLAVADLILAFGLPFWAITIANNFDWLFGEVLCRMVNTMIQMNMYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLVIWGCALLLSSPMLVFRTMKDYRDEGHNVTACLIIYPSLTWQVFTNVLLNLVGFLLPLSIITFCTVQIMQVLRNNEMQKFKEIQTERRATVLVLAVLLLFVVCWLPFQIGTFLDTLRLLGFLPGCWEHVIDLITQISSYLAYSNSCLNPLVYVIVGKRFRKKSREVYHGLCRSGGCVSEPAQSENSMGTLRTSISVDRQIHKLQDWARSSSEGTPPGLL
978917,Q62053,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,19.9526231496888,nM,IUPHAR,341,1916,14699136,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP2 subtype,Ptger2,Mus musculus (Mouse),MDNFLNDSKLMEDCKSRQWLLSGESPAISSVMFSAGVLGNLIALALLARRWRGDTGCSAGSRTSISLFHVLVTELVLTDLLGTCLISPVVLASYSRNQTLVALAPESHACTYFAFTMTFFSLATMLMLFAMALERYLSIGYPYFYRRHLSRRGGLAVLPVIYGASLLFCSLPLLNYGEYVQYCPGTWCFIRHGRTAYLQLYATMLLLLIVAVLACNISVILNLIRMHRRSRRSRCGLSGSSLRGPGSRRRGERTSMAEETDHLILLAIMTITFAICSLPFTIFAYMDETSSLKEKWDLRALRFLSVNSIIDPWVFAILRPPVLRLMRSVLCCRTSLRTQEAQQTSCSTQSSASKQTDLCGQL
979533,P30557,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,1.4,nM,IUPHAR,342,1883,9313928,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,Ptger3,Mus musculus (Mouse),MASMWAPEHSAEAHSNLSSTTDDCGSVSVAFPITMMVTGFVGNALAMLLVSRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTSPVVILVYLSQRRWEQLDPSGRLCTFFGLTMTVFGLSSLLVASAMAVERALAIRAPHWYASHMKTRATPVLLGVWLSVLAFALLPVLGVGRYSVQWPGTWCFISTGPAGNETDPAREPGSVAFASAFACLGLLALVVTFACNLATIKALVSRCRAKAAVSQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQMSVEQCKTQMGKEKECNSFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRDHTNYASSSTSLPCPGSSALMWSDQLER
982090,O08726,DOHGPSDHRIKTDB-KBAHWNQNSA-N,Kd,>10000,nM,IUPHAR,244,6119,"15240875,15944002",galmic,24748735.0,C51H60N10O11,989.1,"methyl (2S)-6-amino-2-[[(4R,11R,18R)-11-(cyclohexylmethylcarbamoyl)-18-(9H-fluoren-9-ylcarbamoyl)-4,7,11,14,18,21-hexamethyl-2,9,16-trioxo-6,13,20-trioxa-3,10,17,22,23,24-hexazatetracyclo[17.2.1.15,8.112,15]tetracosa-1(21),5(24),7,12(23),14,19(22)-hexaene-4-carbonyl]amino]hexanoate",CC1=C2C(=O)NC(C3=NC(=C(O3)C)C(=O)NC(C4=NC(=C(O4)C)C(=O)NC(C(=N2)O1)(C)C(=O)NCC5CCCCC5)(C)C(=O)NC(CCCCN)C(=O)OC)(C)C(=O)NC6C7=CC=CC=C7C8=CC=CC=C68,CC1=C2C(=O)N[C@@](C3=NC(=C(O3)C)C(=O)N[C@@](C4=NC(=C(O4)C)C(=O)N[C@@](C(=N2)O1)(C)C(=O)NCC5CCCCC5)(C)C(=O)N[C@@H](CCCCN)C(=O)OC)(C)C(=O)NC6C7=CC=CC=C7C8=CC=CC=C68,"InChI=1S/C51H60N10O11/c1-26-36-41(64)61-51(6,45(68)55-38-32-21-13-11-19-30(32)31-20-12-14-22-33(31)38)48-58-37(28(3)72-48)40(63)60-50(5,44(67)54-34(42(65)69-7)23-15-16-24-52)47-57-35(27(2)71-47)39(62)59-49(4,46(56-36)70-26)43(66)53-25-29-17-9-8-10-18-29/h11-14,19-22,29,34,38H,8-10,15-18,23-25,52H2,1-7H3,(H,53,66)(H,54,67)(H,55,68)(H,59,62)(H,60,63)(H,61,64)/t34-,49-,50-,51-/m0/s1",4.4,7.0,15.0,Galanin receptor type 2,Galr2,Rattus norvegicus (Rat),MNGSGSQGAENTSQEGGSGGWQPEAVLVPLFFALIFLVGTVGNALVLAVLLRGGQAVSTTNLFILNLGVADLCFILCCVPFQATIYTLDDWVFGSLLCKAVHFLIFLTMHASSFTLAAVSLDRYLAIRYPLHSRELRTPRNALAAIGLIWGLALLFSGPYLSYYRQSQLANLTVCHPAWSAPRRRAMDLCTFVFSYLLPVLVLSLTYARTLRYLWRTVDPVTAGSGSQRAKRKVTRMIIIVAVLFCLCWMPHHALILCVWFGRFPLTRATYALRILSHLVSYANSCVNPIVYALVSKHFRKGFRKICAGLLRPAPRRASGRVSILAPGNHSGSMLEQESTDLTQVSEAAGPLVPPPALPNCTASSRTLDPAC
982151,P47211,YWWOWEJNZKADMM-INAUZTMPSA-N,Kd,0.4,nM,ChEMBL,CHEMBL4894,CHEMBL499179,19053761,CID 44587986,44587986.0,C136H205N41O41,3070.382,"(3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[(2S)-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutanoic acid",CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC6=CNC7=CC=CC=C76)NC(=O)CN)O,"InChI=1S/C136H205N41O41/c1-64(2)38-83(162-119(201)85(40-66(5)6)163-121(203)87(43-74-31-33-78(183)34-32-74)158-104(188)55-148-112(194)69(11)154-129(211)96(59-178)172-125(207)94(49-102(141)186)167-120(202)86(41-67(7)8)170-134(216)110(71(13)181)175-128(210)89(156-103(187)51-138)44-75-52-147-80-27-19-18-26-79(75)80)114(196)151-58-107(191)177-37-23-30-99(177)132(214)169-90(45-76-53-144-62-152-76)118(200)155-70(12)113(195)174-109(68(9)10)133(215)150-57-106(190)159-93(48-101(140)185)124(206)165-91(46-77-54-145-63-153-77)123(205)161-82(29-22-36-146-136(142)143)117(199)171-97(60-179)130(212)164-88(42-73-24-16-15-17-25-73)122(204)173-98(61-180)131(213)168-95(50-108(192)193)126(208)160-81(28-20-21-35-137)116(198)166-92(47-100(139)184)115(197)149-56-105(189)157-84(39-65(3)4)127(209)176-111(72(14)182)135(217)218/h15-19,24-27,31-34,52-54,62-72,81-99,109-111,147,178-183H,20-23,28-30,35-51,55-61,137-138H2,1-14H3,(H2,139,184)(H2,140,185)(H2,141,186)(H,144,152)(H,145,153)(H,148,194)(H,149,197)(H,150,215)(H,151,196)(H,154,211)(H,155,200)(H,156,187)(H,157,189)(H,158,188)(H,159,190)(H,160,208)(H,161,205)(H,162,201)(H,163,203)(H,164,212)(H,165,206)(H,166,198)(H,167,202)(H,168,213)(H,169,214)(H,170,216)(H,171,199)(H,172,207)(H,173,204)(H,174,195)(H,175,210)(H,176,209)(H,192,193)(H,217,218)(H4,142,143,146)/t69-,70-,71+,72+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,109-,110-,111-/m0/s1",-14.6,46.0,46.0,Galanin receptor type 1,GALR1,Homo sapiens (Human),MELAVGNLSEGNASWPEPPAPEPGPLFGIGVENFVTLVVFGLIFALGVLGNSLVITVLARSKPGKPRSTTNLFILNLSIADLAYLLFCIPFQATVYALPTWVLGAFICKFIHYFFTVSMLVSIFTLAAMSVDRYVAIVHSRRSSSLRVSRNALLGVGCIWALSIAMASPVAYHQGLFHPRASNQTFCWEQWPDPRHKKAYVVCTFVFGYLLPLLLICFCYAKVLNHLHKKLKNMSKKSEASKKKTAQTVLVVVVVFGISWLPHHIIHLWAEFGVFPLTPASFLFRITAHCLAYSNSSVNPIIYAFLSENFRKAYKQVFKCHIRKDSHLSDTKESKSRIDTPPSTNCTHV
982289,P47211,JREYXTUFVSQVCZ-ZKEPBWIVSA-N,Kd,879,nM,ChEMBL,CHEMBL4894,CHEMBL506210,19053761,WTLNSAGYLL,11953323.0,C54H80N12O15,1137.303,"(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoic acid",CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)O,"InChI=1S/C54H80N12O15/c1-26(2)17-37(49(75)64-41(54(80)81)19-28(5)6)61-50(76)39(20-31-13-15-33(69)16-14-31)60-44(71)24-58-46(72)29(7)59-52(78)42(25-67)65-51(77)40(22-43(56)70)62-48(74)38(18-27(3)4)63-53(79)45(30(8)68)66-47(73)35(55)21-32-23-57-36-12-10-9-11-34(32)36/h9-16,23,26-30,35,37-42,45,57,67-69H,17-22,24-25,55H2,1-8H3,(H2,56,70)(H,58,72)(H,59,78)(H,60,71)(H,61,76)(H,62,74)(H,63,79)(H,64,75)(H,65,77)(H,66,73)(H,80,81)/t29-,30+,35-,37-,38-,39-,40-,41-,42-,45-/m0/s1",-2.1,16.0,16.0,Galanin receptor type 1,GALR1,Homo sapiens (Human),MELAVGNLSEGNASWPEPPAPEPGPLFGIGVENFVTLVVFGLIFALGVLGNSLVITVLARSKPGKPRSTTNLFILNLSIADLAYLLFCIPFQATVYALPTWVLGAFICKFIHYFFTVSMLVSIFTLAAMSVDRYVAIVHSRRSSSLRVSRNALLGVGCIWALSIAMASPVAYHQGLFHPRASNQTFCWEQWPDPRHKKAYVVCTFVFGYLLPLLLICFCYAKVLNHLHKKLKNMSKKSEASKKKTAQTVLVVVVVFGISWLPHHIIHLWAEFGVFPLTPASFLFRITAHCLAYSNSSVNPIIYAFLSENFRKAYKQVFKCHIRKDSHLSDTKESKSRIDTPPSTNCTHV
984207,Q9UBY5,VWFJDQUYCIWHTN-FBXUGWQNSA-N,Kd,154.881661891248,nM,IUPHAR,274,2910,17092771,"2-cis,6-cis-farnesyl diphosphate",11132720.0,C15H28O7P2,382.33,"phosphono [(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl] hydrogen phosphate",CC(=CCCC(=CCCC(=CCOP(=O)(O)OP(=O)(O)O)C)C)C,CC(=CCC/C(=C\CC/C(=C\COP(=O)(O)OP(=O)(O)O)/C)/C)C,"InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/b14-9-,15-11-",2.6,3.0,7.0,Lysophosphatidic acid receptor 3,LPAR3,Homo sapiens (Human),MNECHYDKHMDFFYNRSNTDTVDDWTGTKLVIVLCVGTFFCLFIFFSNSLVIAAVIKNRKFHFPFYYLLANLAAADFFAGIAYVFLMFNTGPVSKTLTVNRWFLRQGLLDSSLTASLTNLLVIAVERHMSIMRMRVHSNLTKKRVTLLILLVWAIAIFMGAVPTLGWNCLCNISACSSLAPIYSRSYLVFWTVSNLMAFLIMVVVYLRIYVYVKRKTNVLSPHTSGSISRRRTPMKLMKTVMTVLGAFVVCWTPGLVVLLLDGLNCRQCGVQHVKRWFLLLALLNSVVNPIIYSYKDEDMYGTMKKMICCFSQENPERRPSRIPSTVLSRSDTGSQYIEDSISQGAVCNKSTS
986533,P35375,WCTJTYALDQBUBV-UHFFFAOYSA-N,Kd,2630.27,nM,ChEMBL,CHEMBL2181,CHEMBL2315054,23218714,CHEMBL2315054,24753314.0,C20H15Cl2FN2O2,405.25,6-[[5-chloro-2-[(4-chloro-2-fluorophenyl)methoxy]phenyl]methyl]pyridine-2-carboxamide,C1=CC(=NC(=C1)CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F)C(=O)N,C1=CC(=NC(=C1)CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F)C(=O)N,"InChI=1S/C20H15Cl2FN2O2/c21-14-6-7-19(27-11-12-4-5-15(22)10-17(12)23)13(8-14)9-16-2-1-3-18(25-16)20(24)26/h1-8,10H,9,11H2,(H2,24,26)",4.8,1.0,4.0,Prostaglandin E2 receptor EP1 subtype,Ptger1,Mus musculus (Mouse),MSPCGLNLSLADEAATCATPRLPNTSVVLPTGDNGTSPALPIFSMTLGAVSNVLALALLAQVAGRMRRRRSAATFLLFVASLLAIDLAGHVIPGALVLRLYTAGRAPAGGACHFLGGCMVFFGLCPLLLGCGMAVERCVGVTQPLIHAARVSVARARLALAVLAAMALAVALLPLVHVGRYELQYPGTWCFISLGPRGGWRQALLAGLFAGLGLAALLAALVCNTLSGLALLRARWRRRRSRRFRKTAGPDDRRRWGSRGPRLASASSASSITSATATLRSSRGGGSARRVHAHDVEMVGQLVGIMVVSCICWSPLLVLVVLAIGGWNSNSLQRPLFLAVRLASWNQILDPWVYILLRQAMLRQLLRLLPLRVSAKGGPTELGLTKSAWEASSLRSSRHSGFSHL
986534,P35375,WCTJTYALDQBUBV-UHFFFAOYSA-N,Kd,2630,nM,ChEMBL,CHEMBL2181,CHEMBL2315054,23218714,CHEMBL2315054,24753314.0,C20H15Cl2FN2O2,405.25,6-[[5-chloro-2-[(4-chloro-2-fluorophenyl)methoxy]phenyl]methyl]pyridine-2-carboxamide,C1=CC(=NC(=C1)CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F)C(=O)N,C1=CC(=NC(=C1)CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F)C(=O)N,"InChI=1S/C20H15Cl2FN2O2/c21-14-6-7-19(27-11-12-4-5-15(22)10-17(12)23)13(8-14)9-16-2-1-3-18(25-16)20(24)26/h1-8,10H,9,11H2,(H2,24,26)",4.8,1.0,4.0,Prostaglandin E2 receptor EP1 subtype,Ptger1,Mus musculus (Mouse),MSPCGLNLSLADEAATCATPRLPNTSVVLPTGDNGTSPALPIFSMTLGAVSNVLALALLAQVAGRMRRRRSAATFLLFVASLLAIDLAGHVIPGALVLRLYTAGRAPAGGACHFLGGCMVFFGLCPLLLGCGMAVERCVGVTQPLIHAARVSVARARLALAVLAAMALAVALLPLVHVGRYELQYPGTWCFISLGPRGGWRQALLAGLFAGLGLAALLAALVCNTLSGLALLRARWRRRRSRRFRKTAGPDDRRRWGSRGPRLASASSASSITSATATLRSSRGGGSARRVHAHDVEMVGQLVGIMVVSCICWSPLLVLVVLAIGGWNSNSLQRPLFLAVRLASWNQILDPWVYILLRQAMLRQLLRLLPLRVSAKGGPTELGLTKSAWEASSLRSSRHSGFSHL
986600,P32240,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,2.5,nM,IUPHAR,343,1883,9313928,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP4 subtype,Ptger4,Mus musculus (Mouse),MAEVGGTIPRSNRELQRCVLLTTTIMSIPGVNASFSSTPERLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGDQALCDYSTFILLFFGLSGLSIICAMSIERYLAINHAYFYSHYVDKRLAGLTLFAIYASNVLFCALPNMGLGRSERQYPGTWCFIDWTTNVTAYAAFSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAAAVASVACRGHAGASPALQRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFINQLYQPNVVKDISRNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSGRDSSAQHCSESRRTSSAMSGHSRSFLARELKEISSTSQTLLYLPDLTESSLGGRNLLPGSHGMGLTQADTTSLRTLRISETSDSSQGQDSESVLLVDEVSGSHREEPASKGNSLQVTFPSETLKLSEKCI
987478,P25095,HYVAXSWWMCGPNH-UHFFFAOYSA-N,Kd,10,nM,ChEMBL,CHEMBL329,CHEMBL131365,18158200,CHEMBL131365,10094851.0,C27H27N3O3,441.531,2-[4-[(5-acetamido-2-butylbenzimidazol-1-yl)methyl]phenyl]benzoic acid,CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=CC(=C2)NC(=O)C,CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=CC(=C2)NC(=O)C,"InChI=1S/C27H27N3O3/c1-3-4-9-26-29-24-16-21(28-18(2)31)14-15-25(24)30(26)17-19-10-12-20(13-11-19)22-7-5-6-8-23(22)27(32)33/h5-8,10-16H,3-4,9,17H2,1-2H3,(H,28,31)(H,32,33)",5.1,2.0,4.0,Type-1A angiotensin II receptor,Agtr1,Rattus norvegicus (Rat),MALNSSAEDGIKRIQDDCPKAGRHSYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNHLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLMAGLASLPAVIHRNVYFIENTNITVCAFHYESRNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFRIIMAIVLFFFFSWVPHQIFTFLDVLIQLGVIHDCKISDIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSSLSTKMSTLSYRPSDNMSSSAKKPASCFEVE
991984,P43114,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,1,nM,IUPHAR,343,1916,9537820,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP4 subtype,Ptger4,Rattus norvegicus (Rat),MSIPGVNASFSSTPERLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGDQALCDYSTFILLFFGLSGLSIICAMSIERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGRSERQYPGTWCFIDWTTNVTAYAAFSYMYAGFSSFLILATVLCNVLVCGALLRMLRQFMRRTSLGTEQHHAAAAAAVASVACRGHAAASPALQRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFINQLYQPSVVKDISRNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSGRDGSAQHCSESRRTSSAMSGHSRSFLSRELREISSTSHTLLYLPDLTESSLGGKNLLPGTHGMGLTQADTTSLRTLRISETSDSSQGQDSESVLLVDEVSGSQREEPASKGNSLQVTFPSETLKLSEKCI
992296,Q62928,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,5.01187233627271 - 15.8489319246111,nM,IUPHAR,341,1916,"9537820,9440134",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP2 subtype,Ptger2,Rattus norvegicus (Rat),MDNSFNDSRRVENCESRQYLLSDESPAISSVMFTAGVLGNLIALALLARRWRGDTGCSAGSRTSISLFHVLVTELVLTDLLGTCLISPVVLASYSRNQTLVALAPESRACTYFAFTMTFFSLATMLMLFAMALERYLAIGHPYFYRRRVSRRGGLAVLPAIYGVSLLFCSLPLLNYGEYVQYCPGTWCFIQHGRTAYLQLYATVLLLLIVAVLGCNISVILNLIRMQLRSKRSRCGLSGSSLRGPGSRRRGERTSMAEETDHLILLAIMTITFAVCSLPFTIFAYMDETSSRKEKWDLRALRFLSVNSIIDPWVFVILRPPVLRLMRSVLCCRTSLRAPEAPGASCSTQQTDLCGQL
993327,P51679,XJIPRGACXFXEME-UHFFFAOYSA-N,Kd,1000,nM,ChEMBL,CHEMBL2414,CHEMBL2018964,23409871,CHEMBL2018964,59456102.0,C22H21ClN4O4S2,505.004,N-[[3-[[3-[(5-chlorothiophen-2-yl)sulfonylamino]-4-methoxyindazol-1-yl]methyl]phenyl]methyl]acetamide,CC(=O)NCC1=CC=CC(=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl,CC(=O)NCC1=CC=CC(=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl,"InChI=1S/C22H21ClN4O4S2/c1-14(28)24-12-15-5-3-6-16(11-15)13-27-17-7-4-8-18(31-2)21(17)22(25-27)26-33(29,30)20-10-9-19(23)32-20/h3-11H,12-13H2,1-2H3,(H,24,28)(H,25,26)",4.1,2.0,7.0,C-C chemokine receptor type 4,CCR4,Homo sapiens (Human),MNPTDIADTTLDESIYSNYYLYESIPKPCTKEGIKAFGELFLPPLYSLVFVFGLLGNSVVVLVLFKYKRLRSMTDVYLLNLAISDLLFVFSLPFWGYYAADQWVFGLGLCKMISWMYLVGFYSGIFFVMLMSIDRYLAIVHAVFSLRARTLTYGVITSLATWSVAVFASLPGFLFSTCYTERNHTYCKTKYSLNSTTWKVLSSLEINILGLVIPLGIMLFCYSMIIRTLQHCKNEKKNKAVKMIFAVVVLFLGFWTPYNIVLFLETLVELEVLQDCTFERYLDYAIQATETLAFVHCCLNPIIYFFLGEKFRKYILQLFKTCRGLFVLCQYCGLLQIYSADTPSSSYTQSTMDHDLHDAL
993330,P51679,XJIPRGACXFXEME-UHFFFAOYSA-N,Kd,1000,nM,ChEMBL,CHEMBL2414,CHEMBL2018964,22437117,CHEMBL2018964,59456102.0,C22H21ClN4O4S2,505.004,N-[[3-[[3-[(5-chlorothiophen-2-yl)sulfonylamino]-4-methoxyindazol-1-yl]methyl]phenyl]methyl]acetamide,CC(=O)NCC1=CC=CC(=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl,CC(=O)NCC1=CC=CC(=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl,"InChI=1S/C22H21ClN4O4S2/c1-14(28)24-12-15-5-3-6-16(11-15)13-27-17-7-4-8-18(31-2)21(17)22(25-27)26-33(29,30)20-10-9-19(23)32-20/h3-11H,12-13H2,1-2H3,(H,24,28)(H,25,26)",4.1,2.0,7.0,C-C chemokine receptor type 4,CCR4,Homo sapiens (Human),MNPTDIADTTLDESIYSNYYLYESIPKPCTKEGIKAFGELFLPPLYSLVFVFGLLGNSVVVLVLFKYKRLRSMTDVYLLNLAISDLLFVFSLPFWGYYAADQWVFGLGLCKMISWMYLVGFYSGIFFVMLMSIDRYLAIVHAVFSLRARTLTYGVITSLATWSVAVFASLPGFLFSTCYTERNHTYCKTKYSLNSTTWKVLSSLEINILGLVIPLGIMLFCYSMIIRTLQHCKNEKKNKAVKMIFAVVVLFLGFWTPYNIVLFLETLVELEVLQDCTFERYLDYAIQATETLAFVHCCLNPIIYFFLGEKFRKYILQLFKTCRGLFVLCQYCGLLQIYSADTPSSSYTQSTMDHDLHDAL
995994,Q16602,IDKKNSOZWQOAAS-KYJUHHDHSA-N,Kd,0.1445,nM,ChEMBL,CHEMBL3798,CHEMBL2035983,22607672,MK-8825,56944164.0,C31H30F2N6O3,572.617,"2-[(8R)-8-(3,5-difluorophenyl)-8-methyl-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(3S)-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-yl]acetamide",CC1(CNC2(CCCC2)C(=O)N1CC(=O)NC3=CN=C4CC5(CC4=C3)C6=C(NC5=O)N=CC=C6)C7=CC(=CC(=C7)F)F,C[C@]1(CNC2(CCCC2)C(=O)N1CC(=O)NC3=CN=C4C[C@@]5(CC4=C3)C6=C(NC5=O)N=CC=C6)C7=CC(=CC(=C7)F)F,"InChI=1S/C31H30F2N6O3/c1-29(19-10-20(32)12-21(33)11-19)17-36-31(6-2-3-7-31)28(42)39(29)16-25(40)37-22-9-18-13-30(14-24(18)35-15-22)23-5-4-8-34-26(23)38-27(30)41/h4-5,8-12,15,36H,2-3,6-7,13-14,16-17H2,1H3,(H,37,40)(H,34,38,41)/t29-,30-/m0/s1",1.9,3.0,8.0,Calcitonin gene-related peptide type 1 receptor,CALCRL,Homo sapiens (Human),MEKKCTLNFLVLLPFFMILVTAELEESPEDSIQLGVTRNKIMTAQYECYQKIMQDPIQQAEGVYCNRTWDGWLCWNDVAAGTESMQLCPDYFQDFDPSEKVTKICDQDGNWFRHPASNRTWTNYTQCNVNTHEKVKTALNLFYLTIIGHGLSIASLLISLGIFFYFKSLSCQRITLHKNLFFSFVCNSVVTIIHLTAVANNQALVATNPVSCKVSQFIHLYLMGCNYFWMLCEGIYLHTLIVVAVFAEKQHLMWYYFLGWGFPLIPACIHAIARSLYYNDNCWISSDTHLLYIIHGPICAALLVNLFFLLNIVRVLITKLKVTHQAESNLYMKAVRATLILVPLLGIEFVLIPWRPEGKIAEEVYDYIMHILMHFQGLLVSTIFCFFNGEVQAILRRNWNQYKIQFGNSFSNSEALRSASYTVSTISDGPGYSHDCPSEHLNGKSIHDIENVLLKPENLYN
999476,P50052,UCRMCWFIVZYPFA-LGXQCQDRSA-N,Kd,0.0398107520237631,nM,IUPHAR,35,585,"8242249,2775266",ang III,44299731.0,C40H60N12O11,884.993,(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid,CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N,CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,"InChI=1S/C40H60N12O11/c1-20(2)31(50-34(57)26(7-5-13-45-40(42)43)47-33(56)25(41)17-30(54)55)36(59)48-27(15-22-9-11-24(53)12-10-22)35(58)51-32(21(3)4)37(60)49-28(16-23-18-44-19-46-23)38(61)52-14-6-8-29(52)39(62)63/h9-12,18-21,25-29,31-32,53H,5-8,13-17,41H2,1-4H3,(H,44,46)(H,47,56)(H,48,59)(H,49,60)(H,50,57)(H,51,58)(H,54,55)(H,62,63)(H4,42,43,45)/t25-,26-,27-,28-,29-,31-,32-/m0/s1",-3.4,12.0,14.0,Type-2 angiotensin II receptor,AGTR2,Homo sapiens (Human),MKGNSTLATTSKNITSGLHFGLVNISGNNESTLNCSQKPSDKHLDAIPILYYIIFVIGFLVNIVVVTLFCCQKGPKKVSSIYIFNLAVADLLLLATLPLWATYYSYRYDWLFGPVMCKVFGSFLTLNMFASIFFITCMSVDRYQSVIYPFLSQRRNPWQASYIVPLVWCMACLSSLPTFYFRDVRTIEYLGVNACIMAFPPEKYAQWSAGIALMKNILGFIIPLIFIATCYFGIRKHLLKTNSYGKNRITRDQVLKMAAAVVLAFIICWLPFHVLTFLDALAWMGVINSCEVIAVIDLALPFAILLGFTNSCVNPFLYCFVGNRFQQKLRSVFRVPITWLQGKRESMSCRKSSSLREMETFVS
1001647,P25025,BDGUZDOTNGSANE-SSDOTTSWSA-N,Kd,1,nM,ChEMBL,CHEMBL2434,CHEMBL397237,17382543,CHEMBL397237,11440492.0,C15H15F2N5OS2,383.436,"(2R)-2-[[2-amino-5-[(2,3-difluorophenyl)methylsulfanyl]-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]amino]propan-1-ol",CC(CO)NC1=NC(=NC2=C1SC(=N2)N)SCC3=C(C(=CC=C3)F)F,C[C@H](CO)NC1=NC(=NC2=C1SC(=N2)N)SCC3=C(C(=CC=C3)F)F,"InChI=1S/C15H15F2N5OS2/c1-7(5-23)19-12-11-13(20-14(18)25-11)22-15(21-12)24-6-8-3-2-4-9(16)10(8)17/h2-4,7,23H,5-6H2,1H3,(H3,18,19,20,21,22)/t7-/m1/s1",3.3,3.0,10.0,C-X-C chemokine receptor type 2,CXCR2,Homo sapiens (Human),MEDFNMESDSFEDFWKGEDLSNYSYSSTLPPFLLDAAPCEPESLEINKYFVVIIYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLFALTLPIWAASKVNGWIFGTFLCKVVSLLKEVNFYSGILLLACISVDRYLAIVHATRTLTQKRYLVKFICLSIWGLSLLLALPVLLFRRTVYSSNVSPACYEDMGNNTANWRMLLRILPQSFGFIVPLLIMLFCYGFTLRTLFKAHMGQKHRAMRVIFAVVLIFLLCWLPYNLVLLADTLMRTQVIQETCERRNHIDRALDATEILGILHSCLNPLIYAFIGQKFRHGLLKILAIHGLISKDSLPKDSRPSFVGSSSGHTSTTL
1001649,P25025,BDGUZDOTNGSANE-SSDOTTSWSA-N,Kd,12.59,nM,ChEMBL,CHEMBL2434,CHEMBL397237,25708618,CHEMBL397237,11440492.0,C15H15F2N5OS2,383.436,"(2R)-2-[[2-amino-5-[(2,3-difluorophenyl)methylsulfanyl]-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]amino]propan-1-ol",CC(CO)NC1=NC(=NC2=C1SC(=N2)N)SCC3=C(C(=CC=C3)F)F,C[C@H](CO)NC1=NC(=NC2=C1SC(=N2)N)SCC3=C(C(=CC=C3)F)F,"InChI=1S/C15H15F2N5OS2/c1-7(5-23)19-12-11-13(20-14(18)25-11)22-15(21-12)24-6-8-3-2-4-9(16)10(8)17/h2-4,7,23H,5-6H2,1H3,(H3,18,19,20,21,22)/t7-/m1/s1",3.3,3.0,10.0,C-X-C chemokine receptor type 2,CXCR2,Homo sapiens (Human),MEDFNMESDSFEDFWKGEDLSNYSYSSTLPPFLLDAAPCEPESLEINKYFVVIIYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLFALTLPIWAASKVNGWIFGTFLCKVVSLLKEVNFYSGILLLACISVDRYLAIVHATRTLTQKRYLVKFICLSIWGLSLLLALPVLLFRRTVYSSNVSPACYEDMGNNTANWRMLLRILPQSFGFIVPLLIMLFCYGFTLRTLFKAHMGQKHRAMRVIFAVVLIFLLCWLPYNLVLLADTLMRTQVIQETCERRNHIDRALDATEILGILHSCLNPLIYAFIGQKFRHGLLKILAIHGLISKDSLPKDSRPSFVGSSSGHTSTTL
1002078,P25025,RGVHAQJTGULLAX-LLVKDONJSA-N,Kd,10,nM,ChEMBL,CHEMBL2434,CHEMBL3403851,25708618,CHEMBL3403851,10479451.0,C17H21ClFN5O3S2,461.955,N-[2-[(3-chloro-2-fluorophenyl)methylsulfanyl]-6-[[(2R)-1-hydroxypropan-2-yl]amino]pyrimidin-4-yl]azetidine-1-sulfonamide,CC(CO)NC1=CC(=NC(=N1)SCC2=C(C(=CC=C2)Cl)F)NS(=O)(=O)N3CCC3,C[C@H](CO)NC1=CC(=NC(=N1)SCC2=C(C(=CC=C2)Cl)F)NS(=O)(=O)N3CCC3,"InChI=1S/C17H21ClFN5O3S2/c1-11(9-25)20-14-8-15(23-29(26,27)24-6-3-7-24)22-17(21-14)28-10-12-4-2-5-13(18)16(12)19/h2,4-5,8,11,25H,3,6-7,9-10H2,1H3,(H2,20,21,22,23)/t11-/m1/s1",2.7,3.0,10.0,C-X-C chemokine receptor type 2,CXCR2,Homo sapiens (Human),MEDFNMESDSFEDFWKGEDLSNYSYSSTLPPFLLDAAPCEPESLEINKYFVVIIYALVFLLSLLGNSLVMLVILYSRVGRSVTDVYLLNLALADLLFALTLPIWAASKVNGWIFGTFLCKVVSLLKEVNFYSGILLLACISVDRYLAIVHATRTLTQKRYLVKFICLSIWGLSLLLALPVLLFRRTVYSSNVSPACYEDMGNNTANWRMLLRILPQSFGFIVPLLIMLFCYGFTLRTLFKAHMGQKHRAMRVIFAVVLIFLLCWLPYNLVLLADTLMRTQVIQETCERRNHIDRALDATEILGILHSCLNPLIYAFIGQKFRHGLLKILAIHGLISKDSLPKDSRPSFVGSSSGHTSTTL
1003541,O43603,YWWOWEJNZKADMM-INAUZTMPSA-N,Kd,2.3,nM,ChEMBL,CHEMBL3176,CHEMBL499179,19053761,CID 44587986,44587986.0,C136H205N41O41,3070.382,"(3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[(2S)-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutanoic acid",CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC6=CNC7=CC=CC=C76)NC(=O)CN)O,"InChI=1S/C136H205N41O41/c1-64(2)38-83(162-119(201)85(40-66(5)6)163-121(203)87(43-74-31-33-78(183)34-32-74)158-104(188)55-148-112(194)69(11)154-129(211)96(59-178)172-125(207)94(49-102(141)186)167-120(202)86(41-67(7)8)170-134(216)110(71(13)181)175-128(210)89(156-103(187)51-138)44-75-52-147-80-27-19-18-26-79(75)80)114(196)151-58-107(191)177-37-23-30-99(177)132(214)169-90(45-76-53-144-62-152-76)118(200)155-70(12)113(195)174-109(68(9)10)133(215)150-57-106(190)159-93(48-101(140)185)124(206)165-91(46-77-54-145-63-153-77)123(205)161-82(29-22-36-146-136(142)143)117(199)171-97(60-179)130(212)164-88(42-73-24-16-15-17-25-73)122(204)173-98(61-180)131(213)168-95(50-108(192)193)126(208)160-81(28-20-21-35-137)116(198)166-92(47-100(139)184)115(197)149-56-105(189)157-84(39-65(3)4)127(209)176-111(72(14)182)135(217)218/h15-19,24-27,31-34,52-54,62-72,81-99,109-111,147,178-183H,20-23,28-30,35-51,55-61,137-138H2,1-14H3,(H2,139,184)(H2,140,185)(H2,141,186)(H,144,152)(H,145,153)(H,148,194)(H,149,197)(H,150,215)(H,151,196)(H,154,211)(H,155,200)(H,156,187)(H,157,189)(H,158,188)(H,159,190)(H,160,208)(H,161,205)(H,162,201)(H,163,203)(H,164,212)(H,165,206)(H,166,198)(H,167,202)(H,168,213)(H,169,214)(H,170,216)(H,171,199)(H,172,207)(H,173,204)(H,174,195)(H,175,210)(H,176,209)(H,192,193)(H,217,218)(H4,142,143,146)/t69-,70-,71+,72+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,109-,110-,111-/m0/s1",-14.6,46.0,46.0,Galanin receptor type 2,GALR2,Homo sapiens (Human),MNVSGCPGAGNASQAGGGGGWHPEAVIVPLLFALIFLVGTVGNTLVLAVLLRGGQAVSTTNLFILNLGVADLCFILCCVPFQATIYTLDGWVFGSLLCKAVHFLIFLTMHASSFTLAAVSLDRYLAIRYPLHSRELRTPRNALAAIGLIWGLSLLFSGPYLSYYRQSQLANLTVCHPAWSAPRRRAMDICTFVFSYLLPVLVLGLTYARTLRYLWRAVDPVAAGSGARRAKRKVTRMILIVAALFCLCWMPHHALILCVWFGQFPLTRATYALRILSHLVSYANSCVNPIVYALVSKHFRKGFRTICAGLLGRAPGRASGRVCAAARGTHSGSVLERESSDLLHMSEAAGALRPCPGASQPCILEPCPGPSWQGPKAGDSILTVDVA
1003736,O43603,JREYXTUFVSQVCZ-ZKEPBWIVSA-N,Kd,1.8,nM,ChEMBL,CHEMBL3176,CHEMBL506210,19053761,WTLNSAGYLL,11953323.0,C54H80N12O15,1137.303,"(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoic acid",CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N)O,"InChI=1S/C54H80N12O15/c1-26(2)17-37(49(75)64-41(54(80)81)19-28(5)6)61-50(76)39(20-31-13-15-33(69)16-14-31)60-44(71)24-58-46(72)29(7)59-52(78)42(25-67)65-51(77)40(22-43(56)70)62-48(74)38(18-27(3)4)63-53(79)45(30(8)68)66-47(73)35(55)21-32-23-57-36-12-10-9-11-34(32)36/h9-16,23,26-30,35,37-42,45,57,67-69H,17-22,24-25,55H2,1-8H3,(H2,56,70)(H,58,72)(H,59,78)(H,60,71)(H,61,76)(H,62,74)(H,63,79)(H,64,75)(H,65,77)(H,66,73)(H,80,81)/t29-,30+,35-,37-,38-,39-,40-,41-,42-,45-/m0/s1",-2.1,16.0,16.0,Galanin receptor type 2,GALR2,Homo sapiens (Human),MNVSGCPGAGNASQAGGGGGWHPEAVIVPLLFALIFLVGTVGNTLVLAVLLRGGQAVSTTNLFILNLGVADLCFILCCVPFQATIYTLDGWVFGSLLCKAVHFLIFLTMHASSFTLAAVSLDRYLAIRYPLHSRELRTPRNALAAIGLIWGLSLLFSGPYLSYYRQSQLANLTVCHPAWSAPRRRAMDICTFVFSYLLPVLVLGLTYARTLRYLWRAVDPVAAGSGARRAKRKVTRMILIVAALFCLCWMPHHALILCVWFGQFPLTRATYALRILSHLVSYANSCVNPIVYALVSKHFRKGFRTICAGLLGRAPGRASGRVCAAARGTHSGSVLERESSDLLHMSEAAGALRPCPGASQPCILEPCPGPSWQGPKAGDSILTVDVA
1004485,Q91ZY1,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,125.892541179417,nM,IUPHAR,265,1247,11561071,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H4 receptor,Hrh4,Rattus norvegicus (Rat),MSESNGTDVLPLTAQVPLAFLMSLLAFAITIGNAVVILAFVADRNLRHRSNYFFLNLAISDFFVGVISIPLYIPHTLFNWNFGSGICMFWLITDYLLCTASVYSIVLISYDRYQSVSNAVRYRAQHTGILKIVAQMVAVWILAFLVNGPMILASDSWKNSTNTEECEPGFVTEWYILAITAFLEFLLPVSLVVYFSVQIYWSLWKRGSLSRCPSHAGFIATSSRGTGHSRRTGLACRTSLPGLKEPAASLHSESPRGKSSLLVSLRTHMSGSIIAFKVGSFCRSESPVLHQREHVELLRGRKLARSLAVLLSAFAICWAPYCLFTIVLSTYRRGERPKSIWYSIAFWLQWFNSLINPFLYPLCHRRFQKAFWKILCVTKQPAPSQTQSVSS
1005557,Q9UKP6,YZWMTFORQSIEAP-UHFFFAOYSA-N,Kd,100,nM,ChEMBL,CHEMBL3764,CHEMBL523566,18768319,CHEMBL523566,44580475.0,C16H19N3,253.349,"N-(2-methylbutyl)-5H-pyrido[4,3-b]indol-1-amine",CCC(C)CNC1=NC=CC2=C1C3=CC=CC=C3N2,CCC(C)CNC1=NC=CC2=C1C3=CC=CC=C3N2,"InChI=1S/C16H19N3/c1-3-11(2)10-18-16-15-12-6-4-5-7-13(12)19-14(15)8-9-17-16/h4-9,11,19H,3,10H2,1-2H3,(H,17,18)",4.3,2.0,2.0,Urotensin-2 receptor,UTS2R,Homo sapiens (Human),MALTPESPSSFPGLAATGSSVPEPPGGPNATLNSSWASPTEPSSLEDLVATGTIGTLLSAMGVVGVVGNAYTLVVTCRSLRAVASMYVYVVNLALADLLYLLSIPFIVATYVTKEWHFGDVGCRVLFGLDFLTMHASIFTLTVMSSERYAAVLRPLDTVQRPKGYRKLLALGTWLLALLLTLPVMLAMRLVRRGPKSLCLPAWGPRAHRAYLTLLFATSIAGPGLLIGLLYARLARAYRRSQRASFKRARRPGARALRLVLGIVLLFWACFLPFWLWQLLAQYHQAPLAPRTARIVNYLTTCLTYGNSCANPFLYTLLTRNYRDHLRGRVRGPGSGGGRGPVPSLQPRARFQRCSGRSLSSCSPQPTDSLVLAPAAPARPAPEGPRAPA
1009339,P25104,DZFNZWQGZFYCMN-JTXXMHATSA-N,Kd,2238.72,nM,ChEMBL,CHEMBL3374,CHEMBL402669,9379447,CHEMBL402669,44340064.0,C70H103N13O13,1334.672,(2R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hexadecanoyloxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-naphthalen-1-ylpropanoic acid,CCCCCCCCCCCCCCCC(=O)OCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC5=CC=CC=C54)C(=O)O)NC(=O)C,CCCCCCCCCCCCCCCC(=O)OC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@H](CC4=CC=CC5=CC=CC=C54)C(=O)O)NC(=O)C,"InChI=1S/C70H103N13O13/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-31-59(86)96-42-57(76-46(6)84)64(89)77-53(29-23-36-74-70(71)72)62(87)81-60(44(2)3)66(91)78-54(38-47-32-34-51(85)35-33-47)63(88)82-61(45(4)5)67(92)79-55(40-50-41-73-43-75-50)68(93)83-37-24-30-58(83)65(90)80-56(69(94)95)39-49-27-22-26-48-25-20-21-28-52(48)49/h20-22,25-28,32-35,41,43-45,53-58,60-61,85H,7-19,23-24,29-31,36-40,42H2,1-6H3,(H,73,75)(H,76,84)(H,77,89)(H,78,91)(H,79,92)(H,80,90)(H,81,87)(H,82,88)(H,94,95)(H4,71,72,74)/t53-,54-,55-,56+,57-,58-,60-,61-/m0/s1",9.5,12.0,15.0,Type-1 angiotensin II receptor,AGTR1,Bos taurus (Bovine),MILNSSTEDGIKRIQDDCPKAGRHNYIFIMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPTIIHRNVFFIENTNITVCAFHYESQNSTLPVGLGLTKNILGFLFPFLIILTSYTLIWKTLKKAYEIQKNKPRKDDIFKIILAIVLFFFFSWVPHQIFTFMDVLIQLGLIRDCKIEDIVDTAMPITICLAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSENGNSSTKKPAPCIEVE
1009416,P25104,KFYXYASZBFBMJE-XGTFHEKHSA-N,Kd,1548.82,nM,ChEMBL,CHEMBL3374,CHEMBL408098,9379447,CHEMBL408098,44340033.0,C66H107N13O10,1242.663,"(2R)-3-cyclohexa-1,5-dien-1-yl-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-octadecoxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid",CCCCCCCCCCCCCCCCCCOC1=CC=C(C=C1)CC(C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(CC4=CCCC=C4)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC,CCCCCCCCCCCCCCCCCCOC1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@H](CC4=CCCC=C4)C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC,"InChI=1S/C66H107N13O10/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-38-89-50-34-32-48(33-35-50)39-52(74-62(84)57(45(2)3)77-59(81)51(73-56(80)43-69-6)30-26-36-71-66(67)68)60(82)78-58(46(4)5)63(85)75-53(41-49-42-70-44-72-49)64(86)79-37-27-31-55(79)61(83)76-54(65(87)88)40-47-28-23-22-24-29-47/h23,28-29,32-35,42,44-46,51-55,57-58,69H,7-22,24-27,30-31,36-41,43H2,1-6H3,(H,70,72)(H,73,80)(H,74,84)(H,75,85)(H,76,83)(H,77,81)(H,78,82)(H,87,88)(H4,67,68,71)/t51-,52-,53-,54+,55-,57-,58-/m0/s1",7.9,11.0,13.0,Type-1 angiotensin II receptor,AGTR1,Bos taurus (Bovine),MILNSSTEDGIKRIQDDCPKAGRHNYIFIMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPTIIHRNVFFIENTNITVCAFHYESQNSTLPVGLGLTKNILGFLFPFLIILTSYTLIWKTLKKAYEIQKNKPRKDDIFKIILAIVLFFFFSWVPHQIFTFMDVLIQLGLIRDCKIEDIVDTAMPITICLAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSENGNSSTKKPAPCIEVE
1009456,P25104,GAFOXACHWRJHSW-NGDPIIIVSA-N,Kd,489.78,nM,ChEMBL,CHEMBL3374,CHEMBL406888,9379447,CHEMBL406888,10606411.0,C66H101N13O13,1284.612,(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hexadecanoyloxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid,CCCCCCCCCCCCCCCC(=O)OCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)O)NC(=O)C,CCCCCCCCCCCCCCCC(=O)OC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)NC(=O)C,"InChI=1S/C66H101N13O13/c1-7-8-9-10-11-12-13-14-15-16-17-18-22-29-55(82)92-40-53(72-44(6)80)60(85)73-49(27-23-34-70-66(67)68)58(83)77-56(42(2)3)62(87)74-50(36-46-30-32-48(81)33-31-46)59(84)78-57(43(4)5)63(88)75-51(38-47-39-69-41-71-47)64(89)79-35-24-28-54(79)61(86)76-52(65(90)91)37-45-25-20-19-21-26-45/h19-21,25-26,30-33,39,41-43,49-54,56-57,81H,7-18,22-24,27-29,34-38,40H2,1-6H3,(H,69,71)(H,72,80)(H,73,85)(H,74,87)(H,75,88)(H,76,86)(H,77,83)(H,78,84)(H,90,91)(H4,67,68,70)/t49-,50-,51-,52-,53-,54-,56-,57-/m0/s1",8.2,12.0,15.0,Type-1 angiotensin II receptor,AGTR1,Bos taurus (Bovine),MILNSSTEDGIKRIQDDCPKAGRHNYIFIMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPTIIHRNVFFIENTNITVCAFHYESQNSTLPVGLGLTKNILGFLFPFLIILTSYTLIWKTLKKAYEIQKNKPRKDDIFKIILAIVLFFFFSWVPHQIFTFMDVLIQLGLIRDCKIEDIVDTAMPITICLAYFNNCLNPLFYGFLGKKFKKYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSENGNSSTKKPAPCIEVE
1010151,Q8K4Z4,IUFUTNJTGYHQHZ-UHFFFAOYSA-N,Kd,186208.71,nM,ChEMBL,CHEMBL5414,CHEMBL174106,6134834,CHEMBL174106,13157412.0,C23H29N3O4,411.502,"1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-[4-(5-methyl-1H-imidazol-2-yl)phenoxy]propan-2-ol",CC1=CN=C(N1)C2=CC=C(C=C2)OCC(CNCCC3=CC(=C(C=C3)OC)OC)O,CC1=CN=C(N1)C2=CC=C(C=C2)OCC(CNCCC3=CC(=C(C=C3)OC)OC)O,"InChI=1S/C23H29N3O4/c1-16-13-25-23(26-16)18-5-7-20(8-6-18)30-15-19(27)14-24-11-10-17-4-9-21(28-2)22(12-17)29-3/h4-9,12-13,19,24,27H,10-11,14-15H2,1-3H3,(H,25,26)",2.8,3.0,6.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010214,Q8K4Z4,JWZZKOKVBUJMES-UHFFFAOYSA-N,Kd,17.78,nM,ChEMBL,CHEMBL5414,CHEMBL434,25592716,isoproterenol,3779.0,C11H17NO3,211.261,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol",CC(C)NCC(C1=CC(=C(C=C1)O)O)O,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",-0.6,4.0,4.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010229,Q8K4Z4,JWZZKOKVBUJMES-UHFFFAOYSA-N,Kd,25.12,nM,ChEMBL,CHEMBL5414,CHEMBL434,25592716,isoproterenol,3779.0,C11H17NO3,211.261,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol",CC(C)NCC(C1=CC(=C(C=C1)O)O)O,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",-0.6,4.0,4.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010347,Q8K4Z4,AQNDDEOPVVGCPG-UHFFFAOYSA-N,Kd,6309.57,nM,ChEMBL,CHEMBL5414,CHEMBL768,6130154,ESMOLOL,59768.0,C16H25NO4,295.379,methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,"InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3",1.9,2.0,5.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010641,Q8K4Z4,QNMDRPAWNOJQTC-UHFFFAOYSA-N,Kd,2.291,nM,ChEMBL,CHEMBL5414,CHEMBL3228931,34040,CHEMBL3228931,12484297.0,C13H19N3O2,249.314,1-(1H-benzimidazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,CC(C)NCC(COC1=CC=CC2=C1N=CN2)O,CC(C)NCC(COC1=CC=CC2=C1N=CN2)O,"InChI=1S/C13H19N3O2/c1-9(2)14-6-10(17)7-18-12-5-3-4-11-13(12)16-8-15-11/h3-5,8-10,14,17H,6-7H2,1-2H3,(H,15,16)",1.2,3.0,4.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010734,Q8K4Z4,RRGAEANAARFCJL-UHFFFAOYSA-N,Kd,10000,nM,ChEMBL,CHEMBL5414,CHEMBL156683,2882026,CHEMBL156683,44371562.0,C12H19NO3S,257.348,[2-hydroxy-3-(propan-2-ylamino)propyl] 2-thiophen-2-ylacetate,CC(C)NCC(COC(=O)CC1=CC=CS1)O,CC(C)NCC(COC(=O)CC1=CC=CS1)O,"InChI=1S/C12H19NO3S/c1-9(2)13-7-10(14)8-16-12(15)6-11-4-3-5-17-11/h3-5,9-10,13-14H,6-8H2,1-2H3",1.2,2.0,5.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010909,Q8K4Z4,LTSPETXJLSXLKS-UHFFFAOYSA-N,Kd,251188.64,nM,ChEMBL,CHEMBL5414,CHEMBL11219,2872332,CHEMBL11219,13621725.0,C20H31N5O3,389.5,1-butyl-3-[2-[[2-hydroxy-3-[4-(5-methyl-1H-imidazol-2-yl)phenoxy]propyl]amino]ethyl]urea,CCCCNC(=O)NCCNCC(COC1=CC=C(C=C1)C2=NC=C(N2)C)O,CCCCNC(=O)NCCNCC(COC1=CC=C(C=C1)C2=NC=C(N2)C)O,"InChI=1S/C20H31N5O3/c1-3-4-9-22-20(27)23-11-10-21-13-17(26)14-28-18-7-5-16(6-8-18)19-24-12-15(2)25-19/h5-8,12,17,21,26H,3-4,9-11,13-14H2,1-2H3,(H,24,25)(H2,22,23,27)",1.4,5.0,5.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1010932,Q8K4Z4,GCZOJYSLSKVFNN-UHFFFAOYSA-N,Kd,5248.07,nM,ChEMBL,CHEMBL5414,CHEMBL11307,2872332,CHEMBL11307,13621631.0,C23H28BrN3O4,490.398,"1-[4-(4-bromo-5-methyl-1H-imidazol-2-yl)phenoxy]-3-[2-(3,4-dimethoxyphenyl)ethylamino]propan-2-ol",CC1=C(N=C(N1)C2=CC=C(C=C2)OCC(CNCCC3=CC(=C(C=C3)OC)OC)O)Br,CC1=C(N=C(N1)C2=CC=C(C=C2)OCC(CNCCC3=CC(=C(C=C3)OC)OC)O)Br,"InChI=1S/C23H28BrN3O4/c1-15-22(24)27-23(26-15)17-5-7-19(8-6-17)31-14-18(28)13-25-11-10-16-4-9-20(29-2)21(12-16)30-3/h4-9,12,18,25,28H,10-11,13-14H2,1-3H3,(H,26,27)",3.9,3.0,6.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011006,Q8K4Z4,MJXGIIVJTPVZCW-UHFFFAOYSA-N,Kd,7.079,nM,ChEMBL,CHEMBL5414,CHEMBL67151,2903245,CHEMBL67151,2840793.0,C13H21NO2,223.316,1-(4-methylphenoxy)-3-(propan-2-ylamino)propan-2-ol,CC1=CC=C(C=C1)OCC(CNC(C)C)O,CC1=CC=C(C=C1)OCC(CNC(C)C)O,"InChI=1S/C13H21NO2/c1-10(2)14-8-12(15)9-16-13-6-4-11(3)5-7-13/h4-7,10,12,14-15H,8-9H2,1-3H3",1.7,2.0,3.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011020,Q8K4Z4,PAWPHGFYSPEYBZ-JKSUJKDBSA-N,Kd,25.12,nM,ChEMBL,CHEMBL5414,CHEMBL66324,2903245,CHEMBL66324,21595423.0,C16H25NO2,263.381,(1S)-2-(3-phenylpropoxy)-1-[(2S)-piperidin-2-yl]ethanol,C1CCNC(C1)C(COCCCC2=CC=CC=C2)O,C1CCN[C@@H](C1)[C@@H](COCCCC2=CC=CC=C2)O,"InChI=1S/C16H25NO2/c18-16(15-10-4-5-11-17-15)13-19-12-6-9-14-7-2-1-3-8-14/h1-3,7-8,15-18H,4-6,9-13H2/t15-,16+/m0/s1",2.3,2.0,3.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011090,Q8K4Z4,ZSRTVSDWWVDXRC-UHFFFAOYSA-N,Kd,1548.82,nM,ChEMBL,CHEMBL5414,CHEMBL11092,2872332,CHEMBL11092,13621593.0,C22H25BrClN3O4,510.813,"1-[4-(5-bromo-1H-imidazol-2-yl)-2-chlorophenoxy]-3-[2-(3,4-dimethoxyphenyl)ethylamino]propan-2-ol",COC1=C(C=C(C=C1)CCNCC(COC2=C(C=C(C=C2)C3=NC=C(N3)Br)Cl)O)OC,COC1=C(C=C(C=C1)CCNCC(COC2=C(C=C(C=C2)C3=NC=C(N3)Br)Cl)O)OC,"InChI=1S/C22H25BrClN3O4/c1-29-19-5-3-14(9-20(19)30-2)7-8-25-11-16(28)13-31-18-6-4-15(10-17(18)24)22-26-12-21(23)27-22/h3-6,9-10,12,16,25,28H,7-8,11,13H2,1-2H3,(H,26,27)",4.2,3.0,6.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011162,Q8K4Z4,BMNFPSSKIXXDNS-UHFFFAOYSA-N,Kd,630.96,nM,ChEMBL,CHEMBL5414,CHEMBL31099,6130153,CHEMBL31099,15578561.0,C15H18N2O3,274.32,2-[(2-hydroxy-3-naphthalen-1-yloxypropyl)amino]acetamide,C1=CC=C2C(=C1)C=CC=C2OCC(CNCC(=O)N)O,C1=CC=C2C(=C1)C=CC=C2OCC(CNCC(=O)N)O,"InChI=1S/C15H18N2O3/c16-15(19)9-17-8-12(18)10-20-14-7-3-5-11-4-1-2-6-13(11)14/h1-7,12,17-18H,8-10H2,(H2,16,19)",1.1,3.0,4.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011285,Q8K4Z4,KECFTHUMGLODBS-UHFFFAOYSA-N,Kd,>10000,nM,ChEMBL,CHEMBL5414,CHEMBL31677,6130154,CHEMBL31677,13040911.0,C18H27NO6,353.415,methyl 3-[4-[3-[(3-ethoxy-3-oxopropyl)amino]-2-hydroxypropoxy]phenyl]propanoate,CCOC(=O)CCNCC(COC1=CC=C(C=C1)CCC(=O)OC)O,CCOC(=O)CCNCC(COC1=CC=C(C=C1)CCC(=O)OC)O,"InChI=1S/C18H27NO6/c1-3-24-18(22)10-11-19-12-15(20)13-25-16-7-4-14(5-8-16)6-9-17(21)23-2/h4-5,7-8,15,19-20H,3,6,9-13H2,1-2H3",1.1,2.0,7.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011323,Q8K4Z4,MOAJWVAXQNJPPR-UHFFFAOYSA-N,Kd,6456.54,nM,ChEMBL,CHEMBL5414,CHEMBL274830,2872332,CHEMBL274830,13621720.0,C19H23N3O2S,357.472,1-(propylamino)-3-[4-(5-thiophen-2-yl-1H-imidazol-2-yl)phenoxy]propan-2-ol,CCCNCC(COC1=CC=C(C=C1)C2=NC=C(N2)C3=CC=CS3)O,CCCNCC(COC1=CC=C(C=C1)C2=NC=C(N2)C3=CC=CS3)O,"InChI=1S/C19H23N3O2S/c1-2-9-20-11-15(23)13-24-16-7-5-14(6-8-16)19-21-12-17(22-19)18-4-3-10-25-18/h3-8,10,12,15,20,23H,2,9,11,13H2,1H3,(H,21,22)",2.9,3.0,5.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011382,Q8K4Z4,HBYIEJQLZYCNSI-UHFFFAOYSA-N,Kd,616.6,nM,ChEMBL,CHEMBL5414,CHEMBL174783,6134834,CHEMBL174783,12521588.0,C16H23N3O2,289.379,1-(tert-butylamino)-3-[4-(1H-imidazol-2-yl)phenoxy]propan-2-ol,CC(C)(C)NCC(COC1=CC=C(C=C1)C2=NC=CN2)O,CC(C)(C)NCC(COC1=CC=C(C=C1)C2=NC=CN2)O,"InChI=1S/C16H23N3O2/c1-16(2,3)19-10-13(20)11-21-14-6-4-12(5-7-14)15-17-8-9-18-15/h4-9,13,19-20H,10-11H2,1-3H3,(H,17,18)",1.6,3.0,4.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011433,Q8K4Z4,RCTCJGLBICXHON-LBPRGKRZSA-N,Kd,57.54,nM,ChEMBL,CHEMBL5414,CHEMBL2096752,6134834,CHEMBL2096752,13157364.0,C16H18F3N3O2,341.334,(2S)-1-(cyclopropylamino)-3-[4-[5-(trifluoromethyl)-1H-imidazol-2-yl]phenoxy]propan-2-ol,C1CC1NCC(COC2=CC=C(C=C2)C3=NC=C(N3)C(F)(F)F)O,C1CC1NC[C@@H](COC2=CC=C(C=C2)C3=NC=C(N3)C(F)(F)F)O,"InChI=1S/C16H18F3N3O2/c17-16(18,19)14-8-21-15(22-14)10-1-5-13(6-2-10)24-9-12(23)7-20-11-3-4-11/h1-2,5-6,8,11-12,20,23H,3-4,7,9H2,(H,21,22)/t12-/m0/s1",2.1,3.0,7.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011576,Q8K4Z4,DYQHVMHNWPPXFI-UHFFFAOYSA-N,Kd,100,nM,ChEMBL,CHEMBL5414,CHEMBL31938,6130153,CHEMBL31938,15578606.0,C14H21NO4,267.325,methyl 3-[[2-hydroxy-3-(2-methylphenoxy)propyl]amino]propanoate,CC1=CC=CC=C1OCC(CNCCC(=O)OC)O,CC1=CC=CC=C1OCC(CNCCC(=O)OC)O,"InChI=1S/C14H21NO4/c1-11-5-3-4-6-13(11)19-10-12(16)9-15-8-7-14(17)18-2/h3-6,12,15-16H,7-10H2,1-2H3",1.5,2.0,5.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1011748,Q8K4Z4,XYXMJNFELPKDTE-CHWSQXEVSA-N,Kd,>75.86,nM,ChEMBL,CHEMBL5414,CHEMBL67331,2903245,CHEMBL67331,14201535.0,C13H19NO2,221.3,(1S)-2-phenoxy-1-[(2R)-piperidin-2-yl]ethanol,C1CCNC(C1)C(COC2=CC=CC=C2)O,C1CCN[C@H](C1)[C@@H](COC2=CC=CC=C2)O,"InChI=1S/C13H19NO2/c15-13(12-8-4-5-9-14-12)10-16-11-6-2-1-3-7-11/h1-3,6-7,12-15H,4-5,8-10H2/t12-,13-/m1/s1",1.8,2.0,3.0,Beta-2 adrenergic receptor,Adrb2,Cavia porcellus (Guinea pig),MGHLGNGSDFLLAPNASHAPDHNVTRERDEAWVVGMAIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGASHILMNMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVVILMVWVVSGLTSFLPIQMHWYRATHKDAINCYAEETCCDFFTNQAYAIASSIVSFYLPLVVMVFVYSRVFQVAKKQLQKIDRSEGRFHTQNLSQVEQDGRSGHGLRRSSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIPKEVYILLNWVGYVNSAFNPLIYCRSPDFRIAFQELLCLRRSALKAYGNDCSSNSNGKTDYTGEPNVCHQGQEKERELLCEDPPGTEDLVSCPGTVPSDSIDSQGRNYSTNDSLL
1021430,Q91ZY2,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,39.8107170553497,nM,IUPHAR,265,1247,11561071,histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H4 receptor,Hrh4,Mus musculus (Mouse),MSESNSTGILPPAAQVPLAFLMSSFAFAIMVGNAVVILAFVVDRNLRHRSNYFFLNLAISDFLVGLISIPLYIPHVLFNWNFGSGICMFWLITDYLLCTASVYNIVLISYDRYQSVSNAVSYRAQHTGIMKIVAQMVAVWILAFLVNGPMILASDSWKNSTNTKDCEPGFVTEWYILTITMLLEFLLPVISVAYFNVQIYWSLWKRRALSRCPSHAGFSTTSSSASGHLHRAGVACRTSNPGLKESAASRHSESPRRKSSILVSLRTHMNSSITAFKVGSFWRSESAALRQREYAELLRGRKLARSLAILLSAFAICWAPYCLFTIVLSTYPRTERPKSVWYSIAFWLQWFNSFVNPFLYPLCHRRFQKAFWKILCVTKQPALSQNQSVSS
1022387,P34978,BZYFYLPNTYTHJE-KPZIQFQPSA-N,Kd,50.12,nM,ChEMBL,CHEMBL3156,CHEMBL161427,"Bioorg. Med. Chem. Lett., (1991) 1:12:689",CHEMBL161427,13560651.0,C29H37NO4,463.618,"(Z)-6-[(1R,2S,5S)-2-[(4-phenylphenyl)methoxy]-5-piperidin-1-ylcyclopentyl]oxyhex-4-enoic acid",C1CCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1CCN(CC1)[C@H]2CC[C@@H]([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H37NO4/c31-28(32)12-6-2-9-21-33-29-26(30-19-7-3-8-20-30)17-18-27(29)34-22-23-13-15-25(16-14-23)24-10-4-1-5-11-24/h1-2,4-5,9-11,13-16,26-27,29H,3,6-8,12,17-22H2,(H,31,32)/b9-2-/t26-,27-,29+/m0/s1",2.6,1.0,5.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1022388,P34978,BZYFYLPNTYTHJE-KPZIQFQPSA-N,Kd,31.62,nM,ChEMBL,CHEMBL3156,CHEMBL161427,"Bioorg. Med. Chem. Lett., (1991) 1:12:689",CHEMBL161427,13560651.0,C29H37NO4,463.618,"(Z)-6-[(1R,2S,5S)-2-[(4-phenylphenyl)methoxy]-5-piperidin-1-ylcyclopentyl]oxyhex-4-enoic acid",C1CCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,C1CCN(CC1)[C@H]2CC[C@@H]([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4,"InChI=1S/C29H37NO4/c31-28(32)12-6-2-9-21-33-29-26(30-19-7-3-8-20-30)17-18-27(29)34-22-23-13-15-25(16-14-23)24-10-4-1-5-11-24/h1-2,4-5,9-11,13-16,26-27,29H,3,6-8,12,17-22H2,(H,31,32)/b9-2-/t26-,27-,29+/m0/s1",2.6,1.0,5.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1022462,P34978,XCXKTQPMCWBJCT-GAFDFGGTSA-N,Kd,63.1,nM,ChEMBL,CHEMBL3156,CHEMBL159814,"Bioorg. Med. Chem. Lett., (1991) 1:12:689",CHEMBL159814,44374550.0,C31H41N3O5,535.685,"(Z)-6-[(1R,2S)-2-(azepan-1-yl)-5-[[4-[2-(carbamoylamino)phenyl]phenyl]methoxy]cyclopentyl]oxyhex-4-enoic acid",C1CCCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4NC(=O)N,C1CCCN(CC1)[C@H]2CCC([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4NC(=O)N,"InChI=1S/C31H41N3O5/c32-31(37)33-26-11-6-5-10-25(26)24-15-13-23(14-16-24)22-39-28-18-17-27(34-19-7-1-2-8-20-34)30(28)38-21-9-3-4-12-29(35)36/h3,5-6,9-11,13-16,27-28,30H,1-2,4,7-8,12,17-22H2,(H,35,36)(H3,32,33,37)/b9-3-/t27-,28?,30+/m0/s1",1.6,3.0,6.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1022515,P34978,WHSSOYNNHOWWJE-MFKUBSTISA-N,Kd,125.89,nM,ChEMBL,CHEMBL3156,CHEMBL422017,"Bioorg. Med. Chem. Lett., (1991) 1:12:699",CHEMBL422017,44375168.0,C26H28N2O4S,464.58,(E)-6-[3-[3-(benzenesulfonamido)propyl]phenyl]-6-pyridin-3-ylhex-5-enoic acid,C1=CC=C(C=C1)S(=O)(=O)NCCCC2=CC=CC(=C2)C(=CCCCC(=O)O)C3=CN=CC=C3,C1=CC=C(C=C1)S(=O)(=O)NCCCC2=CC=CC(=C2)/C(=C\CCCC(=O)O)/C3=CN=CC=C3,"InChI=1S/C26H28N2O4S/c29-26(30)16-5-4-15-25(23-12-8-17-27-20-23)22-11-6-9-21(19-22)10-7-18-28-33(31,32)24-13-2-1-3-14-24/h1-3,6,8-9,11-15,17,19-20,28H,4-5,7,10,16,18H2,(H,29,30)/b25-15+",4.8,2.0,6.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1022555,P34978,RMGXUWDQFIYRBZ-UHFFFAOYSA-N,Kd,138.04,nM,ChEMBL,CHEMBL3156,CHEMBL102692,"Bioorg. Med. Chem. Lett., (1995) 5:24:3017",CHEMBL102692,44333075.0,C24H25FN4O4S,484.546,3-[1-[2-[(4-fluorophenyl)sulfonylamino]ethyl]-2-(imidazol-1-ylmethyl)-3-methylindol-5-yl]propanoic acid,CC1=C(N(C2=C1C=C(C=C2)CCC(=O)O)CCNS(=O)(=O)C3=CC=C(C=C3)F)CN4C=CN=C4,CC1=C(N(C2=C1C=C(C=C2)CCC(=O)O)CCNS(=O)(=O)C3=CC=C(C=C3)F)CN4C=CN=C4,"InChI=1S/C24H25FN4O4S/c1-17-21-14-18(3-9-24(30)31)2-8-22(21)29(23(17)15-28-12-10-26-16-28)13-11-27-34(32,33)20-6-4-19(25)5-7-20/h2,4-8,10,12,14,16,27H,3,9,11,13,15H2,1H3,(H,30,31)",2.5,2.0,7.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1022558,P34978,YKPJTNNQDJFQBF-HLOJMEPRSA-N,Kd,39.81,nM,ChEMBL,CHEMBL3156,CHEMBL433884,"Bioorg. Med. Chem. Lett., (1991) 1:12:695",CHEMBL433884,15024085.0,C29H38N2O4,478.633,"(Z)-6-[(1R,2S,5R)-2-(azepan-1-yl)-5-[(4-pyridin-3-ylphenyl)methoxy]cyclopentyl]oxyhex-4-enoic acid",C1CCCN(CC1)C2CCC(C2OCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CN=CC=C4,C1CCCN(CC1)[C@H]2CC[C@H]([C@@H]2OC/C=C\CCC(=O)O)OCC3=CC=C(C=C3)C4=CN=CC=C4,"InChI=1S/C29H38N2O4/c32-28(33)10-4-3-7-20-34-29-26(31-18-5-1-2-6-19-31)15-16-27(29)35-22-23-11-13-24(14-12-23)25-9-8-17-30-21-25/h3,7-9,11-14,17,21,26-27,29H,1-2,4-6,10,15-16,18-20,22H2,(H,32,33)/b7-3-/t26-,27+,29+/m0/s1",1.9,1.0,6.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1022566,P34978,DJPVNHLABTYAMF-LSHDLFTRSA-N,Kd,199.53,nM,ChEMBL,CHEMBL3156,CHEMBL164109,"Bioorg. Med. Chem. Lett., (1991) 1:12:699",CHEMBL164109,15684009.0,C25H25N3O6S,495.55,(E)-6-[3-[2-[(2-nitrophenyl)sulfonylamino]ethyl]phenyl]-6-pyridin-3-ylhex-5-enoic acid,C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)NCCC2=CC=CC(=C2)C(=CCCCC(=O)O)C3=CN=CC=C3,C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)NCCC2=CC=CC(=C2)/C(=C\CCCC(=O)O)/C3=CN=CC=C3,"InChI=1S/C25H25N3O6S/c29-25(30)13-4-1-10-22(21-9-6-15-26-18-21)20-8-5-7-19(17-20)14-16-27-35(33,34)24-12-3-2-11-23(24)28(31)32/h2-3,5-12,15,17-18,27H,1,4,13-14,16H2,(H,29,30)/b22-10+",4.2,2.0,8.0,Thromboxane A2 receptor,Tbxa2r,Rattus norvegicus (Rat),MWLNSTSLGACFRPVNITLQERRAIASPWFAASFCALGLGSNLLALSVLAGARPGAGPRSSFLALLCGLVLTDFLGLLVTGAVVASQHAALLDWRATDPGCRLCHFMGAAMVFFGLCPLLLGAAMAAERFVGITRPFSRPAATSRRAWATVGLVWVGAGTLGLLPLLGLGRYSVQYPGSWCFLTLGAERGDVAFGLMFALLGSVSVGLSLLLNTVSVATLCRVYHAREATQRPRDCEVEMMVQLVGIMVVATVCWMPLLVFILQTLLQTLPVMSPSGQLLRTTERQLLIYLRVATWNQILDPWVYILFRRSVLRRLHPRFTSQLQAVSLHSPPTQAMLSGP
1025121,O60755,YWWOWEJNZKADMM-INAUZTMPSA-N,Kd,69,nM,ChEMBL,CHEMBL2731,CHEMBL499179,19053761,CID 44587986,44587986.0,C136H205N41O41,3070.382,"(3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[(2S)-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-oxobutanoic acid",CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN,C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CC6=CNC7=CC=CC=C76)NC(=O)CN)O,"InChI=1S/C136H205N41O41/c1-64(2)38-83(162-119(201)85(40-66(5)6)163-121(203)87(43-74-31-33-78(183)34-32-74)158-104(188)55-148-112(194)69(11)154-129(211)96(59-178)172-125(207)94(49-102(141)186)167-120(202)86(41-67(7)8)170-134(216)110(71(13)181)175-128(210)89(156-103(187)51-138)44-75-52-147-80-27-19-18-26-79(75)80)114(196)151-58-107(191)177-37-23-30-99(177)132(214)169-90(45-76-53-144-62-152-76)118(200)155-70(12)113(195)174-109(68(9)10)133(215)150-57-106(190)159-93(48-101(140)185)124(206)165-91(46-77-54-145-63-153-77)123(205)161-82(29-22-36-146-136(142)143)117(199)171-97(60-179)130(212)164-88(42-73-24-16-15-17-25-73)122(204)173-98(61-180)131(213)168-95(50-108(192)193)126(208)160-81(28-20-21-35-137)116(198)166-92(47-100(139)184)115(197)149-56-105(189)157-84(39-65(3)4)127(209)176-111(72(14)182)135(217)218/h15-19,24-27,31-34,52-54,62-72,81-99,109-111,147,178-183H,20-23,28-30,35-51,55-61,137-138H2,1-14H3,(H2,139,184)(H2,140,185)(H2,141,186)(H,144,152)(H,145,153)(H,148,194)(H,149,197)(H,150,215)(H,151,196)(H,154,211)(H,155,200)(H,156,187)(H,157,189)(H,158,188)(H,159,190)(H,160,208)(H,161,205)(H,162,201)(H,163,203)(H,164,212)(H,165,206)(H,166,198)(H,167,202)(H,168,213)(H,169,214)(H,170,216)(H,171,199)(H,172,207)(H,173,204)(H,174,195)(H,175,210)(H,176,209)(H,192,193)(H,217,218)(H4,142,143,146)/t69-,70-,71+,72+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,109-,110-,111-/m0/s1",-14.6,46.0,46.0,Galanin receptor type 3,GALR3,Homo sapiens (Human),MADAQNISLDSPGSVGAVAVPVVFALIFLLGTVGNGLVLAVLLQPGPSAWQEPGSTTDLFILNLAVADLCFILCCVPFQATIYTLDAWLFGALVCKAVHLLIYLTMYASSFTLAAVSVDRYLAVRHPLRSRALRTPRNARAAVGLVWLLAALFSAPYLSYYGTVRYGALELCVPAWEDARRRALDVATFAAGYLLPVAVVSLAYGRTLRFLWAAVGPAGAAAAEARRRATGRAGRAMLAVAALYALCWGPHHALILCFWYGRFAFSPATYACRLASHCLAYANSCLNPLVYALASRHFRARFRRLWPCGRRRRHRARRALRRVRPASSGPPGCPGDARPSGRLLAGGGQGPEPREGPVHGGEAARGPE
1026229,P25102,NTYJJOPFIAHURM-UHFFFAOYSA-N,Kd,117489.76,nM,ChEMBL,CHEMBL4654,CHEMBL90,"Bioorg. Med. Chem. Lett., (1994) 4:16:1913",histamine,774.0,C5H9N3,111.148,2-(1H-imidazol-5-yl)ethanamine,C1=C(NC=N1)CCN,C1=C(NC=N1)CCN,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",-0.7,2.0,2.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1026233,P25102,BUPULZSGJRTAJI-UHFFFAOYSA-N,Kd,316.23,nM,ChEMBL,CHEMBL4654,CHEMBL282645,"Bioorg. Med. Chem. Lett., (1996) 6:13:1421",CHEMBL282645,44280372.0,C45H53N7O6,787.962,"4-[[2-[3-[1-methyl-3-[(3-methylphenyl)carbamoylamino]-2-oxo-3H-1,4-benzodiazepin-5-yl]phenoxy]acetyl]amino]-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]butanamide",CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC(=CC=C4)OCC(=O)NCCCC(=O)NCCCOC5=CC=CC(=C5)CN6CCCCC6)C,CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC(=CC=C4)OCC(=O)NCCCC(=O)NCCCOC5=CC=CC(=C5)CN6CCCCC6)C,"InChI=1S/C45H53N7O6/c1-32-13-8-16-35(27-32)48-45(56)50-43-44(55)51(2)39-20-5-4-19-38(39)42(49-43)34-15-10-18-37(29-34)58-31-41(54)47-22-11-21-40(53)46-23-12-26-57-36-17-9-14-33(28-36)30-52-24-6-3-7-25-52/h4-5,8-10,13-20,27-29,43H,3,6-7,11-12,21-26,30-31H2,1-2H3,(H,46,53)(H,47,54)(H2,48,50,56)",5.4,4.0,8.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1026239,P25102,OSTNHMODDQIWKV-UHFFFAOYSA-N,Kd,794.33,nM,ChEMBL,CHEMBL4654,CHEMBL31090,"Bioorg. Med. Chem. Lett., (1996) 6:13:1421",CHEMBL31090,44280224.0,C44H51N7O5,757.936,"4-[[2-[3-[(3-methylphenyl)carbamoylamino]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-1-yl]acetyl]amino]-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]butanamide",CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)CC(=O)NCCCC(=O)NCCCOC5=CC=CC(=C5)CN6CCCCC6,CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)CC(=O)NCCCC(=O)NCCCOC5=CC=CC(=C5)CN6CCCCC6,"InChI=1S/C44H51N7O5/c1-32-14-10-18-35(28-32)47-44(55)49-42-43(54)51(38-21-7-6-20-37(38)41(48-42)34-16-4-2-5-17-34)31-40(53)46-23-12-22-39(52)45-24-13-27-56-36-19-11-15-33(29-36)30-50-25-8-3-9-26-50/h2,4-7,10-11,14-21,28-29,42H,3,8-9,12-13,22-27,30-31H2,1H3,(H,45,52)(H,46,53)(H2,47,49,55)",5.4,4.0,7.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1026283,P25102,UZFBINGRHVFVJI-WBCKFURZSA-N,Kd,398.11,nM,ChEMBL,CHEMBL4654,CHEMBL290122,"Bioorg. Med. Chem. Lett., (1996) 6:13:1427",CHEMBL290122,44280740.0,C45H53N7O6,787.962,"2-[3-[[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoylamino]phenyl]ethyl N-[4-oxo-4-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]butyl]carbamate",CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC=CC(=C3)CCOC(=O)NCCCC(=O)NCCCOC4=CC=CC(=C4)CN5CCCCC5)C6=CC=CC=C6,CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)CCOC(=O)NCCCC(=O)NCCCOC4=CC=CC(=C4)CN5CCCCC5)C6=CC=CC=C6,"InChI=1S/C45H53N7O6/c1-51-39-21-7-6-20-38(39)41(35-16-4-2-5-17-35)49-42(43(51)54)50-44(55)48-36-18-10-14-33(30-36)23-29-58-45(56)47-24-12-22-40(53)46-25-13-28-57-37-19-11-15-34(31-37)32-52-26-8-3-9-27-52/h2,4-7,10-11,14-21,30-31,42H,3,8-9,12-13,22-29,32H2,1H3,(H,46,53)(H,47,56)(H2,48,50,55)/t42-/m0/s1",5.7,4.0,8.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1026311,P25102,HTNVOFNARQMQGV-UHFFFAOYSA-N,Kd,3981.07,nM,ChEMBL,CHEMBL4654,CHEMBL281082,"Bioorg. Med. Chem. Lett., (1996) 6:13:1421",CHEMBL281082,44279808.0,C34H36N10O4S2,712.848,"N-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-2-[[2-[3-[(3-methylphenyl)carbamoylamino]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-1-yl]acetyl]amino]acetamide",CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)CC(=O)NCC(=O)NCCSCC5=CSC(=N5)N=C(N)N,CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)CC(=O)NCC(=O)NCCSCC5=CSC(=N5)N=C(N)N,"InChI=1S/C34H36N10O4S2/c1-21-8-7-11-23(16-21)39-33(48)42-30-31(47)44(26-13-6-5-12-25(26)29(41-30)22-9-3-2-4-10-22)18-28(46)38-17-27(45)37-14-15-49-19-24-20-50-34(40-24)43-32(35)36/h2-13,16,20,30H,14-15,17-19H2,1H3,(H,37,45)(H,38,46)(H2,39,42,48)(H4,35,36,40,43)",2.5,6.0,9.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1026351,P25102,GBTCDSUSVMDXPF-FAIXQHPJSA-N,Kd,316.23,nM,ChEMBL,CHEMBL4654,CHEMBL406844,"Bioorg. Med. Chem. Lett., (1996) 6:13:1427",CHEMBL406844,44280741.0,C43H49N7O6,759.908,"[3-[[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoylamino]phenyl]methyl N-[3-oxo-3-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]propyl]carbamate",CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC=CC(=C3)COC(=O)NCCC(=O)NCCCOC4=CC=CC(=C4)CN5CCCCC5)C6=CC=CC=C6,CN1C2=CC=CC=C2C(=N[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)COC(=O)NCCC(=O)NCCCOC4=CC=CC(=C4)CN5CCCCC5)C6=CC=CC=C6,"InChI=1S/C43H49N7O6/c1-49-37-20-7-6-19-36(37)39(33-15-4-2-5-16-33)47-40(41(49)52)48-42(53)46-34-17-10-14-32(27-34)30-56-43(54)45-23-21-38(51)44-22-12-26-55-35-18-11-13-31(28-35)29-50-24-8-3-9-25-50/h2,4-7,10-11,13-20,27-28,40H,3,8-9,12,21-26,29-30H2,1H3,(H,44,51)(H,45,54)(H2,46,48,53)/t40-/m0/s1",4.9,4.0,8.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1026368,P25102,PUMVZQPDPMFSFN-UHFFFAOYSA-N,Kd,5011.87,nM,ChEMBL,CHEMBL4654,CHEMBL29888,"Bioorg. Med. Chem. Lett., (1996) 6:13:1421",CHEMBL29888,44280213.0,C33H35N9O4S2,685.822,"N-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-2-[3-[1-methyl-3-[(3-methylphenyl)carbamoylamino]-2-oxo-3H-1,4-benzodiazepin-5-yl]phenoxy]acetamide",CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC(=CC=C4)OCC(=O)NCCSCC5=CSC(=N5)N=C(N)N)C,CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC(=CC=C4)OCC(=O)NCCSCC5=CSC(=N5)N=C(N)N)C,"InChI=1S/C33H35N9O4S2/c1-20-7-5-9-22(15-20)37-32(45)40-29-30(44)42(2)26-12-4-3-11-25(26)28(39-29)21-8-6-10-24(16-21)46-17-27(43)36-13-14-47-18-23-19-48-33(38-23)41-31(34)35/h3-12,15-16,19,29H,13-14,17-18H2,1-2H3,(H,36,43)(H2,37,40,45)(H4,34,35,38,41)",3.1,5.0,9.0,Histamine H2 receptor,Hrh2,Rattus norvegicus (Rat),MEPNGTVHSCCLDSMALKVTISVVLTTLILITIAGNVVVCLAVSLNRRLRSLTNCFIVSLAATDLLLGLLVLPFSAIYQLSFTWSFGHVFCNIYTSLDVMLCTASILNLFMISLDRYCAVTDPLRYPVLVTPVRVAISLVFIWVISITLSFLSIHLGWNSRNGTRGGNDTFKCKVQVNEVYGLVDGLVTFYLPLLIMCVTYYRIFKIAREQAKRINHISSWKAATIREHKATVTLAAVMGAFIICWFPYFTAFVYRGLRGDDAINEAVEGIVLWLGYANSALNPILYAALNRDFRTAYQQLFHCKFASHNSHKTSLRLNNSLLPRSQSREGRWQEEKPLKLQVWSGTELTHPQGNPIR
1028035,Q9BPV8,WLMZTKAZJUWXCB-JLOOSCHCSA-N,Kd,0.251188422515362,nM,IUPHAR,329,1774,12815166,[33P]2-methylthio-ADP,73755009.0,C11H17N5O10P2S,477.285,"[(2R,3S,4R,5R)-5-(6-amino-2-methylsulfanylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydroxy(33P)phosphoryl hydrogen phosphate",CSC1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O,CSC1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO[33P](=O)(O)O[33P](=O)(O)O)O)O,"InChI=1S/C11H17N5O10P2S/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1/i27+2,28+2",-3.8,6.0,15.0,P2Y purinoceptor 13,P2RY13,Homo sapiens (Human),MTAAIRRQRELSILPKVTLEAMNTTVMQGFNRSERCPRDTRIVQLVFPALYTVVFLTGILLNTLALWVFVHIPSSSTFIIYLKNTLVADLIMTLMLPFKILSDSHLAPWQLRAFVCRFSSVIFYETMYVGIVLLGLIAFDRFLKIIRPLRNIFLKKPVFAKTVSIFIWFFLFFISLPNTILSNKEATPSSVKKCASLKGPLGLKWHQMVNNICQFIFWTVFILMLVFYVVIAKKVYDSYRKSKSKDRKNNKKLEGKVFVVVAVFFVCFAPFHFARVPYTHSQTNNKTDCRLQNQLFIAKETTLFLAATNICMDPLIYIFLCKKFTEKLPCMQGRKTTASSQENHSSQTDNITLG
1028895,Q28044,JWZZKOKVBUJMES-UHFFFAOYSA-N,Kd,330,nM,ChEMBL,CHEMBL3373,CHEMBL434,2993621,isoproterenol,3779.0,C11H17NO3,211.261,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol",CC(C)NCC(C1=CC(=C(C=C1)O)O)O,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",-0.6,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Bos taurus (Bovine),MGQPGNRSVFLLAPNASHAPDQNVTLERDEAWVVGMGILMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGACHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYLAITSPFKYQCLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRASHKEAINCYAKETCCDFFTNQPYAIASSIVSFYLPLVVMVFVYSRVFQVAKRQLQKIDKSEGRFHAQNVSQVEQDGRSGLGQRRTSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIKDNLIRKEIYILLNWLGYINSAFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGCSSNSNDRTDYTGEQSGYHLGEEKDSELLCEDPPGTENFVNQQGTVPSDSIDSQGRNCSTNDSLL
1029037,Q28044,LMOINURANNBYCM-UHFFFAOYSA-N,Kd,9120,nM,ChEMBL,CHEMBL3373,CHEMBL776,2993621,metaproterenol,4086.0,C11H17NO3,211.261,"5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol",CC(C)NCC(C1=CC(=CC(=C1)O)O)O,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",0.7,4.0,4.0,Beta-2 adrenergic receptor,ADRB2,Bos taurus (Bovine),MGQPGNRSVFLLAPNASHAPDQNVTLERDEAWVVGMGILMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGACHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYLAITSPFKYQCLLTKNKARVVILMVWIVSGLTSFLPIQMHWYRASHKEAINCYAKETCCDFFTNQPYAIASSIVSFYLPLVVMVFVYSRVFQVAKRQLQKIDKSEGRFHAQNVSQVEQDGRSGLGQRRTSKFYLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIKDNLIRKEIYILLNWLGYINSAFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGCSSNSNDRTDYTGEQSGYHLGEEKDSELLCEDPPGTENFVNQQGTVPSDSIDSQGRNCSTNDSLL
1029151,P48044,UTJQBVZALNERNH-JVYXSLHOSA-N,Kd,240,nM,ChEMBL,CHEMBL2344,CHEMBL265264,7507528,CHEMBL265264,44321207.0,C49H70N14O12S2,1111.305,"(10S,13S,16S,19S,22S)-13-(2-amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-16-(3-amino-3-oxopropyl)-19-benzyl-22-[(4-hydroxyphenyl)methyl]-N-methyl-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carboxamide",CN(CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)C(=O)C1CSSC2(CCCCC2)CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O,CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O,"InChI=1S/C49H70N14O12S2/c1-63(26-41(69)57-31(11-8-20-55-48(53)54)42(70)56-25-39(52)67)47(75)36-27-76-77-49(18-6-3-7-19-49)24-40(68)58-33(22-29-12-14-30(64)15-13-29)44(72)60-34(21-28-9-4-2-5-10-28)45(73)59-32(16-17-37(50)65)43(71)61-35(23-38(51)66)46(74)62-36/h2,4-5,9-10,12-15,31-36,64H,3,6-8,11,16-27H2,1H3,(H2,50,65)(H2,51,66)(H2,52,67)(H,56,70)(H,57,69)(H,58,68)(H,59,73)(H,60,72)(H,61,71)(H,62,74)(H4,53,54,55)/t31-,32-,33-,34-,35-,36+/m0/s1",-2.9,13.0,15.0,Vasopressin V2 receptor,AVPR2,Bos taurus (Bovine),MFMASTTSAVPWHLSQPTPAGNGSEGELLTARDPLLAQAELALLSTVFVAVALSNGLVLGALVRRGRRGRWAPMHVFIGHLCLADLAVALFQVLPQLAWDATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAHRHGGGTHWNRPVLLAWAFSLLFSLPQLFIFAQRDVDGSGVLDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLGPGPVPRAGGPRRGCRPGSPAEGARVSAAVAKTVKMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPREGPPFVLLMLLASLNSCTNPWIYASFSSSISSELRSLLCCTWRRAPPSPGPQEESCATASSFLAKDTPS
1029152,P48044,HRSISEQPKZEMCR-RZLJCCINSA-N,Kd,1.4,nM,ChEMBL,CHEMBL2344,CHEMBL406303,2416923,CHEMBL406303,44386183.0,C44H63N13O11S2,1014.188,"(4R,7S,10R,13S,16R)-7-(2-amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-13-benzyl-16-[(4-hydroxyphenyl)methyl]-N-methyl-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N(C)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N,CC(C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N,"InChI=1S/C44H63N13O11S2/c1-24(2)37-42(67)54-31(20-33(45)59)40(65)55-32(43(68)57(3)22-36(62)51-28(10-7-16-49-44(47)48)38(63)50-21-34(46)60)23-70-69-17-15-35(61)52-29(19-26-11-13-27(58)14-12-26)39(64)53-30(41(66)56-37)18-25-8-5-4-6-9-25/h4-6,8-9,11-14,24,28-32,37,58H,7,10,15-23H2,1-3H3,(H2,45,59)(H2,46,60)(H,50,63)(H,51,62)(H,52,61)(H,53,64)(H,54,67)(H,55,65)(H,56,66)(H4,47,48,49)/t28-,29+,30-,31-,32-,37+/m0/s1",-2.4,12.0,14.0,Vasopressin V2 receptor,AVPR2,Bos taurus (Bovine),MFMASTTSAVPWHLSQPTPAGNGSEGELLTARDPLLAQAELALLSTVFVAVALSNGLVLGALVRRGRRGRWAPMHVFIGHLCLADLAVALFQVLPQLAWDATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAHRHGGGTHWNRPVLLAWAFSLLFSLPQLFIFAQRDVDGSGVLDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLGPGPVPRAGGPRRGCRPGSPAEGARVSAAVAKTVKMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPREGPPFVLLMLLASLNSCTNPWIYASFSSSISSELRSLLCCTWRRAPPSPGPQEESCATASSFLAKDTPS
1029154,P48044,HRSISEQPKZEMCR-RZLJCCINSA-N,Kd,1300000000,nM,ChEMBL,CHEMBL2344,CHEMBL406303,2416923,CHEMBL406303,44386183.0,C44H63N13O11S2,1014.188,"(4R,7S,10R,13S,16R)-7-(2-amino-2-oxoethyl)-N-[2-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-13-benzyl-16-[(4-hydroxyphenyl)methyl]-N-methyl-6,9,12,15,18-pentaoxo-10-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide",CC(C)C1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N(C)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N,CC(C)[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N,"InChI=1S/C44H63N13O11S2/c1-24(2)37-42(67)54-31(20-33(45)59)40(65)55-32(43(68)57(3)22-36(62)51-28(10-7-16-49-44(47)48)38(63)50-21-34(46)60)23-70-69-17-15-35(61)52-29(19-26-11-13-27(58)14-12-26)39(64)53-30(41(66)56-37)18-25-8-5-4-6-9-25/h4-6,8-9,11-14,24,28-32,37,58H,7,10,15-23H2,1-3H3,(H2,45,59)(H2,46,60)(H,50,63)(H,51,62)(H,52,61)(H,53,64)(H,54,67)(H,55,65)(H,56,66)(H4,47,48,49)/t28-,29+,30-,31-,32-,37+/m0/s1",-2.4,12.0,14.0,Vasopressin V2 receptor,AVPR2,Bos taurus (Bovine),MFMASTTSAVPWHLSQPTPAGNGSEGELLTARDPLLAQAELALLSTVFVAVALSNGLVLGALVRRGRRGRWAPMHVFIGHLCLADLAVALFQVLPQLAWDATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAHRHGGGTHWNRPVLLAWAFSLLFSLPQLFIFAQRDVDGSGVLDCWARFAEPWGLRAYVTWIALMVFVAPALGIAACQVLIFREIHASLGPGPVPRAGGPRRGCRPGSPAEGARVSAAVAKTVKMTLVIVIVYVLCWAPFFLVQLWAAWDPEAPREGPPFVLLMLLASLNSCTNPWIYASFSSSISSELRSLLCCTWRRAPPSPGPQEESCATASSFLAKDTPS
1029456,P41586,LXBKAFMXHOZAQJ-RTJRHOEESA-N,Kd,52.48,nM,ChEMBL,CHEMBL5399,CHEMBL526923,19413310,[N-Me-Ile5]PACAP38,91935837.0,C204H333N63O53S,4548.356,"(3S)-4-[[2-[[(2S,3S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-methylamino]-2-oxoethyl]amino]-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid",CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)N)N(C)C(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC6=CN=CN6)N,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC5=CC=C(C=C5)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N)N(C)C(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CN=CN6)N,"InChI=1S/C204H333N63O53S/c1-19-110(12)164(267(17)157(280)100-231-171(291)148(96-158(281)282)256-194(314)150(101-268)260-169(289)125(212)94-120-98-225-104-232-120)200(320)259-146(89-115-41-21-20-22-42-115)192(312)266-163(114(16)271)199(319)258-149(97-159(283)284)191(311)262-152(103-270)195(315)254-145(93-119-60-68-124(275)69-61-119)189(309)261-151(102-269)193(313)244-135(52-39-84-228-203(221)222)181(301)252-143(91-117-56-64-122(273)65-57-117)187(307)243-133(50-37-82-226-201(217)218)177(297)238-128(45-25-32-77-207)174(294)246-138(71-73-154(214)277)183(303)247-139(74-86-321-18)172(292)234-113(15)168(288)263-160(107(6)7)196(316)248-131(48-28-35-80-210)176(296)239-130(47-27-34-79-209)178(298)253-144(92-118-58-66-123(274)67-59-118)188(308)250-141(88-106(4)5)185(305)235-111(13)166(286)233-112(14)167(287)264-161(108(8)9)198(318)257-140(87-105(2)3)170(290)230-99-156(279)236-127(44-24-31-76-206)173(293)240-134(51-38-83-227-202(219)220)180(300)251-142(90-116-54-62-121(272)63-55-116)186(306)242-129(46-26-33-78-208)175(295)245-137(70-72-153(213)276)182(302)241-136(53-40-85-229-204(223)224)184(304)265-162(109(10)11)197(317)249-132(49-29-36-81-211)179(299)255-147(95-155(215)278)190(310)237-126(165(216)285)43-23-30-75-205/h20-22,41-42,54-69,98,104-114,125-152,160-164,268-275H,19,23-40,43-53,70-97,99-103,205-212H2,1-18H3,(H2,213,276)(H2,214,277)(H2,215,278)(H2,216,285)(H,225,232)(H,230,290)(H,231,291)(H,233,286)(H,234,292)(H,235,305)(H,236,279)(H,237,310)(H,238,297)(H,239,296)(H,240,293)(H,241,302)(H,242,306)(H,243,307)(H,244,313)(H,245,295)(H,246,294)(H,247,303)(H,248,316)(H,249,317)(H,250,308)(H,251,300)(H,252,301)(H,253,298)(H,254,315)(H,255,299)(H,256,314)(H,257,318)(H,258,319)(H,259,320)(H,260,289)(H,261,309)(H,262,311)(H,263,288)(H,264,287)(H,265,304)(H,266,312)(H,281,282)(H,283,284)(H4,217,218,226)(H4,219,220,227)(H4,221,222,228)(H4,223,224,229)/t110-,111-,112-,113-,114+,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,160-,161-,162-,163-,164-/m0/s1",-17.9,67.0,67.0,Pituitary adenylate cyclase-activating polypeptide type I receptor,ADCYAP1R1,Homo sapiens (Human),MAGVVHVSLAALLLLPMAPAMHSDCIFKKEQAMCLEKIQRANELMGFNDSSPGCPGMWDNITCWKPAHVGEMVLVSCPELFRIFNPDQVWETETIGESDFGDSNSLDLSDMGVVSRNCTEDGWSEPFPHYFDACGFDEYESETGDQDYYYLSVKALYTVGYSTSLVTLTTAMVILCRFRKLHCTRNFIHMNLFVSFMLRAISVFIKDWILYAEQDSNHCFISTVECKAVMVFFHYCVVSNYFWLFIEGLYLFTLLVETFFPERRYFYWYTIIGWGTPTVCVTVWATLRLYFDDTGCWDMNDSTALWWVIKGPVVGSIMVNFVLFIGIIVILVQKLQSPDMGGNESSIYLRLARSTLLLIPLFGIHYTVFAFSPENVSKRERLVFELGLGSFQGFVVAVLYCFLNGEVQAEIKRKWRSWKVNRYFAVDFKHRHPSLASSGVNGGTQLSILSKSSSQIRMSGLPADNLAT
1029972,P28646,RQNQJIVKBHFCBI-DNVFCKCGSA-N,Kd,2.754,nM,ChEMBL,CHEMBL4652,CHEMBL251120,17512199,CHEMBL251120,44441885.0,C26H31N5O2S,477.627,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(2,1,3-benzothiadiazol-4-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=NSN=C65,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=NSN=C65,"InChI=1S/C26H31N5O2S/c1-29-16-19(13-18-14-20-17(15-23(18)29)5-3-8-24(20)33-2)26(32)31-11-9-30(10-12-31)22-7-4-6-21-25(22)28-34-27-21/h3-8,18-19,23H,9-16H2,1-2H3/t18-,19-,23-/m1/s1",3.6,0.0,7.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1029975,P28646,FXCGZOIUXOVRMD-STROYTFGSA-N,Kd,104.71,nM,ChEMBL,CHEMBL4652,CHEMBL251116,17512199,CHEMBL251116,44441873.0,C32H38N4O3,526.681,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(6-phenylmethoxypyridin-2-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=NC(=CC=C5)OCC6=CC=CC=C6,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=NC(=CC=C5)OCC6=CC=CC=C6,"InChI=1S/C32H38N4O3/c1-34-21-26(18-25-19-27-24(20-28(25)34)10-6-11-29(27)38-2)32(37)36-16-14-35(15-17-36)30-12-7-13-31(33-30)39-22-23-8-4-3-5-9-23/h3-13,25-26,28H,14-22H2,1-2H3/t25-,26-,28-/m1/s1",4.8,0.0,6.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1029977,P28646,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,0.7079,nM,ChEMBL,CHEMBL4652,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1029980,P28646,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,0.7079,nM,ChEMBL,CHEMBL4652,CHEMBL251541,17512199,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1029985,P28646,DKHKTKQQUHFLPD-TXTKFYIRSA-N,Kd,1862.09,nM,ChEMBL,CHEMBL4652,CHEMBL250111,17512199,CHEMBL250111,44441867.0,C25H32N4O2,420.557,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(4-pyridin-4-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=NC=C5,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=NC=C5,"InChI=1S/C25H32N4O2/c1-27-17-20(14-19-15-22-18(16-23(19)27)4-3-5-24(22)31-2)25(30)29-12-10-28(11-13-29)21-6-8-26-9-7-21/h3-9,19-20,23H,10-17H2,1-2H3/t19-,20-,23-/m1/s1",2.7,0.0,5.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1029995,P28646,LSPLUDUYNUDLND-JFIYKMOQSA-N,Kd,10471.29,nM,ChEMBL,CHEMBL4652,CHEMBL251301,17512199,CHEMBL251301,44441932.0,C20H29N3O2,343.471,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-piperazin-1-ylmethanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCNCC4,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCNCC4,"InChI=1S/C20H29N3O2/c1-22-13-16(20(24)23-8-6-21-7-9-23)10-15-11-17-14(12-18(15)22)4-3-5-19(17)25-2/h3-5,15-16,18,21H,6-13H2,1-2H3/t15-,16-,18-/m1/s1",1.5,1.0,4.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030043,P28646,WMZQFLOCOUHOFA-SFGWALBWSA-N,Kd,2.399,nM,ChEMBL,CHEMBL4652,CHEMBL253879,18162395,CHEMBL253879,44447019.0,C26H31N5OS,461.628,"[(6aR,9R,10aR)-7-methyl-5-methylsulfanyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)SC)C(=O)N5CCN(CC5)C6=CC=CC=N6,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(NC4=CC=CC2=C34)SC)C(=O)N5CCN(CC5)C6=CC=CC=N6,"InChI=1S/C26H31N5OS/c1-29-16-17(26(32)31-12-10-30(11-13-31)23-8-3-4-9-27-23)14-19-18-6-5-7-21-24(18)20(15-22(19)29)25(28-21)33-2/h3-9,17,19,22,28H,10-16H2,1-2H3/t17-,19-,22-/m1/s1",3.5,1.0,5.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030052,P28646,FABFUAOVAJIURP-PRVBGKCFSA-N,Kd,87.1,nM,ChEMBL,CHEMBL4652,CHEMBL250521,17512199,CHEMBL250521,44441876.0,C30H35N3O2,469.629,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(4-naphthalen-1-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=CC=CC=C65,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=CC=CC=C65,"InChI=1S/C30H35N3O2/c1-31-20-24(17-23-18-26-22(19-28(23)31)9-6-12-29(26)35-2)30(34)33-15-13-32(14-16-33)27-11-5-8-21-7-3-4-10-25(21)27/h3-12,23-24,28H,13-20H2,1-2H3/t23-,24-,28-/m1/s1",5.0,0.0,4.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030094,P28646,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,181.97,nM,ChEMBL,CHEMBL4652,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030102,P28646,MQBKGCCJZRCLOT-FKCDAAJZSA-N,Kd,1.202,nM,ChEMBL,CHEMBL4652,CHEMBL399464,17507221,CHEMBL399464,44441670.0,C31H34N6O2S,554.713,"[(3R,4aR,10aR)-1-methyl-6-phenylmethoxy-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-([1,2,5]thiadiazolo[3,4-b]pyridin-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OCC4=CC=CC=C4)C(=O)N5CCN(CC5)C6=NC7=NSN=C7C=C6,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OCC4=CC=CC=C4)C(=O)N5CCN(CC5)C6=NC7=NSN=C7C=C6,"InChI=1S/C31H34N6O2S/c1-35-19-24(31(38)37-14-12-36(13-15-37)29-11-10-26-30(32-29)34-40-33-26)16-23-17-25-22(18-27(23)35)8-5-9-28(25)39-20-21-6-3-2-4-7-21/h2-11,23-24,27H,12-20H2,1H3/t23-,24-,27-/m1/s1",4.7,0.0,8.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030149,P28646,PMQOXWUBJSYNHV-KKLQWCBXSA-N,Kd,1479.11,nM,ChEMBL,CHEMBL4652,CHEMBL400066,18162395,CHEMBL400066,44447034.0,C27H32BrN5O2,538.49,"[(6aR,9R,10aR)-5-bromo-7-(2-methoxyethyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone",COCCN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC=CC=N6,COCCN1C[C@@H](C[C@H]2[C@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC=CC=N6,"InChI=1S/C27H32BrN5O2/c1-35-14-13-33-17-18(27(34)32-11-9-31(10-12-32)24-7-2-3-8-29-24)15-20-19-5-4-6-22-25(19)21(16-23(20)33)26(28)30-22/h2-8,18,20,23,30H,9-17H2,1H3/t18-,20-,23-/m1/s1",3.6,1.0,5.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030171,P28646,IJWFRTSKNOENFW-MPCDZSKCSA-N,Kd,70.79,nM,ChEMBL,CHEMBL4652,CHEMBL251300,17512199,CHEMBL251300,44441930.0,C27H31N3O2,429.564,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCC5=C(C4)NC6=CC=CC=C56,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCC5=C(C4)NC6=CC=CC=C56,"InChI=1S/C27H31N3O2/c1-29-15-19(12-18-13-22-17(14-25(18)29)6-5-9-26(22)32-2)27(31)30-11-10-21-20-7-3-4-8-23(20)28-24(21)16-30/h3-9,18-19,25,28H,10-16H2,1-2H3/t18-,19-,25-/m1/s1",3.8,1.0,3.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030200,P28646,AGOCNFSXCAGJEC-BHDDXSALSA-N,Kd,158.49,nM,ChEMBL,CHEMBL4652,CHEMBL251335,17507221,CHEMBL251335,44441660.0,C24H30N4O,390.531,"[(3R,4aR,10aR)-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=CC=CC=C3C2)C(=O)N4CCN(CC4)C5=CC=CC=N5,CN1C[C@@H](C[C@H]2[C@H]1CC3=CC=CC=C3C2)C(=O)N4CCN(CC4)C5=CC=CC=N5,"InChI=1S/C24H30N4O/c1-26-17-21(15-20-14-18-6-2-3-7-19(18)16-22(20)26)24(29)28-12-10-27(11-13-28)23-8-4-5-9-25-23/h2-9,20-22H,10-17H2,1H3/t20-,21+,22+/m0/s1",3.0,0.0,4.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030223,P28646,HYSQHKYRRHCWCP-UHFFFAOYSA-N,Kd,11.48,nM,ChEMBL,CHEMBL4652,CHEMBL517921,19208473,CHEMBL517921,44564703.0,C31H34N4O3,510.638,"3-[methyl-[2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)ethyl]amino]-1-[4-(4-nitrophenyl)piperazin-1-yl]propan-1-one",CN(CCC1C2=CC=CC=C2C=CC3=CC=CC=C13)CCC(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN(CCC1C2=CC=CC=C2C=CC3=CC=CC=C13)CCC(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C31H34N4O3/c1-32(18-16-30-28-8-4-2-6-24(28)10-11-25-7-3-5-9-29(25)30)19-17-31(36)34-22-20-33(21-23-34)26-12-14-27(15-13-26)35(37)38/h2-15,30H,16-23H2,1H3",5.4,0.0,5.0,Somatostatin receptor type 1,Sstr1,Rattus norvegicus (Rat),MFPNGTAPSPTSSPSSSPGGCGEGVCSRGPGSGAADGMEEPGRNSSQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCASRISTL
1030301,P30680,RQNQJIVKBHFCBI-DNVFCKCGSA-N,Kd,10000,nM,ChEMBL,CHEMBL2978,CHEMBL251120,17512199,CHEMBL251120,44441885.0,C26H31N5O2S,477.627,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(2,1,3-benzothiadiazol-4-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=NSN=C65,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=NSN=C65,"InChI=1S/C26H31N5O2S/c1-29-16-19(13-18-14-20-17(15-23(18)29)5-3-8-24(20)33-2)26(32)31-11-9-30(10-12-31)22-7-4-6-21-25(22)28-34-27-21/h3-8,18-19,23H,9-16H2,1-2H3/t18-,19-,23-/m1/s1",3.6,0.0,7.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030306,P30680,FXCGZOIUXOVRMD-STROYTFGSA-N,Kd,6606.93,nM,ChEMBL,CHEMBL2978,CHEMBL251116,17512199,CHEMBL251116,44441873.0,C32H38N4O3,526.681,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(6-phenylmethoxypyridin-2-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=NC(=CC=C5)OCC6=CC=CC=C6,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=NC(=CC=C5)OCC6=CC=CC=C6,"InChI=1S/C32H38N4O3/c1-34-21-26(18-25-19-27-24(20-28(25)34)10-6-11-29(27)38-2)32(37)36-16-14-35(15-17-36)30-12-7-13-31(33-30)39-22-23-8-4-3-5-9-23/h3-13,25-26,28H,14-22H2,1-2H3/t25-,26-,28-/m1/s1",4.8,0.0,6.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030308,P30680,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,7762.47,nM,ChEMBL,CHEMBL2978,CHEMBL251541,17512199,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030309,P30680,INULNSAIIZKOQE-YOSAUDMPSA-N,Kd,7762.47,nM,ChEMBL,CHEMBL2978,CHEMBL251541,17507221,Obelin,5311377.0,C26H32N4O4,464.566,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-(4-nitrophenyl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1",3.6,0.0,6.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030314,P30680,DKHKTKQQUHFLPD-TXTKFYIRSA-N,Kd,17782.79,nM,ChEMBL,CHEMBL2978,CHEMBL250111,17512199,CHEMBL250111,44441867.0,C25H32N4O2,420.557,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(4-pyridin-4-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=NC=C5,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=NC=C5,"InChI=1S/C25H32N4O2/c1-27-17-20(14-19-15-22-18(16-23(19)27)4-3-5-24(22)31-2)25(30)29-12-10-28(11-13-29)21-6-8-26-9-7-21/h3-9,19-20,23H,10-17H2,1-2H3/t19-,20-,23-/m1/s1",2.7,0.0,5.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030331,P30680,LSPLUDUYNUDLND-JFIYKMOQSA-N,Kd,43651.58,nM,ChEMBL,CHEMBL2978,CHEMBL251301,17512199,CHEMBL251301,44441932.0,C20H29N3O2,343.471,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-piperazin-1-ylmethanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCNCC4,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCNCC4,"InChI=1S/C20H29N3O2/c1-22-13-16(20(24)23-8-6-21-7-9-23)10-15-11-17-14(12-18(15)22)4-3-5-19(17)25-2/h3-5,15-16,18,21H,6-13H2,1-2H3/t15-,16-,18-/m1/s1",1.5,1.0,4.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030388,P30680,WMZQFLOCOUHOFA-SFGWALBWSA-N,Kd,8511.38,nM,ChEMBL,CHEMBL2978,CHEMBL253879,18162395,CHEMBL253879,44447019.0,C26H31N5OS,461.628,"[(6aR,9R,10aR)-7-methyl-5-methylsulfanyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)SC)C(=O)N5CCN(CC5)C6=CC=CC=N6,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(NC4=CC=CC2=C34)SC)C(=O)N5CCN(CC5)C6=CC=CC=N6,"InChI=1S/C26H31N5OS/c1-29-16-17(26(32)31-12-10-30(11-13-31)23-8-3-4-9-27-23)14-19-18-6-5-7-21-24(18)20(15-22(19)29)25(28-21)33-2/h3-9,17,19,22,28H,10-16H2,1-2H3/t17-,19-,22-/m1/s1",3.5,1.0,5.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030399,P30680,FABFUAOVAJIURP-PRVBGKCFSA-N,Kd,5495.41,nM,ChEMBL,CHEMBL2978,CHEMBL250521,17512199,CHEMBL250521,44441876.0,C30H35N3O2,469.629,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(4-naphthalen-1-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=CC=CC=C65,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=CC6=CC=CC=C65,"InChI=1S/C30H35N3O2/c1-31-20-24(17-23-18-26-22(19-28(23)31)9-6-12-29(26)35-2)30(34)33-15-13-32(14-16-33)27-11-5-8-21-7-3-4-10-25(21)27/h3-12,23-24,28H,13-20H2,1-2H3/t23-,24-,28-/m1/s1",5.0,0.0,4.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030443,P30680,GZFMZJDVLOZLLL-WIRVKHDMSA-N,Kd,12589.25,nM,ChEMBL,CHEMBL2978,CHEMBL252232,18162395,CHEMBL252232,44447078.0,C26H27BrN6O2,535.446,"[(6aS,9S,10aS)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-[4-(2,1,3-benzoxadiazol-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,CN1C[C@H](C[C@@H]2[C@@H]1CC3=C(NC4=CC=CC2=C34)Br)C(=O)N5CCN(CC5)C6=CC7=NON=C7C=C6,"InChI=1S/C26H27BrN6O2/c1-31-14-15(11-18-17-3-2-4-21-24(17)19(13-23(18)31)25(27)28-21)26(34)33-9-7-32(8-10-33)16-5-6-20-22(12-16)30-35-29-20/h2-6,12,15,18,23,28H,7-11,13-14H2,1H3/t15-,18-,23-/m0/s1",3.7,1.0,6.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030450,P30680,MQBKGCCJZRCLOT-FKCDAAJZSA-N,Kd,4786.3,nM,ChEMBL,CHEMBL2978,CHEMBL399464,17507221,CHEMBL399464,44441670.0,C31H34N6O2S,554.713,"[(3R,4aR,10aR)-1-methyl-6-phenylmethoxy-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-[4-([1,2,5]thiadiazolo[3,4-b]pyridin-5-yl)piperazin-1-yl]methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OCC4=CC=CC=C4)C(=O)N5CCN(CC5)C6=NC7=NSN=C7C=C6,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OCC4=CC=CC=C4)C(=O)N5CCN(CC5)C6=NC7=NSN=C7C=C6,"InChI=1S/C31H34N6O2S/c1-35-19-24(31(38)37-14-12-36(13-15-37)29-11-10-26-30(32-29)34-40-33-26)16-23-17-25-22(18-27(23)35)8-5-9-28(25)39-20-21-6-3-2-4-7-21/h2-11,23-24,27H,12-20H2,1H3/t23-,24-,27-/m1/s1",4.7,0.0,8.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030518,P30680,IJWFRTSKNOENFW-MPCDZSKCSA-N,Kd,6165.95,nM,ChEMBL,CHEMBL2978,CHEMBL251300,17512199,CHEMBL251300,44441930.0,C27H31N3O2,429.564,"[(3R,4aR,10aR)-6-methoxy-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)methanone",CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCC5=C(C4)NC6=CC=CC=C56,CN1C[C@@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCC5=C(C4)NC6=CC=CC=C56,"InChI=1S/C27H31N3O2/c1-29-15-19(12-18-13-22-17(14-25(18)29)6-5-9-26(22)32-2)27(31)30-11-10-21-20-7-3-4-8-23(20)28-24(21)16-30/h3-9,18-19,25,28H,10-16H2,1-2H3/t18-,19-,25-/m1/s1",3.8,1.0,3.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030552,P30680,AGOCNFSXCAGJEC-BHDDXSALSA-N,Kd,32359.37,nM,ChEMBL,CHEMBL2978,CHEMBL251335,17507221,CHEMBL251335,44441660.0,C24H30N4O,390.531,"[(3R,4aR,10aR)-1-methyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-3-yl]-(4-pyridin-2-ylpiperazin-1-yl)methanone",CN1CC(CC2C1CC3=CC=CC=C3C2)C(=O)N4CCN(CC4)C5=CC=CC=N5,CN1C[C@@H](C[C@H]2[C@H]1CC3=CC=CC=C3C2)C(=O)N4CCN(CC4)C5=CC=CC=N5,"InChI=1S/C24H30N4O/c1-26-17-21(15-20-14-18-6-2-3-7-19(18)16-22(20)26)24(29)28-12-10-27(11-13-28)23-8-4-5-9-25-23/h2-9,20-22H,10-17H2,1H3/t20-,21+,22+/m0/s1",3.0,0.0,4.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1030569,P30680,HYSQHKYRRHCWCP-UHFFFAOYSA-N,Kd,5128.61,nM,ChEMBL,CHEMBL2978,CHEMBL517921,19208473,CHEMBL517921,44564703.0,C31H34N4O3,510.638,"3-[methyl-[2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)ethyl]amino]-1-[4-(4-nitrophenyl)piperazin-1-yl]propan-1-one",CN(CCC1C2=CC=CC=C2C=CC3=CC=CC=C13)CCC(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],CN(CCC1C2=CC=CC=C2C=CC3=CC=CC=C13)CCC(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-],"InChI=1S/C31H34N4O3/c1-32(18-16-30-28-8-4-2-6-24(28)10-11-25-7-3-5-9-29(25)30)19-17-31(36)34-22-20-33(21-23-34)26-12-14-27(15-13-26)35(37)38/h2-15,30H,16-23H2,1H3",5.4,0.0,5.0,Somatostatin receptor type 2,Sstr2,Rattus norvegicus (Rat),MELTSEQFNGSQVWIPSPFDLNGSLGPSNGSNQTEPYYDMTSNAVLTFIYFVVCVVGLCGNTLVIYVILRYAKMKTITNIYILNLAIADELFMLGLPFLAMQVALVHWPFGKAICRVVMTVDGINQFTSIFCLTVMSIDRYLAVVHPIKSAKWRRPRTAKMINVAVWGVSLLVILPIMIYAGLRSNQWGRSSCTINWPGESGAWYTGFIIYAFILGFLVPLTIICLCYLFIIIKVKSSGIRVGSSKRKKSEKKVTRMVSIVVAVFIFCWLPFYIFNVSSVSVAISPTPALKGMFDFVVILTYANSCANPILYAFLSDNFKKSFQNVLCLVKVSGAEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI
1031310,P25023,ITWVUFJONPNTGF-RFIHDBAVSA-N,Kd,22.39,nM,ChEMBL,CHEMBL2501,CHEMBL2372278,8691478,CHEMBL2372278,73353240.0,C52H76N14O12S,1121.326,"(2S)-2-[[2-[cyclohexyl-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2R,4S)-1-[(2R)-1-[5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoic acid",C1CCC(CC1)N(CC(=O)NC(CCCN=C(N)N)C(=O)O)C(=O)C2CC3=CC=CC=C3CN2C(=O)C(CO)NC(=O)C(CC4=CC=CS4)NC(=O)CNC(=O)C5CC(CN5C(=O)C6CCCN6C(=O)CCCCN=C(N)N)O,C1CCC(CC1)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(=O)[C@H]2CC3=CC=CC=C3CN2C(=O)[C@H](CO)NC(=O)[C@H](CC4=CC=CS4)NC(=O)CNC(=O)[C@H]5C[C@@H](CN5C(=O)[C@H]6CCCN6C(=O)CCCCN=C(N)N)O,"InChI=1S/C52H76N14O12S/c53-51(54)57-19-7-6-18-44(71)63-21-9-17-39(63)48(75)66-28-34(68)24-40(66)46(73)59-26-42(69)61-37(25-35-15-10-22-79-35)45(72)62-38(30-67)47(74)65-27-32-12-5-4-11-31(32)23-41(65)49(76)64(33-13-2-1-3-14-33)29-43(70)60-36(50(77)78)16-8-20-58-52(55)56/h4-5,10-12,15,22,33-34,36-41,67-68H,1-3,6-9,13-14,16-21,23-30H2,(H,59,73)(H,60,70)(H,61,69)(H,62,72)(H,77,78)(H4,53,54,57)(H4,55,56,58)/t34-,36-,37-,38-,39+,40+,41+/m0/s1",-1.9,11.0,15.0,B2 bradykinin receptor,Bdkrb2,Rattus norvegicus (Rat),MDTRSSLCPKTQAVVAVFWGPGCHLSTCIEMFNITTQALGSAHNGTFSEVNCPDTEWWSWLNAIQAPFLWVLFLLAALENIFVLSVFCLHKTNCTVAEIYLGNLAAADLILACGLPFWAITIANNFDWLFGEVLCRVVNTMIYMNLYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLVIWSCTLLLSSPMLVFRTMKDYREEGHNVTACVIVYPSRSWEVFTNMLLNLVGFLLPLSIITFCTVRIMQVLRNNEMKKFKEVQTEKKATVLVLAVLGLFVLCWFPFQISTFLDTLLRLGVLSGCWNERAVDIVTQISSYVAYSNSCLNPLVYVIVGKRFRKKSREVYQAICRKGGCMGESVQMENSMGTLRTSISVDRQIHKLQDWAGNKQ
1031372,P70597,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,25.1188643150958 - 50.1187233627272,nM,IUPHAR,340,1916,"8940129,9537820",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP1 subtype,Ptger1,Rattus norvegicus (Rat),MSPYGLNLSLVDEATTCVTPRVPNTSVVLPTGGNGTSPALPIFSMTLGAVSNVLALALLAQVAGRLRRRRSTATFLLFVASLLAIDLAGHVIPGALVLRLYTAGRAPAGGACHFLGGCMVFFGLCPLLLGCGMAVERCVGVTQPLIHAARVSVARARLALALLAAMALAVALLPLVHVGHYELQYPGTWCFISLGPPGGWRQALLAGLFAGLGLAALLAALVCNTLSGLALLRARWRRRRSRRFRENAGPDDRRRWGSRGLRLASASSASSITSTTAALRSSRGGGSARRVHAHDVEMVGQLVGIMVVSCICWSPLLVLVVLAIGGWNSNSLQRPLFLAVRLASWNQILDPWVYILLRQAMLRQLLRLLPLRVSAKGGPTELSLTKSAWEASSLRSSRHSGFSHL
1031458,P34980,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,3.9 - 15,nM,IUPHAR,342,1883,"8076679,15937517",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,Ptger3,Rattus norvegicus (Rat),MAGVWAPEHSVEAHSNQSSAADGCGSVSVAFPITMMVTGFVGNALAMLLVVRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTSPVVILVYLSQRRWEQLDPSGRLCTFFGLTMTVFGLSSLLVASAMAVERALAIRAPHWYASHMKTRATPVLLGVWLSVLAFALLPVLGVGRYSVQWPGTWCFISTGPAGNETDSAREPGSVAFASAFACLGLLALVVTFACNLATIKALVSRCRAKAAASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQMSVEQCKTQMGKEKECNSFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRDHTNYASSSTSLPCPGSSVLMWSDQLER
1031459,P34980,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,0.8 - 5,nM,IUPHAR,342,1883,"9537820,15937517,18632791",Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,Ptger3,Rattus norvegicus (Rat),MAGVWAPEHSVEAHSNQSSAADGCGSVSVAFPITMMVTGFVGNALAMLLVVRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTSPVVILVYLSQRRWEQLDPSGRLCTFFGLTMTVFGLSSLLVASAMAVERALAIRAPHWYASHMKTRATPVLLGVWLSVLAFALLPVLGVGRYSVQWPGTWCFISTGPAGNETDSAREPGSVAFASAFACLGLLALVVTFACNLATIKALVSRCRAKAAASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQMSVEQCKTQMGKEKECNSFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRDHTNYASSSTSLPCPGSSVLMWSDQLER
1031460,P34980,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,0.794328234724282,nM,IUPHAR,342,1916,9537820,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,Ptger3,Rattus norvegicus (Rat),MAGVWAPEHSVEAHSNQSSAADGCGSVSVAFPITMMVTGFVGNALAMLLVVRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTSPVVILVYLSQRRWEQLDPSGRLCTFFGLTMTVFGLSSLLVASAMAVERALAIRAPHWYASHMKTRATPVLLGVWLSVLAFALLPVLGVGRYSVQWPGTWCFISTGPAGNETDSAREPGSVAFASAFACLGLLALVVTFACNLATIKALVSRCRAKAAASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQMSVEQCKTQMGKEKECNSFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRDHTNYASSSTSLPCPGSSVLMWSDQLER
1031462,P34980,XEYBRNLFEZDVAW-ARSRFYASSA-N,Kd,1.1,nM,IUPHAR,342,1883,18632791,Prostaglandin E2,5280360.0,C20H32O5,352.471,"(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid",CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",2.8,3.0,5.0,Prostaglandin E2 receptor EP3 subtype,Ptger3,Rattus norvegicus (Rat),MAGVWAPEHSVEAHSNQSSAADGCGSVSVAFPITMMVTGFVGNALAMLLVVRSYRRRESKRKKSFLLCIGWLALTDLVGQLLTSPVVILVYLSQRRWEQLDPSGRLCTFFGLTMTVFGLSSLLVASAMAVERALAIRAPHWYASHMKTRATPVLLGVWLSVLAFALLPVLGVGRYSVQWPGTWCFISTGPAGNETDSAREPGSVAFASAFACLGLLALVVTFACNLATIKALVSRCRAKAAASQSSAQWGRITTETAIQLMGIMCVLSVCWSPLLIMMLKMIFNQMSVEQCKTQMGKEKECNSFLIAVRLASLNQILDPWVYLLLRKILLRKFCQIRDHTNYASSSTSLPCPGSSVLMWSDQLER
1033890,Q64077,RBAMYRNPYOAKGB-JBBXVCRQSA-N,Kd,50.12,nM,ChEMBL,CHEMBL2647,CHEMBL66441,12127519,CHEMBL66441,44307757.0,C35H43Cl4N5O5,755.559,"3,5-dichloro-N-[(2Z,3R)-3-(3,4-dichlorophenyl)-5-[4-[3-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]-2-oxopiperidin-1-yl]piperidin-1-yl]-2-methoxyiminopentyl]-N-methylbenzamide",CN(CC(=NOC)C(CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N3CC(C3)O)C4=CC(=C(C=C4)Cl)Cl)C(=O)C5=CC(=CC(=C5)Cl)Cl,CN(C/C(=N\OC)/[C@H](CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N3CC(C3)O)C4=CC(=C(C=C4)Cl)Cl)C(=O)C5=CC(=CC(=C5)Cl)Cl,"InChI=1S/C35H43Cl4N5O5/c1-41(34(47)24-14-25(36)18-26(37)15-24)21-32(40-49-2)29(22-5-6-30(38)31(39)16-22)9-13-42-11-7-27(8-12-42)44-10-3-4-23(35(44)48)17-33(46)43-19-28(45)20-43/h5-6,14-16,18,23,27-29,45H,3-4,7-13,17,19-21H2,1-2H3/b40-32+/t23?,29-/m1/s1",5.3,1.0,7.0,Substance-K receptor,TACR2,Cavia porcellus (Guinea pig),MGACVIVTNTNISSGLESNTTGITAFSMPTWQLALWATAYLALVLVAVTGNATVTWIILAHQRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAIDRYMAIVHPFQPRLSAPSTKAVIGGIWLVALALAFPQCFYSTITEDEGATKCVVAWPEDSRDKSLLLYHLVVIVLIYLLPLTVMFVAYSIIGLTLWRRAVPRHQAHGANLRHLQAKKKFVKTMVLVVVTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNRRFRSGFRLAFRCCPWVTPTEEDKLELTHTPSFSLRVNRCHTKEILFMAGDTVPSEATNGQAGGPQDRESVELSSLPGCRAGPSILAKASS
1033970,Q64077,AZJXZOMJEDHZHJ-JVCQONLDSA-N,Kd,50.12,nM,ChEMBL,CHEMBL2647,CHEMBL66635,12127519,CHEMBL66635,44307758.0,C32H39Cl4N5O4,699.495,"N-[(2Z,3S)-5-[4-[3-(2-amino-2-oxoethyl)-2-oxopiperidin-1-yl]piperidin-1-yl]-3-(3,4-dichlorophenyl)-2-methoxyiminopentyl]-3,5-dichloro-N-methylbenzamide",CN(CC(=NOC)C(CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC(=CC(=C4)Cl)Cl,CN(C/C(=N\OC)/[C@@H](CCN1CCC(CC1)N2CCCC(C2=O)CC(=O)N)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC(=CC(=C4)Cl)Cl,"InChI=1S/C32H39Cl4N5O4/c1-39(31(43)22-14-23(33)18-24(34)15-22)19-29(38-45-2)26(20-5-6-27(35)28(36)16-20)9-13-40-11-7-25(8-12-40)41-10-3-4-21(32(41)44)17-30(37)42/h5-6,14-16,18,21,25-26H,3-4,7-13,17,19H2,1-2H3,(H2,37,42)/b38-29+/t21?,26-/m0/s1",5.6,1.0,6.0,Substance-K receptor,TACR2,Cavia porcellus (Guinea pig),MGACVIVTNTNISSGLESNTTGITAFSMPTWQLALWATAYLALVLVAVTGNATVTWIILAHQRMRTVTNYFIVNLALADLCMAAFNAAFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAIDRYMAIVHPFQPRLSAPSTKAVIGGIWLVALALAFPQCFYSTITEDEGATKCVVAWPEDSRDKSLLLYHLVVIVLIYLLPLTVMFVAYSIIGLTLWRRAVPRHQAHGANLRHLQAKKKFVKTMVLVVVTFAICWLPYHLYFILGSFQEDIYCHKFIQQVYLALFWLAMSSTMYNPIIYCCLNRRFRSGFRLAFRCCPWVTPTEEDKLELTHTPSFSLRVNRCHTKEILFMAGDTVPSEATNGQAGGPQDRESVELSSLPGCRAGPSILAKASS
1036608,P30082,BUTKKOZVNAJNLB-AGEBCJOZSA-N,Kd,562.34,nM,ChEMBL,CHEMBL4720,CHEMBL409611,9258362,CID 44319559,44319559.0,C143H214N42O47S,3305.592,"(3R)-3-[[(2R)-5-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R,3S)-2-[[(2R,3S)-2-[[2-[[(2R)-5-amino-2-[[(2R)-2-[[(2R)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2R)-1-[[(2R)-1-[[(2R)-5-amino-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-4-amino-1-[[(2R,3S)-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxo-4-sulfanylbutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid",CC(C)CC(C(=O)NC(CCS)C(=O)NC(CC(=O)N)C(=O)NC(C=O)C(C)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N,C[C@@H]([C@H](C=O)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@@H](CCS)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H](CCC(=O)N)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CC3=CC=CC=C3)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CCC(=O)N)NC(=O)[C@@H](C)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC4=CC=C(C=C4)O)NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC5=CC=C(C=C5)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@@H]([C@H](C)O)NC(=O)[C@@H]([C@H](C)O)NC(=O)CNC(=O)[C@@H](CCC(=O)N)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC6=CNC=N6)N)O,"InChI=1S/C143H214N42O47S/c1-66(2)46-90(125(216)166-89(41-45-233)124(215)174-96(53-108(149)199)130(221)178-100(60-186)70(8)191)169-129(220)95(51-76-57-157-82-23-15-14-22-80(76)82)173-123(214)88(37-40-107(148)198)167-139(230)113(68(5)6)184-134(225)94(48-73-20-12-11-13-21-73)172-131(222)97(54-110(201)202)175-122(213)87(36-39-106(147)197)161-116(207)69(7)160-119(210)84(25-18-43-155-142(150)151)162-120(211)85(26-19-44-156-143(152)153)164-137(228)103(63-189)181-133(224)99(56-112(205)206)176-126(217)91(47-67(3)4)168-127(218)92(49-74-27-31-78(194)32-28-74)170-121(212)83(24-16-17-42-144)163-136(227)102(62-188)180-128(219)93(50-75-29-33-79(195)34-30-75)171-132(223)98(55-111(203)204)177-138(229)104(64-190)182-140(231)115(72(10)193)185-141(232)114(71(9)192)183-109(200)59-158-118(209)86(35-38-105(146)196)165-135(226)101(61-187)179-117(208)81(145)52-77-58-154-65-159-77/h11-15,20-23,27-34,57-58,60,65-72,81,83-104,113-115,157,187-195,233H,16-19,24-26,35-56,59,61-64,144-145H2,1-10H3,(H2,146,196)(H2,147,197)(H2,148,198)(H2,149,199)(H,154,159)(H,158,209)(H,160,210)(H,161,207)(H,162,211)(H,163,227)(H,164,228)(H,165,226)(H,166,216)(H,167,230)(H,168,218)(H,169,220)(H,170,212)(H,171,223)(H,172,222)(H,173,214)(H,174,215)(H,175,213)(H,176,217)(H,177,229)(H,178,221)(H,179,208)(H,180,219)(H,181,224)(H,182,231)(H,183,200)(H,184,225)(H,185,232)(H,201,202)(H,203,204)(H,205,206)(H4,150,151,155)(H4,152,153,156)/t69-,70+,71+,72+,81-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100+,101-,102-,103-,104-,113-,114-,115-/m1/s1",-19.5,52.0,53.0,Glucagon receptor,Gcgr,Rattus norvegicus (Rat),MLLTQLHCPYLLLLLVVLSCLPKAPSAQVMDFLFEKWKLYSDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPPNTTANISCPWYLPWYHKVQHRLVFKRCGPDGQWVRGPRGQSWRDASQCQMDDDEIEVQKGVAKMYSSYQVMYTVGYSLSLGALLLALVILLGLRKLHCTRNYIHGNLFASFVLKAGSVLVIDWLLKTRYSQKIGDDLSVSVWLSDGAVAGCRVATVIMQYGIIANYCWLLVEGVYLYSLLSITTFSEKSFFSLYLCIGWGSPLLFVIPWVVVKCLFENVQCWTSNDNMGFWWILRIPVLLAILINFFIFVRIIHLLVAKLRAHQMHYADYKFRLARSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSTKLFFDLFFSSFQGLLVAVLYCFLNKEVQAELLRRWRRWQEGKALQEERMASSHGSHMAPAGTCHGDPCEKLQLMSAGSSSGTGCEPSAKTSLASSLPRLADSPT
1036628,P30082,ZRUCDQDLYNILGL-RURLHBFASA-N,Kd,6.31,nM,ChEMBL,CHEMBL4720,CHEMBL441209,"Bioorg. Med. Chem. Lett., (1995) 5:16:1849",BDBM50284992,91934821.0,C130H203N39O44S,3048.343,"(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-[[(2S)-2-[[(2S,3R)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoic acid",CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)N,C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)O,"InChI=1S/C130H203N39O44S/c1-59(2)45-81(115(200)153-80(40-44-214-11)114(199)160-86(50-95(136)181)122(207)168-101(63(8)174)104(137)189)156-118(203)85(49-68-53-144-72-24-16-15-23-70(68)72)159-112(197)78(34-38-94(135)180)154-126(211)100(61(5)6)167-121(206)84(47-66-21-13-12-14-22-66)158-119(204)87(51-98(185)186)161-111(196)77(33-37-93(134)179)147-105(190)62(7)146-108(193)74(26-19-42-142-129(138)139)149-109(194)75(27-20-43-143-130(140)141)151-124(209)90(57-172)164-120(205)88(52-99(187)188)162-116(201)82(46-60(3)4)155-110(195)73(25-17-18-41-131)150-123(208)89(56-171)163-117(202)83(48-67-28-30-69(177)31-29-67)157-113(198)79(35-39-97(183)184)152-125(210)91(58-173)165-127(212)103(65(10)176)169-128(213)102(64(9)175)166-96(182)54-145-107(192)76(32-36-92(133)178)148-106(191)71(132)55-170/h12-16,21-24,28-31,53,59-65,71,73-91,100-103,144,170-177H,17-20,25-27,32-52,54-58,131-132H2,1-11H3,(H2,133,178)(H2,134,179)(H2,135,180)(H2,136,181)(H2,137,189)(H,145,192)(H,146,193)(H,147,190)(H,148,191)(H,149,194)(H,150,208)(H,151,209)(H,152,210)(H,153,200)(H,154,211)(H,155,195)(H,156,203)(H,157,198)(H,158,204)(H,159,197)(H,160,199)(H,161,196)(H,162,201)(H,163,202)(H,164,205)(H,165,212)(H,166,182)(H,167,206)(H,168,207)(H,169,213)(H,183,184)(H,185,186)(H,187,188)(H4,138,139,142)(H4,140,141,143)/t62-,63+,64+,65+,71-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,100-,101-,102-,103-/m0/s1",-19.1,50.0,49.0,Glucagon receptor,Gcgr,Rattus norvegicus (Rat),MLLTQLHCPYLLLLLVVLSCLPKAPSAQVMDFLFEKWKLYSDQCHHNLSLLPPPTELVCNRTFDKYSCWPDTPPNTTANISCPWYLPWYHKVQHRLVFKRCGPDGQWVRGPRGQSWRDASQCQMDDDEIEVQKGVAKMYSSYQVMYTVGYSLSLGALLLALVILLGLRKLHCTRNYIHGNLFASFVLKAGSVLVIDWLLKTRYSQKIGDDLSVSVWLSDGAVAGCRVATVIMQYGIIANYCWLLVEGVYLYSLLSITTFSEKSFFSLYLCIGWGSPLLFVIPWVVVKCLFENVQCWTSNDNMGFWWILRIPVLLAILINFFIFVRIIHLLVAKLRAHQMHYADYKFRLARSTLTLIPLLGVHEVVFAFVTDEHAQGTLRSTKLFFDLFFSSFQGLLVAVLYCFLNKEVQAELLRRWRRWQEGKALQEERMASSHGSHMAPAGTCHGDPCEKLQLMSAGSSSGTGCEPSAKTSLASSLPRLADSPT
1040389,P97583,HYDMCZYUJWEDCS-XOELGGNHSA-N,Kd,100,nM,ChEMBL,CHEMBL4613,CHEMBL264517,9986712,CHEMBL264517,44354176.0,C46H76N12O8,925.19,"(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[12-[[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]dodecanoylamino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid",C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)CCCCCCCCCCCNC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)O,C1CC[C@H]2[C@@H](C1)C[C@H](N2C(=O)[C@H]3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)CCCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)C(=O)O,"InChI=1S/C46H76N12O8/c47-33(19-14-24-53-45(48)49)40(61)56-34(20-15-25-54-46(50)51)41(62)52-23-13-7-5-3-1-2-4-6-8-22-39(60)55-35(29-59)42(63)57-28-32-18-10-9-16-30(32)26-37(57)43(64)58-36-21-12-11-17-31(36)27-38(58)44(65)66/h9-10,16,18,31,33-38,59H,1-8,11-15,17,19-29,47H2,(H,52,62)(H,55,60)(H,56,61)(H,65,66)(H4,48,49,53)(H4,50,51,54)/t31-,33+,34-,35-,36-,37+,38-/m0/s1",-0.9,10.0,11.0,B1 bradykinin receptor,Bdkrb1,Rattus norvegicus (Rat),MASEVLLELQPSNRSLQAPANITSCESALEDWDLLYRVLPGFVITICFFGLLGNLLVLSFFLLPWRQWWWQQRQRQQRLTIAEIYLANLAASDLVFVLGLPFWAENIGNRFNWPFGTDLCRVVSGVIKANLFVSIFLVVAISQDRYRLLVYPMTSWGYRRRRQAQATCLLIWVAGGLLSIPTFLLRSVKVVPDLNVSACILLFPHEAWHFARMVELNVLGFLLPVTAIIFFNYHILASLRGQKEASRTRCGGPKGSKTTGLILTLVASFLVCWCPYHFFAFLDFLVQVRVIQDCSWKEITDLGLQLANFFAFVNSCLNPLIYVFAGRLLKTRVLGTL
1041279,P51144,DWPNGIXRJQQAFI-LTWKBGODSA-N,Kd,15.85,nM,ChEMBL,CHEMBL2304405,CHEMBL421062,7932590,CHEMBL421062,44347003.0,C40H56N8O6,744.938,"3-[(2R,5S,8R,11S,14R)-14-benzyl-11-(1H-indol-3-ylmethyl)-2,5-bis(2-methylpropyl)-6,9,12,15,19-pentaoxo-1,4,7,10,13,16-hexazacyclononadec-8-yl]propanamide",CC(C)CC1CNC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CC(C)C,CC(C)C[C@@H]1CN[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CC(C)C,"InChI=1S/C40H56N8O6/c1-24(2)18-28-23-44-32(19-25(3)4)39(53)46-31(14-15-35(41)49)38(52)48-34(21-27-22-43-30-13-9-8-12-29(27)30)40(54)47-33(20-26-10-6-5-7-11-26)37(51)42-17-16-36(50)45-28/h5-13,22,24-25,28,31-34,43-44H,14-21,23H2,1-4H3,(H2,41,49)(H,42,51)(H,45,50)(H,46,53)(H,47,54)(H,48,52)/t28-,31-,32+,33-,34+/m1/s1",3.0,8.0,7.0,Substance-K receptor,TACR2,Mesocricetus auratus (Golden hamster),MGGRAIVTDTNIFSGLESNTTGVTAFSMPAWQLALWATAYLGLVLVAVTGNATVIWIILAHERMRTVTNYFIINLALADLCMAAFNATFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPITKATIAGIWLVALALASPQCFYSTITVDQGATKCVVAWPNDNGGKMLLLYHLVVFVLVYFLPLVVMFVAYSVIGLTLWKRAVPRHQAHGANLRHLHAKKKFVKAMVLVVLTFAICWLPYHLYFILGSFQKDIYYRKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDRLELTRTPSLSRRVNRCHTKETLFMTADMTHSEATNGQVGSPQDVEPAAP
1041379,P51144,LYIZVKRYLGRVLP-ZIBKNMLNSA-N,Kd,12.88,nM,ChEMBL,CHEMBL2304405,CHEMBL121571,7932590,CHEMBL121571,44347083.0,C39H54N8O6S,762.971,"3-[(2R,5S,8R,11S,14R)-14-benzyl-11-(1H-indol-3-ylmethyl)-2-(2-methylpropyl)-5-(2-methylsulfanylethyl)-6,9,12,15,19-pentaoxo-1,4,7,10,13,16-hexazacyclononadec-8-yl]propanamide",CC(C)CC1CNC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CCSC,CC(C)C[C@@H]1CN[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCC(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCC(=O)N)CCSC,"InChI=1S/C39H54N8O6S/c1-24(2)19-27-23-43-30(16-18-54-3)37(51)45-31(13-14-34(40)48)38(52)47-33(21-26-22-42-29-12-8-7-11-28(26)29)39(53)46-32(20-25-9-5-4-6-10-25)36(50)41-17-15-35(49)44-27/h4-12,22,24,27,30-33,42-43H,13-21,23H2,1-3H3,(H2,40,48)(H,41,50)(H,44,49)(H,45,51)(H,46,53)(H,47,52)/t27-,30+,31-,32-,33+/m1/s1",2.3,8.0,8.0,Substance-K receptor,TACR2,Mesocricetus auratus (Golden hamster),MGGRAIVTDTNIFSGLESNTTGVTAFSMPAWQLALWATAYLGLVLVAVTGNATVIWIILAHERMRTVTNYFIINLALADLCMAAFNATFNFVYASHNIWYFGRAFCYFQNLFPITAMFVSIYSMTAIAADRYMAIVHPFQPRLSAPITKATIAGIWLVALALASPQCFYSTITVDQGATKCVVAWPNDNGGKMLLLYHLVVFVLVYFLPLVVMFVAYSVIGLTLWKRAVPRHQAHGANLRHLHAKKKFVKAMVLVVLTFAICWLPYHLYFILGSFQKDIYYRKFIQQVYLALFWLAMSSTMYNPIIYCCLNHRFRSGFRLAFRCCPWVTPTEEDRLELTRTPSLSRRVNRCHTKETLFMTADMTHSEATNGQVGSPQDVEPAAP
1044441,P16235,LHDAVEHXXAYDKT-YFSHTKBMSA-N,Kd,0.5623,nM,ChEMBL,CHEMBL2456,CHEMBL216617,2552116,CHEMBL216617,44314940.0,C57H72N10O9,1041.264,1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-3-hydroxy-2-(3-naphthalen-1-ylpropanoylamino)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-4-methylpentanoyl]amino]pentanoyl]-N-ethylpyrrolidine-2-carboxamide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)CCC5=CC=CC6=CC=CC=C65,CCNC(=O)C1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)CCC5=CC=CC6=CC=CC=C65,"InChI=1S/C57H72N10O9/c1-4-60-55(75)49-19-11-29-67(49)56(76)44(18-10-28-61-57(58)59)63-51(71)45(30-35(2)3)64-53(73)47(33-37-20-23-38-12-5-6-14-41(38)31-37)65-52(72)46(32-36-21-25-42(69)26-22-36)66-54(74)48(34-68)62-50(70)27-24-40-16-9-15-39-13-7-8-17-43(39)40/h5-9,12-17,20-23,25-26,31,35,44-49,68-69H,4,10-11,18-19,24,27-30,32-34H2,1-3H3,(H,60,75)(H,62,70)(H,63,71)(H,64,73)(H,65,72)(H,66,74)(H4,58,59,61)/t44-,45-,46-,47+,48-,49?/m0/s1",5.0,10.0,10.0,Lutropin-choriogonadotropic hormone receptor,Lhcgr,Rattus norvegicus (Rat),MGRRVPALRQLLVLAVLLLKPSQLQSRELSGSRCPEPCDCAPDGALRCPGPRAGLARLSLTYLPVKVIPSQAFRGLNEVVKIEISQSDSLERIEANAFDNLLNLSELLIQNTKNLLYIEPGAFTNLPRLKYLSICNTGIRTLPDVTKISSSEFNFILEICDNLHITTIPGNAFQGMNNESVTLKLYGNGFEEVQSHAFNGTTLISLELKENIYLEKMHSGAFQGATGPSILDISSTKLQALPSHGLESIQTLIALSSYSLKTLPSKEKFTSLLVATLTYPSHCCAFRNLPKKEQNFSFSIFENFSKQCESTVRKADNETLYSAIFEENELSGWDYDYGFCSPKTLQCAPEPDAFNPCEDIMGYAFLRVLIWLINILAIFGNLTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDSQTKGQYYNHAIDWQTGSGCGAAGFFTVFASELSVYTLTVITLERWHTITYAVQLDQKLRLRHAIPIMLGGWLFSTLIATMPLVGISNYMKVSICLPMDVESTLSQVYILSILILNVVAFVVICACYIRIYFAVQNPELTAPNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLITVTNSKILLVLFYPVNSCANPFLYAIFTKAFQRDFLLLLSRFGCCKRRAELYRRKEFSAYTSNCKNGFPGASKPSQATLKLSTVHCQQPIPPRALTH
1044509,P16235,USFGGIRCAFZEHP-ZUQDGUHMSA-N,Kd,190.55,nM,ChEMBL,CHEMBL2456,CHEMBL2369791,2552116,CHEMBL2369791,14557592.0,C46H67N11O9,918.11,N-[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]-1H-indole-3-carboxamide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C3=CNC4=CC=CC=C43,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)C3=CNC4=CC=CC=C43,"InChI=1S/C46H67N11O9/c1-6-49-44(65)38-14-10-20-57(38)45(66)33(13-9-19-50-46(47)48)52-40(61)34(21-26(2)3)53-41(62)35(22-27(4)5)54-42(63)36(23-28-15-17-29(59)18-16-28)55-43(64)37(25-58)56-39(60)31-24-51-32-12-8-7-11-30(31)32/h7-8,11-12,15-18,24,26-27,33-38,51,58-59H,6,9-10,13-14,19-23,25H2,1-5H3,(H,49,65)(H,52,61)(H,53,62)(H,54,63)(H,55,64)(H,56,60)(H4,47,48,50)/t33-,34-,35+,36-,37-,38-/m0/s1",2.1,11.0,10.0,Lutropin-choriogonadotropic hormone receptor,Lhcgr,Rattus norvegicus (Rat),MGRRVPALRQLLVLAVLLLKPSQLQSRELSGSRCPEPCDCAPDGALRCPGPRAGLARLSLTYLPVKVIPSQAFRGLNEVVKIEISQSDSLERIEANAFDNLLNLSELLIQNTKNLLYIEPGAFTNLPRLKYLSICNTGIRTLPDVTKISSSEFNFILEICDNLHITTIPGNAFQGMNNESVTLKLYGNGFEEVQSHAFNGTTLISLELKENIYLEKMHSGAFQGATGPSILDISSTKLQALPSHGLESIQTLIALSSYSLKTLPSKEKFTSLLVATLTYPSHCCAFRNLPKKEQNFSFSIFENFSKQCESTVRKADNETLYSAIFEENELSGWDYDYGFCSPKTLQCAPEPDAFNPCEDIMGYAFLRVLIWLINILAIFGNLTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDSQTKGQYYNHAIDWQTGSGCGAAGFFTVFASELSVYTLTVITLERWHTITYAVQLDQKLRLRHAIPIMLGGWLFSTLIATMPLVGISNYMKVSICLPMDVESTLSQVYILSILILNVVAFVVICACYIRIYFAVQNPELTAPNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLITVTNSKILLVLFYPVNSCANPFLYAIFTKAFQRDFLLLLSRFGCCKRRAELYRRKEFSAYTSNCKNGFPGASKPSQATLKLSTVHCQQPIPPRALTH
1044517,P16235,DQRRYRQAOSFVHU-HRIYKSKUSA-N,Kd,79.43,nM,ChEMBL,CHEMBL2456,CHEMBL386525,2552116,CHEMBL386525,44314898.0,C62H77N11O9,1120.366,1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2R)-2-[[(2S)-3-(4-hydroxyphenyl)-2-[[(2S)-2-(3-naphthalen-1-ylpropanoylamino)-3-phenylmethoxypropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]pentanoyl]-N-ethylpyrrolidine-2-carboxamide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(COCC5=CC=CC=C5)NC(=O)CCC6=CC=CC7=CC=CC=C76,CCNC(=O)C1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](COCC5=CC=CC=C5)NC(=O)CCC6=CC=CC7=CC=CC=C76,"InChI=1S/C62H77N11O9/c1-4-65-60(80)54-24-14-32-73(54)61(81)49(23-13-31-66-62(63)64)69-56(76)50(33-39(2)3)70-58(78)52(35-44-36-67-48-22-11-10-21-47(44)48)72-57(77)51(34-40-25-28-45(74)29-26-40)71-59(79)53(38-82-37-41-15-6-5-7-16-41)68-55(75)30-27-43-19-12-18-42-17-8-9-20-46(42)43/h5-12,15-22,25-26,28-29,36,39,49-54,67,74H,4,13-14,23-24,27,30-35,37-38H2,1-3H3,(H,65,80)(H,68,75)(H,69,76)(H,70,78)(H,71,79)(H,72,77)(H4,63,64,66)/t49-,50-,51-,52+,53-,54?/m0/s1",5.9,10.0,10.0,Lutropin-choriogonadotropic hormone receptor,Lhcgr,Rattus norvegicus (Rat),MGRRVPALRQLLVLAVLLLKPSQLQSRELSGSRCPEPCDCAPDGALRCPGPRAGLARLSLTYLPVKVIPSQAFRGLNEVVKIEISQSDSLERIEANAFDNLLNLSELLIQNTKNLLYIEPGAFTNLPRLKYLSICNTGIRTLPDVTKISSSEFNFILEICDNLHITTIPGNAFQGMNNESVTLKLYGNGFEEVQSHAFNGTTLISLELKENIYLEKMHSGAFQGATGPSILDISSTKLQALPSHGLESIQTLIALSSYSLKTLPSKEKFTSLLVATLTYPSHCCAFRNLPKKEQNFSFSIFENFSKQCESTVRKADNETLYSAIFEENELSGWDYDYGFCSPKTLQCAPEPDAFNPCEDIMGYAFLRVLIWLINILAIFGNLTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDSQTKGQYYNHAIDWQTGSGCGAAGFFTVFASELSVYTLTVITLERWHTITYAVQLDQKLRLRHAIPIMLGGWLFSTLIATMPLVGISNYMKVSICLPMDVESTLSQVYILSILILNVVAFVVICACYIRIYFAVQNPELTAPNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLITVTNSKILLVLFYPVNSCANPFLYAIFTKAFQRDFLLLLSRFGCCKRRAELYRRKEFSAYTSNCKNGFPGASKPSQATLKLSTVHCQQPIPPRALTH
1044573,P16235,CMOKQRSZSSBVCR-NKSNMKHQSA-N,Kd,8.511,nM,ChEMBL,CHEMBL2456,CHEMBL413887,2552116,CHEMBL413887,44315220.0,C56H73N11O9,1044.268,1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-3-hydroxy-2-[4-(1H-indol-3-yl)butanoylamino]propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-4-methylpentanoyl]amino]pentanoyl]-N-ethylpyrrolidine-2-carboxamide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)CCCC5=CNC6=CC=CC=C65,CCNC(=O)C1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC3=CC=CC=C3C=C2)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)CCCC5=CNC6=CC=CC=C65,"InChI=1S/C56H73N11O9/c1-4-59-54(75)48-18-11-27-67(48)55(76)43(17-10-26-60-56(57)58)63-50(71)44(28-34(2)3)64-52(73)46(31-36-20-23-37-12-5-6-13-38(37)29-36)65-51(72)45(30-35-21-24-40(69)25-22-35)66-53(74)47(33-68)62-49(70)19-9-14-39-32-61-42-16-8-7-15-41(39)42/h5-8,12-13,15-16,20-25,29,32,34,43-48,61,68-69H,4,9-11,14,17-19,26-28,30-31,33H2,1-3H3,(H,59,75)(H,62,70)(H,63,71)(H,64,73)(H,65,72)(H,66,74)(H4,57,58,60)/t43-,44-,45-,46+,47-,48?/m0/s1",4.2,11.0,10.0,Lutropin-choriogonadotropic hormone receptor,Lhcgr,Rattus norvegicus (Rat),MGRRVPALRQLLVLAVLLLKPSQLQSRELSGSRCPEPCDCAPDGALRCPGPRAGLARLSLTYLPVKVIPSQAFRGLNEVVKIEISQSDSLERIEANAFDNLLNLSELLIQNTKNLLYIEPGAFTNLPRLKYLSICNTGIRTLPDVTKISSSEFNFILEICDNLHITTIPGNAFQGMNNESVTLKLYGNGFEEVQSHAFNGTTLISLELKENIYLEKMHSGAFQGATGPSILDISSTKLQALPSHGLESIQTLIALSSYSLKTLPSKEKFTSLLVATLTYPSHCCAFRNLPKKEQNFSFSIFENFSKQCESTVRKADNETLYSAIFEENELSGWDYDYGFCSPKTLQCAPEPDAFNPCEDIMGYAFLRVLIWLINILAIFGNLTVLFVLLTSRYKLTVPRFLMCNLSFADFCMGLYLLLIASVDSQTKGQYYNHAIDWQTGSGCGAAGFFTVFASELSVYTLTVITLERWHTITYAVQLDQKLRLRHAIPIMLGGWLFSTLIATMPLVGISNYMKVSICLPMDVESTLSQVYILSILILNVVAFVVICACYIRIYFAVQNPELTAPNKDTKIAKKMAILIFTDFTCMAPISFFAISAAFKVPLITVTNSKILLVLFYPVNSCANPFLYAIFTKAFQRDFLLLLSRFGCCKRRAELYRRKEFSAYTSNCKNGFPGASKPSQATLKLSTVHCQQPIPPRALTH
1045192,Q28642,UPJSDLQRNMKAFA-HYTDYXHHSA-N,Kd,851.14,nM,ChEMBL,CHEMBL3453,CHEMBL2369400,8642569,CHEMBL2369400,73354461.0,C36H48N8O6,688.83,"(2S)-2-[[(2S)-1-[(3S)-2-[(2S)-2-[(2-aminoacetyl)amino]-3-phenylpropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid",C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CC5=CC=CC=C5)NC(=O)CN)C(=O)NC(CCCN=C(N)N)C(=O)O,C1CCC2C(C1)C[C@H](N2C(=O)[C@@H]3CC4=CC=CC=C4CN3C(=O)[C@H](CC5=CC=CC=C5)NC(=O)CN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,"InChI=1S/C36H48N8O6/c37-20-31(45)41-27(17-22-9-2-1-3-10-22)33(47)43-21-25-13-5-4-11-23(25)18-30(43)34(48)44-28-15-7-6-12-24(28)19-29(44)32(46)42-26(35(49)50)14-8-16-40-36(38)39/h1-5,9-11,13,24,26-30H,6-8,12,14-21,37H2,(H,41,45)(H,42,46)(H,49,50)(H4,38,39,40)/t24?,26-,27-,28?,29-,30-/m0/s1",-1.0,6.0,8.0,B2 bradykinin receptor,BDKRB2,Oryctolagus cuniculus (Rabbit),MLNITSQVLAPALNGSVSQSSGCPNTEWSGWLNVIQAPFLWVLFVLATLENLFVLSVFCLHKSSCTVAEVYLGNLAAADLILACGLPFWAVTIANHFDWLFGEALCRVVNTMIYMNLYSSICFLMLVSIDRYLALVKTMSIGRMRRVRWAKLYSLVIWGCTLLLSSPMLVFRTMKDYRDEGYNVTACIIDYPSRSWEVFTNVLLNLVGFLLPLSVITFCTVQILQVLRNNEMQKFKEIQTERRATVLVLAVLLLFVVCWLPFQVSTFLDTLLKLGVLSSCWDEHVIDVITQVGSFMGYSNSCLNPLVYVIVGKRFRKKSREVYRAACPKAGCVLEPVQAESSMGTLRTSISVERQIHKLPEWTRSSQ
1045501,P41593,GKDKCXZPVZTKFP-UHFFFAOYSA-N,Kd,512.86,nM,ChEMBL,CHEMBL1075300,CHEMBL242784,17850061,CHEMBL242784,23626557.0,C27H32N6O,456.594,"5-cyclohexyl-1-[4-[2-(1H-imidazol-2-yl)ethylamino]phenyl]-3,8-dimethyl-1,3,4-benzotriazepin-2-one",CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,CC1=CC2=C(C=C1)C(=NN(C(=O)N2C3=CC=C(C=C3)NCCC4=NC=CN4)C)C5CCCCC5,"InChI=1S/C27H32N6O/c1-19-8-13-23-24(18-19)33(27(34)32(2)31-26(23)20-6-4-3-5-7-20)22-11-9-21(10-12-22)28-15-14-25-29-16-17-30-25/h8-13,16-18,20,28H,3-7,14-15H2,1-2H3,(H,29,30)",5.2,2.0,4.0,Parathyroid hormone/parathyroid hormone-related peptide receptor,Pth1r,Mus musculus (Mouse),MGTARIAPSLALLLCCPVLSSAYALVDADDVFTKEEQIFLLHRAQAQCDKLLKEVLHTAANIMESDKGWTPASTSGKPRKEKAPGKFYPESKENKDVPTGSRRRGRPCLPEWDNIVCWPLGAPGEVVAVPCPDYIYDFNHKGHAYRRCDRNGSWEVVPGHNRTWANYSECLKFMTNETREREVFDRLGMIYTVGYSMSLASLTVAVLILAYFRRLHCTRNYIHMHMFLSFMLRAASIFVKDAVLYSGFTLDEAERLTEEELHIIAQVPPPPAAAAVGYAGCRVAVTFFLYFLATNYYWILVEGLYLHSLIFMAFFSEKKYLWGFTIFGWGLPAVFVAVWVGVRATLANTGCWDLSSGHKKWIIQVPILASVVLNFILFINIIRVLATKLRETNAGRCDTRQQYRKLLRSTLVLVPLFGVHYTVFMALPYTEVSGTLWQIQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIRKSWSRWTLALDFKRKARSGSSSYSYGPMVSHTSVTNVGPRAGLSLPLSPRLLPATTNGHSQLPGHAKPGAPAIENETIPVTMTVPKDDGFLNGSCSGLDEEASGSARPPPLLQEEWETVM
1045658,F8VQN3,ZNHVWPKMFKADKW-LQWMCKPYSA-N,Kd,4.87,nM,IUPHAR,98,5508,21712392,12(S)-HETE,5283155.0,C20H32O3,320.473,"(5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid",CCCCCC=CCC(C=CC=CCC=CCCCC(=O)O)O,CCCCC/C=C\C[C@@H](/C=C/C=C\C/C=C\CCCC(=O)O)O,"InChI=1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1",5.2,2.0,3.0,"12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor",Gpr31,Mus musculus (Mouse),MERTNCSAASTVVETAVGTMLTLECVLGLMGNAVALWTFFYRLKVWKPYAVYLFNLVVADLLLATSLPFFAAFYLKGKTWKLGHMPCQVLLFLLAFSRGVGVAFLTTVALDRYLRVVHPRLRVNLLSLRAAWGISSLIWLLMVVLTPQNLLTCRTTQNSTECPSFYPTGGAKAIATCQEVLFFLQVLLPFGLISFCNSGLIRTLQKRLRESDKQPRIRRARVLVAIVLLLFGLCFLPSVLTRVLVHIFQEFKSCSVQQAIVRASDIAGSLTCLHSTLSPAIYCFSNPAFTHSYRKVLKSLRGRRKAAESPSDNLRDSYS
